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ABSTRACT: Tripartite efflux pumps and the related type 1 secretion systems (T1SSs) in
Gram-negative organisms are diverse in function, energization, and structural organization.
They form continuous conduits spanning both the inner and the outer membrane and are
composed of three principal componentsthe energized inner membrane transporters
(belonging to ABC, RND, and MFS families), the outer membrane factor channel-like
proteins, and linking the two, the periplasmic adaptor proteins (PAPs), also known as the
membrane fusion proteins (MFPs). In this review we summarize the recent advances in
understanding of structural biology, function, and regulation of these systems, highlighting
the previously undescribed role of PAPs in providing a common architectural scaffold across
diverse families of transporters. Despite being built from a limited number of basic structural domains, these complexes present a
staggering variety of architectures. While key insights have been derived from the RND transporter systems, a closer inspection of
the operation and structural organization of different tripartite systems reveals unexpected analogies between them, including those
formed around MFS- and ATP-driven transporters, suggesting that they operate around basic common principles. Based on that we
are proposing a new integrated model of PAP-mediated communication within the conformational cycling of tripartite systems,
which could be expanded to other types of assemblies.
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1. INTRODUCTION: THE PROBLEM OF PUMPING
ACROSS TWO MEMBRANES IN GRAM-NEGATIVE
BACTERIA
The cell envelope of Gram-negative bacteria consists of three
fundamental layers: the inner or cytoplasmic membrane, the
peptidoglycan cell wall, and the outer membrane. The two
membrane layers are separated by an aqueous cellular
compartment known as the periplasm.1 Although the double
membrane cell envelope is a sophisticated barrier that affords
Gram-negative bacteria protection from various environmental
insults, it also presents a biological challenge for transporting
molecules out of cells. This has given rise to a plethora of
transenvelope transport machinery, namely tripartite efflux
systems and the related type 1 secretion systems (T1SSs).2,3
Tripartite efflux systems and the related T1SSs consist of a
transmembrane inner-membrane transporter protein, a peri-
plasmic adaptor protein (PAP) that spans the periplasm, and
an outer membrane factor (OMF) protein that penetrates the
outer membrane. This tripartite organization allows Gram-
negative bacteria to directly transport molecules across the
outer membrane to the extracellular environment. Tripartite
efflux systems can be categorized into three superfamilies based
on the type of the inner-membrane transporter around which
they are built: with multidrug efflux pumps being formed with
the participation of transporters belonging to either the ATP-
binding cassette (ABC) superfamily, the major facilitator
superfamily (MFS), or the resistance-nodulation-division
(RND) superfamily, whereas the transporters associated with
the related T1SS belong exclusively to the ABC superfamily
(Figure 1).2,4,5 The T1SSs secrete diverse proteins, many of
which are involved in host pathogenesis and virulence.6
Tripartite efflux systems play a major role in the multidrug
resistance of Gram-negative bacteria, including ESKAPE
pathogens such as Acinetobacter baumannii, Enterobacter spp.,
Klebsiella pneumoniae, and Pseudomonas aeruginosa, which have
contributed significantly to the increasing rate of antimicrobial
resistance (AMR)-related infections.7 AMR is a major global
public health crisis that undermines not only human health,
but also animal health, food security, and development. The
severity of this problem has led the World Health Organization
to adopt the Global Action Plan on AMR that consists of five
strategic objectives to combat AMR, one of which is to
stimulate the development of new medicines.8 Therefore, to
develop new therapeutics to target tripartite efflux systems and
T1SSs, we must better understand their physiology and roles in
Gram-negative bacteria.
In the sections below, we will discuss the genes, function,
and structural organization of tripartite efflux systems and
T1SSs. This is a vast topic, which is also reflected in the
volume of this systematic review, and to facilitate the reader,
Figure 1. Representative structures of multidrug transporters and tripartite assemblies. Structures of members of the ATP-driven ATP-binding
cassette (ABC) superfamily and the proton-motive force-dependent secondary antiporters of the major facilitator superfamily (MFS), multidrug
and toxin extrusion (MATE) family, small multidrug resistance (SMR) family, and resistance nodulation-cell division (RND) superfamily are
shown. A substrate for each of the transporters is indicated (colored double triangles). The single-component transporters are independent
multidrug/H+ (or Na+) antiporters which transport the drugs from the cytoplasm to the periplasm. The tripartite RND superfamily member
MexAB-OprM and the tripartite ABC superfamily member MacAB-TolC are postulated to sequester their substrates from the periplasm (or outer
leaflet of the inner membrane) and transport them across the outer membrane. The single component multidrug efflux antiporters and the RND-
type tripartite efflux pumps act in a synergistic fashion to efflux drug substrates across both inner and outer membranes. Structures of a
proteobacterial antimicrobial compound efflux (PACE) member are elusive and therefore not included in the figure. ABC superfamily members
and the 14-transmembrane helix MFS transporters form also tripartite pumps. The ABC superfamily member HlyBD-TolC transports hemolysin
from the cytoplasm to the outside of the cell. The ABC-type tripartite MacAB-TolC complex transports macrolide antibiotics, outer membrane
glycolipids, lipopeptides, and protoporphyrinand polypeptide virulence factors such as enterotoxin II. The MFS-type tripartite EmrAB-TolC system
has been shown to transport several small molecular weight drugs. EmrE Protein Databank (PDB) entry: 3B5D; DinF-BH PDB: 4LZ9; MdfA PDB:
4ZOW; MexAB-OprM EM Data Bank (EMDB) entry: EMD-10395, PDB: 6TA6; EmrAB-TolC adapted from Yousefian et al.;9 MacAB-TolC
EMDB: EMD-3652, PDB: 5NIK; MacB EMDB: EMD-3653, PDB: 5NIL. The HlyB model (based on PCAT1 (PDB: 4RY2)) and the full assembly
of the HlyD-docked homology model are provided by V. Bavro. LPS, lipopolysaccharide.
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Table 1. List of Characterized Tripartite Systems in Gram-Negative Bacteria and Their Substrate Profilesa
Microorganism
Efflux pump
family Efflux system Substrates refs
Acinetobacter baumannii RND AdeABC AG, BL, CHL, CHX, ML, FA, FQ, TET, TGC, TMP 11, 19, 20
AdeFGH CHL, FQ, SUL, TET, TGC, TMP 21
AdeIJK BL, CHL, CHX, ERY, FA, FQ, NOV, TET, TGC, TMP, TRI 11
AbuO AG, BL, TGC 22
ArpAB AG 23
ABC MacAB-TolC ML 24
Acinetobacter Genomic DNA
Group 3
RND AdeDE CHL, FQ, TET 25, 26
AdeXYZ CHL, FQ, BL, TET 25
Achromobacter spp. RND AxyXY-OprZ AG, FQ 27
NccABC Cd2+, Co2+, Ni2+ 28
Aeromonas hydrophila RND AheABC RIF 29
Aggregatibacter
actinomycetemcomitans
ABC LtxDB-TolC LTX 30
Bacteroides f ragilis RND BmeABC3 BL, FQ 31
Borrelia burgdorferi RND BesABC ML 32
Bordetella pertussis ABC CyaBDE ACT 33
Bradyrhizobium japonicum RND BdeAB-? AG 34
Brucella suis RND BepDE-BepC ACR, AMP, DOC, EB, FQ, NOV, PMB, SDS, TET 35
BepFG-BepC DOC, NAL, SDS 35
Burkholderia cenocepacia RND CeoAB-OpcM CHL, FQ 36
BCAL2820-
BCAL2822
ATM, AG, CHL, FQ 37
Burkholderia pseudomallei RND AmrAB-OprA AG, ML 38
BpeAB-OprB AG, CHL, ML, TET 38, 39
BpeEF-OprC CHL, TET, TMP 40
Burkholderia thailandensis RND AmrAB-OprA AG, ML, TET 41
Campylobacter jejuni RND CmeABC CHL, CTX, ML, FA, FQ, TRI 42, 43
CmeDEF CTX, FQ, TRI 44
Caulobacter crescentus RND NczABC Co2+, Cd2+, Ni2+, Zn2+ 45
Cupriavidus metallidurans RND ZneCAB Zn2+ 46
Dickeya zeae RND DesABC ZMN 47




OqxAB-TolCc CHL, FQ, ML, NIT, TGC 53
Escherichia coli RND AcrAD-TolC AG, BL 54, 55
AcrEF-TolC ACR, BL, CHL, FQs, EB, ERY, R6G, TET, TGC 10, 56, 57
MdtEF-TolC BL, BAC, ML, OXN 10, 56−58
CusABC Ag+, Cu+ 59
ABC MacAB-TolC ML 60
HlyBD-TolC AH 61
YhbFGSR- EB, TET 62
TolC MJ25 63
YojI?-TolC
MFS EmrAB-TolC FQ, NOV, TRI 10, 56
EmrKY-TolC TET 64
MdtNOP ACR, PUR 56
AaeAB-? pHBA 65
Helicobacter pylori RND HefABC AG, BL, CHL, EB, ERY, FQ, NOV, TET 66
HefDEF Cd2+, Ni2+, Zn2+ 67
Klebsiella aerogenes RND EefABC CHL, BL, ERY, FQ 68
Klebsiella pneumoniae RND AcrAB BAC, BL, ML, FQ, TET, NOV 69, 70
EefABC BAC, BL, FQ, ERY, TET, NOV 70





AG, FQ, TGC 72
MFS KpnGH-TolC BL, AG, ML 73
Legionella pneumophila RND LpeAB ML 74
Moraxella catarrhalis RND AcrAB-OprM CTX, ML 75
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family Efflux system Substrates refs
Neisseria gonorrhoeae RND MtrCDE BL, BS, FQ, ML, TET 76, 77
ABC MacAB-MtrE ML 78
MFS FarAB-MtrE FA 79
Porphyromonas gingivalis RND XepCAB RIF 80
Pseudomonas aeruginosa RND MexAB-OprM AG, BL, CHL, COL, EB, FQ, ML, SDS, SUL, TET, TMP, TRI 12, 81
MexCD-OprJ BL, CHL, CHX, COL, FQ, ML, QAC, TET, TGC, TMP, TRI 81
MexEF-OprN CHL, FQ, TET, TMP, TRI 82
MexGHI-OpmD ACR, EB, FQ, TET 83
MexJK-OprM/
OpmH
ERY, TET, TRI 84
MexMN-OprM CHL 85
MexPQ-OpmE ML, FQ 85
MexVW-OprM ACR, CHL, EB, ERY, FQ, TET 86
MexXY-OprA/
OprM
AG, BL, CHL, FQ, ML, TET, TGC 81
MuxABC-OpmB ATM, ERY, FQ, NOV, TET 87
TriABC-OpmH TRI 88
Pseudomonas putida RND ArpABC BL, CHL, ERY, TET 89
MepABC BL, ERY, TET 90
ParXY/TtgC AG, FQ 91
SrpABC OS 92
TtgABC BL, CHL, ERY, OS, TET 93
TtgDEF OS 94
TtgGHI OS 95
Pseudomonas f luorescens RND EmhABC CHL 96
Pseudomonas syringae RND PseABC ACR, ERY, TET 97
Riemerella anatipestifer RND RaeABC AG, SDS 98
RaeEF-RopN AG, SDS 99
Salmonella enterica RND AcrAD-TolC ATM, BL, NOV, SDS 100
AcrEF-TolC ACR, BAC, BL, CHL, EB, FUS, FQs, NOV, R6G, SDS, TET, TRI 101
MdtABC-TolC NOV 101
MdsABC Au3+, BAC, BL, CHL, NOV 102
SilABCc Ag+ 103
ABC MacAB-TolC ML 101
MFS EmrAB-TolC NAL, NOV, TRI 101
Serratia marcescens RND SdeAB CHL, FQ, QAC 104
SdeGH FQ 105
SdePQ FQ 105
SdeXY-HasF BAC, CHL, CHX, FQ, ML, QAC, TET, TGC, TRI 106, 107
Sinorhizobium meliloti RND SmeAB-TolC ACR, CHL, ERY, NAL, RIF, SDS, TET 108
SmeCD-TolC CHL, NAL 108
SmeEF-TolC ERY, TET 108
Stenotrophomonas maltophilia RND SmeABC AG, BL, FQ 109
SmeDEF CHL, FQ, ML, TET, TRI 110
SmeGH BL, CHL, FQ, ML, TET 109, 111
SmeIJK AG, TET 109
SmeOP-TolC AG, FQ, ML, TET 112
SmeVWX CHL, FQ, TET 113
SmeYZ AG, TET 114
MFS EmrCAB CCCP, NAL 115




Vibrio cholerae RND VexAB- TolC AMP, ERY, NOV, PEN, PMB, SDS 119, 120
VexCD-TolC BS, DTG, ERY 119
VexEF- TolC BAC, DOC, EB, ERY, NOR, NOV, SDS, TET, TMP 119
VexGH DTG, NOV 121
VexIJK BS, DTG 120
MFS VceCAB CCCP, DOC, NAL 122
Chemical Reviews pubs.acs.org/CR Review
https://doi.org/10.1021/acs.chemrev.1c00055
Chem. Rev. XXXX, XXX, XXX−XXX
E
we would like to highlight the structure of this manuscript. It is
organized into four major divisions, which cover first the
biological roles of the tripartite pumps including their
contribution to antimicrobial resistance, as well as their genetic
organization and regulation (sections 2−4). The second group
of sections (5−7) deals with the molecular organization of the
individual components of the tripartite complexes, with
particular effort being put into highlighting the modularity
and similarities in the structural organization of the different
transporter groups, notably the ABC and RND families
(sections 5.7.6−5.7.7), as well as the unexpected correlations
in the organization of the PAP proteins (section 7.7) that may
be of interest to structural biologist beyond the immediate field
of efflux pumps. The third group of chapters (8−11) focuses
on the current knowledge of the mechanisms of assembly of
the respective tripartite pumps but also aims to provide a
synthesis of the data in the form of a synthetic new model of
assembly and functional cycling of the RND-based tripartite
pumps (section 8.6), which spotlights the new roles for the
PAPs highlighted by the latest research in the field. Insights
from this model allow us to underline the communality of the
assembly between the RND-, MacB-, MFS-, and T1SS-based
systems (sections 9−11). The review concludes with an
overview of the current strategies for disruption of the pump
function (section 12).
2. INVOLVEMENT OF TRIPARTITE SYSTEMS IN
ANTIBIOTIC RESISTANCE AND DRUG EFFLUX
PROFILES FOR PRINCIPAL CLASSES OF
TRANSPORTERS
Numerous tripartite efflux complexes have been characterized
and defined across Gram-negative bacteria (Table 1). The
overwhelming majority of tripartite efflux pumps belong to the
RND family, although a few pumps in the ABC and MFS
families have also been described. Tripartite efflux complexes
often recognize and export a range of physicochemically
diverse substrates, consisting of some lipophilic (quinolines,
macrolides, and glycylcyclines) as well as cationic (amino-
glycosides), anionic (β-lactams), and neutral (chlorampheni-
col) compounds. For instance, AcrAB-TolC is the predom-
inant efflux system in members of Enterobacteriaceae and has a
remarkably wide substrate profile, consisting of multiple
different classes of antibiotics (chloramphenicols, tetracyclines,
quinolones, macrolides, and β-lactams).10 Other examples
include MexAB-OprM of P. aeruginosa and AdeABC of A.
baumannii, which can also export multiple different classes of
antibiotics.11,12 Tripartite efflux pumps and their regulatory
systems have been shown to be involved in clinically relevant
antibiotic resistance. For example, overexpression of the
MtrCDE efflux pump due to mutations in mtrR have
contributed to penicillin resistance in Neisseria gonorrhoeae,
which has contributed to the inefficacy of older β-lactams in
the treatment of gonorrhoeae.13 There is now evidence that
the efficacy of azithromycin, which is a current first-line
treatment option for gonorrhoeae, is also under threat due to
overexpression of the MtrCDE pump in clinical isolates.14 In
another example, overexpression of AcrAB-TolC and MdfA in
clinical Escherichia coli UTI isolates has been correlated with
fluoroquinolone resistance,15 severely limiting treatment
options. In addition to clinically relevant antibiotics, several
tripartite efflux pumps also export commonly used biocides.
The AcrAB-TolC pump of E. coli can export benzalkonium
chloride, chlorhexidine, and triclosan, and P. aeruginosa
possesses multiple efflux pumps capable of exporting
triclosan.16 This has serious implications for infection control
in a wide range of healthcare settings by jeopardizing the
efficacy of important biocides and selecting for cross-resistance
to clinically relevant antibiotics.17 Tripartite systems also
include T1SSs, such as HlyBD-TolC from E. coli and LipBCD
from S. marcescens, which are involved in the export of
virulence factors.18
3. BIOLOGICAL FUNCTIONS OUTSIDE OF
MULTIDRUG RESISTANCE
Efflux-mediated antibiotic resistance was first discovered in the
1970s by Levy and McMurry,125 who showed active efflux of
tetracycline from bacterial cells possessing the pBR322
plasmid. Since then, efflux-mediated resistance has been
identified for nearly all classes of antibiotics. Although efflux
pumps are associated with antimicrobial resistance, they likely
existed long before the advent of modern medicine. This is
evident from the highly conserved nature of efflux pump genes
across bacterial genomes. A recent review by Teelucksingh et
al.126 found that the majority of E. coli efflux pumps are highly
conserved and make up 1% of the core genome. This indicates




family Efflux system Substrates refs
Vibrio parahaemolyticus RND VmeAB-VpoC ACR, BL, BS, EB, FQ, ML, NOV, R6G, SDS, TET, TMP 123
VmeCD-VpoC BAC, BL, BS, ML, NOV, R6G, SDS 124
VmeEF-VpoC BC, EB, NOV, R6G, SDS 124
VmeGHI-VpoC SDS 124
VmeTUV-VpoC ACR, BL, BAC, BC, CHX, EB, R6G, SDS 124
VmeYZ-VpoC BC, NOV, SDS 124
aABC, ATP-binding cassette; ACR, acriflavine; ACT, adenylate cyclase toxin; AG, aminoglycosides; AH, α-hemolysin; AMK, amikacin; AMP,
ampicillin; ATM, aztreonam; BAC, benzalkonium chloride; BL, β-lactams; BS, bile salts; CCCP, carbonyl cyanide m-chlorophenylhydrazone; CHL,
chloramphenicol; CHX, chlorhexidine; COL, colistin; CTX, cefotaxime; DOC, deoxycholate; DTG, detergents; ERY, erythromycin; EB, ethidium
bromide; FA, fatty acids; FUS, fusidic acid; FQ, fluoroquinolones; FUA, fusaric acid; LEV, levofloxacin; LTX, leukotoxin; MFS, major facilitator
superfamily; MJ25, microcin J25; ML, macrolides; NAL, nalidixic acid; NIT, nitrofurantoin; NOR, norfloxacin; NOV, novobiocin; OS, organic
solvents; OXN, oxazolidinones; PEN, penicillin; pHBA, p-hydroxybenzoic acid; PMB, polymyxin B; PUR, puromycin; QAC, quaternary
ammonium compounds; R6G, rhodamine 6G; RIF, rifampicin; RND, resistance-nodulation-division; SDS, sodium dodecyl sulfate; SUL,
sulfonamides; TET, tetracycline; TGC, tigecycline; TMP, trimethoprim; TRI, triclosan; ZMN, zeamines. bA large family of Gram-negative bacteria
that includes several important pathogenic species such as Citrobacter f reundii, Escherichia coli, Klebsiella pneumoniae, Salmonella enterica, and
Shigella f lexneri. cPumps that are encoded in plasmids.
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efflux pumps have remained relatively stable. Phylogenetic
analysis of RND-type transporters by Zwama et al.127 revealed
that AcrB from Haemophilus inf luenzae is evolutionarily ancient
compared to AcrB from Escherichia coli. Despite its evolu-
tionary age, AcrB of H. inf luenzae was shown to export the
same range of antibiotics as AcrB of E. coli. Based on their
findings, they speculated that multidrug recognition by RND-
type transporters is an ancient trait rather than an
evolutionarily acquired ability. A different phylogenetic analysis
found that the MdtB and MdtC inner membrane RND
transporters are conserved throughout Proteobacteria and that
their existence was due to a single gene duplication event
before the split of Proteobacteria into the α-, β-, and γ-classes.
This also suggests that efflux pump genes have remained
relatively stable throughout bacterial evolution.128 Similarly,
ABC transporters constitute one of the largest transporter
superfamilies. In E. coli, there are approximately 80 distinct
ABC transporters, which represent 5% of the genome.129 Many
ABC transporters are linked with multidrug resistance;
however, it remains unclear how multidrug recognition was
acquired. Studies on the resistome of ancient bacteria in
archeological samples have also identified multiple different
efflux pump genes.130 Accordingly, if efflux pumps are so
conserved and were present before the age of modern
medicine, what are their physiological roles in bacteria?
Compared to our knowledge on the role of efflux pumps in
antibiotic resistance, our understanding of the biological roles
of efflux pumps is lagging. However, studies have suggested
increasingly diverse roles for efflux pumps in bacterial
physiology.
Genes encoding tripartite efflux systems are ubiquitous
among Gram-negative bacteria, including pathogenic and
nonpathogenic species, indicating that efflux pumps are
evolutionarily ancient with fundamental physiological roles in
bacteria.131 Studies have demonstrated increasingly diverse
roles for efflux pumps in bacterial biology, including virulence,
biofilm formation, and quorum sensing (QS). The role of
efflux pumps in detoxification and pH homeostasis has been
recently reviewed by Teelucksingh et al.126 and therefore will
not be discussed here. In this section, the role of tripartite
efflux systems in virulence, QS, and biofilm formation will be
discussed.
3.1. Virulence
Tripartite efflux systems have been shown in numerous studies
to play an essential role in the ability of Gram-negative bacteria
to colonize and disseminate during host infection. These
studies have demonstrated that the inactivation or deletion of
tripartite efflux components has detrimental effects on
virulence (Table 2). Tripartite efflux pump genes are




family Efflux system Cell/host infection model ref(s)






ABC MacAB-TolC Mouse 101, 138, 139
SiiCDF Cattle and bovine enterocytes 156
K. pneumoniae RND AcrAB-TolC Mouse 51
E. coli ABC MacAB-TolC Galleria mellonella and murine mammary glands 161
RND MdtB Mouse spleen 161
MdtEF Human macrophages 162
A. baumannii RND AdeABC Galleria mellonella 163
AdeIJK Caenorhabditis elegans 164
E. cloacae RND AcrAB-TolC Mouse 165
F. tularensis RND AcrAB Mouse 166
N. gonorrhoeae RND MtrCDE Human neutrophils, mouse 146, 167
P. aeruginosa RND MexAB-OprM Mouse, canine epithelial cells 168
MexGHI-OpmD Rat 83
S. maltophilia RND SmeYZ Mouse 114
B. pseudomallei RND BpeAB-OprB Human epithelial cells and macrophages 169
B. burgdorferi RND BesABC Mouse 32
C. jejuni RND CmeABC Acanthamoeba polyphaga, Chicken 170
143
S. f lexneri MFS EmrKY Human macrophages 144
L. pneumophila ABC LssBD-TolC Ameoba and human macrophages 157





RND RaeEF-RopN Duck 99
E. amylovora RND MdtABC Apple rootstock 147
MdtUVW
AcrAB 171
R. solanacearum RND AcrAB Tomato plant 148
aABC, ATP-binding cassette; MFS, major facilitator superfamily; RND, resistance-nodulation-division.
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conserved regardless of the host species, highlighting an
important role for virulence.
3.1.1. Defense against Host-Derived Molecules. The
host environment can be challenging for bacteria due to the
presence of various host antimicrobial compounds, such as bile
salts, antimicrobial peptides (AMP), and fatty acids.132 This
especially holds for the mammalian gut, which is enriched with
bile salts that confer protection to the gut mucosa against
bacteria.133 Therefore, tripartite efflux systems are likely to be
involved in the extrusion of host innate defense compounds,
thereby enabling the survival of bacteria within the host. This is
best exemplified by the tripartite efflux system AcrAB-TolC of
Enterobacteriaceae, which can actively efflux and confer
resistance to bile salts, AMP such as LL-37 and defensin
HBD-1, and fatty acids.134−136 A recent metabolomics study
strongly suggests that oxidized fatty acids are the native
substrates for AcrB in both Salmonella and E. coli.137
Additionally, the ABC pump MacAB-TolC has been shown
to protect S. Typhimurium from oxidative stress. Reactive
oxygen species (ROS), such as hydrogen peroxide, are
produced by macrophages as a defense mechanism against
intracellular pathogens. Bogomolnaya et al.138 demonstrated
that macAB mutants of S. Typhimurium were unable to grow
in cultured macrophages that produce ROS but grew normally
in ROS-deficient macrophages. Furthermore, macAB mutants
were unable to confer resistance to hydrogen peroxide upon
exogenous administration in vitro, indicating a role for MacAB
in ROS detoxification. Recently, the same group also showed
that the linearized enterobactin trimer dihydroxybenzoylserine,
an enterobactin metabolite, protects S. Typhimurium against
peroxide-mediated killing and is a natural substrate of the
MacAB pump.139 This indicates that the MacAB efflux system
plays an important role in the survival of S. Typhimurium in
the host environment during infection by conferring protection
against ROS-mediated oxidative stress. As a pathogen with
only one host, N. gonorrhoeae is particularly well adapted to
infecting humans. The MtrCDE efflux system of N. gonorrhoeae
has been reported to confer resistance to neutrophil-derived
AMP and proteins, indicating that the MtrCDE pump
contributes to the defense of N. gonorrhoeae against immune
cells. The local regulator of the MtrCDE pump, MtrR, has also
been shown to bind bile as a physiological inducer, resulting in
the depression of mtrCDE expression to confer protection from
host-derived and clinically relevant antimicrobials.140 In a
different study, the RND transporter MtrD was shown to
export the hormone progesterone and the cationic antimicro-
bial peptide polymyxin B.141 The MFS tripartite pump FarAB-
MtrE of N. gonorrhoeae can extrude long-chained antibacterial
fatty acids, such as linoleic acid, oleic acid, and palmitic acid,
thereby enhancing the in vivo survival of N. gonorrhoeae.79 In
the related species N. meningitidis, the MtrCDE pump has also
been reported to confer resistance to human cationic AMP.142
Other efflux systems, including VexAB and VexCD of V.
cholerae, CmeABC of C. jejuni, and AcrAB of S. f lexneri, have
also been reported to confer resistance bile salts and
AMP.120,143,144 In E. coli, the AcrAB-TolC and EmrAB-TolC
efflux systems can export mammalian steroid hormones,
including estradiol, progesterone, and hydrocortisone.145
Steroid hormones have been reported to inhibit growth of
N. gonorrhoeae and N. meningitidis; hence, some efflux systems
may protect bacteria from such compounds146 Recently, the
AdeIJK efflux system of A. baumannii was shown to export and
confer resistance to host antimicrobial fatty acids, such as
arachidonic and docosahexaenoic acid.20 The plant pathogen
E. amylovora also requires tripartite efflux systems MdtABC
and MdtUVW to cause infection in apple rootstock.
Intriguingly, both efflux systems are also involved in resistance
to some antimicrobial plant flavonoids, which are produced
and commonly used by plants as a defense mechanism against
invading pathogens.147 The plant pathogen Ralstonia solana-
cearum, the causative agent of bacterial wilt, also requires the
RND efflux genes acrAB to cause infection. Compared to wild-
type, the acrAB-deleted mutant strain was significantly less
virulent on tomato plants. Furthermore, various plant
antimicrobial compounds were found to induce acrAB
expression, suggesting a protective role for AcrAB against
plant antimicrobials.148
3.1.2. Export of Virulence Factors and Toxins.
Tripartite efflux systems can also contribute to the infection
process by extruding virulence factors and toxins that cause
damage to the host. Siderophores are virulence factors which
are secreted by bacteria to acquire iron and other required
metals from their environment. Freely available iron is scarce
within the host since it is mostly bound to heme and other
circulating proteins; hence, bacteria use siderophores to
scavenge for iron to use for intracellular processes.149 Several
tripartite efflux pumps have been found to secrete siderophores
to allow iron acquisition. The VexGH-TolC efflux system of V.
cholerae can export the siderophore vibriobactin to acquire iron
and maintain cellular homeostasis.150 In E. coli, the AcrAB-
TolC, AcrAD-TolC, and MdtABC tripartite efflux systems are
required for the secretion of enterobactin, a siderophore with
the highest known affinity for iron.151 Pyoverdines are another
group of siderophores synthesized and secreted by fluorescent
Pseudomonads. In P. aeruginosa, pyoverdine is exported by an
ABC family tripartite efflux system, PvdRT-OpmQ. Further-
more, it can export pyoverdine that has already transported
iron into the periplasm and any other pyoverdine−metal
complex, suggesting a role for PvdRT-OpmQ in maintaining
iron and metal homeostasis.152 S. marcescens employs the T1SS
HasDEF/TolC to secrete the heme-binding protein HasA,
which can bind here heme and also acquire heme from host
hemoglobin.153 Toxins are another virulence factor which are
exported by tripartite efflux systems. The ABC family pump
MacAB-TolC has been reported to be involved in the secretion
of enterotoxin II from the periplasm into the extracellular
environment in E. coli.154 MacAB-TolC is also involved in the
export of protoporphyrin, the immediate heme precursor. It
has been proposed that MacAB-TolC may play a role in
maintaining protoporphyrin levels to avoid excess accumu-
lation, which can be toxic to bacteria since it can degrade to
ROS in the presence of oxygen.155 The V. cholerae RND
transporter VexH of the VexGH-TolCVc efflux system has been
reported to be involved in the production of the cholera toxin,
although its role in secretion has not been determined.121
Type 1 secretion systems (T1SSs) are another class of
tripartite complexes involved in toxin secretion. T1SSs play a
critical role in the virulence of these pathogens by helping to
disseminate toxins to host cells. HlyBD-TolC is a T1SS found
in pathogenic E. coli strains involved in the secretion of the α-
hemolysin (HlyA) toxin. Hemolysins plays a major role in the
virulence of pathogenic E. coli by forming pores on the surface
of host cells, such as erythrocytes, thereby causing lysis. This
allows bacterial cells to penetrate mucosal barriers and infect
effector immune cells to prevent clearance of infection.
Another important T1SS in E. coli is CvaAB-TolC, which is
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responsible for exporting colicin V (CvaC), a pore-forming
toxin.6 As an important human pathogen, B. pertussis employs
the T1SS CyaBDE to export the adenylate cyclase toxin
(CyaA) to colonize host cells.33 In S. enterica, the SiiCDF
T1SS is involved in the secretion of the large nonfimbrial
adhesin SiiE. Deletion of either siiE or siiF results in attenuated
colonization in cattle and invasion of bovine enterocytes.156
LssBD-TolC is a T1SS from L. pneumophila, which has been
reported to be important for the secretion of the RtxA toxin.157
3.2. Quorum Sensing
Quorum sensing (QS) is a process of intercellular
communication, wherein bacteria synthesize, secrete, and
respond to extracellular signaling molecules known as
autoinducers (AI) to modulate gene expression according to
cell population density. Therefore, QS allows bacteria to only
express genes involved in energetically costly behaviors once
the conditions are deemed necessary, for instance during host
infection. Bacteria use the concentration of AI in their
environment to monitor changes in cell density and modulate
the expression of quorum-specific genes. QS has been reported
to regulate a wide range of bacterial processes and behaviors,
such as antibiotic production, biofilm formation, motility,
sporulation, and virulence.172 In Gram-negative bacteria,
acylated homoserine lactones (AHL) are predominantly used
as AI, whereas Gram-positive bacteria use processed
oligopeptides. To exert their effect, AHL must be secreted
from the cytosol of Gram-negative bacteria to the external
environment.173
Tripartite efflux systems have been reported to be involved
in the export of AHL in some Gram-negative bacteria, thereby
contributing to QS. The MexAB-OprM efflux system of P.
aeruginosa actively exports a class of AHL known as 3-oxo-acyl-
homoserine lactones (HSL) of different acyl chain lengths.174
Furthermore, MexAB-OprM also influences the accessibility of
noncognate HSLs to LasR, the intracellular receptor for HSLs
in P. aeruginosa.175 This suggests a role for MexAB-OprM in
regulating the QS response. A recent study reported that in
MexAB-OprM overproducing P. aeruginosa mutant strains, the
observed impairment in the QS response was due to the
impaired synthesis of alkyl quinolone QS signals, likely due to
the decreased availability of a precursor molecule, such as
octanoate.176 The MexEF-OprN efflux system has been shown
to export the precursor of the AI Pseudomonas quinolone signal
(PQS), which is important for the virulence of P. aeruginosa.177
By exporting an AI precursor, MexEF-OprN may play a role in
modulating P. aeruginosa virulence by limiting the intracellular
availability of AI precursors. In the phytopathogen P. syringae,
MexEF-OprN was also reported to act as a negative
determinant of AHL production and accumulation, suggesting
that it may also export AI precursors in other Pseudomonads
to regulate AHL production.178 Interestingly, overexpression of
the MexCD-OprJ efflux system in P. aeruginosa has been
reported to reduce the QS response. Additionally, the MexXD-
OprJ pump extrudes kynurenine, a precursor of alkyl-
quinolone signals, such as PQS.179 Similar to MexEF-OprN,
the MexCD-OprJ pump may also play a role in regulating QS
by modulating the intracellular levels of PQS precursors and
thus PQS production. Although MexEF-OprN and MexCD-
OprJ are inducible efflux systems, they seem to be involved in
the QS response. This can be puzzling within the context of an
antibiotic-free host environment, which can be considered
noninducable. However, RND efflux pumps are induced not
just by antibiotics but also by host-derived compounds, such as
bile and fatty acids,180 and possibly the host immune
response.144 In B. pseudomallei, the BpeAB-OprB efflux system
is involved in the active efflux of several different types of AHL.
Besides, inactivation of bpeAB-oprB in B. pseudomallei results in
complete inhibition of QS and diminished virulence, indicating
a critical role for this efflux system in the physiology of B.
pseudomallei.181 In E. coli, the AcrAB-TolC efflux system may
also be involved in the efflux of AI. A study by Yang et al.182
suggested that AcrB-TolC efflux may facilitate more efficient
efflux of AI, although the identity of the AI was not
determined. These studies suggest a role for tripartite efflux
systems in QS; however, further research is required to
elucidate their role in regulating QS.
3.3. Biofilm Formation
A biofilm is an aggregation of bacteria that is enclosed in a self-
produced matrix of extracellular polymeric substances and
commonly attached to a surface and/or to each other. Bacteria
within a biofilm display an altered phenotype concerning
growth rate and gene transcription to reflect the biofilm
lifestyle, which differs significantly from planktonic bacterial
cells. The biofilm matrix is a highly diverse environment,
consisting of polysaccharides, lipids, proteins, nucleic acids,
and even inorganic materials, such as mineral crystals and clay
particles. The matrix plays a critical role as a structural scaffold
to maintain the integrity of the biofilm. Importantly, biofilms
are characterized by heterogeneity, such as oxygen, nutrient,
pH, and QS gradients, as well as social interactions, consisting
of microbial communication, cooperation, and competition.183
Bacteria form biofilms in response to a wide range of
environmental and mechanical signals, which can trigger a
host of processes, including QS, to promote biofilm
formation.184
Studies suggest several roles for tripartite efflux systems in
biofilm formation, including export of harmful metabolic
intermediates, export of extracellular polymeric substances,
export of AI to modulate biofilm formation, and export of
protein factors to enable adhesion.185 Inactivation of genes
encoding tripartite efflux systems can result in impaired biofilm
formation. Kvist et al.186 demonstrated that inactivation of
efflux pumps in E. coli caused impaired biofilm formation.
Specifically, the aaeX-deleted E. coli mutant exhibited
significantly lower biofilm formation.186 The aaeX gene
encodes a membrane component of the MFS efflux system
AaeAB, which has been previously reported to be involved in
the efflux of toxic metabolic intermediates.65 The emrY gene,
encoding a component of the MFS efflux system EmrKY-TolC,
has been reported to be important for the growth of E. coli
biofilms.187 Matsumura et al.188 reported that the inactivation
of all genes encoding for the components of tripartite efflux
systems in E. coli resulted in significantly reduced biofilm
formation. In particular, acrD-, acrE-, emrK-, and mdtE-deleted
mutants displayed extremely lower biofilm formation. In
agreement with this study, Baugh et al.189 reported that
acrB-, acrD-, acrEF-, mdtABC-, mdsABC-, emrAB-, and macAB-
deleted S. Typhimurium mutants also exhibited significantly
reduced biofilm formation. These studies suggest that tripartite
efflux systems contribute to biofilm formation. In E. coli,
inactivation of emrK or emrY has been found to significantly
impair survival of cells in response to physical and chemical
stresses, including UV radiation, mitomycin C, and hydrogen
peroxide.190 Therefore, the EmrKY-TolC system may protect
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cells by exporting toxic metabolic intermediates induced by
environmental stresses. A different study found that the EmrB
and MdtB tripartite efflux components contribute to extreme
acid survival in E. coli.191 The MdtEF-TolC efflux system has
been shown to protect E. coli against nitrosative damage in
anaerobic conditions. Specifically, the mdtEF-deleted mutant
was found to grow significantly more slowly during anaerobic
respiration of nitrate.192 This suggests MdtEF-TolC plays an
important role in detoxifying cells in anaerobic conditions by
exporting harmful nitrosyl indole derivatives. Several E. coli
cellular metabolites have been found to induce the expression
of the acrAB operon, possibly by inactivating acrR and/or
upregulating marA and soxS expression. Thus, it is possible that
the AcrAB-TolC system exports toxic metabolites and/or
signaling molecules to maintain homeostasis of gene
expression.193 T1SSs have also been reported to be involved
in biofilm formation. The T1SS LapEBC from P. f luorescens is
involved in the secretion of LapA, a biofilm-promoting adhesin,
into the extracellular environment to enable bacterial cells to
adhere to surfaces. Additionally, mutant strains lacking lapA,
lapB, or lapE have been shown to display impaired biofilm
formation and maturation.194
How might tripartite efflux systems contribute to biofilm
formation? As described above, the biofilm environment is
heterogeneous, with the biofilm core being more anoxic, acidic,
and nutrient-deprived than the biofilm surface.183 This can
exert pressure and stress on cells within the biofilm core;
hence, tripartite efflux systems may contribute to their survival.
There is some evidence that expression of some efflux pumps is
induced by stress within the biofilm core. De Kievit et al.195
showed that expression of mexAB-oprM and mexCD-oprJ in P.
aeruginosa was the highest in the bottom of the biofilm, near
the solid substratum. These efflux systems may also extrude QS
molecules to regulate QS, thereby also regulating the
expression of biofilm-specific genes. Some tripartite efflux
systems like AcrAB-TolC and AaeAB may play roles in
exporting harmful metabolic intermediates to prevent toxic
accumulation within biofilm cells. Owing to their role in
biofilm formation, tripartite efflux systems could be attractive
drug targets to inhibit biofilm formation in clinical settings.
3.4. Other Reported Biological Roles
The multifunctional OMF protein TolC is also involved in
colicin E1 import196 and is employed by bacteriophage TLS as
a cell surface receptor to enter E. coli cells.197 Similarly, in
Salmonella Typhimurium, the TolC appears to be essential for
Figure 2. Diverse genetic organization of tripartite efflux systems across a representative sample of Gram-negative bacteria. ABC, ABC-binding
cassette; MFS, major facilitator superfamily; RND, resistance-nodulation-division.
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the infection by the Chi-phage.198 Likewise, TolC from V.
cholerae is also utilized by the VP3 phage to gain entry into
cells.199 The AcrEF-TolC complex from E. coli has been
posited to play a role in the maintenance of normal cell
division. Lau and Zgurskaya200 reported that AcrEF-deficient
cells exhibited defective chromosome condensation and
segregation during cell division. Furthermore, the absence of
AcrEF was also found to result in cell filamentation. The
SmeIJK efflux system of S. maltophilia has been reported to
contribute to cell envelope integrity and the envelope stress
response. Compared to wild-type, the smeIJK-deleted mutant
strain was found to exhibit increased sensitivity to membrane
damaging agents and elevated RpoE-mediated envelope stress
response. Additionally, sublethal concentrations of membrane
damaging agents were reported to induce smeIJK expression in
a RpoE-dependent manner.201 In A. baumannii, the RND
transporter AdeJ has been reported to play a role in surface-
associated motility.164 Similarly, the AcrD RND transporter
from S. enterica has also been shown to play a role in swarming
motility.202 There is also some evidence that tripartite efflux
pumps play a role in lipid modulation, which could potentially
effect resistance to membrane targeting antibiotics. In P.
f luorescens, the RND pump EmhABC has been found to be
involved in the efflux of fatty acids. Furthermore, changes in
the growth temperature altered the composition of fatty acids
in the membrane and significantly increased expression of
emhABC, with increased extracellular fatty acids. This suggests
that EmhABC is involved in the efflux of fatty acids that are
replaced due to membrane damage or phospholipid turn-
over.203 The AdeIJK RND pump of A. baumannii has also been
implicated in membrane modulation. Jiang et al. found that the
AdeIJK pump can export the ω-6 fatty acid arachidonic acid
and the ω-3 fatty acid decosahexaenoic acid. Furthermore,
lipid analyses showed that adeJ deletion resulted in significant
changes in endogenous lipid concentrations.20 The role of
efflux pumps in lipid modulation could act as a defense
mechanism against membrane targeting antibiotics, which has
been previously shown in Staphylococcus auereus as a
daptomycin resistance mechanism.204,205
In nitrogen-fixing symbiotic bacteria, tripartite efflux systems
have been reported to play various roles in nitrogen-fixation
and nodulation. In B. japonicum, the RND efflux system BdeAB
is crucial for symbiotic nitrogen-fixation of the soybean plant.
The bdeAB-deleted B. japonicum mutant strain has been shown
to exhibit strongly diminished nitrogen fixation, which was
evident by discolored plant leaves, a typical sign of nitrogen
starvation.34 In S. meliloti, the RND system SmeAB-TolC plays
a role in nodulation competitiveness by protecting cells from
antimicrobial compounds produced by the host plant.108 In the
filamentous cyanobacterium Anabaena sp. PCC 7120, the
tripartite ABC systems DevBCA-HgdD and HgdBCD have
been shown to play critical roles for envelope formation in
heterocysts, which are specialized nitrogen-fixing cells.206,207
These studies suggest an increasingly important and diverse
role of tripartite efflux systems in bacterial physiology.
4. GENES AND REGULATION OF EXPRESSION
Genes encoding tripartite efflux systems are generally organ-
ized as operons, wherein the inner membrane tranporter and
the PAP genes are located within the same operon (Figure 2).
The OMF gene can be encoded within the same operon, such
as oprN of P. aeruginosa,82 or elsewhere in the genome, such as
tolC of E. coli and S. enterica.208 The majority of tripartite efflux
systems also have a gene encoding for a local regulator protein
within the operon, such as acrR and mexR, which typically act
to repress efflux gene expression.209,210 However, a few local
regulators can activate efflux gene expression, such as mexT
and vexR, which activate expression of the mexEF-oprN and the
vexAB efflux genes, respectively.82,211 Some tripartite efflux
systems, such as MacABC of S. maltophilia and AdeABC of A.
baumannii, are regulated by two-component systems (TCS),
which are encoded divergently upstream of the efflux pump
operon.116,212 Certain tripartite efflux systems also have more
than one type of PAP or inner membrane transporter encoded
within their operon. For example, the triABC system of P.
aeruginosa comprises two PAP genes triA and triB,88 and the
mdtABC system of S. enterica possesses two inner membrane
transporter genes mdtB and mdtC.213 T1SSs are also usually
organized as operons, with the cognate toxin gene located
within the same operon as the efflux pump genes. For example,
the hlyA gene encoding the α-hemolysin toxin is found
upstream of the hlyB and hlyD genes.214 As an extreme
example, the genes encoding the AcrAD-TolC efflux system are
all located in different genetic loci within the genome.100
Therefore, there is significant diversity in the genetic
organization of tripartite efflux systems (Figure 2).
Efflux pump overexpression frequently contributes to
clinically relevant levels of antibiotic and biocide resistance.
Therefore, it is critical to understand how tripartite efflux
pumps are regulated to elucidate the mechanisms of over-
expression, which could be used to identify novel drug targets
to prevent or reverse efflux pump overexpression.215 The
regulation of tripartite efflux systems can vary between species
and even within a species depending on environmental and
physiological factors. Normally, efflux pumps are expressed at
basal levels through tight regulation of highly complex and
interconnected systems. Therefore, the deletion or inhibition
of one efflux pump can affect the expression of other pumps.
For example, deletion of acrAB in S. Typhimurium results in
significant upregulation of many other genes encoding for
tripartite efflux systems, including acrD, acrF, mdsB, mdtB,
macA, and emrA.216 Hence, the complexity of efflux pump
regulatory networks can often cloud resistance phenotypes.
4.1. Local Regulation
Genes encoding for components of tripartite efflux systems are
regulated by local and global transcriptional regulators that act
to maintain baseline expression (Figure 3). These regulators
respond to a wide range of environmental signals, including
antibiotic exposure and iron limitation, to increase the
expression of efflux pump genes.215 The majority of the
genes encoding tripartite efflux systems are arranged in an
operon, which also contains a divergently oriented gene
encoding for a local TetR family regulator (TFTR). TFTRs
generally consist of a N-terminal DNA binding domain, which
recognizes and binds to a palindromic DNA sequence located
in the intergenic region between the regulator and the
regulated gene, and a larger C-terminal domain, which is
responsible for ligand binding.217 Functioning as a dimer,
TFTRs act to locally repress the expression of the efflux
genes.218 Examples of local TFTRs include AcrR, which
represses expression of acrAB in several different members of
Enterobacteriaceae;209 MtrR, which represses expression of
mtrCDE in N. gonorrhoeae;219 and CmeR, which represses the
expression of cmeABC in C. jejuni.220 Binding of ligands to the
C-terminal domain of TFTRs induces conformational changes
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in their structure, thus preventing their binding to target
DNA.217 For instance, rhodamine 6G, a substrate of the
AcrAB-TolC pump, can bind to AcrR and prevent its binding
to target DNA, thereby resulting in derepression and
expression of acrAB.209 Mutations conferring loss-of-function
of local repressors can result in overexpression of tripartite
efflux systems. For example, mutations in acrR can lead to
overexpression of AcrAB and have been documented in the
fluoroquinolone resistance of clinical E. coli221 and K.
pneumoniae222 isolates. Likewise, in clinical isolates of N.
gonorrhoeae, mutations in mtrR have been reported to
contribute to decreased azithromycin223 and cephalosporin
susceptibility.224
In contrast to trans-acting mutations, cis-acting mutations
often have a far greater impact on efflux gene expression. Cis-
acting mutations mainly consist of changes in the promoter
region of efflux pump genes, whereas trans-acting mutations
abrogate repressor activity. For example, a 13-bp inverted-
repeat sequence between the divergent mtrR and mtrC genes in
N. gonorrhoeae, corresponding to the promoter regions of mtR
and mtrC, has been shown to significantly increase mtrC
expression and MtrC protein levels, resulting in increased
resistance to antiubiotics, detergents, and bile salts.76 It has
also been found that a 1-bp deletion in a 13-bp inverted repeat
within the mtrR promoter region is prevalent in 80% of N.
gonorrhoeae isolates with increased resistance to antimicrobials,
bile salts, detergents, and host-derived compounds. These cis-
acting mutations impair transcription of mtR and promote
transcription of mtrCDE, even more so than loss of MtrR.14
However, negative regulation of tripartite efflux systems is
now known to be diverse. Contrasting the conventional
negative regulation of the acrAB operon, studies have shown
that multiple regulators can function as a network to regulate
the same efflux pump gene and that non-TFTRs can also
regulate efflux pump genes. For example, the mexAB-oprM
operon in P. aeruginosa, which encodes for the MexAB-OprM
efflux system, is repressed by the divergently encoded MarR-
family protein MexR. Yet, mexAB-oprM expression is also
repressed by the TFTRs NalC and NalD, which are encoded
elsewhere in the P. aeruginosa genome.225,226 Recently, two
additional repressors of the mexAB-oprM operon, MdrR1 and
MdrR2, have been characterized.227 Together, these regulators
work as a network to maintain the constitutive basal levels of
MexAB-OprM efflux pump expression. Furthermore, not all
TFTRs function to repress efflux pump genes. For instance, the
RND pump VexAB of V. cholerae is organized in an operon
with a divergently encoded TFTR VexR, much like AcrAB.
However, VexR does not repress vexRAB but rather is
necessary for the activation of vexRAB expression in response
to noxious substances (Figure 3).211 Notably, some TFTRs are
now understood to be much more than simply regulators of
efflux pump genes. For example, in addition to repressing the
cmeABC operon, the TFTR CmeR of C. jejuni has been found
to regulate the expression of many other genes encoding
transport proteins and enzymes involved in capsular
polysaccharide biosynthesis. Furthermore, loss-of-function
mutations in cmeR were shown to diminish the ability of C.
jejuni to colonize chickens.228 In N. gonorrhoeae, the TFTR
MtrR has been shown to modulate the expression of least 69
genes, which encode for proteins involved in metabolism,
general stress, and heat shock response.229 Therefore, it has
become increasingly evident that TFTRs possess further
physiological roles within bacteria.
4.2. Global Regulation
Global regulation of tripartite efflux systems is mediated chiefly
by the AraC/XylS family of transcription factors. These global
regulators are involved in the transcriptional regulation of
many processes inside cells, including induction of efflux pump
gene expression. In Enterobacteriaceae, characterized AraC/
XylS transcription factors include MarA, SoxS, and Rob, all of
which can activate expression of the acrAB operon in response
to harmful substances or stressors (Figure 3).230 In K.
pneumoniae, in addition to acrAB, RamA has also been recently
shown to upregulate the expression of oqxAB.231 These
regulators recognize and bind to a degenerate approximately
Figure 3. Schematic diagram of the different mechanisms of tripartite
efflux pump regulation. (A) Local regulation usually involves a TetR
family transcriptional regulator, such as AcrR, that acts to locally
repress efflux gene expression and maintain basal levels of expression.
Global regulation generally involves AraC/XylS family transcriptional
regulators, such as MarA, RamA, and SoxS, that activate efflux pump
gene expression. These global regulators themselves are locally
regulated by their own TetR family transcriptional regulators, such as
MarR, RamR, and SoxR. The presence of antibiotics or other external
stressors can release these repressors to allow activation of efflux gene
expression. Other types of regulators, such as the quorum sensing
regulator SdiA, can also activate efflux gene expression. Two
component systems (TCSs) consist of a sensor histidine kinase
(EvgS) that detects external stimuli, such as drugs, and phosphor-
ylates a response regulator (EvgA), which becomes activated to
trigger efflux pump gene expression. Post-transcriptional regulation
includes RNA-binding proteins, such as CrsA, that stabilize efflux
gene mRNA to promote efficient efflux protein translation. (B) In V.
cholerae, the TetR family transcriptional regulator VexR activates
expression of the vexAand vexB efflux pump genes.
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20 bp sequence, which is located in the promoter sequence of
acrAB and many other genes.232 The majority of AraC/XylS
transcription factors are encoded alongside their local
repressor. For example, MarA, SoxS, and RamA are
autoregulated by their local repressors, marR, soxR, and
ramR, respectively (Figure 3).233 AraC/XylS family transcrip-
tional regulators involved in efflux pump induction also exist in
members of other families, including MtrA of N. gonorrhoeae
which induces expression of mtrCDE.234 Repression of global
transcriptional regulators is relieved through binding of ligands
to the local repressor proteins, which prevents their binding to
DNA. For instance, binding of ligands, such as ethidium
bromide, rhodamine 6G, and crystal violet, to RamR reduces
its binding affinity to target DNA, thus resulting in increased
expression of ramA.235 However, the AraC/XylS family is not
the only family of transcription factors involved in the
regulation of efflux genes. SdiA is a LuxR-type transcription
factor involved in the regulation of cell division through
quorum sensing. In addition, SdiA has also been shown to be
involved in the positive regulation of AcrAB protein levels
(Figure 3).236 The T1SS HlyBD of E. coli is regulated by the
transcription antitermination protein RfaH, which enhances
hlyCABD transcript elongation. Additionally, RfaH has been
found to increase the efficacy of the HlyA toxin protein.237 In
S. enterica, RfaH also regulates the siiCDEF operon encoding
for the SiiCDEF T1SS and the large nonfimbrial adhesin
SiiE.238
The increased expression of global transcriptional regulators
leads to the induction of efflux pump gene expression.
Therefore, mutations that result in derepression of global
transcriptional regulators can trigger the overexpression of
tripartite efflux pumps. For example, reduced tigecycline
susceptibility in clinical K. pneumoniae isolates has been
associated with loss-of-function mutations in ramR, resulting in
increased ramA and acrAB expression.239 Mutations in the
promoter sequence of global transcriptional regulators can also
lead to overexpression by preventing binding of local repressor
proteins. Baucheron et al.240 demonstrated that mutations in
the promoter sequence of ramA can prevent binding of RamR.
Furthermore, they showed that the MDR phenotype of a
clinical E. coli isolate was due to a 2-bp deletion in the ramA
promoter sequence, which compromised RamR-mediated
repression and increased acrAB and tolC expression. Interest-
ingly, a study that investigated the differential impact of ramRA
mutations in clinical MDR S. Typhimurium isolates found that
mutations in the promoter region of ramA had a greater impact
in increasing expression of ramA than loss-of-function
mutations in ramR.241 There are also reports of novel
mutations that trigger overexpression of global transcriptional
regulators. For instance, a study found that in clinical MDR E.
coli isolates, overexpression of the SoxS protein was not due to
mutations in soxR or the promoter region of soxS but instead a
novel alanine to serine substitution (A12S) mutation in soxS.
Furthermore, overexpression of acrB was reported with
increased resistance to fluoroquinolones, chloramphenicol,
and tetracycline.242 Considering that the position of the
substitution is not within the DNA binding region of SoxS, the
mechanism by which this mutation results in soxS over-
expression remains to be elucidated. Lastly, overexpression of
global transcriptional regulators has been reported to increase
mutation rate and frequency. A recent study reported that
ramR mutants, which overproduce RamA, and thus AcrB,
exposed to ciprofloxacin selected for quinolone-resistant gyrA
mutants. Furthermore, inactivation of ramA was found to
select for soxR mutants, which overproduce SoxS, suggesting a
compensatory role for global transcriptional regulators.243
Although antibiotics are known to induce expression of
efflux pumps, worryingly, nonantibiotic drugs have also been
shown to trigger efflux pump overexpression. One study found
that upon exposure to the antidepressant fluoxetine, E. coli K-
12 developed significantly increased resistance to ampicillin.
chloramphenicol, amd tetracycline. This was shown to be due
to ROS-mediated mutations in the efflux pump regulators
marR and rob, resulting in increased AcrAB-TolC and MdtEF-
TolC expression.244 Several commonly used biocides have also
been documented to trigger efflux pump overexpression.
Exposure to subinhibitory concentrations of benzalkonium
chloride has been reported to promote antibiotic resistance in
P. aeruginosa due to mutations in nf xB, resulting in
overexpression of MexAB-OprM and MexCD-OprJ efflux
pumps thereby increasing benzalkonium chloride and cipro-
floxacin resistance.245 In agreement with this, a recent study
also reported the overexpression of the MexCD-OprJ efflux
pump in P. aeruginosa upon exposure to benzalkonium
chlrodide, resulting in increased ciprofloxacin and tetracycline
resistance.246 Several other studies have also reported similar
findings in P. aeruginosa, pointing to a link between biocide
exposure and cross-resistance to clinically relevant anti-
biotics.247,248 Similarly, triclosan exposure has also been
reported to promote significantly high levels of cross-resistance
to other antibiotics, including ciprofloxacin, tetracycline, and
erythromycin, in P. aeruginosa. The triclosan resistant mutants
were found to harbor mutations in nfxB, the local repressor
gene of the mexCD-oprJ operon, which resulted in the
overexpression of the MexCD-OprJ plasmids carrying anti-
biotic resistance genes.249 Worryingly, the presence of biocides
in the environment can also select for MDR. Amsalu et al.250
found that 19% of P. aeruginosa isolates collected from diverse
ecological niches exhibited MexAB-OprM overexpression due
to mutations in the efflux pump regulators MexR, NalC, or
NalD, resulting in MDR.
Owing to their role as global transcriptional regulators,
MarA, SoxS, Rob, and RamA have been shown in several
studies to have wider roles in bacterial physiology. For
example, MarA, SoxS, Rob, and RamA have been reported to
repress flagellar gene expression and motility in S. Typhimu-
rium. Specifically, each of these global regulators was found to
directly interact with the promoter of f lhDC, the master
regulator of motility in Salmonella.251 In E. coli, MarA has been
demonstrated to regulate genes involved in DNA repair and
lipid trafficking. Identified MarA targets include the xseA gene
and the mlaFEDCB operon, which encode an endonuclease
subunit and a lipid trafficking ABC transporter complex,
respectively.252 Lastly, the elucidation of the RamA regulon in
K. pneumoniae found that RamA binds directly to the
promoters of lpxC, lpxL-2, and lpxO genes, which are involved
in lipid A biosynthesis. This suggests that RamA plays a role in
the modification of the lipid A moiety of lipopolysaccharide
(LPS). Furthermore, overexpression of RamA was found to
reduce K. pneumoniae adhesion and uptake into macrophages,
thus conferring protection against the innate host response.253
Together, these results signify that in addition to their role in
MDR, regulators of tripartite efflux systems also play a wider
physiological role in bacteria.
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4.3. Post-transcriptional Regulation
In contrast to transcriptional regulation, less is known about
the regulation of tripartite efflux systems at a post-transcrip-
tional and translational level. However, recent studies have
demonstrated that post-transcriptional regulation is likely to
play an important role in fine-tuning efflux pump expression.
One mechanism of post-transcriptional regulation is through
the action of RNA-binding proteins, which are seen as
increasingly important modulators of protein function.254
The RNA-binding protein CsrA (Carbon Storage Regulator
A) acts as a global regulator of a wide range of genes. Ricci et
al.255 reported that CsrA binds to and stabilizes acrAB mRNA,
presumably through preventing the formation of repressive
RNA structures that hinder ribosome binding (Figure 3).
Furthermore, deletion or mutagenesis of crsA was shown to
decrease the production of AcrAB. Therefore, CsrA may be
involved in facilitating the efficient translation of AcrAB.
Another study reported that Hfq, an RNA-binding protein and
RNA chaperone, may also be involved in the post-transcrip-
tional regulation of AcrB. Deletion of hfq in E. coli does not
affect the transcription of the acrAB operon; however, it does
diminish the levels of AcrB protein production and increase
susceptibility to antibiotics.256 In a different study, SdsR, a
noncoding small RNA expressed at the stationary phase, was
shown to repress the expression of tolC by binding to the
region upstream of its ribosomal binding site. Furthermore,
overexpression of SdsR was found to result in the loss of tolC
mRNA, a reduction in TolC protein production, and increased
susceptibility to some AcrAB-TolC substrates, including
novobiocin and crystal violet.257 The role of SdsR-mediated
tolC repression has also been reported in S. Typhimurium.258
4.4. Regulation by Two-Component Systems
Bacteria can adjust their physiological behavior in response to
environmental changes through two-component systems
(TCSs). In essence, TCSs mediate signal transduction by
enabling bacteria to sense external stimuli, such as pH,
temperature, nutrient levels, and antibiotics, and convey this
signal to the intracellular environment to facilitate changes in
gene expression.259 TCSs are present in all domains of life and
typically consist of a membrane-bound sensor histidine kinase
(HK) and its cognate response regulator (RR). Upon sensing
external stimuli, the sensor HK catalyzes the autophosphor-
ylation of a conserved histidine residue in its C-terminal
domain using ATP. The phosphoryl group is then transferred
to a conserved aspartate residue on the receiver domain of the
RR. This triggers a conformational change in the effector
domain of the RR, resulting in a cellular response. The
majority of the characterized RR belongs to the DNA binding
superfamily and thus is assumed to function as transcription
factors to induce changes in gene expression. TCSs regulate
many physiological processes, such as motility, cell division,
and nutrient uptake, but also antibiotic resistance and
virulence.260
In addition to transcriptional regulation, many of the
tripartite efflux systems (Table 1) are also regulated by
TCSs. For example, the AdeABC efflux system of A. baumannii
is regulated by the TCS AdeRS, encoded by the divergently
encoded adeRS operon upstream of adeABC. The AdeS protein
is a sensor HK that detects environmental stimuli, and the
AdeR protein is a DNA-binding RR that induces changes in
gene expression.212 AdeR activates adeABC expression by
binding to a direct-repeat motif in the intergenic region
between adeR and adeA.261 Importantly, mutations in adeRS
can result in overexpression of the AdeABC pump. This has
been reported in clinical MDR A. baumannii isolates due to
various point mutations in both AdeR and AdeS.262 As a TCS,
AdeRS also regulates genes involved in several other processes,
including biofilm formation, motility, and virulence.163 The
tripartite ABC efflux pump MacAB-TolC is regulated by the
pleiotropic TCS PhoPQ, which governs virulence, adaptation
to magnesium limiting environments, resistance to antimicro-
bial peptides, and various other processes. Nishino et al.101
demonstrated that in S. enterica, phosphorylated PhoP binds to
a PhoP box upstream of the macAB operon thereby directly
repressing macAB expression. However, a recent study found
that PhoP-inducing signals, such as low magnesium, generally
act to increase macAB transcription in Salmonella. The
difference in the role of PhoPQ in macAB regulation may
arise from differences in experimental conditions, PhoP
turnover, and changes in rRNA levels in response to low
magnesium. Whereas MacAB-TolC remains functional in the
majority of S. Typhimrium lineages, the S. Typhimrium ST313
lineage has been reported to exhibit a pattern of evolutionary
convergence toward an impaired MacAB-TolC efflux system.
This possibly represents a unique adaptation to allow systemic
infections of permissive hosts who are unable to clear
infection.263 Interestingly, the MacAB-TolC homologue in S.
maltophilia, MacABC, has been reported to be intrinsically
expressed as inactivation of the TCS genes macRS was found
to not affect macABC expression.116 Some TCS are capable of
regulating more than one tripartite efflux complex. For
example, EvgAS in E. coli has been demonstrated to regulate
the expression of acrAB, emrKY, mdtEF, and tolC (Figure 3),264
which encode AcrAB-TolC, EmrKY-TolC, and MdtEF-TolC
pumps, respectively. Likewise, the TCS BaeSR in E. coli and S.
Typhimurium can detect heavy metals and in response activate
the expression of both mdtABC and acrD, which encode
MdtABC and the AcrD RND transporter of AcrAD-TolC
efflux systems, respectively.213,265 In A. baumannii, BaeSR can
detect antimicrobial compounds, such as tigecycline and tannic
acid, and in response is believed to regulate the expression of
AdeABC, AdeIJK, and MacAB-TolC tripartite efflux sys-
tems.266 Owing to their role in antibiotic resistance and
virulence, TCSs could be attractive drug targets for the
development of inhibitors.
4.5. Other Types of Regulation
Aside from the canonical pathways of efflux pump regulation,
several other types of regulatory mechanisms have been
posited. Another possible mechanism of efflux pump regulation
is through the action of bacterial secondary messenger
molecules, such as ppGpp (guanosine pentaphosphate),
which is involved in the stringent response. A recent study
found that the deletion of the A1S_0579 gene, which is
involved in the synthesis of ppGpp, increased antibiotic
susceptibility in A. baumannii. To elucidate the mechanism of
increased antibiotic susceptibility, expression levels of efflux
pump genes were determined. Interestingly, the expression of
the genes adeB and adeIJK, which encode components of
tripartite efflux systems, was significantly reduced (at least 10-
fold reduction).267 This suggests a link between secondary
messenger molecules and efflux pump regulation; however,
further research is required to elucidate the molecular
mechanisms. A recent study found that post-translational
modification is another determinant of efflux pump activity. In
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C. jejuni, the CmeABC RND pump is subjected to N-linked
glycosylation, which was shown to enhance protein thermo-
stability, stabilize protein complexes, and promote protein−
protein interaction, thereby facilitating efflux activity.268
5. CLASSES OF TRANSPORTER PROTEINS
The multidrug efflux transporters of Gram-negative bacteria
are diverse and are categorized into one of six families: the
Resistance-Nodulation-Division (RND) superfamily, the
Major Facilitator Superfamily (MFS), the Multidrug and
Toxic Compound Extrusion (MATE) family, the Small
Multidrug Resistance (SMR) family, the Proteobacterial
Antimicrobial Compound Efflux (PACE) transporter family,
and the ATP-Binding Cassette (ABC) superfamily. The
representative known structures of the transporters belonging
to these families, along with their representative partner
proteins, which participate in tripartite complex formation are
shown in Figure 4. The individual components, structure, and
assembly of each of these systems are described as
comprehensively as possible below.
5.1. Resistance−Nodulation−Division (RND) Transporter
Superfamily
Representatives of the RND superfamily can be found in all
domains of life. Members are characterized by conserved
transmembrane structures comprising 12, sometimes 13 or 14,
transmembrane helices (TMs) arranged in two pseudosym-
metric bundles. The transmembrane domains (TMDs) of
these secondary active transport proteins are involved in the
binding and release of H+ (or Na+). Between TM1 and TM2
and between TM7 and TM8, soluble loops of lesser
conservation constitute domains involved in various biological
functions.274 From the known structural and functional
analysis of these proteins, the soluble domains often display
large conformational changes as a result of ligand/substrate
binding and release. The energy required for the entire
transport process is transduced via the TMD upon
consumption of the proton (or sodium-ion) motive force
(PMF or SMF). Based on these functions and their phylogeny,
RND transporters are assigned to distinct families.275,276
5.1.1. Bacterial Drug Efflux Proteins from the HAE
Family of RND Transporters. The hydrophobe/amphiphile
Figure 4. Overview of the principal components of the tripartite assemblies. The primary and tertiary structures of the main group of proteins
involved formation of tripartite efflux complexes and type 1 secretion systems. The coloring of the key structural features is the same on the primary
and the 3D structure. (A) Outer membrane factor (OMF) family on the example of the Pseudomonas aeruginosa OprM channel monomer, based on
the PDB ID 1WP1.269 (B) Periplasmic adaptor protein (PAP), also known as the Membrane Fusion Protein (MFP) family, on the example of the
Pseudomonas aeruginosaMexA associating with the RND transporter MexB. Two conformers are presented based on the PDB ID 6TA6;270 see text
in section 7.2 for details. (C) A representative RND-family transporterMexB, from P. aeruginosa. Trimeric assembly based on PDB ID 6T7S.270
PN and PCperiplasmic or porter domain N-terminal and C-terminal subdomains; DN and DCdocking/funnel domain N- and C-terminal
subdomains, respectively. See section 5.1 and Figures 5 and 6 for details. (D) A representative structure of the Major Facilitator Superfamily (MFS)
transporter with 14-transmembrane helices based on the POT-family member PepTSo from Shewanella oneidensis. PBD ID 4UVM,271 monomer
presented. See Section Y for details. (E) A dimeric structure of the MacB transporter from E. coli based on PDB ID 5NIK.272 (F) Representative
structure of the ABC transporters involved in the formation of the type 1 Secretion system (T1SS), on the example of Hemolysin alpha exporter
HlyB. Dimer structure based on a homology model derived from the peptidase containing ABC transporter PCAT1 structure (PBD ID 4RY2).273
For details see section 5.6. NBD, nucleotide binding domain; CLD, C39 like domain.
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efflux exporter (HAE) family is subdivided into three
subfamilies.275 The HAE-1 family is from Gram-negative
bacterial origin and includes the secondary active drug efflux
RND transporters which are only active in vivo in conjunction
with PAPs and outer membrane factors/channels (OMFs).
The HAE-2 family members are lipid exporters of Gram-
positive bacteria, and recently, structures of the monomeric
mycolic acid RND transporter MmpL3 from Mycobacterium
smegmatis were solved in apo-form and in complex with anti-
TB drugs.277 Members of the HAE-3 family include archaeal
and bacterial exporters of hopanoids.275 A crystal structure of
the homodimeric hopanoid exporter HpnN from Burkholderia
multivorans was elucidated.278
Structures of apo and substrate bound E. coli HAE-1
member AcrB,279−294 P. aeruginosa MexB,291,295,296 apo and
substrate bound N. gonorrhoeaeMtrD,297,298 C. jejuni CmeB,299
A. baumannii AdeB,300 AcrB from S. Typhimurium,301 and
TriC from P. aeruginosa302 could be solved by crystallography
or recently by single particle cryo-EM. HAE-1 family RND
transporters are embedded in the inner membrane as
homotrimers and rarely also as heterotrimers, such as
MdtBC.303 The RND pumps form larger two-membrane
spanning tripartite complexes in conjunction with a PAP and
an OMF; the latter two form channel structures to create a
long drug exit tunnel toward the outside of the Gram-negative
cell.270,287,304−307
5.1.2. The E. coli HAE-1 Member Acriflavine Resist-
ance Protein B (AcrB). Acriflavine resistance protein B
(AcrB) from E. coli was identified in 1978 to be a factor in
resistance against the topical antiseptic acriflavine.308 Later,
AcrB was shown to act as an efflux pump of bile salts, and its
gene is upregulated under several stress conditions.180,309 Early
reports indicated the large substrate spectrum of this efflux
pump,309,310 exporting a broad range of structurally diverse
molecules comprising diverse classes of antibiotics, including
β-lactams, macrolides, quinolones, rifamycins, aminocoumar-
ins, tetracyclines, and oxazolidinones, as well as anticancer
drugs, dyes, bile salts, detergents, and solvents5 (Table 1). The
substrates of the pump commonly harbor hydrophobic
moieties. Bianionic β-lactams are apparently poor substrates
for AcrB, and the more hydrophilic aminoglycosides are not
substrates for the pump. The latter compounds are preferably
extruded by the homologous AcrAD-TolC efflux pump in E.
coli.55,311,312
Figure 5. Structure of asymmetric AcrB comprising three protomers in the loose (L, blue), tight (T, yellow), and open (O, red) conformation. (A)
Side view of trimeric AcrB along the membrane plane. Indicated are the transmembrane, periplasmic porter, and funnel domains (TMD, PD, and
FD). (B) Top view on the porter domain. In the L protomer (blue), the PN1, PN2, PC1, and PC2 subdomains are indicated. The PC1 and PC2
subdomains constitute a cleft as part of the access pocket (AP, dashed oval). The T protomer contains also an open PC1/PC2 cleft but is less
voluminous compared to the one in the L protomer. Between the PN2 and PC1 subdomains, the deep binding pocket (DBP, dashed oval) is
indicated. The switch loop (green) separates the AP and the DBP. In the O protomer (red), the PC1/PC2 cleft, the AP, and the DBP are closed.
From the closed DBP, a tunnel is present which exits at the funnel domain. In the asymmetric LTO AcrB porter domain representations (top view)
on the left, binding of drugs to the access pocket is shown. Rifampicin (sphere representation in pink) binds in the L protomer (highlighted in
blue) at the proximal side of the access pocket, and erythromycin (sphere representation in pink) binds to most distal part of the access pocket,
underneath the switch loop (green).289 On the right, the T protomer is highlighted (in yellow), and bound minocycline (sphere representation in
pink) is located in the distal groove region of the deep binding pocket,288,290 whereas puromycin (sphere representation in cyan) binds to the more
proximal cave region of the deep binding pocket underneath the switch loop (in green).305 (C) Top view of the funnel domain (FD). The N-
terminal FN and the C-terminal FC subdomains are indicated. The AcrB trimer is stabilized by a loop protruding from the FN subdomain
connected to the FD subdomain of the neighboring protomer emerging from subdomain DN to DC of the adjacent protomer. The distal FD
remains largely unaffected by the conformational cycling and remains structurally unchanged during the LTO cycle. (D) Top view (from the
periplasm) of the transmembrane domain (TMD). The TMD displays 12 transmembrane helices (TMHs). The proton relay network consists of
residues D407, D408, and K940 associated with R971 and T978 located in the center of the TM-domains. Adjacent protomers interact via TM1
and TM8. The large central cavity is depicted by a circle. This image was constructed with PDB 4DX5 (in complex with minocycline)290 for the
structure images in complex with drugs. Coordinates for rifampicin (PDB 3AOB), erythromycin (PDB 3AOC), minocycline (PDB 4DX5), and
puromycin (PDB 5NC5) were superposed to the 4DX5 structure.
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The membrane topology of the AcrB transmembrane
domain was initially accurately predicted to comprise 12
TMHs and a periplasmic region composed of two large
loops.313 Periplasmic domain swapping between AcrB and
AcrD314 or exchange of the periplasmic domains of MexB and
MexY315 clearly indicated that the substrate specificity of the
RND pumps was determined inside the periplasmic domains.
Furthermore, Tikhonova et al.316 showed with AcrB and MexB
fusions that the specificity of interaction is encoded in the
periplasmic T60-V612 region of these transporters. Soon after
initial diffraction studies were published,317 the first crystal
structure of the symmetric trimeric AcrB was solved at a
resolution of 3.5 Å in 2002.279 The three protomers of the
trimer are arranged in 3-fold symmetry perpendicular to the
membrane plane, all adopting the same distinct conformation
(later defined as the loose (L) or access conformation) and
thus constituting a LLL trimer.
In 2006 and 2007, three independent studies reported an
asymmetric trimeric setup of AcrB288,318,319 (Figure 5). The
use of designed ankyrin-repeat proteins (DARPins) as
crystallization chaperones resulted in a higher resolution
structure (2.5 Å) of the otherwise congruent asymmetric
AcrB trimer.319 In 2012, under optimized conditions, a high-
resolution structure at 1.9 Å was obtained allowing detailed
insight on substrate binding.290 Moreover, the presence of
water molecules in the TMD suggested the presence of water
channels to the H+-titratable residues (D407, D408).292 The
“asymmetric” crystal structures revealed three distinct con-
formations assigned to consecutive states of the transport
cycle, generally denoted as access, binding, and extrusion
states288 or loose (L), tight (T), and open (O) states,318 with
the latter designation in analogy to the conformations
established for the functional rotation (binding change)
mechanism of the F1F0 ATP-synthase
320 (Figure 5). The
functional rotation mechanism hypothesis was supported by
structure-based site-directed disulfide cross-linking studies.
Experiments confirmed not only the presence of asymmetric
AcrB in vivo but also the necessity of conformational cycling in
substrate extrusion.321,322 Studies with a genetic fusion
construct encoding a covalently linked AcrB trimer provided
further evidence for interdependent conformer cycling by
demonstrating that the inactivation of a single protomer
abolishes the function of the entire AcrAB-TolC system.323
The first structures in complex with the AcrB substrates
minocycline and doxorubicin were obtained by Murakami et
al.288 at 2.8 Å resolution. The use of brominated minocycline
was of crucial importance, to assign the different densities to
minocycline, as the anomalous signal of bromine yields
unequivocal proof of its presence in the region defined as
the deep binding pocket (DBP) (Figure 5B). The use of
brominated substrates was later also used to identify a novel
binding site for carboxylated drugs, by the use of brominated
fusidic acid.324
5.1.3. Structural Features of AcrB. The three protomers
within the AcrB trimer279 each comprise a transmembrane
domain (50 Å height) characterized by two parallel pseudo-2-
Figure 6. Topology of AcrB protomer. The structure of AcrB is a representation of an architecture that is shared across the HAE and HME families
of RND transporters. The protomer of AcrB presents a pseudo-2-fold symmetry, associated with a gene duplication of the ancestral gene, giving two
semi-identical N-terminal and C-terminal portions of the protein, each including a 6 TM-helical component with a large periplasmic loop spliced
between the TM1/TM2. These loops form the porter or periplasmic domain (PD) and a docking domain. Porter domains display highly modular
organization, presenting a mixed α-β sandwich of a general (β−α−β−β−α−β) configuration dubbed the PD-module (lower inset). This is repeated
through the porter subdomains PN1/PN2 (belonging to the N-terminal loop) and PC1/PC2 (C-terminal loop), respectively. Subdomains PN1/
PC2 and PN2/PC1 form discrete units coupled by a shared β-sheet. The docking or funnel domain comprises two subdomains, DN (or FN) and
DC (or FC) respectively, which are topologically derived from the basic PD-fold of the PN/PC domains, by a flippage of the β2-β3 hairpin out of
the central β-sheet (upper inset). The long β-hairpins of the DN and DC domains connect neighboring protomers by forming interprotomer β-
sheets.
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fold symmetric repeats of 6 TM helices (Figure 5A, D). Two
central helices, TM4 from repeat 1 and TM10 from repeat 2,
are surrounded by the other TMs. TM1 and TM7 are located
more at the periphery of the TMD of each protomer (Figure
5D). Structures and mutational studies were conducted on
charged residues within the TMD, i.e. residues D407 and
D408 in TM4, K940 in TM10, and R971 in TM11,279,325−328
and indicated the importance of the respective charges at these
positions. Both TMD repeats are connected between TM6 and
TM7 by a horizontal amphipathic helix (Iα), which is located
in the cytoplasm presumably near the membrane (Figure 5A).
Between the protomers, there is a small contact interface
located between TM1 and TM8.329 The TMDs of the
protomers encircle a lipid filled central cavity279,330 (Figure
5D). The extensive periplasmic part with a maximum diameter
of 100 Å is formed by the periplasmic loops protruding into
the periplasm between TM1 and TM2 as well as TM7 and
TM8 (Figure 5A). This part is subdivided into the membrane-
proximal porter domain (40 Å length) and the distal funnel
domain (30 Å) (Figure 5A, B, C). The porter domain
comprises four subdomains (Figure 5B; Figure 6). The
periplasmic N-terminal PN1 and PN2 subdomains are
protruding from TM1 and TM2; subdomains PC1 and PC2
are the C-terminal segments of the TM7/TM8 loop. The
subdomain structures display two α-helices at the external side
together with four- (PN2 and PC2) or five- (PN1 and PC1)
stranded antiparallel β-sheets at the interior. The cores of the
PN1/PN2 and PC1/PC2 domains are organized around a
similar basic architecture, which we refer to as the porter
domain or PD module, presenting a mixed α-β sandwich of a
general (β−α−β−β−α−β) configuration (Figure 6). This is a
very versatile module, that is shared across a number of
transporters both within and outside the RND family, as well
as with a number of other, predominantly periplasmic proteins,
as will be discussed in detail in the MacB section below.
Subdomains PN1/PC2 and PN2/PC1 form discrete units
coupled by a shared β-sheet. A top view of the porter domain
(Figure 5B; Figure 6) exhibits an arrangement of the PN1
subdomain located in the trimer’s inner surface and the more
peripheral exposed PN2, PC1, and PC2 subdomains. A cleft
between the PC1 and PC2 subdomains in the L and T
conformation forms a solvent exposed protomer substrate
entry site. The funnel domain (also called the docking domain)
comprises two subdomains, FN (DN) of the N-terminal
periplasmic loop and FC (DC) of the C-terminal periplasmic
loop (Figure 5C; Figure 6). The funnel domain is a large water
exposed cavity and is involved in the collection of exported
drugs from the O protomer (Figure 7A). The membrane-
located and proximal central cavity and the distal periplasmic
funnel are separated by the central pore helices of the PN1
subdomains at the center of the trimer porter domain (Figure
6B; Figure 7A). The protomers are noncovalently connected
by long interconnecting loops emerging from the FN to the FC
subdomains protruding in the neighboring protomers279
(Figure 6A) and have been found essential for the trimeric
assembly.331,332 The asymmetric structure of AcrB comprising
the L, T, and O protomers revealed the presence of a substrate
tunnel or channels (referred to as CH1 to CH4)318,319,333,334
(Figure 7). The concept of tunnels leading from the surface of
the protein to the active/substrate binding site of proteins was
known for soluble proteins; however, the peristaltic pump
concept318 was rather different, as it suggested that drugs are
not diffusing through these tunnels (Figure 7C) but guided
along the path by conformational change, therefore enforcing
directionality (to the outside). The initial hypothesis
anticipated an ordered binding process (assumed to be valid
for all drugs recognized by this pump, e.g., β-lactams,
Figure 7. Structural features of AcrB. The asymmetric AcrB trimer comprises three protomers adopting different conformations (L, looseblue; T,
tightyellow; O, openred). (a) AcrB can be structurally subdivided into a funnel (FD), a porter (PD), and a transmembrane domain (TMD).
The TMD consists of 12 transmembrane helices (TMs) per protomer (shown are the L (blue) and T (yellow) protomers; the O protomer is
omitted for clarity). The TMD of the three protomers encloses a central lipid-filled cavity. Likewise, the FD of the AcrB trimer forms a funnel
region, which is exposed to the channel structures of AcrA and TolC and facilitates the export of drugs across the OM. (b) Drug entrance sites are
highlighted on the L protomer (blue). The vestibules are interprotomeric entrance channels (shown here is the vestibule between the O (red) and
L protomers) toward the central cavity. The indicated TM7/8 groove in the L protomer is the entrance toward channel 1 (CH1, shown in panel c).
This groove is also present in the T protomer. The cleft between the PC1 and PC2 subdomains, apparent in both the L and T protomers (indicated
only for the L protomer), is the entry side for channel 2 (CH2, shown in panel c). (c) The asymmetric AcrB trimer comprises substrate entry
channels in the L and T conformations. The entrance of channel 1 (CH1) starts above the TM8/TM9 groove and guides substrates from the outer
leaflet of the inner membrane to the AP and further to the DBP. The cleft pathway via channel 2 (CH2) likewise leads to the AP. Compounds
sequestered in the central cavity via the vestibules between the protomer interfaces can access channel 3 (CH3) for transport directly to the DBP.
All entry channels are closing during the T to O transition. Concomitantly, an exit channel is created in the O protomer that connects the closed
DBP to the FD.
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tetracyclines, fluoroquinolones, macrolides, detergents), com-
prising initial binding to the access pocket, followed by binding
to a deep binding pocket and finally extrusion via an exit
tunnel. In the L protomer, the AP is open and the DBP is
closed. Substrates can access the AP from the periplasm via the
open PC1/PC2 cleft (Figure 5B). Furthermore, a large groove
is formed by TM7-9, where the substrate dodecylmaltoside is
observed in several AcrB structures.290,319 However, the T
protomer appears to have multiple channels leading to both
the AP (reduced in volume compared to the L protomer access
pocket) and the DBP (Figure 7C). Channel 1 (CH1) starts at
the TM7/8 groove (also referred to as the TM8/9 groove) and
leads to the AP, past the switch loop, to the DBP.290,319,335 The
channel 2 (CH2) entrance is at the PC1/PC2 cleft and also
leads to both binding pockets.318,319,333 Channel 3 starts from
the lipid filled central cavity and leads directly to the DBP (and
not to the AP).333 Finally, a fourth channel (CH4, not shown)
was postulated starting from the TM1/2 groove also directly
toward the DBP.334 Interestingly, despite the overall substrate
polyspecificity of the AcrB efflux pump, the channels appear to
have restricted access to certain drugs, although it is not yet
clearly defined for every channel and channels might have
overlapping specificities.333 CH1 is possibly involved in the
transport detergents and smaller drugs, such as β-lactams. CH2
has a wide entrance and leads directly from the periplasm to
the AP and is most likely involved in the transport of high
molecular weight drugs such as macrolides. CH3 has been
shown to be involved in planar aromatic cations, such as
ethidium or rhodamine 6G.333 CH4 is proposed to be involved
in the transport of carboxylated drugs, such as fusidic acid and
β-lactams.334 Further studies have to be conducted to analyze
the precise substrate preferences and overlap between the
different channels.
5.1.4. Substrate and Inhibitor Binding to Multidrug
Efflux RND Transporter. Structural analysis has been
conducted for several RND transporters, among them
structures revealing the binding of substrates (drugs) to
various areas within the porter domain and to the TMD
grooves between TM1 and TM2 and between TM7 and TM8.
Here, we describe the substrate and inhibitor binding to the
multidrug efflux RND transporters from the hydrophobic/
amphipathic exporter-1 (HAE-1) family. For an excellent
review of antibiotic/inhibitor complex structures of this family
and those of the related heavy metal ion exporter family
(HME), the reader is referred to the work of the group of
Edward Yu and his current review in the same issue of this
journal.336 The L, T, and O states are structurally different
both in the TMD and the porter domain, but the differences
are especially apparent at the structural level of the porter
domains (Figure 5B). Of note, crystallographic analysis of the
symmetric (LLL) state279−287,337 suggests that this trimeric
conformation might be the resting state of the transporter.
Some of the structures presented in the articles referenced
above also present drugs bound to the L protomer TMD/
periplasm interface region and the PC1/PC2 cleft region in
this symmetric state.
For the asymmetric AcrB structures,288−294 binding in the
trimeric HAE-1 pumps occurs in the L and T states. In the
compact O state, the only volume inside the periplasmic porter
domain is the exit tunnel (Figure 7C). The drug binding access
pocket (AP) is located between the β-sheets of the PC1 and
PC2 subdomains in the L state. AcrB co-structures with high
molecular weight compounds such as rifampicin, erythromy-
cin289 (Figure 5B), and dimeric doxorubicin290 indicate
different binding preferences within the AP. In accordance
with the multisite-drug oscillation hypothesis,338 drug binding
occurs at various subsites with the AP. While rifampicin and
dimeric doxorubicin bind in the approximate center of the AP,
the interaction surface of erythromycin is shifted deeper into
the AP of the protein (Figure 5B).
During conformational change from the L to the T
conformation, the DBP opens and is accessible for drug
binding. The AP and DBP are separated by a glycine rich
(G614, G616, G619, G621) switch loop emerging from
subdomain PC1. Consisting of only 11 amino acids, the switch
loop is highly flexible. Structures revealed its function as an
adapter for the binding of various drugs, modulating the shape
and interaction surface of both binding pockets without
changing the overall AcrB structure.289 The switch loop is
therefore directly involved in substrate binding, adopting
diverse conformations. The important role of the switch loop
for the drug transport mechanism was further emphasized in
biochemical assays, exhibiting dramatic effects of single side
chain substitutions (especially substitutions of glycine to
proline) on the resistance phenotype.289,290,339,340 On the
other hand, a complete inactive AcrB variant, where the glycine
to proline substitutions apparently rigidify the loop, can be
rescued by additional substitution of F615 and F617 to
alanine.340 Moreover, binding of erythromycin to its binding
site as observed in the wild-type protein, appears to be
unaffected in an AcrB variant devoid of the switch loop (by
deletion).293
The opening of the DBP during the L to T conversion is
mediated by an outward movement of the PN2/PC1
subdomains, while the PN1/PC2 subdomain unit remains
almost rigid.292 Simultaneously, the AP is contracting and
narrowing the available binding sites. It is anticipated in this
step that substrates can slide underneath the switch loop from
the AP into the DBP. Substrates are observed at diverse
positions of the DBP.290,305,341,342 Figure 8 illustrates the
positions of the substrate molecules minocycline, doxorubicin,
Figure 8. Drug binding to the DBP of the AcrB T conformer.
Superimposition of the coordinates of minocycline (MIN, carbon =
green; PDB: 4DX5), doxorubicin (DOX, carbon = violet; PDB:
4DX7), rhodamine 6G (R6G, carbon = pink; PDB: 5ENS), and
puromycin (PUY, carbon = orange; PDB: 5NC5) in the DBP.
Substrates are shown as sticks, the PN2/PC1 subdomains are
represented as a cartoon, colored in yellow. The switch-loop is
highlighted in green.
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rhodamine-6G, and puromycin in the DBP of AcrB. Binding by
conserved Phe residues (F136, F178, F615, F617, and F628) is
especially apparent for many of the substrates in the DBP. The
phenyl rings of rhodamine 6G favor an interaction via π−π
stacking in the DBP cave341,343 near the hydrophobic trap,
located in the center of the DBP (Figure 5. The planar
tetracycline minocycline on the other hand is bound in the
more distal narrow groove (DBP groove) in the upper part of
the pocket288,290 (Figure 5B, Figure 8). The AP in the L
protomer binds high molecular weight drugs such as
macrolides or ansamycins289 (Figure 5B). Direct transport
competition of macrolides with another high molecular mass
compound, the fluorophore DiBAC4-(3), substantiated the
drug size-preference by the AP,344 whereas low molecular
weight drugs such as tetracyclines, which are observed to
preferentially bind to the DBP, do not interfere with DiBAC4-
(3) transport. Low molecular weight compounds rather affect
the transport of the low molecular mass fluorophore Nile
Red.344,345 While planar aromatic cations are preferably
transported via CH3, all substrates have to traverse the DBP
region during the T to O transition which results in transport
toward the funnel domain via the exit gate (Figure 5C).
Analysis of the published AcrB/substrate co-structures
indicates which and how many residues are located around
the individual substrates within a radius of 3.5 Å, a distance
which makes them likely to be involved in substrate binding.
Table 3 shows an organization of the residues into the outer
and the inner AP, the AP-DBP interface at the switch loop, and
the DBP groove and cave as well as an assignment of the
(potentially) interacting substrates.
The assignment of substrates binding to the upper DBP
groove region or the lower DBP cave region or binding to both
regions of the DBP (i.e., mixed binders) is based on docking
and MD simulations.343,346 The groove region is formed by
converging β-sheets of the PN2 and PC1 subdomains in the
upper part of the DBP, while the cave (limited downward by
the TMD) provides a much larger cavity. In contrast to
substrate binding, AcrB inhibitors of the pyridopyrimidine
(ABI-PP) and the pyranopyridine class (e.g., MBX3132) bind
to a much larger area of the DBP.291,341 Both inhibitors were
shown to significantly potentiate the activity of known
antimicrobials without exhibiting membrane disruption effects
or antibacterial activity.347,348 The co-structures display
extensive interactions of the inhibitors with both groove and
cave regions. From this, the mechanism of action was
suggested to be competition with substrates to bind to the
DBP and/or conformational arrest of the T protomer.291,341
The aromatic moieties of the inhibitors engage in intensive
π−π stacking interactions with specifically side chains F178
and F628. The pyranopyridine core structures of other MBX
derivatives (MBX2319, MBX2931, and MBX3135) showed
thereby essentially the same binding properties as
MBX3132.341 Binding and stabilization of the inhibitor
includes water-mediated protein−ligand interactions, and
computational structural analysis indicated that the binding
affinities of the inhibitors were significantly exceeding those of
AcrB substrates.341,349 Both inhibitors ABIPP and MBX3132
are of similar size as DBP binding drugs; however, the
inhibitors contact 2−3 additional side chains (Table 3)
apparently stabilizing the inhibitor/protein interaction. Sub-
strate (drug) binding appears to be less reliant on specific
interactions as van der Waals interactions are preferred over
hydrogen bonding. Cocrystallized rifampicin, erythromycin,
and doxorubicin dimer are in contact with 13−20 amino acid
side chains within the AP, and residues such as M575 and
F666 are contacted by any of these drugs (Table 3). Smaller
drugs such as minocycline, doxorubicin monomer, rhodamine
6G, and puromycin display less contact sites in the DBP. The
additional hydrogen bonding contacts with the inhibitors
might stabilize the overall geometry of inhibitor binding and
intensify the van der Waals interactions in other regions of
inhibitor contact.
Some progress has also been made in understanding the
residues involved in binding of natural substrates to RND
transporters. For example, in MtrD critical residues including
F136, F176, I605, F610, F612, and F623 have been highlighted
to be essential for bacterial resistance to cationic antimicrobial
peptides including polymyxin B.141 Additionally, the W136 and
R176 residues in MtrR have also been shown to be important
for binding of the bile salt chenodeoxycholate.140
Table 3. Assignment of Potentially Interacting Residues with Substrates Found in Crystal Structuresa
aAll residues with atoms found in a radius of 3.5 Å around one of the co-crystallized ligands were assigned according to their localization to the
outer AP (cleft), the AP-DBP interface, and the DBP cave and groove regions. Potential interactions with a substrate are indicated in green. The
numbers after the ligand/substrate give the sum of potential interacting residues per substrate. Rifampicin and the doxorubicin dimer are found
exclusively interacting with residues of the AP and the interface region between the AP and DBP, while erythromycin also interacts with parts of the
DBP cave and groove. Puromycin, binding underneath the switch loop, makes contact to all five indicated sections. Rhodamine 6G, minocycline,
and doxorubicin bind to the DBP, primarily (but not only) to the groove region. The inhibitors, ABIPP and MBX3132 as a consequence of their
orthogonal orientation, are interacting with both groove and cave regions of the DBP. Adapted with permission from Kobylka et al.342 Copyright
2019, Kobylka, Kuth, Müller, Geertsma & Pos under Creative Commons Attribution 4.0 International Public License: https://creativecommons.
org/licenses/by/4.0/legalcode.
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5.1.5. Drug/Proton Antiport Coupling in AcrB. For all
characterized RND efflux pumps thus far, energy coupling is
mediated via the proton-motive force (in one described case,
sodium-ion motive force).119 In the TMDs of all RND
transporters, at least one acidic residue appears to stay central
to proton binding and release.233 Proton binding or release is
coupled to changes in the electrostatics at the interface of the
N- and C-terminal transmembrane repeats (TMRs) leading to
conformational change and transduction of that movement
toward the soluble parts of the transporters involved in
substrate or ligand binding. For AcrB, this process has been
studied by many laboratories in more detail compared to other
RND transporters. Substitution of the central acidic residue or
residues has been conducted most of the time for all studied
RND proteins and was shown to be essential for activity. For
AcrB, proton binding and release is facilitated by residues
D407, D408 (on TM4), and K940 (TM10), the proton relay
triad, located in the TMD core of each protomer at the
interface of the TMRs described below (Figure 9). A further
critical residue is R971 on TM11, possibly involved in the
coordination of a network of water molecules connecting R971
with D407 and D408 and, in this way, affecting the pKa values
Figure 9. Proton binding or release induces conformational change of the transmembrane domain structural repeats. (A) Substrate/proton antiport
catalyzed by AcrB can be described by two coupled mechanisms. A conformational switch from L (blue) to T (yellow) is mediated by substrate
binding in the DBP of the porter domain. The rearrangement of subdomain unit PN2/PC1 leads to a downward movement of linked TM2.
Consequently, the TMR1−TMR2 interface rearranges and opens a periplasmic proton entry site. Protonation of residues D407 and/or D408
results in separation of the TMR1−TMR2 interaction network. A conformational change to the disengaged state results in a switch to the O-
conformation (red). TM2 moves upward and the upper part of TM8 undergoes a random-coil-to-helix transition, while binding pockets in the
porter domain collapse and the exit channel becomes accessible. The proton binding site opens to the cytoplasmic side. Protons are released in the
cytoplasm, down the electrochemical gradient. Charged D407 and/or D408 switch the TM domain back to the engaged state. This conformational
change translates back to the porter domain. Proton entry and exit are presumably mediated through a network of water molecules. (B) Close view
of the proton relay comprising D407, D408, K940, and R971. These residues undergo the most dramatic conformational change during the T to O
transition. In the L (blue) and T (yellow) conformations, water molecules mediate electrostatic contact between D407/D408/K940 with R971. In
the O state (red), the transmembrane domain is (almost) dehydrated, greatly affecting the pKa values of the titratable residues. (C) Insight into the
structural details of the interaction of D407 in the O conformation; the H-bonding interaction of the carboxyl group of D407 with the carbonyl
group of G403 is only possible if D407 is protonated. A central water molecule connects (by hydrogen bonding) the interaction partners on TM4
(D407), TM10 (K940), and TM11 (T978).
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of the carboxylates.292 Substitution of one of these highly
conserved residues abolishes substrate extrusion alto-
gether.279,325−328 Two TMRs consisting of transmembrane
helix 1 (TM1) and TM3-TM6 (transmembrane repeat 1,
TMR1) as well as TM7 and TM9-TM12 (TMR2) are
arranged in parallel pseudosymmetric fashion.292 During
conformational cycling, the TMR1 and TMR2 repeats act as
rigid bodies and remain internally largely unchanged. However,
relative movements between the TMRs are a rocking motion
during L to T transition and a shear motion when the TMD
changes from T to O. The cytoplasmic horizontal helix Iα
(Figure 6A), connecting TMR1 and TMR2, shows a rigid
motion in relation to TMR2. Flanking helices TM2 and TM8
are presumably the coupling elements mediating crosstalk
between the TMD and the porter domain of AcrB292 (Figure
9); TM2 is thereby linked to the PN2/PC1 subdomain unit,
and TM8 is connected to the PN1/PC2 tandem (Figure 6B).
A downward movement of TM2 relative to TMR1 occurs
during the conformational change from L to T. This is most
likely due to the binding of substrate to the DBP, which
stabilizes the separation of the PN2/PC1 subdomain unit. This
process is reversed during the T to O transition. The latter
transition is catalyzed by the protonation of the TMD causing
conformational change between the two TMRs. As a result,
TM8 switches from a disengaged state from TMR2 in the L
and T state, to an engaged state in the O conformation. A short
sequence between TM8 and the PC2 subdomain, the hoisting
loop,350 thereby undergoes a random-coil-to-helix transition,
and TM8 becomes a compact elongated α-helix.292 The
hoisting loop is an important factor in conformational coupling
of TMD and the periplasmic porter domain. Mutagenesis
studies revealed that it is not actively involved in energy
transduction, but its high flexibility is crucial for conforma-
tional cycling.350 High resolution structures of the L-, T-, and
O-states, both of wild-type AcrB and D407N, D408N, K940A,
and R971A variants, reveal different interaction networks in
this energy conversion machinery.290,292 In the L- and T-
conformations, TMR2 K940 forms an ionic interaction with
D407 and D408 in TMR1. An additional hydrogen bond
between D407 and T978 in the second repeat further
contributes to the stabilization of the TMR1−TMR2 complex.
Residue R971 in TMR2 forms yet another interaction with
TMR1 via E414 and N415. With change to the O-
conformation, the proton relay residues twist and reconfigure
as a result of the rigid body motion of TMR 1 and TMR2. In
the disengaged state, connections of TMR1 and TMR2 are
replaced by intra-TM repeat interactions.292 As such, the
TMRs switch between an engaged and a disengaged state
during cycling (Figure 9). One of the most discussed questions
on the proton transport is the number of protons transported
per LTO cycle. Since there are two titratable residues (D407
and D408), the anticipated number is either one or two. There
is good biochemical, structural, and molecular dynamic
evidence that D408 is protonated and deprotonated during
the entire cycle.292,328,351−353 For D407, molecular dynamics
studies show that it remains deprotonated (charged) in the O
state,351,352 whereas other structural and molecular dynamics
studies suggest a protonation of D407 (and D408) in the O
state.292 In particular, the D407 residue in the wild-type AcrB
structure (at 1.9 Å resolution) is in hydrogen bond distance
with the carbonyl oxygen of G403 of TM4, implicated to be
responsible for the stabilization of the observed kink in TM4 in
the O state (Figure 9C). A hydrogen bond as observed in the
structure will only be feasible if the D407 is protonated. It is
very clear that further analysis, including determination of
proton per cycle stoichiometry in in vitro reconstituted systems
and the protonation state of K940 during the cycle, have to be
done to obtain more insights onto this basic question.
5.1.6. Structures of Other HAE-1 RND Transporters.
Besides AcrB, HAE-1 RND transporter structures have been
solved via X-ray crystallography or single-particle cryo-EM. For
MexB from P. aeruginosa, crystal costructures showed
dodecylmaltoside (DDM),295 a pyridopyrimidine inhibitor
(D13-9001, also referred to as ABI-PP,291 lauryl maltose
neopentyl glycol (LMNG), CYMAL6 neopentyl glycol, or
CYMAL-7 neopentyl glycol296 bound to the DBP of the T
protomer. For MtrD of N. gonorrhoeae, an X-ray structure of a
symmetric LLL trimer297 showed a possible resting state of this
pump. Recently, a cryo-EM structure of the asymmetric LTO
trimer in complex with hydrolyzed, decarboxylated ampicillin
or erythromycin in the DBP of the T protomer was solved.298
In the case of erythromycin binding, it clearly revealed that a
high molecular weight, despite its size, can be present in the
DBP cave region. Further structures of HAE-1 family
transporters included those of AdeB of A. baumannii300 and
CmeB from C. jejuni.299 The AdeB trimer, with its structure
solved by single particle cryo-EM, showed an OOO
conformation, where every protomer lacks a distinct drug
binding site. This OOO conformation was previously
suggested to be sterically precluded in the case of the AcrB
trimer transport cycle.292 For CmeB, two different trimer
conformations were observed from structures obtained by X-
ray crystallography. One state appeared to be again an
approximate OOO state, i.e. with every protomer in the
trimer in the extrusion state revealing an exit channel toward
the funnel domain. In the other trimeric state, three different
conformations were observed, one binding state, similar to the
T state of AcrB, and one extrusion or O state, and the third
protomer was in an intermediate state, unlike the L, T, and O
states, which was designated a “resting” state. A similar
protomer conformation was found for the HME-family Cu+-
RND pump, CusA, in the apo-state354 of the crystal structure.
The functional implication for this observation was tested with
CmeB-containing proteoliposomes and different labeling of the
protomers in order to observe single-molecule FRET signals
upon conformational change of the protomers relative to each
other. Interestingly, the results were not in accordance with a
concerted cycling of the protomers in the trimer but rather
supported the independent (i.e., not dependent on the
conformation of the neighboring protomer) conformational
change of each of the protomers during transport. Of note, the
study was done with the isolated RND component (CmeB).
Concerted cycling, however, might be highly supported by the
PAPs (like in this case CmeA) and the outer membrane
channel (CmeC) to generate a concerted cycling in vivo.
Recently, single-particle cryo-EM structures of AcrB wild-type
and of a clinically relevant resistance mutant G288D355 from S.
Typhimuirum were solved using purified samples in styrene
maleic acid (SMA) copolymer.301 The AcrB trimer structure
revealed a similar state as observed for the E. coli LLL state;279
however, slight differences between the protomers were
observed, in accordance with previously predicted flexibility
within the porter domain of E. coli AcrB by molecular
dynamics simulations.356 For the G288D variant, it was
observed that the residues around D288 show a notable
shift, which may represent the observed increase in bulk waters
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and large change in electrostatics.355 All-atom molecular
dynamics simulations indicated the increase in volume in the
area close to D288 compared to the wild-type (G288) and
increase in the number of water molecules present in that
region.
5.1.7. HME Family. The members of the Gram-negative
heavy metal-ion exporter (HME) family catalyze the efflux of
heavy metal ions from the periplasm across the outer
membrane albeit that in vitro studies show that these proteins
are also able to transport heavy metal ions across the inner
membrane. These family members can be further categorized
into several subfamilies (HME1-5).357 The tripartite Zn2+-
exporter ZneCAB is involved in the extrusion of specifically
Zn2+ ions, and the structures of the RND-component ZneA
were solved in different conformations of the anticipated
transport cycle, with Zn2+ bound to a proximal or distal
binding site in the periplasmic domain.358 Reconstitution of
ZneA in liposomes and Zn2+ transport experiments suggests
transport of Zn2+ from the cytoplasm or periplasm, in an
electrogenic fashion. The CusCBA complex catalyzes the efflux
of Cu+ or Ag+. Structures of CusA alone and in complex with
the PAP CusB have been solved.354,359 The TMD and the
periplasmic part of the RND transporter CusA contains five
methionine clusters which are proposed to coordinate metal
ion transport through the protein. The uptake of Cu+ or Ag+
from the periplasm involves also the nonessential metal-ion
chaperone CusF, from which Cu+ is transported via the PAP
CusB to the Cu+-binding site in the periplasmic part of
CusA.360
5.1.8. Other Bacterial RND Transporters. Nodulation
factor exporter (NFE) family members are supposed to act as a
single component of nodulation factors as NolGHI, coding for
a single gene,361 was identified in the Gram-negative root
nodule bacterium Rhizobium meliloti.362 An NFE transporter of
the plant pathogen Pseudomonas syringae, involved in the
export of the lipodepsipeptides syringopeptin and syringomy-
cin, and YerP from the Gram-positive bacterium Bacillus
subtilis, involved in the secretion of lipodepsipeptide surfactin,
are further examples of NFE family members.274 Members of
the SecDF family are of bacterial or archaeal origin and have
been shown to assist in protein translocation over the
cytoplasmic membrane mediated by the SecYEG translocon.
Thermus thermophilus SecD and SecF display a heterodimeric 2
× 6 TM setup with a typical monomeric RND motif.363−366
SecDF captures the SecYEG transported precursor protein on
the periplasmic side with its soluble periplasmic domain and
can independently finalize the complete translocation at the
expense of the PMF, even in the absence of SecA-mediated
ATP-hydrolysis (see section below).
5.2. Major Facilitator Superfamily (MFS) Transporters
The diverse major facilitator superfamily (MFS) is thought to
be the largest group of membrane transporters found in all
organisms.367−371 Members are uniporters, symporters, and
antiporters comprising approximately 400 to 600 amino acids
and 12 or 14 transmembrane helices (TMHs). Many MFS-
members are involved in the uptake of nutrients, such as sugars
and amino acids. This occurs in symport with H+ and depends
on the substrate and stoichiometry, at the expense of the
electrochemical gradient across the inner membrane. The
general architecture of the prototypical MFS transporters
(Figure 10) consists of a polypeptide chain that contains 2
lobes of 6 (or 7) transmembrane α-helices, which gives rise to
a 12-TM or 14-TM “clam-like” assembly with a central
symmetry between the two respective N- and C-terminal
lobes,372 although 24 TM-spanners exist, such as NarK from
Paracoccus pantotophus,373 which can be demonstrated to have
evolved from the fusion of two homologous, but distinct 12-
TM MFS permeases. The substrate pathway is thought to be
formed between the two lobes of the permeases using an
alternating access mechanism with a single substrate binding
site.374 The high-resolution structures of the glycerol-3-
phosphate:P antiporter GlpT374 and the lactose:H+ symporter
LacY375,376 confirmed the existence of a pseudo-2-fold
symmetry, which was predicted based on the sequence
similarity of the two 6 TM-lobes of the prototypical MFS
transporters, suggested to have arisen from a 3 TM helical
element, known as MFS fold via two successive gene-
duplication events,377,378 although this evolutionary scenario
has been challenged more recently.379
In MFS transporters four motifs, A−D, have been identified.
Motifs A and B can be found in antiporters as well as
symporters. In the multidrug efflux antiporter MdfA from E.
coli, the sequence of motif A is 73GPLSDRIGRRP83 (mapping
to the TM2−TM3 junction; numbers relate to the position in
the EcMdfA sequence)381 and has been proposed to stabilize
the outward facing state,382 and that of motif B is
108FTLLRFLQG116 (TM4), with R112 as a pivotal residue
involved in the alternative access mechanism of drug/H+
antiport (Figure 11). Motif-C (154PLLGPLVGA162; TM5) is
unique for antiporters including MdfA381,383 and MdtM384 and
because of this is called the antiporter motif.385 Preceding
motif C is TM5, which shows a large deviation when
superposing the inward and outward open structures of
Figure 10. General topology of MFS transporters based on a
representative of the structure of E. coli EmrD (PDB ID: 2GFP).380
The topological diagram highlights the inverted structural repeats,
forming the N- and C-terminal lobes of the transporter, suggesting
multiple gene duplication events.
Figure 11. Alternating access mechanism by MFS transporters. The
transport cycle of MFS proteins seems to involve ordered binding and
release of proton and substrate; however, drug/proton stoichiometry
varies between family members.
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MdfA.383 Motif-D (26EFSTYIGNDMIQPGM40; TM1) is not
very common in MFS transporters but conserved in MdfA
orthologs. It includes the important titratable residues E26 and
D34 involved in proton binding and release (see below).
The X-ray structures of the GlpT374 and LacY375 also
provided a mechanistic model for the operation of the MFS
transporters which has become known as the “rocker-switch”
mechanism. In this model, the clamlike transporter opens up
only to one side of the membrane at a time, preventing
formation of a continuous aqueous conduit across it. In the
case of LacY (symporter) this cycle involves binding of lactose
and protons on the periplasmic side, causing closure of the
“clam” to the periplasm but opening toward the cytoplasm
releasing the cargo. The cycle for efflux pumps is suggested to
be inverted. In terms of energy coupling, the MFS transporters
catalyze uniport and symport of solutes using cation gradients
(predominantly protons but occasionally Na+) and, in the case
of exporters/efflux pumps, the antiport of solutes against
protons,369 often in conjunction with the negative-inside
membrane potential.386 Most MFS transporters exhibit a very
distinct substrate specificity; however, MFS transporters
involved in multidrug resistance, i.e. having a polyspecific
substrate spectrum, have also been identified.387 Drug/H+
antiporters (DHA) from the DHA-1 (12 TM segments) and
DHA-2 (14 TM segments) families are most commonly found
in bacteria. MFS transporters of the DHA-1 family are
arranged in 2 domains of 6 TMH bundles related in a
pseudo-2-fold symmetry.374,388 The well-studied DHA-1 family
protein E. coli MdfA transports a broad range of zwitterionic
and uncharged drugs from the cytoplasmic side to the
periplasm.389 Crystallographic structures indicate a central
cavity at the interface of the two TM bundles containing
exposed side chains involved in both drug and proton binding.
In MdfA, drug binds to the central cavity, formed by TM1,
TM4, TM7, and TM10. For MdfA, an inward open381 and an
outward-open conformation was recently reported.383 Trans-
port is mediated in an alternating access mechanism381,390,391
(Figure 11).
Two conserved acidic residues, E26 and D34, have been
shown in MdfA to be involved in proton binding and release,
and the negative charge on D34 is not essential for substrate
binding as it could be replaced with asparagine without having
an effect on in vitro substrate binding.392 MdfA is broadly
flexible in recognizing electroneutral or monovalent cationic
drugs and catalyzes the efflux of these drugs in exchange with a
single proton, and there appears to be an indirect competition
mechanism between protons and substrates. However, MdfA
was shown to also transport divalent cations where the charges
were separated by a long linker. It is anticipated that the export
of these kinds of divalent drug molecules is in need of two
consecutive transport cycles, thereby consuming 2 protons.393
In Gram-negative bacteria, this large superfamily comprises
not only single component transporters but also tripartite efflux
machineries. Tripartite multidrug pumps of the MFS family are
encoded by chromosomal or plasmid genes, and usually PAP
and MFS are coded on a single operon (e.g., emrAB in E. coli,
salAB in Rhyzobium leguminosarum, or emrKY in Shigella
f lexneri), while the OMF is borrowed from another operon.
However, in some cases all three pump components are
encoded on one operon, such as the emrAB-emrC from
Chromobacterium violaceum.394 As an example, a tripartite
system is formed by the E. coli DHA-2 family MFS transporter
E. coli EmrB, which interacts with the PAP EmrA, connecting it
to the OMF TolC.395 While this is one of the first multidrug
efflux systems to be identified,396 direct structural information
about the complete assembly has not been available until very
recently.9 The EmrAB-TolC system provides resistance to a
number of antibiotics, from thiolactomycin (TLM) and
cerulenin397 to nalidixic acid and nitroxolone and of hydro-
phobic proton uncouplers, including carbonyl-cyanide m-
chlorophenylhydrazone (CCCP).396,398 EmrB contains 14
transmembrane helices, which sets it apart from other related
MFS exporters such as MdfA and EmrD, which feature 12 TM
helices. On TM1 and TM7, candidate aspartic acid candidates
for H+ and/or drug binding are present. To our knowledge, no
mutational analysis has been conducted on EmrB or EmrA, e.g.
to determine residues involved in H+ or drug binding. Other
identified tripartite MFS transporters are the VceABC system
from V. cholerae399 and the FarAB-MtrE system from
gonococci,79 with the latter involved in fatty-acid resistance.
The expression of the farAB genes is under the control of the
same regulator protein (MtrR) as the genes encoding the
RND-tripartite MtrCDE system, and for resistance, the FarAB
system shares the OMF (MtrE) with the MtrCD system.
5.3. Multiple Antibiotic and Toxin Extrusion (MATE)
Transporters
Based on phylogenetic analyses, bacterial MATE transporters
can be divided into the NorM and DinF subfamilies of 12TM
drug/Na+ or drug/H+ antiporters400 (for xenobiotic-trans-
porting eukaryotic MATE transporters the reader is referred to
Miyauchi et al.401). MATE family members transport
polyaromatic and cationic compounds, such as rhodamine
6G, ethidium bromide, and tetraphenylphosphonium
(TPP).233,400 Structures of Na+-dependent NorM subfamily
transporters have been solved by X-ray crystallography at 3.6 Å
resolution in cation- and substrate-bound states.402,403 X-ray
structures (3.2 Å resolution) of the Bacillus halodurans DinF
(DinF-BH) transporter of the DinF subfamily were solved in
complex with rhodamine 6G bound to the central cavity via
mostly hydrophobic interactions.404 From the same subfamily,
structures of pfMATE from Pyrococcus furiosus in two distinct
apo-form conformations, and in complexes with a derivative of
norfloxacin and three thioether-macrocyclic peptides, were
solved at 2.1−3.0 Å resolution.405 Despite MATE and MFS
transporters having different topologies in their pseudosym-
metrical 6 TM helix bundles, an alternating access mechanism
with ordered binding and release of proton and substrate
similar to that for MFS transporters has been proposed.406
5.4. Small Multidrug Resistance (SMR) Transporters
Members of the small multidrug resistance (SMR) transporter
family are the smallest membrane transporters identified thus
far.407 SMR transporters form parallel or antiparallel homo- or
heterodimers comprising 4 TMs to transport drugs in
dependence of the PMF.408,409 EmrE is the most studied
SMR transporter and contains an interprotomeric hydrophobic
drug binding pocket including a highly conserved Glu residue
that is essential for transport. In A. baumannii, a homologue of
EmrE, AbeS410 selects for the size and planarity of the
conjugated aromatic moieties on drugs. Moderate changes in
the property of side chains in the substrate binding site
resulted in large phenotypic differences.411 SMR family
members recognize and transport cationic lipophilic molecules
such as ethidium, tetraphenylphosphonium (TPP), or
acriflavine, which are extruded in an alternating access
mechanism.412 An apo-structure of EmrE and in complex
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with various substrates was created by molecular dynamic
(MD) simulations413 on the basis of a low-resolution EmrE X-
ray structure in complex with TPP.414
5.5. Proteobacterial Antimicrobial Compound Efflux
(PACE) Transporter Family
A transcriptomic study when A. baumannii was challenged with
the disinfectant chlorhexidine, resulted in the discovery of
AceI, which was the founding member of the proteobacterial
antimicrobial compound efflux (PACE) transporter family.415
PACE family members are small membrane proteins
comprising approximately 150 amino acids. Topology
prediction revealed putative 4 TMs in a setup similar to
members of the SMR family.416 AceI homologues were shown
to confer resistance to additional biocides, including
benzalkonium, dequalinium, proflavine, and acriflavine. For
the AceI homologue from Vibrio parahaemolyticus resistance to
proflavine and acriflavine was shown to be mediated by an
active efflux mechanism. Recently, it has been reported that
AceI of A. baumannii exists in a monomer−dimer equilibrium
that is regulated by pH. The binding of chlorhexidine and an
increase in pH was found to facilitate the functional form of
the protein.417
5.6. ABC Transporter Family
The ATP-binding cassette (ABC) transporters are an
extremely diverse superfamily of transporters with equally
diverse functions within the cell that are widespread across
both pro- and eukaryotic organisms. Classified as the TC#
3.A.1 by the transporter classification database, TCDB (http://
www.tcdb.org),418 the ABC superfamily forms the largest
functional superfamily of primary active transporters known,
and in Escherichia coli alone 79 ABC proteins have been
identified, making the ABC transporters the largest paralogous
family of proteins in its genome comprising 5% of its total,419
forming 69 independent functional systems, with some 57
being ABC transporters.129,420 Several different classification
systems have been proposed over the years to address this
diversity within the family, see refs 421−423, taking into
account both functional and topological data. Despite their
considerable diversity across the family, in general organ-
ization, the ABC transporters are built around a common basic
blueprint and in a first approximation can be seen as composed
of a dimeric transmembrane porter section, typically in a 6 + 6
transmembrane helix configuration, and a pair of cytoplasmic
nucleotide binding domains (NBDs), which provide energy
coupling for the transport process by ATP-hydrolysis and
could be found either as a part of a single polypeptide chain or
as separate subunits.424 While the NBDs of the ABC
transporters are relatively conserved across the superfamily
and contain highly conserved nucleotide binding motifs,
known as Walker A (GXXXXGS/T) and Walker B (hhhhD,
or h4B where “h” is a hydrophobic residue),
425 as well as the
ABC signature sequence LSGGQ (aka the C-motif), that
defines the family419,422 (see section 5.6.6 for detail and
graphic), the transmembrane porter domains are rather
diverse426 (see section 5.7.7 for details). Extensive bioinfor-
matic analysis427 has suggested that the porter domains of
ATP-binding cassette transport systems are polyphyletic and
have evolved three times independently, forming three families
which the authors designated ABC1, ABC2, and ABC3, upon
which the monophyletic ATPases have been superimposed for
energy-coupling purposes. It has been suggested that ABC1
porters have originated from intragenic triplication of a
primordial two-transmembrane segment (TMS)-encoding
genetic element, yielding six TMS proteins, while the ABC2
porters arose by intragenic duplication of a dissimilar
primordial three-TMS-encoding genetic element, yielding a
distinctive protein family, which is nonhomologous to the
ABC1 proteins.427 ABC3 clade of porters on the other hand is
suggested to have arisen via duplication of a primordial four-
TMS-encoding genetic element, yielding either 8- or 10-TMS
proteins.
Recent reclassification of the ABC transporters has
established some order in this overwhelming diversity of
ever-expanding structural and topological data, resulting in 7
main family “types”,423,428 and to avoid confusion the
discourse below follows this latest classification. Of these
newly defined seven classes, three types are importers, which
are of limited interest to the topic of interest here, while the
others include the following families: “type IV”, possessing 6 +
6 TM-helices membrane topology, includes both exporters
(e.g., Sav1866 and MsbA floppase) and importers (e.g.,
YbtPQ; Rv1819c); “type V”, in prokaryotes a 6 + 6 TM
topology of exporters/floppases including the Wzm-WztN O-
antigen transport system;429 and the “extractor”, ABC
transporters that remove compounds from the outer leaflet
of the membrane, that includes members with a 6 + 6 TM
membrane topology such as LptB2FG,
430 which possess
specialized β-jellyroll domains forming the type VI group, as
well as the 4 + 4 TM members of the MacB/FtsX family
constituting the newly defined type VII group.423 The known
structures of the latter group include MacB itself,24,272,431 as
well as the heterodimeric LolCDE lipoprotein sorting system
(LolC, PDB ID 5NAA;432 LolE, PDB ID 5UDF432) and the
FtsX family members (PDB ID 4N8N; 6HEE, 6HFX).433,434
In addition, the maintenance of phospholipid asymmetry
(Mla) MlaFEDB complex,435,436 the structure of which has
recently become available (PDB ID 7CGN; 7CH0; 7CGE;
6XBD),437−439 revealed unexpected structural organization of
the MlaE transmembrane domain, which might merit its
isolation into a new, separate topological group.
As the ABC transporters are subject to a number of reviews
(see refs 423 and 440), including in the current special issue of
Chemical Reviews itself,441 to avoid redundancy, below we will
focus on aspects of the organization of the ABC transporters
that are specific to their function within the context of the
tripartite assemblies. Indeed, despite the diversity of folds and
architectures described above, only two groups of prokaryotic
ABC transporters participate in tripartite assembliesnamely
the transporters associated with protein secretion and type 1
secretion systems (belonging to the type IV [exporter] group)
and the MacB/FtsX-like transporters (belonging to the newly
defined type VII),428,442 with only the latter of them
conclusively associated with efflux-function, despite some
recent circumstantial evidence.443
5.6.1. Type IV Family of ABC Transporters Involved in
Tripartite Assemblies. As mentioned above the ABC
transporters present a great structural variety, which corre-
sponds to an equally vast diversity of transported cargoes,
which vary from xenobiotics and dyes, to lipid and glyco-lipid
molecules; lipoproteins and outer-membrane components to
S-layer proteins; as well as an array of virulence factors,
including large adhesins, toxins, and smaller antibacterial
peptides.422,428 The latter two functions, that allow secretion of
proteinaceous cargoes bypassing the Sec-pathway, are served
by two related families of type IV ABC transporters, the first of
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which, often called the NisT/McjD family after its
representative members,444,445 is solely dedicated to cargo
transport and exclusively deals with smaller cargoes without
changing them during transport, while the second family
covers bifunctional transporters, which provide maturation as
well as transport function, proteolytically processing their
substrates, which are hence known as the peptidase-containing
ATP-binding transporters (PCAT) or ABC transporter
maturation secretion (AMS) family.446,447 These AMS/
PCAT family transporters, apart from small antimicrobial
peptides, are capable of transporting very large cargoes such as
toxins and adhesins and participate in formation of type 1
secretion systems (T1SSs) in Gram-negative bacteria.448,449 A
detailed description of these tripartite systems alongside a
graphic overview is provided in section 10. In the following
paragraphs, we will discuss both these transporter families in
turn, focusing on the transporters from Gram-negative
organisms, which contribute to tripartite assemblies. For
comprehensive reviews of the ABC transporters associated
with the antimicrobial transport in Gram-positive (Firmicutes)
bacteria please consult refs 444 and 445
5.6.2. NisT/McjD Family of Bacteriocin Transporters.
In their interspecies warfare, bacteria have developed a number
of adaptive strategies, including the production of narrow-
spectrum antimicrobial peptides, which they deploy against
their competitors, which are generally termed “bacteriocins” (a
term that also includes the heavily modified lantibiotics, which
do not always perform bactericidal function), and which in
Gram-positive organisms exert their action by disrupting the
membrane potential.450,451 When applicable to Gram-negative
bacteria these antimicrobial peptides are designated “micro-
cins”.447,452 A large class of these are the so-called ribosomally
synthesized and post-translationally modified peptides
(RiPPs),453,454 and they are primarily secreted by dedicated
ABC transporter systems, bypassing the Sec-pathway. Micro-
cins are gene-encoded antibacterial peptides, with molecular
weight below 10 kDa,455 and could be both modified and
nonmodified, with the latter group encompassing a great
variety of lasso peptides, siderophore peptides, nucleotide
peptides, and linear azole(in)e-containing peptides.452 While
the peptide antibiotics produced by Gram-positive organisms
mainly act as ionophores, the microcins, which are secreted by
the Gram-negative bacteria attack a diverse range of cellular
targets including DNA gyrase (microcin B17),456 protein
synthesis (microcin C7),457 and dissipation of the membrane
potential (colicin V).450
Figure 12. General view of the type IV ABC transporter topology and features of the typical type IV ABC transporter structure. Schematic
representation of the topology of the isolated monomer of ABC transporters belonging to the type IV group (panel A) and the dimeric formation
(panel B), highlighting the cross-protomer engagement of the nucleotide binding domains (NBDs) by the coupling helices 1 and 2 (CH1 and
CH2, respectively). The optional N-terminal C39 or C39-like domain (CLD), which is present in a subset of the family, is shown as a “packman”.
The TMD is presented as a rainbow from N- to C-terminal, and the EH represents the elbow helix. The second protomer of HlyB is presented in
gray. Approximate membrane boundaries are represented by the blue rectangle. (C) View of a microcin-transport associated McjD based on the
PDB ID 4PL0 (two side views 90° apart) highlighting the principal structural elements. Coloring as in panels A and B. (D) PCAT1 in complex with
its transported peptide CtA, based on the PDB ID 6 V9Z. The C39-domain is colored wheat.
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5.6.3. Structural Features of McjD and the Standard
Cycle of the Type IV ABC Family. The best studied member
of the family is the enterobacterial McjD transporter,458,459
which is involved in the transport of the eight-residue
macrolactam-containing lasso-peptide microcin J25 (aka
MccJ25).460 MccJ25 has a narrow spectrum and is principally
active against Salmonella and E. coli and provides the cells
expressing it self-immunity.461 McjD is related to the
prototypical NisT ABC transporter from the Gram-positive
Lactococcus lactis which is involved in the transport of the
commercially important lantibiotic nisin,444 with both of them
giving the name to the wider family. In E. coli, MccJ25 is
secreted by a dedicated ABC transporter McjD; albeit,
additional ABC transporters of the same group may be
involved, including YojI.63,462 Both McjD and YojI require the
action of the OMF TolC for the export of MccJ25, although it
is not clear whether any of them participate in bona f ide
tripartite systems or there is a soluble intermediate of
transport.63,462
The structure of the McjD (PDB ID 4PL0)459 is
representative of the type IV family of ABC transporters,
sharing close topological and structural similarity to other
canonical type IV transporters, such as Sav1866,463 MsbA,464
and Pgp/ABCB1465 (Figure 12). The structure of the
biological unit is homodimeric (overall dimension of ∼125 ×
55 × 50 Å), with each protomer composed of an N-terminal
TMD composed of 6 TM-helices and a C-terminal NBD. The
TM-helices are connected by extracellular and intracellular
loops, with the intracellular loops between TM2 and TM3 and
between TM4 and TM forming the “coupling helices” CH1
and CH2, respectively. Coupling helices interact with the
NBDs transducing the conformational changes induced by
ATP-binding and hydrolysis to conformational changes of the
TMDs. In a configuration that is typical for the type IV ABC
transporters,463,465 the CH1 contacts predominantly the NBD
of its cognate protomer, while the CH2 interacts exclusively
with the NBD from the opposing protomer, in a swapped-
protomer manner459 (see topological schematic Figure 12).
The membrane protein structural biology revolution has
dramatically increased our understanding of the mechanistic
operation of ABC transporters, largely displacing the earlier
models derived from kinetic and biochemical data, e.g. the
“alternating catalytic sites”466 and the connected “two-cylinder
engine” model.467 The “alternating access” allosteric model,
first postulated for major facilitator transport proteins,390 has
become a paradigm for ABC transporter action being used for
rationalization of the available crystal structures of Sav1866,
with the notable distinction being the suggestion that ATP-
binding and hydrolysis rather than substrate acquisition are the
main drivers of the conformational state transition.463 As its
name suggests, the functional cycle of the transporter is based
on the alternating inward- and outward-facing TMD
conformations of the protomers. This rather straightforward
model has undertaken a number of iterations and increased in
complexity over the years as more diverse ABC transporters
came to light. Some notable variations include the “Switch
Model”, which proposes that hydrolysis in each protomer is
sequential and that as the sites are freed of nucleotide, the
protomers lose contact.468−470 In this model, the ATP binding
and ATP-hydrolysis, respectively, induce formation and
dissociation of an NBD dimer, as seen in a number of crystal
structures, e.g., Sav1866463,471 and MsbA;464,472 furthermore, a
derived model of the P-glycoprotein (Pgp, aka ABCB1)
binding has been based on this approach.465
A second major group of models, known as “Constant
Contact”,473 has evolved from the alternating catalytic site
ideas,466,474 which were derived mostly from observations of
the cooperativity between the two nucleotide binding sites in
the P-glycoprotein. In that model, there is an alternating ATP-
hydrolysis in each NBD, with one site opening at the point of
ATP-hydrolysis, while the second site remains closed with
ATP bound and occluded, with the process repeating itself in
alternating cycles without the NBDs losing contact fully. This
model has gained support from a number of structures of
heterodimeric transporters, e.g., the TM287/TM288 from T.
maritima,475,476 BmrCD,477 and TmrAB.478,479 This may not
be restricted to heterodimeric transporters with degenerate
sites; however, e.g., experiments by Siarheyeva et al.480
identified an asymmetric and catalytically active state of the
Pgp/ABCB1 that did not show reduced binding of drug
substrate, suggesting that ATP-binding does not drive
transport, contradicting the “switch model”. It thus seems
plausible that the mechanistic cycles of different ABC
transporters may align closer to either one or the other
model, or indeed by a tuned-up, blended version of each,
giving rise to a considerable variety of allosteric modulation,
and these possibilities are further explored in dedicated reviews
(see refs 423, 473, and 481
The crystal structure of McjD reveals the transporter in an
outward “occluded TMD” conformation, presenting a
substrate-binding cavity, which is sealed both from the
periplasm and the cytoplasmic ends. This cavity, at ∼5900
Å3 is sufficiently large to accommodate the full microcin
allowing for a single-step translocation, with several residues
being specifically important for cargo recognition, notably F86,
N134, N302,459 and TM3/TM6 lining the walls of the cavity.
In comparison, the structure of the MsbA in an occluded,
ligand-bound state464 presents a conformation of its TM3 and
TM6, which bend toward the center of the TMD eliminating
the corresponding cavity.
As the McjD has been co-crystallized with the ATP analogue
AMP-PNP and MgCl2, both of its NBDs were found in a
dimerized, ATP-bound state, with the P-loop and ABC-
signature motifs involved in binding of the nucleotides, and
correspondingly the TMD is also closed up.459 The TMD−
dimer interface is formed by TM2 and TM5/TM6 from one
subunit, the binding of which to the equivalent TM5/TM6 and
TM2 from the opposite subunit buries a surface area of ∼7,100
Å2 per protomer. The structure of McjD suggested a model of
its conformational cycling,459 where the inward facing open
(IFo) apo-conformation allows binding of the transported
substrate to the transporter, which facilitates the transition into
an inward-closed conformation (IFc) which becomes ATP-
binding capable. The binding of the ATP to the NBDs at this
point was proposed to bring the transporter into a hypothetical
substrate-engaged occluded conformation (Occ), and it is
supposed to transit into a nucleotide bound outward-facing
open (OF) conformation. Upon release of the substrate, the
transporter was suggested to adopt an the outward occluded
(Occ) conformation yet again, however this time in a substrate
free state. The structure solved (PDB ID 4PL0)459 was
associated with this post-transport occluded stated, and
subsequent ATP-hydrolysis and release of the bound ADP
and Pi eventually resets the transporter to the initial (IFo)
configuration completing the cycle. Later the structure of the
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eukaryotic P-gp (ABCB1)465 has been used to further refine
this cycle.
Further research, adding pulsed electron−electron double
resonance (PELDOR) and single molecule Förster-resonance
energy transfer (sm-FRET) measurements to probe the
conformational changes and the dynamics of McjD along its
transport cycle,461,482 has led to the suggestion that irrespective
of the presence or absence of nucleotides, in the absence of
MccJ25, McjD remains in an occluded conformation and that
it requires both MccJ25 and ATP to open, presenting a
mechanism for the substrate transport and selectivity that was
dubbed the “occluded-mechanism with transient opening”.
Such a mechanism would make it distinct from the other type
IV ABC transporters discussed above, which are capable of
adopting an outward open conformation in the absence of
substrate.
5.6.4. ABC Transporters with Double FunctionsThe
Peptidase-Containing ATP-Binding Cassette Transport-
ers (PCAT) Family. These peptidase-containing ATP-binding
cassette transporters (or PCATs for short) are also sometimes
designated in the ABC transporter maturation and secretion
(AMS) family and also belong to the wider family of type IV
exporters, which possess a 6 + 6 TM-helix topology423,444 and
are present in both Gram-positive and Gram-negative bacteria.
The transporters involved in protein secretion and maturation
are unique among ABC transporters, due to the presence of
extra domains required for substrate recruitment and
processing. These domains typically have a proteolytic function
and are a result of a gene fusion with peptidases belonging to
the cysteine protease superfamily, classified as family C39,
bacteriocin-processing peptidase, with their protease activity
being dependent upon the catalytic cysteine, histidine, or
aspartate residues that are conserved among papain-like
cysteine proteases483 and are hence designated either as PEP
or C39 domains. Crystal structures of C39 domains, e.g.,
ComA,484 have confirmed their association with the Cys-
protease family. The substrates of the PCAT transporters
contain an N-terminal “leader sequence” that typically ends in
a double Gly-motif (variations G-G, G-A, or G-S), and
mutational analysis, based primarily on the quorum-sensor
pathway-associated transporter ComA, identified a consensus
leader-peptide recognition sequence of Leu(-12)-(X)3-Glu(-
8)-Leu(-7) located upstream from that double Gly-motif.484
In Gram-positive bacteria, PCATs function as both
maturation proteases and exporters for peptides involved in
quorum-sensing485 or antimicrobial peptides, including lanti-
biotic and nonlantibiotic bacteriocins, e.g., colicin V and
similar class II bacteriocins, and various classes of RiPPs, which
are extensively post-translationally modified over their C-
terminal core peptide.453,486−488 The biosynthetic clusters of
bacteriocins typically contain a dedicated PCAT exporter that
directs the processing and secretion of their respective cargoes
prior to membrane translocation at the conserved double Gly-
leader sequence described above,446,489 removing a roughly 2.5
kDa N-terminal fragment, which is necessary for cargo
secretion and activation of their antibacterial function.490
In Gram-negative organisms, PCATs, by pairing with
respective PAPs and OMFs, form type 1 secretion systems
(T1SSs) capable of exporting a range of virulence factors
including ligases, scavenging molecules, and pro-
teases,157,491,492 as well as gigantic adhesins with a mass over
1 MDa,6,493 e.g. in the export of hemolysin A the PCAT
transporter HlyB pairs with HlyCD.214,494
5.6.5. Unique Features of the AMS/PCAT Trans-
portersN-Terminal C39 Protease and CLD Domains.
Many of the T1SS transporters, as well as the PCAT
transporters involved in microcin/bacteriocin secretion possess
unique N-terminal C39-protease domains,3,447 e.g., the E. coli
MchF (UniProtKB: Q9EXN5), involved in the secretion of
microcin H47 ref 495; RaxB fromXanthomonas oryzae
Figure 13. C39 and CLD domains in AMS/PCAT transporters. (A) Structure of the catalytically active C39 domain from PCAT1 (based on PDB
ID 6V9Z).505 The main elements of the secondary structure, as well as the key catalytic residues are highlighted. (B) The structure of the C39-like
domain (CLD) of the HlyB transporter in identical orientation based on PBD ID 3ZUA.506 While the general architecture is preserved, the active
site cysteine residue is substituted by a tyrosine.
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(UniProtKB: Q5GWX4).496 These C39 domains are partic-
ularly associated with Gram-negative T1SSs involved in the
secretion of so-called repeats-in-toxin (RTX) cargoes,449 which
include adhesins,497 as well as hemolytic and cytolytic pore-
forming toxins,498,499 which feature a noncleavable C-terminal
secretion signal.500 As their name suggests, the RTX toxins are
defined by the presence of repeated glycine- and aspartate-rich
nonapeptide consensus sequences known as the “GG-repeats”
(GGxGxDxUx; where x is any residue and U is a bulky
hydrophobic residue).501 Depending on the transported cargo,
the GG-repeat number can vary from less than 10 to over
40.449 Concomitant with the secretion of the T1SS substrate
into the extracellular medium, the GG-repeats bind Ca2+ ions
with high affinity, triggering cargo-domain folding.500,501
The C39-domain (Interprot ID IPR005074) belongs to the
MEROPS502 peptidase cysteine-proteinase family CA,483,503
which includes proteins with a papain-like fold. This
homology-based prediction was confirmed, when the C32
and H105-residues of the N-terminal C39-domain of CvaB
transporter were shown to be critical for the calcium-
dependent cysteine protease activity and the secretion of its
native cargo colicin V.504 The crystal structure of the C39
domain belonging to the bacteriocin-associated ATPase ComA
from Streptococcus provided a structural template to the family
(PDB ID 3K8U).484 The structure revealed a domain
consisting of two subdomains with the active site sandwiched
between them. The smaller subdomain consists of a bundle of
three consecutive N-terminal α-helices, with the catalytic C17
located at the end of the first of them, and is positioned on top
of a larger subdomain, that presents a twisted antiparallel β-
sheet core (β1−β6) supplemented by two small α-helices (α4
and α5), and is contributing the active site residues H96 and
D112, consistent with a classical catalytic triad for CA cysteine
proteinases.484,503 A fourth residue preceding the catalytic
cysteine, in this case Q11, forms a part of an oxyanion hole that
stabilizes the acyl-intermediate formed during catalysis (see
Figure 13).484
The recent structure of the protease domain of the PCAT
transporter LahT from a lanthipeptide biosynthetic operon in
the Gram-positive Lachnospiraceae bacterium C6A11 in
complex with a leader peptide (PDB ID 6MPZ)507 provides
a model for the substrate recognition, where the helical region
of the substrate peptide is oriented in a small groove located
between the C39 domain and the NBD of the transporter,
providing an effective means to lock these domains together. In
addition, the leader peptide may serve as a backstop that
prevents the cleaved cargo from sliding back into the
cytoplasm and thus provides the directionality of transport
upon binding of ATP to the NBDs.
C39-domains have also been revealed in the structures of the
PCAT1 transporter both in the nucleotide free apo-state (PDB
ID 4RY2), in the ATP-analogue occluded state (PDB ID
4S0F),273 and in complex with the cognate substrate CtA
peptide (PDB ID 6 V9Z),505 all showing close correlation with
the one seen in CvaB and confirming the earlier cargo-binding
model derived from the isolated C39-domain507 (Figure 14).
As predicted, the peptide signature sequence (Leu(-12)-(X)3-
Glu(-8)-Leu(−7))484 makes a number of specific interactions
based on the conserved residues in the C39-domain which
facilitates its orientation for processing (Figure 14, panel E).
However, intriguingly the peptide-bound structure of PCAT1
presented asymmetric positioning of the cargoes, with one
being fully threaded into the transporter suggesting a
functional asymmetry. The C39-domain appears to orient
Figure 14. PCAT−cargo interactions mediated by their C39 and CLD domains. (A) Side view of the PCAT1-CtA transporter−cargo complex
based on the PDB ID 6 V9Z (Kieuvongngam et al.505). (B) Zoomed-in view of the C39 domain highlighting the interaction with the secretion
signal of the CtA. (C) Structure of the equivalent CLD domain in HlyB, with CtA superposed into the substrate binding groove. (D) View of the
CtA-threading into the substrate binding cavity of PCAT reveals the large substrate access cavern delineated by TM4 and TM6. (E) Position of the
cargo targeting motif of the CtA on the surface of the C39 domain, indicating the location of the conserved hydrophobic residues which provide the
docking and the GG-motif where the proteolytic cleavage occurs.
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the cargo, feeding the C-terminus first into a cleft formed by
the TM helices 4 and 6 leading into the large central cavity of
the transporter (Figure 14, panel D). Consistent with the
biochemical data, the cargo is not seen making specific
contacts with the TMD, which may explain the apparent
promiscuity of the PCATs.505 The energetic implications of
the CtA-bound structure are discussed in some detail in the
following sections.
A number of Gram-negative PCAT-type transporters seem
to possess “C39-like domains” or CLDs, which lack the
required proteolytic function,3 especially the ones associated
with the export of the so-called “repeats-in-toxin” (RTX)
cargos. These CLDs present different noncatalytic amino acids;
e.g., in the exotoxin-translocating ATPase PaxB (UniProtKB:
Q9RCG7), which is part of the PaxA secreting PaxBD
complex, a Y13 is present in lieu of a catalytic cysteine. The
leukotoxin translocation ATPase LktB from Mannheimia
haemolytica presents a L10, while an N9-residue is found in
place of the cysteine residue expected in the CLD of the
hemolysin B (RtxB) transporter from E. coli O157:H7
(UniProtKB: Q46717). While this is generally the rule, not
all RTX-repeat transporters have disabled C39-domains, e.g.,
CyaB involved in the transport of calmodulin-sensitive
adenylate cyclase-hemolysin (cyclolysin) (UniProtKB:
P0DKX5).33
One of the best-studied examples of a CLD-containing
PCATs is HlyB (UniProtKB: P08716), which is part of the
T1SS involved in the secretion of α-hemolysin (HlyA).508 The
N-terminal domain of HlyB shares ∼40% homology to C39
peptidases, but critically, this “C39-like domain” or CLD
displays a degenerated proteolytic site, with a catalytically
essential cysteine504 being replaced by a tyrosine (Y9).509
Consistent with this, HlyA does not contain an N-terminal
leader peptide or a GG motif and is not cleaved during or after
the transport, suggesting an alternative mechanism is in action
for its secretion. Compared to the catalytical histidine of
ComA-PEP (H96), the equivalent histidine of the HlyB-CLD
(H83) is flipped by 180° and the solution NMR structure of
the HlyB-CLD (PDB ID 3ZUA)506 revealed a π−π stacking
between the H83 and W77 residues, which might be a
characteristic feature of CLDs, as the tryptophan residue in the
equivalent position is conserved across the family. This π−π
stacking requirement explains why reintroduction of Cys at
position 9 (Y9C) does not restore the proteolytic activity of
the CLD. Despite the apparent homology and the similar
overall fold between the C39-domain seen in the Streptococcal
peptidase ComA,484 and the HlyB-CLD, which results in an
overall similar fold, the CLD of HlyB represents a particular
protein class with a distinct binding site imposing specificity for
the RTX-toxin HlyA506 with the binding pocket for the latter
being located on the opposite side compared to the substrate-
binding site of ComA-C39. Notably, all PCAT transporters
containing an active C39-peptidase domain appear to transport
relatively small substrates with an upper MW limit of ∼10 kDa,
belonging to the bacteriocin family that possesses an N-
terminal, cleavable leader peptide.506 In contrast, CLD-
containing PCATs are associated with the transport of large
cargoes of above 50 kDa, which contain a C-terminal secretion
signal and, importantly, belong to the RTX (repeat in toxin)-
toxin family. Thus, the existence of an RTX-domain in the
Figure 15. Structure of the ABC transporter nucleotide-binding domains (NBDs). (A) Linear graph from the N- to C-terminus of the typical NBD
domain, using HlyB as a template. (B) View of the dimerized NBD based on the crystal structure of the ATP-bound HlyB monomer (PDB ID
1XEF),516 highlighting the positions of the conserved sequence motifs involved in nucleotide binding. In one subunit, the RecA-like and β-sheet
domain is colored pale blue, while the α-helical subdomain, harboring the ABC-motif, is colored yellow. The second NBD protomer is colored
wheat. Motifs are presented in colors matching the sequence boxes in panel A. For illustrative purposes, the side chain of the catalytic H662, which
is substituted by an alanine in the above structure to stabilize the ATP-bound state, is being modeled in. The side chains of Y477 (loop A;
coordinates the adenine ring of ATP); the E631 (the invariant Glu-residue following Walker B, which helps to coordinate the ATP) and H662 (H-
loop) are presented as sticks. The Walker B motif usually features four hydrophobic residues that form a β-strand and is terminated by a conserved
Asp (in this case D630), which coordinates the catalytic Mg2+ cofactor via water-molecule mediation. Two ATP molecules are colored in purple.
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transported substrate can be correlated to the presence of a
CLD in the cognate PCAT transporter and vice versa.506
Importantly, despite the lack of proteolytic activity, the CLD
of HlyB appears necessary for the recruitment and tethering of
the unfolded substrate, playing chaperone-like.506 The CLD of
HlyB was shown to tether its cargo HlyA, preventing its
aggregation and/or degradation during secretion, playing the
dual role of a cargo recognition as well as a chaperoning
unit.506 Crucially, combining these data with more recent
findings507 suggests that the CLD may also play a role in
stabilizing the nucleotide-free state of HlyB by binding the
substrate peptide, allowing it to optimally position its cargo for
export upon ATP-binding.
In some cases, such as the multifunctional autoprocessing
RTX-like (MARTX) (e.g., the Vibrio cholerae actin-directed
RTX toxin (Q9KS12)510 and Clostridium sp. glucosylating
toxin families the Vibrio cholerae actin-directed RTX toxin
(Q9KS12)510), the cargoes themselves display an autoprocess-
ing in cis mediated by an internal C80 peptidase domain,
which becomes activated upon binding to the eukaryotic-
specific small molecule, inositol hexakisphosphate (InsP(6)),
present in the target cells.511
Intriguingly, there is also a sizable group of T1SS-associated
PCAT-like ABC transporters that lack a CLD or a C39-domain
altogether.3 One such example is HasD, which is part of the
T1SS of Serratia marcescens which secretes the hemophore
HasA.153,512 HasA is not cleaved during the transport and
contains no RTX domain, and consistent with the observations
of Lecher et al.,506 HasD does not possess an N-terminal
domain. Furthermore, the cellular chaperone SecB is required
for the productive HasA secretion by the T1SS by inhibiting its
folding and maintaining the unfolded, secretion-competent
state of HasA.513 Nevertheless, HasA contains primary
recognition sites that interact with HasD prior to the secretion,
likely within the substrate binding cavity of the transporter,
although their exact identity remains obscure.512 Other notable
members include LipB from the S. marcescens lipase T1SS
(UniProtKB Q54456)514 and PrtD from the protease secretion
system PrtDEF from Aquifex aeolicus VF5 (UniProtKB
O67184),515 both of which are discussed below.
5.6.6. NBDs of PCAT Transporters. The NBDs of HlyB
(PDB ID 1XEF,509 PDB ID 2FF7516), LipB (the ABC
transporter involved in the T1SS that secretes the lipase
LipA in S. marcescens) (PDB ID 5X7K),514 and PrtD (PDB ID
5L22)515 have been solved and present a structure that is
generally identical to that of the canonical type IV ABC
transporters. ATP-binding promotes dimerization of the HlyB-
NBD.517 Indeed, the HlyB NBDs has been solved in an ATP-
bound state (PDB ID 1XEF),509 presenting a dimer in which
two intact ATP molecules are bound at the interface of the
Walker A motif and the C-loop provided by the opposite
protomers (Figure 15). Biochemical data suggests a mecha-
nism of substrate-assisted catalysis, rather than that general
base catalysis might operate in the HlyB-type ABC-ATPases.
Two highly conserved residues, namely E631 and H662, form
a catalytic dyad, with H662 playing the role of a “linchpin”,
that coordinates a complex network of intermolecular
interactions, and were found to be required for interprotomer
communication, that covers ATP, water molecules, as well as
Mg2+ ions and amino-acids both in cis and trans orientation
(Figure 15).509
A couple of follow-up studies516,518 revealed the kinetics of
ATP-driven NBD association alongside the structures of the
ADP-bound form of HlyB NBD, in wild-type (PDB ID 2FF7),
as well as in mutant forms of the transporter (PDB ID 2FFA;
2FFB) allowing us to complete the functional cycle of the
transporter. Cavity analysis of dimeric ATP-bound NBDs
indicates that inorganic phosphate should not be able to diffuse
freely out of the binding site, and its exit requires an additional
conformational change in the domain.516 Intriguingly, these
structures also revealed a structural asymmetry within the
ATP-bound NBD dimer in the form of one open and one
closed phosphate exit tunnel. This tunnel gate is controlled by
a salt bridge between D551 and a R611-residue, the side chain
of which flips open to allow diffusion of the inorganic
phosphate. Analysis of the structures, and the loss of
cooperativity upon mutation of these conserved residues,
strongly suggests a sequential ATP-hydrolysis is taking
place;516 however, whether this sequential release of ADP
and Pi may be connected to the processivity of the transporter
remains unclear. ATP-hydrolysis (∼−30 to −35 kJ/mol) and
NBD dimerization (−33.4 kJ/mol) are comparable from an
energetic point of view, and thus either step could represent
the potential “power stroke” during the reaction cycle of the
ABC transporters. In addition, both ATP binding and ADP-Pi
dissociation could contribute to the power stroke.516,519 In the
case of HlyB, the cycle has been suggested to take two distinct
steps, with the mechanical energy being derived from the rigid-
body motion of the α-helical subdomain and the rearrange-
ment of the N-terminus of the Walker A motif associated with
its binding of ATP and associated NBD-dimerization. This
energy is transmitted to the TMDs likely used as a power-
stroke. The second stage is suggested to employ the chemical
energy of sequential ATP-hydrolysis, which is used for the
recycling of the dimer by enabling the ADP dissociation.
Analysis of the ADP-bound state of the HlyB-NBD revealed a
distortion of helix-6, and it has been suggested that the tilting
of this helix is used as an enthalpic energy storage device, with
the elastic energy being possibly used for programmed release
of ADP from dissociated NBD protomers and additional
transmission to the TMDs to complete substrate translocation.
The archaeal ABC transporter MJ0796 f rom Methanocaldo-
coccus jannaschii520 has been linked to the LolD from the
LolCDE system and is the closest NBD homologue to the E.
coli LolD, with ∼50% identity and 70% similarity between the
two. Due to the close sequence similarity, its NBD may be a
representative of MacB-family transporters, and intriguingly
the dissociation of the NBDs upon ATP-hydrolysis seems to
differ from that observed in the HlyB-family. While in the HlyB
no significant increase in negative charges accompanying ATP-
hydrolysis was detected within the ATP-binding site of
HlyB;516 the dissociation of the NBDs in the LolD/MacB
family appears to be driven primarily by the active electrostatic
repulsion.520 This discrepancy may reflect the different mode
of substrate engagement between the two respective trans-
porter families, with LolD/MacB operating a discontinuous,
single-step extraction of the substrate, while the HlyB is
required to progressively thread its substrate over multiple
cycles.
5.6.7. Structure of AMS/PCAT Family Transporters.
Structurally, the most studied member of the PCAT-family is
the PCAT1 from the thermophilic Gram-positive bacterium
Clostridium thermocellum (aka. Hungateiclostridium thermocel-
lum) (UniProtKB - A3DCU1), which is responsible for the
secretion of the small cargo protein CtA. CtA is encoded in the
same operon as the main transporter and represents a 90-
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residue polypeptide, containing an N-terminal signal sequence
(leader peptide), which is cleaved by the C39 domain of the
PCAT1, to produce a mature, transport-competent cargo of 66
residues273,505 (Figure 14).
Each PCAT1 protomer consists of an N-terminal C39-
domain, a transmembrane domain (TMD) containing 6 TM
helices, and a C-terminal NBD, containing the conserved
signature sequence-motifs for ATP-binding and hydrolysis.273
The ATPase activity of PCAT1 was found to be low and rather
insensitive to the presence of substrate, while its peptidase
activity was found to be negatively impacted by the addition of
ATP (ATPγS). Furthermore, at the same enzyme/substrate
ratio, the isolated C39-domain appeared to cleave the substrate
80% more slowly than the nucleotide-free full-length PCAT1,
while the addition of ATP inhibited the proteolytic activity of
the full-length PCAT1 by 90%, to a level comparable with the
isolated C39-domain.273
The structure of the PCAT1 shows that the two TMDs from
the functional dimer form a large α-helical barrel, with a
rhomboidal cross-section and an area of approximately 440 Å2
traversing nearly the entire lipid bilayer. Its size is large enough
to allow for a small protein cargo such as CtA to be
accommodated even in a folded state. Consistent with that, the
inside of the translocation pathway is lined with charged
residues creating a hydrophilic environment for the cargo
protein.273 The two C39 cysteine-protease domains are
positioned at the opposite ends of the helical-core at the
entryway of the TM-barrel and are loosely associated with
TM3, TM4, and TM6 and make weak contacts with the NBDs
(Figure 12B, D and Figure 14).
The apo-structure of PCAT1, obtained in the absence of
ATP, reveals an inward facing (IF) conformation, with its two
NBDs in a loosely packed dimer primed for ATP binding,
while the cargo-binding cavity is open to the cytosol and
accessible to the cargo at the exact site where the C39-
peptidase domain is docked.273 The structure of the catalyti-
cally inactive E648Q PCAT mutant bound to ATPγS, reported
by the same group, shows an occluded TMD cavity and
presents a supposed catalytic intermediate highlighting the
conformational changes associated with ATP-binding. It
reveals rearrangements of the TMDs that involve the
movement of TM3 and TM6 toward the center of the α-
barrel, resulting in disruption of the binding interfaces of the
C39-domains and their displacement and disengagement from
the translocation pathway.273 Importantly, the PCAT1 has
been shown to be proteolytically active in the absence of ATP,
suggesting that in the apo-conformation, while the C-terminal
region of the substrate is threaded into the translocation
pathway, the N-terminal leader peptide may remain associated
with the C39-peptidase domain. Such orientation of the
substrate is speculated to be optimal for proteolytic cleavage to
free the cargo from the leader peptide. Once cleavage has taken
place, ATP binding would induce closure of the cytoplasmic
opening and dissociation of the peptidase domains. Consistent
with such an interpretation, the lower protease activity in the
ATP-bound form, in which the C39-domains are disengaged
from the translocation pathway, could prevent cleavage of the
substrate when it is not in position for translocation.273
5.6.8. Models of the Mechanism of Cargo Transport
of the PCAT Type ATPases. The cryo-EM structure of the
PCAT1−CtA complex, solved to 3.4 Å resolution, reveals two
copies of CtAs to be bound to the transporter C39-domains via
their N-terminal leader peptides, but only one of these presents
density extending into the TMD cavity of the transporter and
hence is positioned for productive cleavage and trans-
location505 (Figure 14A, B, D). This structure has provided a
possible mechanistic model of the complex assembly and cargo
processing, which is consistent with the general “alternating
access” allosteric model of ABC transporter action,390
exemplified by canonical type IV ABC transporters such as
P-glycoprotein (ABCB1),465 TM287/288,476 and MsbA.464
In the model proposed by Kieuvongngam et al.,505 the
substrate cargo-protein is recognized by the C39-domain of the
transporter via specific interaction with its leader sequence
with the transporter being present in an inward facing
conformation. This allows the cargo-portion of the CtA to
Figure 16. Modified alternating-access mechanism of PCAT1. CtA is recruited and cleaved in the inward-facing (IF) conformation. In the model by
Kieuvongngam et al.,505 the substrate specificity of the transporter is conferred primarily, if not exclusively, by the interaction of the C39-domains
with the leader peptide, and the transporter TMD essentially does not otherwise interact with the cargo. In a modification of the cycle proposed by
Rachman and Mchaourab,522 the cargo is at the center of the interaction, as cargo interactions have been observed in transporter variants lacking
C39-domains. In both cases, the interaction of the cargo proteins with the TMD leads to subsequent cleavage of the leader peptide, and a transient
inward closed conformation (IC), similar to that observed in the McjD,459 is created, which enables the ATP binding. ATP-binding drives
conformational changes in the TMD leading to occlusion of the cargo protein binding chamber, known as the outward occluded state (not shown).
ATP binding stabilizes the outward-facing (OF) conformation in which the PEP domains are disengaged. After cargo release, TMDs isomerize to
form an occluded state (OCC) in the absence of cargo. The energy of ATP-hydrolysis resets PCAT1 back to the inward-facing conformation,
allowing PEP to dock into the TMD−NBD interface. Padlock indicates the closure of the outer “gate” of the transporter.
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get recruited into the transporter cavity, following which the
cleavage of the signal occurs, possibly concomitantly with the
binding of the ATP, which causes the outward-facing
conformation of the transporter to be stabilized, allowing the
now cleaved cargo to leave the cavity. Following cargo release,
the TMDs isomerize to create an “occluded form” of the
cavity, which is sealed from both sides. Subsequent ATP-
hydrolysis resets the transporter conformation to inward-facing
(IF), releasing the prebound signal peptides and allowing the
C39-domain to redock at the TMD−NBD interface where it
can recruit another cargo.
Importantly, this newly proposed model505 implies that the
substrate specificity of the transporter is conferred primarily, if
not exclusively, by the interaction of the C39-domains with the
leader peptide, and the transporter TMD essentially does not
otherwise interact with the cargo. In that, the model of
Kieuvongngam et al.505 differs from the ones described for
other classical type IV ABC exporters, such as P-glycoprotein
(Pgp/ABCB1), which show that the TMDs of the transporter
clearly interact with their cargoes, e.g. as evidenced by the
substate-bound structure of Pgp.521 It has to be noted that the
model proposed by Kieuvongngam et al.505 has also been
contradicted by the recent findings of Rahman and
McHaourab,522 who used spectroscopic detection of the
fluorescent (bimane) and spin-labeled protein substrate of
the PCAT1 as it passes through the transporter. These results
suggested that the cargo protein binds specifically to the core
of the transporter in the inward-facing (IF) conformation and
is modulated by ATP binding. This resulted in a different,
“cargo-centric” model of transport by PCAT1,522 in which the
recognition and binding of the leader peptide of the cargo-
protein by the C39-domain enables interactions of the
transported fragment of the cargo protein with the TMD of
the transporter, which is subsequent to cleavage of the leader
peptide. Importantly, binding of the cargo to the TMD was
reportedly detected in transporter variants lacking C39
proteinase domains, suggesting that while the C39-domain
facilitates cargo recognition and orientation the interaction of
the cargo with the TMD is the main contributor to affinity.
This alternative model of transport suggests that there is an
ATP-dependent equilibrium binding of the cargo to the TMB
domain, which is speculated to transition to an outward-facing
(OF) conformation of the TMB leading to a release of the
cargo.
We have attempted to summarize the above data and the
proposed models into a noncontradictory general model for
PCAT action below, which unites both viewpoints and also
takes into account the possible role of the extracellular gate
closure below (Figure 16).
The actual role and timing of the ATP-hydrolysis within the
functional cycle of the ABC transporters remains an open
question, with significant spontaneous conformational tran-
sitions from IF-to-OF being observed via an occluded
intermediate, e.g., in unbiased molecular dynamics simula-
tions.476 Recent data derived from the heterodimeric ABC
exporter TM287/288 from the thermophilic bacterium
Thermotoga maritima suggests that ATP binding alone is
sufficient for the IF-OF conversion to occur, which is
presumably associated with the active transport of one
substrate molecule.476 Directionality of transport is suggested
to be achieved by an affinity switch of the substrate binding
site, which unavoidably undergoes a conformational transition
due to rearrangements of TM-helices during the switch from
an IF to an OF conformation. Using a synthetic single domain
antibody as conformational probe and a combination of spin-
label, it was shown that the ATP-occlusion firmly traps the
transporter in the OF state, preventing transporter cycling.476
They further demonstrate that efficient extracellular gate
closure, which is based on interactions of charged residues
from TM1s of the opposing protomers, is required to
dissociate the NBD dimer after ATP-hydrolysis to reset the
transporter back to its inward-facing state. In that, the ATP-
hydrolysis appears to be strictly required to initiate dissociation
of the closed NBD dimer, and once the ATPs are hydrolyzed
the mechanical force of this firmly sealed extracellular gate
(termed closed D-lock) is required to dissociate the NBDs.476
In the extreme thermophile Gram-negative bacterium
Thermus themophilus, only a single T1SS has been identified,
which is based around the heterodimeric Thermus thermophilus
multidrug resistance proteins A and B (TmrAB), in which the
TmrB component has a degenerate NBD-binding site.478 E523
from the NBD of TmrA is essential for rapid conversion of the
ATP/ATP-bound complex into its ADP/ATP state, whereas
the corresponding residue in TmrB (D500) was found to play
only a regulatory role.478 Swap of active residues between the
NBDs did not result in rescue of the function, suggesting a
built-in asymmetry of the complex. The prevalence of
heterodimeric ABC half-transporters, especially among eukary-
otic organisms, suggests an underlying functional principle of
NBD asymmetry. TmrAB not only shares structural homology
with the antigen translocation complex TAP but is also able to
complement antigen processing in human TAP-deficient
cells.523 Recent cryo-EM structures of the TmrAB in different
states and conformations,479 which could be attributed to two
inward-facing (IF), four outward-facing (OF), and two
asymmetric posthydrolysis states, have provided significant
insight into the general conformational cycling of the ABC
transporters. Using single-turnover assays, Stefan et al.524 have
been able to further analyze the cycle of the TmrAB
reconstituted in lipid nanodiscs at single-liposome resolution.
Strikingly, the analysis of the data suggests that a single
conformational switch by ATP-binding drives unidirectional
substrate translocation. Under this new model, the ATP-
binding initiates the IF-to-OF transition and is stoichiometri-
cally coupled to substrate translocation in a single step. Along
with this “power stroke” caused by occlusion of two ATP
molecules, the substrate-binding site is being remodeled,
priming substrate release on the extracellular site. Following
this “power stroke”, ATP-hydrolysis and subsequent phosphate
release launch the conformational transition of OF-to-IF and
hence the return to the resting state, which facilitates
nucleotide exchange and thus in turn primes a new round of
substrate binding and translocation.524 This model contrasts
the previously proposed steady-state models, as the utilization
of the single-turnover assays reveals a power stroke in substrate
translocation and the tight chemomechanical coupling in these
molecular machines. Furthermore, the recent structure of the
lipid-linked oligosaccharide (LLO)-flippase PglK essential for
asparagine-linked protein glycosylation in Campylobacter jejuni,
in the outward facing conformation, strongly suggests that the
release of LLO to the outside occurs before ATP-hydrolysis
and is followed by the closing of the periplasmic cavity of
PglK.525
While further details are needed to fully populate the
conformational cycles of the ABC transporters, these results
strongly suggest that ATP-hydrolysis is required to drive the
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transport cycle at the resetting step from the OF to the IF
state. As we will in the later sections, such energy dependency
may have parallels with the pump cycle of the RND-
transporter-based tripartite assemblies.
5.6.9. PCATs Associated with T1SS. The transport
mechanisms discussed above, while possibly applicable to
bacteriocin transporters in Gram-positive organisms, do not
appear to be feasible for the PCAT transporters operating as
part of a T1SS in Gram-negative bacteria, as these are often
carrying cargoes in excess of 8000 amino-acid long and over 1
MDa in weight,3,18,449 while in S. enterica, the giant nonfimbrial
adhesin SiiE (595 kDa), exported by the Pathogenicity Island 4-
encoded type I secretion system (SPI4-T1SS), is the largest
protein in the Salmonella proteome and consists of 53
repetitive bacterial immunoglobulin domains (Big).526 As
known for other T1SS substrates, such as E. coli HlyA, Ca2+
ions bound by conserved D residues within the BIg domains
stabilize the protein and facilitate secretion.527,528 Exporting
such cargoes would require a departure from the classical
“alternate access” mechanism discussed above in favor of some
form of continuous threading. Furthermore, several lines of
experimental evidence suggest that T1SS substrates must be
unfolded in order to be translocation competent,529,530
resulting in the length of an unfolded T1SS substrate that
would far exceed the length of the transporter TMD cavity
itself. These observations imply that T1SS ABC transporters
must operate by a distinct mechanism, where the unfolded
polypeptide is likely progressively threaded through the TMD
of the transporter over multiple ATP-hydrolysis cycles.3,449,512
These hypotheses were confirmed by the structure of the first
ABC transporter associated with T1SSnamely the Aquifex
aeolicus PrtD (AaPrtD) coded by the abcT5 gene (PDB ID:
5L22; UniProtKB: O67184).515 The PrtD is the ABC
transporter within the protease secretion system PrtDEF,
best known from the phytopathogen Dickeya dadantii ( formerly
known as Erwinia chrysanthemi),531 responsible for the
secretion of a number of proteases encoded in the same
operonnamely, PrtA, PrtB, PrtC, and PrtG.532 Secretion of
the Dickeya dadantii protease DdPrtG across the plasma
membrane requires a fully assembled PrtDEF complex, and
secretion of PrtG in vivo requires ATP-hydrolysis by PrtD.515
The AaPrtD structure was revealed in an occluded, ADP-
bound state,515 and despite lacking C39 or CLD-domains,3 the
structure is significant as it provides a blueprint for the wider
RTX-associated subfamily of T1SS transporters and it reveals
an overall organization, which while similar to the standard
PCAT transporters such as the PCAT1 discussed above, has a
number of distinct structural features. In contrast to the other
PCAT transporter structures available to date, e.g., PCAT1, the
hydrophilic TM cavity of which allows at least partial folding of
the cargo,273 the substrate channel of PrtD has been shown to
be very narrow and to run throughout the structure for some
40 Å, spanning the entire membrane and ending just shortly
before the periplasmic exit. In that it shows analogies to the
SecY channel533 and due to its steric restrictions appears
unable to accommodate folded substrate (Figure 17). The
structure also suggests a “substrate entry window” just above
the NBD domain formed by the TM helices 4 and 6, which is
gated by a conserved R307 on the cytoplasmic side,515 while
the periplasmic opening is gated by a hydrophobic seal, similar
to the “pore-ring” of the SecY channel.534
AaPrtD also shows a distinct architecture of its TMD, with
uniquely kinked TM3 and TM6 helices near the cytosolic
solvent−lipid interface. These kinked helices point toward the
dimer interface, creating a highly basic concave “bowl” on the
PrtD surface formed by TM1, TM3, and TM6. Furthermore,
the coupling helix between TM2 and TM3 (CH1), which
packs against the NBD of the same subunit, was found to be
replaced by an extension of TM2 and an extended loop leading
into TM3 presenting a unique architecture among type IV
ABC transporters.515 It is notable that both the “concave bowl”
and the aforementioned “substrate entry window” are highly
basic, which is speculated to play a role in electrostatic
stabilization of the T1SS substrates which tend to be fairly
acidic. The absence of the coupling helix leading into TM3 is
suggested to reflect substrate entering from the cytosolic
Figure 17. General organization of PCAT transporters associated with T1SS. (A) AaPrtD based on the PDB ID 5L22. Note the highly kinked TM3
and TM6 and the supposed “substrate entry window”. Unlike the PCAT transporters discussed previously, the AaPrtD does not present a wide
substrate binding cavity and is suggested to transport unfolded cargoes. The ADP moiety (in red spacefill) is found bound to the protomers. Note
the lack of CH1 helix at the end of TM2. (B) Homology model of HlyB, highlighting features common to both PCAT1 and PrtD. The CLD-
domains are predicted to aid positioning of the cargo into the substrate entry window.
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window between TM4 and TM6. Thus, while the AaPrtD
architecture is similar to the classic 6 + 6 TMD dimer observed
in the type IV transporters, the shape and the character of the
transporter conduit channel differ markedly from the canonical
peptide transporters discussed in the previous sections515
(Figure 17).
The structure of AaPrtD also hints at specific adaptations
that are relevant to the formation of the tripartite T1SS and
shared with other such transporters, including the hemolysin A
transporter HlyB and the related Mannheimia (formerly
Pasteurella) haemolytica leukotoxin pump-associated ABC
transporter LktB,535 both of which serve as prototypes
pumps for a widely disseminated family of virulence factors,
known as the RTX (repeats-in-toxin) cytotoxins. To facilitate
the analysis, we have created a hybrid homology model of
HlyB based on the AaPrtD and PCAT1 structures (Figure 4
and Figure 17).
In comparison with the peptide transporters, the cargo
pathway in the T1SS-associated PCATs is strikingly different
and much more restrictive, which is achieved by the
aforementioned kinks in the TM3 and TM6 leading to
constriction of the substrate channel. These kinks are stabilized
by conserved sequence motifs, which are shared by the T1SS
ABC transporters but not found in peptide PCAT trans-
porterse.g., the TM3 helix is split into three sections, with
the TM3a-TM3b kink being enforced by an “FxT-motif”,515
which in AaPrtD is formed by F128 and T130, while in HlyB
the corresponding residues are F264 and T266. A second
conserved motif is present on TM6 in the form of a bulky
hydrophobic (usually W; W295 in PrtD; W431 in HlyB),
followed by a hydrophilic residue (R296 in AaPrtD; Q432 in
HlyB). These motifs stabilize the kinks via a network of specific
inter- and intraprotomer interactions.
In addition, HlyB seems to share with the AaPrtD a
hydrophobic “gasket-ring”, on the periplasmic side (PrtD M43,
Y47, I425; PCAT I190, F194, L425/L426; HlyB F174/F175,
M179/L410/I411) that is speculated to prevent dissipation of
the proton gradient during transport and the basic-residue
gating (PrtD R307/HlyD R443) at the putative substrate entry
window. The orientation of the CLD-domain of the HlyB
positions its N-terminal tail in direct proximity to the entry of
the predicted substrate entry window, which is consistent with
the position of the threaded peptide seen in the CtA-bound
PCAT1.505
In summary, the recent structural snapshots discussed above
strongly suggest a common overall cargo-selection and
substrate-feeding mechanism between the PCATs associated
with peptide transport and those participating in the T1SS.
Unlike the peptide-transporting PCATs, the latter do not allow
folding of the substrate throughout the single transporter cycle
and necessitate multiple processive steps to transport the
whole cargo protein, in a mechanism that requires further
elucidation.
5.7. MacB/FtsX Transporter Family
Initially identified via a bioinformatic search as one of five
putative ABC transporter clusters in the E. coli genome,536 the
macAB genes were originally designated ybjYZ. The genes were
later renamed to macAB (macrolide-specific ABC-type efflux
carrier) as the pump was reported to transport several
macrolides.60 However, the relevance of this function in vivo
remains somewhat questionable, as in E. coli it is only
pronounced in cells with a deactivated primary AcrAB
multidrug efflux pump, and the loss of the orthologous system
in Neisseria gonorrhoeae did not lead to a pronounced decrease
in resistance to azithromycin or erythromycin.78 In addition,
the MacAB requires TolC for its function to form a tripartite
system.60 Related tripartite systems have been identified in a
number of Gram-negative organisms, such as MacBsm of
Stenotrophomonas maltophilia116 and the PseEF pump of
Pseudomonas syringae.537
Figure 18. The function of the tripartite pump MacAB-TolC in toxin secretion and macrolide resistance. MacAB secretes ribosomally synthesized
and post-translationally modified peptides (RiPPs), such as enterotoxin STII, that are targeted and exported to the periplasm by the SecY-secretion
signal (purple). Following cleavage and disulfide bond formation in the periplasm, the toxin is then secreted out by the MacAB-TolC. Figure
modified based on Crow et al.431
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Strengthening the case for the MacB-family members as
bona f ide multidrug transporters is the E. coli heterooligomeric
YbhFSR, which appears to function with the PAP coded by the
ybhF gene (P0A9U1).538 This tripartite system can efflux
cephalosporins, including the third generation cefoperazone.
Recently, Feng et al.62 characterized the YbhFSR system and
found it to export tetracycline, oxytetracycline, chlortetracy-
cline, doxycycline, EtBr, as well as the Hoechst 33342 dye.
Furthermore, uniquely for the ABC-family, the findings of
Feng et al.62 suggested that YbhFSR exhibits a dual function
both as a MDR efflux pump and as a Na+ (Li+)/H+ antiporter,
although this requires further investigation, especially in light
of the rather high homology of the YbhFSR protomers with
MATE transporters such as NorM.
5.7.1. Biological Functions. In addition to xenobiotics,
the MacB-family pumps are associated with the secretion of a
wide range of nonantibiotic targets, including the heat-stable
enterotoxin II in E. coli154 and the cyclic lipopeptide entolysin
in Pseudomonas entomophila.539 The cargoes range in size from
∼500 Da for macrolides to ∼10 kDa for dispersins,540
suggesting low selectivity of the MacB pump. Notably, and
unlike the typical T1SS which it resembles, the secretion of the
heat-stable toxins by MacB-related pumps appears to be Sec-
dependent in the first stage and requires a Sec-secretion
signal.154 MacB copurifies with and binds specifically to
phosphatidylethanolamine, in an interaction that survives
native mass spectrometry in the gas phase,541 and the related
LolCDE system is differentially modulated by different
phospholipids542 indicating possible lipid transport and/or
modulation. MacAB appears to be capable of binding to the
core lipopolysaccharide, although its exact role is unclear543
(Figure 18).
In a related system in Pseudomonas syringae, PseEF was
found to secrete the lipodepsinonapeptides syringomycin
(syrB1) and syringopeptin (sypA),537 and it was required for
the full virulence of the bacterium. The MacAB-TolC pump
has also been implicated in the efflux of protoporphyrin IX
(PPIX) in E. coli, and mutants of macAB or tolC were reported
to accumulated PPIX and become sensitive to photo-
inactivation.155 Also, in Pseudomonas, an orthologous system
known as PvdRT-OpmQ is involved in the secretion of the
primary virulence factor pyoverdine, which is a siderophore,
acting as both iron-carrier and a virulence-related signaling
molecule.544,545 In enteroaggregative E. coli (EAEC), an export
system for dispersin, a 10.2 kDa protein which promotes
bacterial dispersal across the intestinal mucosa540 able to
convert plasminogen into plasmin,546 is encoded by a virulence
plasmid pAA and has been linked to an MacB-like pump
AatPABCD where the AatP is a permease, AatC is an NBD,
and AatA is a TolC-like OMF.547
In enterotoxigenic E. coli (ETEC), the predicted tripartite
complex CexPABC, which consists of the MacB homologue
CexP (permease)/CexC (NDB), the PAP CexB and the OMF
CexA548 appear to be associated with the export of the coat
protein and virulence factor CexE, later found in Yersinia
enterocolitica, Providencia alcalifaciens, and Citrobacter roden-
tium.549 Intriguingly, despite similarities with the T1SS, this
exporter was shown to accept its cargo from the periplasm,
where CexE accumulates, and to rely on the general secretory
pathway.548,549 At the time of writing of this review, the roles
of the auxiliary transmembrane proteins CexD and AatD are
yet to be established. In Salmonella Typhimurium, the
nonribosomally synthesized siderophore enterobactin is
produced in response to iron starvation and can be processed
into salmochelin and several linear derivatives.550 Trimers of
such linearized enterobactin have been shown to protect S.
Typhimurium against peroxide-mediated killing in a MacAB-
dependent fashion.550 Furthermore, in a mouse model of
Salmonella infection, the deletion of MacB impacted
virulence,101 while MacAB was found to be required for
survival of Salmonella in cultured macrophages which produce
reactive oxygen species (ROS) but was not essential in
macrophages which did not generate ROS.138 Consistent with
a stress-response interpretation, expression of macAB in E. coli
and Salmonella is inducible and regulated by the two-
component system PhoPQ,101,551 which among other things,
senses antimicrobial and pH stress, e.g., responding to
acidification of the phagosome.
A large group of MacB-like transporters have been described
in the multicellular cyanobacteria such as Anabaena and Nostoc
(for recent reviews please consult Shvarev and Mald-
ener552,553) that have been found to associate with diverse
functions covering heterocyst development and diazotrophic
growth (e.g., HgdBCD system, DevBCA system,554 All0809/
8/7); iron metabolism (All2652/1); as well as drug resistance
(Alr4280/1/2 and Alr3647/8/9).553,555 These systems seem to
utilize a single OMF HgdD556 (see section 7 and associated
Figure 33A for details). One of the better studied examples
includes the DevBCA-HgdD.557−559 The pump component
genes are devB (alr3710), coding for the PAP protein; devC
(alr3711), coding for TMD; and devA (alr3712), coding for
the NBD, respectively, and they are positioned on a single
operon. The Anabaena could be considered a multicellular
organism, as it forms filamentous nonbranching strings of cells
called “trichomes”, which, in the presence of combined
nitrogen cells are composed mostly of vegetative cells, but in
its absence, the Anabaena develops specialized cells, called
heterocysts,560,561 which provide N2-fixation capability and
transport nitrogen assimilation products to neighboring
vegetative cells in exchange for sugars produced by photosyn-
thesis.562 These heterocysts build an additional envelope
around the outer membrane, which is itself composed of two
layers: an external heterocyst exopolysaccharide (hep) layer
and an underlying heterocyst glycolipid layer (hgl). The hgl
layer is made of heterocyst-specific glycolipids (HGLs) and is
airtight, restricting oxygen from penetrating into the
heterocyst, creating a microoxic environment which is essential
for dinitrogen fixation by nitrogenase.553,559,561 DevBCA forms
a heterocyst-specific glycolipid exporter that is essential for the
export and development of the hgl layer. To transfer
glycolipids through the Gram-negative cell wall, DevBCA has
to recruit a TolC-homologue protein called HgdD, that is
encoded by the gene alr2887.556,563 The Anabaena sp. hgdD
mutant, like the devB, devC, and devA mutants, does not form
the hgl layer and hence cannot grow diazotrophically; that is,
they are unable to grow without external sources of fixed
nitrogen.556 The HgdD OMF protein is central to secretion
and efflux in Anabaena, as it has been shown to pair with at
least seven different DevBCA paralogues, with varied functions.
While some of these have partially overlapping functions and
are involved in heterocyst-specific roles, at least some of these
DevBCA paralogues such as the tripartite pumps formed of the
gene products of alr4280/alr4281/alr4282 and alr3647/
alr3648/alr3649 that code for the components of putative
MacB-like ABC exporters have been shown to be essential for
resistance to a range of different drugs and efflux of ethidium
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bromide, while having no demonstrable role in heterocyst
development.564
In addition, the YbbAP is a poorly characterized member of
the MacB-family in E. coli,419 where ybbA encodes the
predicted NBD subunit and ybbP encodes the predicted
permease subunit of this putative exporter complex. Although
association with heavy metal export has been suggested,418 this
member of the family remains poorly understood.
5.7.2. Gram-Positive Homologues of the MacB Trans-
porters. Within the wider family of MacB-like transporters,
there are a number of members from Gram-positive organisms;
e.g., in Bacillus subtilis the permease YxdM, forming part of the
ABC transporter YxdLM, appears to be involved in resistance
Figure 19. Structural organization of MacB. (A) General topology of the single MacB protomer highlighting the N-terminal nucleotide binding
domain (NBD; magenta), the connecting helix (CoH), the transmembrane domain (TM domain) with its four helices, as well as the periplasmic
core domain (PCD), which is composed of a PD-module and a SABRE subdomain (green). CH1 and CH2, coupling helices 1 and 2, respectively.
(B) Two orthogonal orientations of the single protomer of MacB from A. baumanii based on PDB ID 5WS4,24 highlighting the principal secondary
structure elements. The blue oval delineates the PD. (C) View of the complete MacB-dimer.
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to antibacterial cationic peptides.565 Also, in B. subtilis, YtrF
appears to be a permease forming part of the YtrBCDEF
complex that plays a role in acetoin utilization.566 While very
little is known about the structure of these transporters, our
bioinformatic analysis suggests that they possess significantly
more expansive PCDs than the rest of the MacB-family,
possibly presenting a duplicated PD-module/LolC-like exten-
sion.
The yknzWXYZ operon in Bacillus subtilis567 has been found
to code an unusual four-component transporter system, which
is built around the principal YknY (NBD)/YknZ (permease)
ABC transporter unit which is homologous to MacB. The
system also associates with a cognate PAP (YknX) and a four-
TM additional membrane protein (YknW)568 to provide
protection against sporulation-delaying-protein-induced killing
by the 42-residues long disulfide-linked SDP toxin.569 The
pump appears to protect B. subtilis against both endogenous
and exogenous SDP, and YknW is critical in the assembly and
functionality of the complex, as YknXYZ complex alone does
not protect against SDP, while overproduction of YknW alone
provides limited protection.
An investigation of the response of Streptococcus pneumoniae
D39 gene-expression patterns to three antimicrobial pep-
tidesnamely nisin, bacitracin, and the human cationic
peptide defensin LL-37 identified upregulation of a hitherto
uncharacterized operon (Sp0785−0787), the deletion of which
increased the cell-susceptibility to LL-37 and lincomycin.570
Similarly, the PAP, NBD, and translocase coded by the
spr0693-spr0694-spr0695 genes belonging to the same operon
in Streptococcus pneumoniae570,571 show high similarity to
MacAB, with Dpr0693 having 21% identity with the PAP
MacA, whereas the Spr0694-0695 complex is 37% sequence
identical to MacB and presents a very similar structure.
5.7.3. Topology and Structural Organization of MacB
Family Members. The first investigation of the structural
organization of the MacB was undertaken by Kobayashi et
al.,572 who found that the protomers of the MacB/FtsX family
are distinct as their NBDs are found at the N-terminus of the
transporter, while their TMDs contain four TM helices thus
presenting a unique topology. Parallels in the organization of
the known tripartite assemblies suggested that MacB-type
transporters may organize into higher stoichiometries;
however, cross-linking, atomic-force microscopy, and native
mass-spectrometry confirmed that the functional unit of the
transporter is organized along the universal dimeric pattern
characteristic of the wider ABC-superfamily.573
In the monomer of the prototypical family member MacB,
the NBD is fused to the N-terminal part of the permease
domain of the transporter572 and it presents a dimeric
architecture; however, a number of other family members
have the permease and NBDs coded by separate genes.
Examples include the FtsEX complex, which gives the name to
the wider MacB/FtsX family. It assembles with a FtsE2FtsX2
stoichiometry, with a porter domain formed by the FtsX
(UniProtKB P0AC30), while the NBDs are provided by the
FtsE (UniProtKB P0A9R7).574 It has to be noted that despite
the close structural homology, and the apparent ATPase
cycles,575 this complex does not seem to perform a transporter
function but is rather engaged in peptidoglycan remodeling, a
role which it exerts by activating the extracellular and
periplasmic amidases, as demonstrated by the direct recruit-
ment of the EnvC by the periplasmic domains of FtsX.576
Similarly, the connected lipoprotein extrusion complex
LolCDE, while having a heterodimeric permease portion
(LolCE), engages a dimeric NDB LolD, to give a general
stoichiometry of LolCED2.
432 All of the permease domains of
the proteins described above contain the 4 TM-helix
architecture of the MacB. However, more exotic architectures
have also been described, e.g., the bacitracin-sensing and
resistance-associated BceAB-type transporters577 that appear to
have 10 TM helices arising from a duplication of the 4-TM
FtsX fold over TM2−4 and 7−10 and featuring a central
helical insertion over TM5−6. These transporters presumably
function as monomeric units. Some other members of the
family feature this arrangement, e.g. YbbP-YbbA2 complex;
442
however, these have been poorly characterized.
The first glimpse of the 3D structural organization came
from the periplasmic domain of the Aggregatibacter (previously
Actinobacillus) actinomycetemcomitans (PDB ID 3FTJ),578
which revealed a structural organization distinct from the
then available ABC transporter structures. In the past decade,
the structural and conformational space for type VII trans-
porters has expanded dramatically to include the complete
MacB from several different species of Gram-negative
bacteria,24,272,431 as well as the Gram-positive homologues
Spr0694−0695 from Streptococcus pneumoniae (PDB ID
5XU1)571 and YknWXYZ from Bacillus amyloliquefaciens
(PDB ID 5F9Q).579 In addition, the related heterodimeric
LolCDE lipoprotein sorting system (LolC, PDB ID 5NAA,
6F49;432 LolE, PDB ID 5UDF (Abendroth et al., to be
published)) and the FtsX family members (PFAM family FtsX
(PDB ID 4N8N, 6HEE, 6HFX)433,434 have also been
determined. Importantly, the complete assembled structure
of the tripartite MacAB-TolC from E. coli has also become
available (PDB ID 5NIL, 5NIK),272 allowing a direct
comparison with the RND-based assemblies.
5.7.4. General Topology of MacB/FtsX Family and TM
Domains. The recent determination of a number of MacB/
FtsX family transporter structures24,272,431,571 has revealed a
number of unique features within the TM region of these
transporters, and these have been the subject of several
excellent reviews (see Greene et al.442 and Murakami et al.580).
First and foremost, the TM-region is composed of only 4
TM helices, with a dimer forming a 4 + 4 helical bundle, which
is a stark contrast from the typical 6 + 6 architecture seen in
the prototypical ABC family members, such as the type IV
family (e.g., Sav1866 and MsbA).428,581 Second, TM helices 1
and 2 are longer than the TM3 and TM4 and protrude above
the membrane plane into the periplasm, where they are
extended into a “stalk-like” structure crowned with a sizable
globular periplasmic domain (Figure 19), known as the
periplasmic core domain” or PCD,578 formed from the large
periplasmic loop which is spliced into the periplasmic
extensions of the stalk-helices TM1 and TM2, and in this
respect resemble somewhat the RND transporters.572
The TM3 and TM4 are notably shorter than the stalk-
helices and pack outside of the helical bundle formed by them.
They do not protrude above the membrane plane and are
linked by a short periplasmic loop, which is sometimes referred
to as a “shoulder”.431 The cytoplasmic, N-terminal part of
TM1 is linked to the NBDs by an amphipathic helix, that runs
parallel to the membrane surface and a “skirting loop” (Figure
19). The former helix is equivalent to the “elbow helix” seen in
the type IV transporters but is commonly referred to as a
connecting helix (CoH)24 due to its linkage with similar
helices in type V ABC transporters, e.g. ABCG5/ABCG8428,582
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Finally, the NBD domains are located much closer to the
membrane than in the typical type IV ABC transporters, which
allows close association of the connecting helices with them,
providing additional allosteric control. Each MacB TMD
provides two coupling helices (CH1 and CH2) for TMD-NBD
interdomain communication. The major coupling helix (CH1)
is located on the cytoplasmic loop connecting TM2 and TM3
and provides a means of communicating conformational
changes from the NBDs to the TMDs, while a second,
“minor coupling helix” (CH2) is located after the TM4 at the
extreme C-terminus. Deletion of the CH2 in A. baumannii
MacB had a notable impact on the macrolide resistance24 but
only a minor effect on the pump activity in the EcMacB.431
In a further departure from the architecture of type IV
transporters where CH1 and CH2 from one-half-transporter
contact the NBDs of the opposing protomer, the coupling
helices (CH1 and CH2) are not shared between the
protomers; i.e., the coupling helices of MacB/FtsX only
engage the NBD of their cognate protomers24,431 (see Figure
12 in the PCAT section and Figure 19).
5.7.5. Periplasmic Core Domains (PCDs). As mentioned
above, the bulk of the periplasmic portion of the type VII ABC
transporters is contributed by a globular “periplasmic core
domain” or PCD.578 It forms a conserved module, which is
presented across the MacB and also FtsX-type trans-
porters574,575 allowing to unite them into a separate PFAM
group (PF02687) and giving the name to the whole family, so
it can often be referred to as MacB/FtsX. The PCD domain
could be split into an “upper” and “lower” subdomain,578
which have also been named periplasmic subdomain C (PSC),
and periplasmic subdomain N (PSN), respectively272 (Figure
20), with the lower portion presenting a mixed α-β sandwich
of a general (β−α−β−β−α−β) configuration, sharing high
structural homology to the porter (PD) domains of the RND
transporters,578 while the “upper subdomain”, which has
become known as the “SABRE” (an acronym for small,
alpha/beta rich, extracytoplasmic), is unique to the wider FtsX
family and can vary significantly in structure. In some of the
recent literature, the PD and SABRE subdomains have also
been referred to as periplasmic subdomain N (PSN) and
periplasmic subdomain C (PSC), respectively,272 but to avoid
confusion, we will stick to the PD and SABRE nomenclature
(Figure 20).
Due to its variability, the SABRE subdomain can be used as
a differentiator within the wider MacB/FtsX family, and based
on this it is possible to subdivide the group into several
cohorts. It is notable that in the prototypical members of the
MacB family, including the Aggregatibacter actinomycetemcomi-
tans AaMacB,431,578 Acinetobacter baumannii AbMacB,24 E. coli
EcMacB,272 and the Gram-positive transporters belonging to
the family, such as the Streptococcal permease Spr0695 (PDB
ID 5XU1),571 the SABRE domain presents a continuous entity,
which is spliced into the middle of the “lower subdomain”
(PD), splitting it evenly into two β−α−β motifs. Within this
“canonical” MacB group, the SABRE forms a pseudocontin-
uous extension of the PD β-sheet, presenting a semirolled β-
barrel.
A number of MacB-related proteins share the extended
architecture above, with their PD modules superposing with
low RMSD,431 and they differ predominantly in the
organization of their SABRE subdomains which display
considerable diversity; however, as they do not form tripartite
complexes, we will not discuss them at length, highlighting
some key members and respective PCD-domain peculiarities.
The second group of proteins that give the joint-name to the
MacB/FtsX family, the aforementioned FtsEX complex,574 is
central for peptidoglycan remodeling, a role which it exerts by
activating the extracellular and periplasmic amidases, via direct
recruitment of the EnvC by the PCD of FtsX.576 FtsEX shares
similar TM-architecture to MacB, featuring 4 TM-helices and a
large periplasmic loop, and it appears to function as a dimeric
assembly of (FtsE)2(FtsX)2 stoichiometry.
In Streptococcus pneumoniae, FtsEX interacts with modular
peptidoglycan hydrolase PcsB (PBD ID 4CGK),583 and the
activation of the ATPase activity by FtsE triggers trans-
membrane activation of PcsB.584 PcsB is a dimer in which the
V-shaped coiled-coil (CC) domain of each protomer acts as a
pair of molecular tweezers locking the catalytic domain of each
dimeric partner in an inactive configuration. It has been
suggested that the release of the catalytic domains likely
requires an ATP-driven conformational change in the FtsEX
complex, and FtsX PCD (referred to as extracellular loop 1 or
ECL1) has been shown to interact directly with the coiled coils
of the PscB.434 The PCD of FtsX reveals an upper extended β-
hairpin and a lower α-helical lobe, with each extending from a
mixed α−β core. The helical lobe mediates a physical
interaction with the peptidoglycan hydrolase PcsB via the
coiled-coil domain of PcsB.
Within the classical FtsX family transporters the mycobacte-
rial homologues (e.g., PDB ID 4N8N)433 could be considered
a basal group, and there the SABRE domain is presented by a
simple helical extension, while the FtsX from Streptococcus
pneumoniae (PDB ID 6HFX; 6HEE; 6HE6)434 presents an
Figure 20. Comparison of the porter domain of RND transporters
and PCD of MacB. (A) The lower part of the periplasmic domain
(PCD) of MacB shares structural homology with the porter domains
(PD) of the RND transporters, as can be seen on the example of the
AaMacB (PDB ID 3FTJ)578 (right) and the PC1 PD module of AcrB
(PDB ID 2DHH)288 (left). (B) The topology diagram of the domain
indicates that the SABRE subdomain is spliced within the core PD
module between the β2 and β3 strands.
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additional β-hairpin insertion between β1 and α1 (see Figure
21 for a comparison of SABRE domains). Intriguingly, exactly
the same expansion of the basic PD-module can be found in
the C-terminal domain (CTD), the PD1-domains of the
eukaryotic RND-related cholesterol transporter NPC1 (e.g.,
PDB ID 5U74,585,586 6W5R,587 and 6UOX588), as well as the
second extracellular domain (ECD-II) of the Hedgehog-
signaling associated Patched1 (PDB ID 6OEU)589 and the
recently resolved Dispatched (DISP1) (PBD ID 6XE6)590
showing the topological versatility of the basic PD-fold.
The recent structure of the EnvC bound to the periplasmic
domain of FtsX (PDB ID 6TPI)591 reveals an EnvC-FtsX
complex with 1-to-2 stoichiometry with two distinct FtsX-
binding sites located within an antiparallel coiled-coil domain
of EnvC, showing that the FtsX-PD modules could be used not
just to provide lipid- and PG-binding but can mediate
protein−protein interactions.
In Gram-negative bacteria the inner-membrane-associated
LolCDE ABC transporter, the LolA chaperone, and the LolB
outer-membrane receptor form an essential system for
membrane extraction and transportation of the newly
produced lipoproteins from the outer leaflet of the plasma
membrane to the inner leaflet of the outer membrane.592
The permease unit of the transporter is formed by the
heterodimer of LolC and LolE, both of which have MacB/
FtsX-like structure, and in E. coli the LolC-LolE heterodimer
cooperates with the NBDs of the ATPase LolD, which
provides energy for the lipoprotein extraction. A very similar
system is present in A. baumannii, where a homodimeric LolF
binds to a dimer of LolD.593 The structures of the PCD of
LolC have been revealed, both in isolation (PDB ID 5NAA431
and 6F49432) and bound to the periplasmic chaperone LolA
(PDB ID 6F3Z)432 which reveals how a solvent-exposed β-
hairpin loop (termed the “Hook”) and trio of surface residues
(the “Pad”) of LolC are essential for recruiting LolA from the
periplasm and priming it to receive lipoproteins (PDB ID
6F49).432
The PCD of LolC presents a departure from the
prototypical MacB PCD fold, and its SABRE domain has a
distinctive β-hairpin structure formed by residues P167−P179
(full-length LolC numbering), which has been named the
“hook”, which is not observed in the MacB, and which, along
with a trio of charged residues from the external side of the
SABRE β-barrel, named the “Pad”, participates in the LolA
recruitment432 (see Figure 21 above). A very similar
arrangement is seen in the structure of the related A.
baumannii LolF (PDB ID 5UDF) generated from a structural
genomics effort
Bacillus subtilis and B. amyloliquefaciens produce sporulation-
delaying protein (SDP), which is a peptide toxin capable of
killing cells within a biofilm to support continued growth,
thereby delaying the onset of biofilm sporulation. SDP
producing cells protect themselves against the endogenous
SDP via the action of the four-component transporter
YknWXYZ which acts as a major SDP efflux pump.568 Within
this assembly, the YknYZ forms a noncanonical ABC
transporter, where YknZ is the permease, while YknY is the
NDB. Heterodimeric assembly of YknY2Z2 forms a transporter
remarkably similar to MacB,579 while the PAP YknX assembles
into a hexameric pattern very similar to MacA.594 Despite the
sequence identity of around 20%, the extracellular domain
(ED) of the BaYknZ reveals a structure which is virtually
identical to that of the PCD of the AaMacB with DaliLite
server bringing a Z-score of 20.1 and structural superposition
returning an RMSD of just 1.6 Å over the C-α backbone of the
corresponding domain.594
Similarly, the structure of the related Gram-positive pump
Spr0694−0695, where Spr0695 is the permease and Spr0694
Figure 21. Diversity of PCD domains in the FtsX/MacB family and porter domain connections. (A) The basic PD-module of the PCD is
conserved across the MacB/FtsX family; however, there are multiple variations on the theme. The architecture of the module is expandable, but
intriguingly, it features conserved regions of insertion, which are shared not only between Gram-positive and Gram-negative bacteria but also with
eukaryotic organisms. The PDB codes for presented structures are as follows: Mycobacterial FtsX (4N8N); SpFtsX (6HE6); Spr0695 (5XU1);
LolC (5NNA); NPC1 (5U74); DISP (6XE6). (B) PD domains present in different proteins outside of the MacB-family (see text for more details).
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provides the ATPase function, is surprisingly similar to the
Gram-negative equivalent (PDB ID 5XU1)571 and presents
PCDs which are virtually identical to those of MacB,
suggesting communality of operation, despite the lack of
OMF engagement in the respective complex. One small
exception is the presence of a well-defined helical loop inserted
in the SABRE domain (residues 202−216), which seems to
form specific contacts with the TM helices of the transporter
and could provide additional conformational coupling or, as
suggested by the authors, plays the role of a gating loop.571
From the data available on the PCD domains, it is clear that
they are predominantly engaged in peptide binding and
protein−protein interactions, and furthermore, they display
major conformational changes between different structures. It
is a bit surprising that the PCD domains do not present high
dimerization propensity on their own.578 However, in the
available apo-EcMacB and the nucleotide bound structures, as
well as the PCDs of the ADP-bound structures of AbMacB,24
they appear to undergo significant conformational rearrange-
ments, which have been suggested to arise from the NBD-liked
allostery.442
5.7.6. Versatility of PD Fold outside of the MacB/FtsX
Family. Modularity of Assembly, Phylogenetic Con-
nections, and Topological Linkage between Different
Transporter Groups. The porter domains are the central
building blocks of the periplasmic part of RND transporters.
Numbering these for an isolated PD domain from the N- to
the C-terminus, by the respective secondary structure
elements, provides a β1−α1−β2−β3−α1−β4 configuration,
which we refer to as the “standard PD” domain, which is
observed in the AcrB PC1 domain279 (Figure 22).
The standard PD domain of RND transporters is a version
of the ferredoxin-like fold,595 which is composed of 2 α-helices
and 4 β-strands, in an α-β sandwich configuration, with the α-
helices being spliced between the β1/β2 and β3/β4,
respectively, and the 4 β-strands forming an antiparallel β-
sheet. The fold has been initially described from the activation
domains of pro-carboxypeptidases (e.g., PDB ID 1NSA596 and
1AYE597) and a number of RNA-binding proteins, including
small nuclear ribonuclear proteins, e.g. U1A small spliceosomal
protein (PDB ID 1URN)598 and ribosomal protein S6 (PBD
ID 1RIS),599,600 with the latter showing a β-roll transition of
the central sheet.
The pore domains of prototypical HAE-1 type transporter
such as AcrB,279 as well as the HME group transporters, such
as CusA,354 contain four variants of the PD fold, namely the
PN1, PN2 and PC1, PC2 domains (Figure 5 and Figure 6),
with PN1 and PC1 being continuous folds, while PN2 and
PC2 harbor insertions between their respective β2 and β3
strands, comprising the funnel (FN) domains.279 Furthermore,
while PN2 and PC2 present a 4 stranded β-sheet, the PN1 and
PC1 show an extended 5-stranded sheet provided by β-
augmentation in trans from the Cβ13 and Nβ13 strands,
respectively279 (Figure 5, Figure 6, and Figure 22).
Figure 22. Topological connections of the basal RND PD-module and the docking/funnel subdomain in RND transporters. (A) The upper panel
presents the topological diagrams, demonstrating the DN domain could be derived from the basal PD-module by flipping out the β2/β3 hairpin
which forms part of the central β-sheet. This disrupted cental sheet is complemented by the corresponding β2/β3 hairpin of the neighboring
subunit by β-augmentation. Note that the antiparallel character of the central sheet changes as a result. PD1 AcrB denotes the organization seen in
PN1/PC1 subdomains. (B) The crystal structures of the corresponding modules on the example of the AcrB PC1 subdomain (PDB ID 2GIF) and
the DN1 subdomain of CusA (PDB ID 2DHH).
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Figure 23. Different families of RND transporters and related proteins. The representatives of the SecDF family, as well as the prokaryotic MmpL
and Hopanoid transporter groups are shown, as well as the known structures of eukaryotic RND transporters. The PDB ID codes are given in
parentheses. Due to the poor resolution and disorder, the missing loops of the DISP1 have been modeled for completeness. See text for more
details.
Figure 24. Structural transitions within the PD-domains of SecDF are linked to the functional cycle of the transporter. The PD modules in the
periplasmic domains of SecDF (P4 and P1-base) undergo a conformational transition from β-barrel to β-sheet between the Super F form (as seen
in the PDB ID YHF) and the F-form (PDB ID 3AQP). Modified based on Furukawa et al.366 These are linked to the substrate engagement by the
P1-head domain of the transporter, and similar transitions may occur within other PD-containing transporters, e.g., the PD-domains of the MacB/
FtsX family.
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Our analysis of the fold of the globular subdomains that
form the funnel or docking domain of the RND transporters
reveals that they could be derived from the “standard” PD
domain topology by an additional β-hairpin insertion following
α2-helix and a flip of the β-hairpin formed by the β2 and β3
strands of the central β-sheet, leading to its disruption. The
central β-sheet is then supplemented during oligomerization,
by the equivalent β2−β3 hairpin from the neighboring
protomer, providing interconnectivity between the subunits
of the functional trimer. As a result of this “hairpin swap”, the
central continuous β-sheet of the “standard PD domain” is
replaced, e.g., in the DN1 domain of AcrB, by a
pseudocontinuous β-sheet, where, due to the outward flip of
the β2−β3 hairpin, the antiparallel interface between the
cognate β1- and β3-strands is substituted by a parallel β1- and
β3′-strand arrangement (Figure 22).
A number of RND and related transporters present
variations on such an architecture including the HAE-2 family,
with representatives such as MmpL3 (PDB ID 6AJF);277 HAE-
3 HpnN (PDB ID 5KHN);278 and the more distantly related
SecDF translocases (e.g., PDB ID 3AQP364 and PBD ID
5YHF366), as well as representatives from eukaryotic groups,
such as the human cholesterol transport associated Niemann−
Pick disease type C protein 1 (NPC1) (PBD ID: 5JNX601 and
Figure 25. PD domains provide a flexible modular architecture which is shared across a number of different transporters. (A) Topological diagram
showing the decoration of PD domains in different transporter classes. Where the transporters are not homooligomers with a single PD module per
domain, the PD1 and PD2 domains of respective subunits are presented. The insertion points are limited and conserved across the known PD-
domains, with notable splicing events taking place between β2 and β3 of the central β-sheet. Minor β-hairpin decorations are seen in the FtsX
family and eukaryotic RND transporters. In addition, the SecDF family displays a unique insertion between α2 and β4. (B) Gallery of the PD-
domains of the notable members of the transporter families discussed above. The domain abbreviation and PDB ID code of the respective
structures are provided in parentheses. Abbreviations: MLD, middle luminal domain; ECD1/2, extracellular domain 1/2; CTD, C-terminal luminal
domain or Cys-rich domain.
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6W5R587), mouse cholesterol translocator Patched (PBD ID
6MG8),602 and the human Patched 1 (PDB ID 6OEU589 and
6DMB603) (Figure 23).
5.7.6.1. MmpLs. In Mycobacterium tuberculosis the 14
members of the MmpL (mycobacterial membrane protein
large) transporter family form a group of proton-driven
carriers, that translocate complex (glyco)lipids and side-
rophores across the cell envelope.604,605 Unlike the RND
transporters of the HAE-1 and HME families, these trans-
porters operate as dimers, although some earlier data on the
orthologous Corynebacterial CmpLs,606 namely CmpL1, has
suggested a possibility of a trimeric assembly.605 As these
transporters are subject to a detailed review in the current issue
of Chemical Reviews,607 we will give only a cursory note about
them here. Phylogenetic analysis has suggested that the group
shares high homology to the classic HAE/HME RND family
and similarly presents an internal gene duplication with
resulting 12 TM-helices,608 with extracellular porter-domains
D1 and D2 homologous to the PD-domains being spliced
between the TM1/TM2 and TM7/TM8, respectively609 (see
Figures 23 and 24 and Figure 25A). Two broad clusters of
MmpLs can be derived based on the topology of their PD
domains, a more basal group, called cluster II, including MmpL
3, 11, and 13, which possess two standard PD domains (with a
β1−α1−β2−β3−α1−β4 configuration), “cluster I” which in-
cludes the rest of the family that have a standard N-terminal
PD domain, and an expanded C-terminal D2 domain featuring
an in se r t i on be tween the β 2−β 3 (β 1−α 1−β 2−
X−β3−α1−β4),609 thus presenting a PD-architecture equiv-
alent to that observed in the MacB/FtsX family discussed
above. Consistent with the prediction, the structure of the
isolated D2 domain from the MmpL11 (PDB ID 4Y0L)609
showed high homology to the PD domains of classical RND
transporters. Cross-linking experiments suggest that the
orientation of the PD domains in MmpL 11609 is similar to
the PC1/PN2 domain orientation on the AcrB, e.g. (PDB ID
2GIF)318 or CusA (PDB ID: 4DNT).610 However, later
structures of the MmpL3 from M. smegmatis (PDB IDs 6AJF-
6AJJ,277 6OR2611) display a distinct domelike arrangement. In
addition, the PD2 domain of MmpL3 (PDB ID 6OR2) does
appear to have a small insert, after β2 (see Figure 25B). At
present there are no experimental structures of PD domains
belonging to cluster I MmpLs, although our bioinformatic
analysis suggests their insertions are not related to the ones
observed in the funnel domains of RND transporters and may
be closer related to the α-helical domains observed in the
HAE-3.
5.7.6.2. Hopanoid Transporters. The hopanoid trans-
porters, which are representatives of the HAE-3 group and
are responsible for the transport of the eponymous pentacyclic
triterpenoids with a sterol-like function in the bacterial
membrane,278 also exhibit high similarity to the RND
transporters, consistent with that present for PD-like domains.
The crystal structure of the HpnN (PDB ID 5KHN)278 (see
Figure 23) revealed a dimeric assembly of the transporter,
which presented four PD domains, with PD1 and PD2 being
equivalent to the classic PD domains observed in HAE-1 and
HME RND transporters, but in addition, they present helical
inserts forming additional PD3/PD4 domains, with no relation
to any hitherto known domains. The splicing of the PD3/PD4
into the PD1 and PD2, respectively, produces the same
topology (β1−α1−β2−X−β3−α1−β4) as discussed above for
MmpL and the MacB/FtsX proteins suggesting a general
pattern for expanding the architecture (see Figure 25, panel B).
5.7.6.3. SecDF. Working in conjunction with the major
secretory complex SecYEG/SecA612 that is driven by SecA
ATP-hydrolysis, the proton motive force powered SecDF
complex facilitates the threading of the unfolded protein
cargoes and plays a chaperone-like function.365,613,614 In
Thermus thermophilus SecDF, the SecD and SecF are fused
into a single polypeptide chain, and its structure (PDB ID
3AQP)364 revealed that similar to the group I MmpLs
discussed above, SecDF presents a pseudosymmetrical, 12-
helix transmembrane domain belonging to the RND super-
family and two homologous major periplasmic domains, P1
and P4 (Figure 24 and Figure 25). While the P4 domain shows
a classic β1−α1−β2−β3−α1−β4 organization, similar to the PD-
domains in HAE-1 PD and MmpL3, the P1 domain presents a
β1−α1−β2−X−β3−α1−β4 organization, where “X” is a large
insert forming the so-called “head” subdomain, while the core
PD β-strands form the cores of both the P1 and P4 form a
pseudosymmetrical 8-stranded antiparallel β-sheet that covers
the TM region of SecDF and is planar in the most structures,
including P1-membrane facing “F” forms and P1-outward
facing “I”-forms;364,615 however, unexpectedly, the PD-
domains of the transporter were also revealed in a β-barrel
form (known as Super F-form) (PDB ID 5YHF).366 The β-
barrelled super F-form is speculated to engage with the
emergent preprotein coming out of the SecYEG on the
periplasmic side of the membrane, which is bound to the P1-
head. The conformational transition from super F-to-F and
planification of the β-sheet is speculated to be associated with
substrate dragging, and consistent with such interpretation,
fixing the β-sheet by cross-linking between the interface of the
P1-base and P4 abolished the translocation activity of SecDF,
suggesting that β-sheet rearrangement occurs during protein
translocation.615 Further transition of the F to I-form is
associated with the formation of a proton-accessible tunnel in
the TM-part of the protein (as seen in PDB ID 5XAN) and
subsequent release of the cargo, leaving the P1-head outward
facing in the cargo-disengaged “I without tunnel form”366
(Figure 24).
In a possible analogy to the efflux RND transporter cycle,
the substrate binding causes conformational transitions, that
allow the access and binding of the protons to the TM-
domains, with actual release of the protons on the cytoplasmic
side being associated with the cargo release and thus, recycling
of the complex. Despite the similarities, the proton relay
network in SecDF does not appear to function the same way as
in canonical RND transporters such as AcrB. Notably, while
there is still a tight interplay between the residues from TM4
(esAspIV; “es”standing for “essential”) and TM10 (Tyr),
unlike the AcrB, the proton-relay is supported by critical
residues located on TM11 (esArgXI).366
5.7.6.4. PD-Domains within the Eukaryotic RND Trans-
porters. Members of the eukaryotic sterol transporter family
include the Niemann−Pick type C protein 1 (NPC1) and the
Niemann−Pick type C protein 1 like 1 (NPC1L1). The first is
a lysosomal membrane protein essential for cholesterol
homeostasis. Defects of NPC1 are associated with hereditary
Niemann−Pick disease leading to a fatal accumulation of low-
density lipoprotein (LDL)-derived cholesterol.616 Active as a
monomer with 13 TM helices and an extended N-terminal
domain, NPC1 presumably acts as a receptor/transporter for
the cholesterol-loaded NPC2 soluble carrier via the N-terminal
Chemical Reviews pubs.acs.org/CR Review
https://doi.org/10.1021/acs.chemrev.1c00055
Chem. Rev. XXXX, XXX, XXX−XXX
AR
soluble loop.274,586 It is also the target of the Ebola virus acting
as an intracellular receptor. Structures for the full-length NPC1
and in complex with the cleaved glycoprotein of the Ebola
virus have been published (PBD ID: 5JNX,601 6W5R587).
NPC1L1 is an intestinal membrane protein involved in the
absorption of cholesterol and a target of the therapeutic
compound ezetimibe, for which recently cryo-EM structures
have been solved.617 Patched (PTCH1) and Dispatched
(DISP) belong to the eukaryotic dispatched RND transporter
family. Both are involved in the hedgehog signaling pathway,
during embryogenesis and tissue homeostasis, where Dis-
patched exports the N-terminal portion of sonic hedgehog,
with C-terminally linked cholesterol,274,618,619 and PTCH1 acts
as a receptor of the lipidated sonic hedgehog protein, binding
of which releases the downstream suppression of Smoothened
(SMO). Cryo-EM structures of monomeric human PTCH1
resemble the architecture of NPC1 (PDB ID 6OEU, 6OEV;589
6DMB603), presenting an RMSD of ∼2.5 Å, and recently the
structure of the human Dispatched-1 (DISP1) homologue has
been obtained (PDB ID 6XE6.590 These eukaryotic homo-
logues possess two separate PD domains, which are decorated
in a similar fashion to the ones discussed above for the Cluster
I MmpLs and Hopanoid transporters. Notably, the two PD-
like domains of NPC1, named the middle luminal domain
(MLD) and C-terminal luminal domain or Cys-rich domain
(CTD), present large insertions between the β2−β3 (PDB ID
5U74),586 an organization which is also shared by the Patched
structure.589,603 In addition, the NPC1 MLD-domain (PD1)
contains a β-hairpin insertion between β1 and α1, which
mimics the ones observed in the FtsX members such as
discussed previously (Figure 25 and Figure 21). A very similar
insertion is seen in the extracellular domain 2 (ECD2/PD2) of
the DISP1 (PDB ID 6XE6)590 but not in the PTCH1.
Taken together, the analysis of the PD domains of the RND-
like transporters presented, as well as the FtsX/MacB family,
displays a clear pattern of usage and modification of the PD
modules, with two “hotspots” of insertion being utilizedthe
first one is located at the tip of the β2-β3 hairpin of the central
PD-β sheet and allows for splicing of large subdomains, e.g.,
the SABRE domain in the case of the FtsX/MacB family, or
the large helical subdomain inserts in the case of PD3/PD4
domains of the hopanoid transporters and the eukaryotic
RND-like transporters (NPC1/DISP1/PTCH1). The second
insertion point accommodates smaller splice-ins in the form of
an additional β-hairpin insertion, as seen in the S. pneumoniae
FtsX (PDB ID 6HE6); the ECD2 of DISP (PDB ID 6XE6),
Figure 26. (A) Schematic representation of the TM helix packing at the dimer interface between different classes of ABC transporters shows close
connections of the MacB architecture to the type VI and type VIII (MlaEF) transporters. Topologies are derived from the structures of MacB
(PDB ID 5GKO),24 MlaE (PDB ID 6XBD),439 LptB2FGC complex (PDB ID 6S8N),635 Wzm-WznT (PDB ID 6M96),429 and ABCG2 (PDB ID
5NJG).632 Top-down view from the periplasm. Note: due to the intertwisting of the helices in the type IV transporters, the diagram depends on the
level at which the slice is cut through the TM; the provided view is representative to the middle of TM segment, based on the ABCB1 structure
(PDB ID 6QEX).521 (B) Topological connections within the ABC transporter families. The ABC transporter families share a common core
architecture, which can be derived from the four TM helices seen in the type VII (MacB/FtsX) family. The other main families of exporters are
presented, which could be seen as derived from MacB by addition of C-terminal helical fragments. Homologous helices are colored consistently
from the N-terminal to the C-terminal. The intracellular coupling helices (CH1 and CH2) are presented in green and red. CoH = connecting helix.
Substrate binding domains are shown as gray boxes (PCD, periplasmic core domain; PH, pore helix; PGH, periplasmic gate helix; ECD1,2,
extracellular domains 1, 2; β-JR, β jelly roll domains). Adopted with modifications based on Schaeffer et al.634
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and the MLD domain of NPC1. Finally, the SecDF presents a
unique insertion in its first PD-domain, with the P1-head
domain being spliced after α2 (see Figure 25).
Notably the architecture seen in the PD domains is also
present in a number of additional periplasmic proteins which
lack transporter function, e.g., the two-component signaling
modulator family of MzrA proteins (PDB ID 4PWU),620 as
well as more distantly related proteins including the archaeal
Tk-subtilisin chaperone pro-peptides (PDB ID 3A3O) and,621
similarly, chaperoning activation domains of carboxypeptidases
(PDB ID 1PBA),622 as well as acylphosphatases (e.g., mtAcP
PDB ID 1APS)623 and the aforementioned small nuclear
ribonuclear proteins such as U1-SNRP A (PBD ID 3G8T,624
3UCU625) (see Figure 21B).
5.7.7. Relations of the Membrane Porter Domains of
MacB/FtsX to Other ABC Transporter Families. At first
sight, there appears to be limited similarity between the porter
domains of MacB/FtsX containing 4-TMs and the more
typical ABC transporters, which contain 6-TMs as standard.
However, closer inspection of the MacB-TM regions utilizing
DALI pairwise fold-comparison software24 and comparison
against different members of the type IV family, such as
ABCB1 (PDB ID 4M1M,626 3G60627), heterodimeric TmrAB
(PDB ID 5MKK), and the ADP-bound form of the lipid-linked
oligosaccharide flippase PglK (PDB ID: 5NBD),628 reveal
unexpectedly high similarity of the MacB/FtsX family to this
family, with the ABCB1 returning a Z-score of 8.7 (PDB ID
3G60), based on the superposition of the first three N-terminal
helices (TM 1−3) of the type IV transporters showing high
structural similarity to the MacB TM helices 1−3. Despite this
similarity, it has to be noted that the dimer interface of MacB is
not matched with the dimer interface presented by the
structures of type IV ABC transporters, e.g. in the MacB/FtsX
TM helices 1−3 do not form part of the substrate binding
cavity and are hence more likely to play a role in energy
transduction, rather than substrate interactions, while in type
IV helices 1−3 face away from the central cavity toward the
lipid bilayer24 (Figure 26, panel A, showing the packing in
ABCB1 6QEX521).
An expanded topological analysis of the type VII ABC-family
topological relationships, which in addition to the type IV
transporters discussed above also included type I importers
(e.g., MetNI(Q) (PDB ID 3DHW),629 YjgP/YjgQ (LptBFG;
type VI family)),630,631 as well as the members of type V
exporters, such as the ABCG582,632 and ABCA633 involved in
eukaryotic lipid export, revealed unexpected similarities,
suggesting that they might be evolutionarily related.634 Based
on these similarities, an alternative classification of ABC
transporter topologies has been proposed, with the core of
these transporters’ structures consisting of the four-TM core
segments (1−4), as observed in the MacB/FtsX family (e.g.,
PDB ID 5WS4), and it has been proposed that MacB/FtsX
(Group VII) may be a basal group of transporters from which
the other topologies covering groups V, VI, and even IV are
derived. Uniquely, the MacB/FtsX family additionally
possesses a second coupling helix (CH2) at the C-terminal
end of the fourth core TM segment (Figure 26, panel B; TM-
segment is colored red), which is not present in the TMDs of
LptBFG (YjgP/YjgQ; type VI) or in group V (ABCG and
ABCA) transporters.634
Intriguingly, the complete topology of type IV floppase/
exporters (formerly type I exporters) could also be derived
when using MacB/FtsX as a basis, as TM segments 1, 2, 3, and
6 can be structurally aligned to the TMs 1−4 of MacB.
Insertion of TM helices 4−5 carrying a canonical coupling
helix between TM3 and 4 of MacB/FtsX produces a topology
equivalent to the type IV floppase/exporters. Consistent with
this, DALI superposition of MacB (PDB ID 5WS4) with type
IV heterodimeric exporter TmrAB (PDB ID 5MKK),523 which
is a homologue of the antigen translocation complex TAP,
returned a Z-score of 7.7.24 While intriguing and appealing in
its simplicity, such systematics do not automatically suggest
that the MacB/FtsX family is a basal group, as it could be a
product of degenerative evolution.
More recently, Murakami et al.580 also extended their DALI
analysis to the type V family members ABCG2 (PDB ID
5NJG)632 and ABCA1 (PDB ID 5XJY)633 that returned high
Z-score values of 7.6 and 7.5, respectively. While the overall
score is lower, these transporters allow better superposition,
covering all four TMs of MacB, and importantly, they provide
a dimer interface matching that of the MacB.
Our initial analysis of MacB-structures has also suggested a
connection of the MacB/FtsX with type V floppases/exporters
such as Wzm-WztN and the ABCG/ABCA family but also
with the yet-to-be classified Mla-system members due to the
overall topology of TMDs, the presence of the amphipathic
connecting helices (CoH), linking the NBDs to the TM
helices, and the close association of the NBDs with the
membrane. In Figure 26 (panel B), we have expanded the
topological classification discussed above,634 incorporating the
data from the recently solved structures of the yet-to-be
classified MlaEF-ABC transporter system,437−439 the structure
of the permease subunit of which, MlaE displays a number
features linking it with the MacB and LptB2FG families, plus a
set of unique elements, that in our view justify classifying it as a
separate group of ABC transporters, which we tentatively
assign to type VIII for clarity of presentation below. Notably,
the MlaE topology can be readily derived from a MacB/FtsX
family basal topology by addition of C-terminal helix 5 (Figure
26, panel B). Furthermore, the TM5-helices of MlaE pack
analogously to the similarly derived helix 5 in the LptFG
complex, and crucially, the packing is dominated by close
bundling of TM2 which is only observed in the MacB family,
setting these two groups into a close sister grouping within the
ABC-superfamily, reaching similar conclusions from the
independent topological analysis by Coudray et al.439 Helical
packing diagrams (Figure 26, panel A) provide further
evidence of common patterns across the ABC-groups V−VII.
5.7.8. TMD and Energy Coupling. As mentioned earlier,
the analysis of the topologies of the available ABC transporter
structures revealed that there are at least seven structurally
distinct ABC transporter folds,428 of which MacB is the most-
recently determined representative. MacB can therefore be
considered the “holotype” for the whole of the type VII ABC
transporter superfamily428,431 and has become the first
structurally characterized member of the ABC3 superfamily
of the ABC transporters as defined by Wang et al.427 Its unique
architecture suggests a mechanistically distinct functional
cycling mechanism.
The EcMacB has been revealed in a nucleotide free form
(PDB ID 5NIK), with the NBDs apart and unable to bind
ATP.272 However, an ATP-bound (PDB ID 5LJ7) and
nonhydrolyzable ATP-analogue bound form (PDB ID 5LJ6,
5LOL)431 have also been reported. For AaMacB and AbMacB,
an ADP-analogue bound form (e.g., adenosine-5′-(β-thio)-
diphosphate (PDB ID 5WS4)) and a nucleotide-free form
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(PDB ID 5GKO) have been obtained, respectively.24 In
addition, the structure of the Streptococcal MacB-like
transporter Spr0694−0695 (PDB ID 5XU1)571 was revealed
in a nucleotide-free state and the comparative analysis of these
structures has allowed us to reconstruct a plausible energy-
coupling cycle of the MacB/FtsX-like transporters.
In none of the structures does the tightly packed dimer
interface of MacB present any credible space for a trans-
membrane cargo to be accommodated. However, the
nucleotide-free, as well as the ADP-bound A. baumannii
structures clearly resemble each other with the extra-
membrane helical protrusions of the TM1 and TM2 being
bent away from the central axis of symmetry, creating a “Y-
shaped” crevice, which appears accessible to potential
periplasmic cargoes.24,272 The PCDs in the nucleotide-free
forms and in the ADP-bound form appear to be separated. In
the presence of ATP, the NBDs are brought together, which
causes the major coupling helix CH1 to push up the TM2,
causing contraction of the interhelical gap, which results in a
transformation of the loose helical arrangement into a rigid
four-helical bundle,431 and this “zipping-up” of the interhelical
interface causes a marked contraction of the PCDs, which are
squeezed together. Such long-range communication from the
NBDs through the TM-stalk helices all the way to the
periplasmic domain has been dubbed “mechanotransmission”,
as the stroke from the ATP-binding is not used to transport the
substrate across the membrane in which the ABC transporter
resides but to cause conformational changes into the
periplasm, or extracellular space, respectively. Consistent with
such an interpretation, disulfide cross-linking of the stalk-
helices has been demonstrated to severely impact MacB
function in vivo431 (see Figure 27).
Thus, in MacB, the tight coupling between the TMD and
the NBDs via CH1 and CH2 is likely used not solely for
conformational changes of TM helices but is also translated
into long-range communication with the PCDs, which is in
turn converted into substrate transport via the PAP- and OMF-
interactions.
Under the currently prevailing paradigm, ATP-binding and
hydrolysis on the inside of the membrane cause large,
transmembrane conformational changes in the MacB structure,
leading to “zipping-up” of the central stalk-helices, and this has
been suggested to drive the PCD-domain rearrangement which
leads to cargo expulsion, although the exact binding sites and
extrusion mechanism are not fully clear. It is clear, however,
that rather than transporting substrates across the inner
membrane, MacB-family transporters remove their substrates
from the periplasm, utilizing long-distance conformational
coupling of the NBD dimerization, in a mechanism which was
dubbed “mechanotransmission”. Members of the MacB/FtsX
family participating in tripartite complex formation may use
the mechanotransmissive conformational coupling of the stalk
helices to the PCDs to efflux substrates across the outer
membrane via OMFs ducts, while the MacB/FtsX homologues
that function alone can utilize such motions for exporting
across the peptidoglycan layer in the Gram-positive organisms,
as well as for a related function in lipoprotein trafficking and
transmembrane signaling.
5.7.9. Substrate Binding Site. In the MacB/FtsX family,
the extra-membrane extensions of TM1 and TM2 protrude out
of the membrane forming a kinked, “Y-shaped” conformation
with a small semioccluded cavity, that is accessible from the
periplasm. In the cryo-EM structure of MacB (PDB ID 5NIL),
an unidentified electron density, occluding this region between
the periplasmic extensions of TM1 and TM2, has been
reported.272 Although, the low resolution of the associated
cryo-EM map (at 5.3 Å) did not permit a clear interpretation,
it has been speculated that it might represent a putative
substrate binding site.272 While there is no direct structural
data on substrate binding, structure-guided mutagenesis was
used to narrow down the potential substrate binding
residues,431 showing a plausible erythromycin binding site,
covering predominantly bulky hydrophobic residues (including
Y315, F320, F320, F503, and M507), mapping mostly to the
PD-subdomain facing the interdomain interface. Their impact
on the activity of the pump was also validated using bacitracin
and colistin. Given their distribution across the PCD, it
appears plausible that the PD subdomain is primarily engaged
with cargo processing, while the SABRE domain, which shows
significant conformational transitions and has been implicated
in protein−protein interactions, is central to coupling to the
PAP and the transmission of the conformational changes
outward to the OMF, although future research is still needed
to validate this hypothesis.
As mentioned above, the structure of the related Gram-
positive pump Spr0694-0695, despite overall similarity with
MacB, reveals a departure from its blueprint in the TMD
portion of the protein.571 Specifically, there is divergence in the
SABRE domain, where there is a short extra helical insertion
(helix 6 of the PCD or rather in that case the extra-cellular
domain or ECD) with the extra-membrane protrusions of the
TM helices 1−3. Several charged residues are seen on this helix
(e.g., K207-R208, K210), and it has been suggested that these
may form a “guard helix” protecting a putative substrate-
entrance tunnel. Mutation of the charged residues of the helix
Figure 27. Mechanotransmission mechanism of MacB. Crystal
structures suggest a possible cycling mechanism for MacB. In the
nucleotide-free structures, the NDBs of the transporter are separated
and appear unable to bind ATP. This coincides with the separation of
the PCDs and lack of helical-bundle formation in the stalk helices. To
the contrary, the ATP-bound forms show significant rearrangement of
the PCDs, which also coincides with a helical bundle formation in the
TM-domain, suggesting that the ATP-binding is communicated long-
range from the NBDs across the membrane to the periplasmic domain
through the TM-stalk helices. This has been dubbed “mechano-
transmission”, as the stroke from ATP-binding is not used to transport
the substrate across the membrane in which the ABC transporter
resides but rather to cause conformational changes in the periplasm.
(Modified, based on the model by Crow et al.431)
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reduced the ATPase activity, suggesting it may also play a role
in energy coupling.
In Lactococcus lactis, the hrtB gene (UniProt A0A2N5WEC6)
codes for the permease, and the hrtA gene (A0A0H1RJ19)
codes for the NBDs of a MacB-like heme transporter, which
was initially suggested to remove it from the cytoplasm or the
membrane-solubilized pool,636,637 although the exact mecha-
nism remains unclear. Newer work suggests that the heme may
instead be removed from the periplasmic side of the membrane
in S. aureus638 and consistent with that mutation of residues in
the HrtB of L. lactis mapping to the SABRE domain of the
PCD (Y168) and the upper part of stalk-helix 2 (Y231),
speculated to coordinate heme-ligands, impacted function,639
suggesting this region may be involved in ligand binding.
Despite this circumstantial evidence, the detailed character-
ization of the binding sites of MacB-like transporters must
await another day.
In summary, the unique structural organization of the
MacB/FtsX family suggests a distinct mode of operation for
the binary PAP transporter pairs and for the tripartite
assemblies in which they participate. We will discuss that in
the context of the structure of the complete tripartite
complexes with their participation below.
6. OUTER MEMBRANE FACTORS (OMFS): TOLC AND
OTHERS
6.1. Introduction to the OMFs
Ubiquitous in Gram-negative bacteria, proteins from the TolC
family were initially characterized based upon their pleiotropic
roles: their ability to induce tolerance to colicin E1,196 a role of
the surface receptor for bacteriophages,197 resistance to
antibacterial agents,640 or secretion of virulence factors.61
Several structural descriptions of TolC641 and its homologues
have emerged over the last 20 years, notably OprM,269,642,643
OprN, and OprJ from P. aeruginosa,644,645 MtrE from Neisseria
gonorrhoeae,297 VceC from Vibrio cholerae,646 CmeC from
Campylobacter jejuni,647 and CusC from E. coli.648 These
structures build upon an important number of (rational or
random) side-directed mutagenesis, biochemical and biophys-
ical studies that have shed light on the way OMFs open and
assemble with their partners. The purpose of the following
paragraphs is to try to confront structural and functional data
obtained over the years and highlight the breakthroughs and
paradoxes that have emerged.
6.2. Overall Organization of OMFs
OMF structures share a very similar architecture although their
percentage of sequence identity is relatively low. OMFs are
trimeric proteins, which form a long tubular channel one end
of which is inserted in the outer membrane with the other end
extending into the periplasmic space and interacting with the
peptidoglycan layer.
They share a characteristic channel-like organization.641
TolC from E. coli is a protein consisting of 471 residues whose
protomers assemble into a homotrimer. This homotrimer of
approximately 150 kDa forms a 140 Å long channel organized
in two main domains: a transmembrane domain that adopts a
porin-like fold consisting of 12 β-strands organized in a β-
barrel of approximately 40 Å inserted into the outer membrane
and a periplasmic domain of about 100 Å long. This second
domain presents a unique “α-barrel” architecture that consists
of 12 α-helices organized into three subdomains: the α-
domain, the equatorial domain, and the coiled-coil domain.
Each protomer is formed by the repetition of a conserved motif
made of two transmembrane β-strands, of a long helix (H3 in
repeat one; H7 in repeat two), and finally of two helices
aligned along their axis (H2/H4; and H6/H8, respectively),
with each having one of their ends at the equatorial domain,
thus forming a pseudohelix of the same length as the long helix.
These pseudocontinuous helices give the trimer extra
flexibility. The equatorial domain (or mixed α/β domain)
consists of a mixture of secondary structures (α-helices and β-
strands) that forms a belt around the medial part of the α-
barrel (see Figure 28).
OprM in P. aeruginosa is a large, slightly conical cylinder
about 140 Å long, 40 Å wide at the top, and 70 Å wide at the
bottom.269,642 OprM protomer consists of four transmembrane
antiparallel strands (β1, β2, β3, and β4) and eight periplasmic
helices (H1 to H8) (Figure 28). The β-strands are composed
of a dozen residues which combine to form an antiparallel β
single sheet curving at a remarkable angle of ∼60°. Each β-
strand is inclined by about 45° relative to the axis of symmetry
of the trimer. The H1 helix consists of 13 residues, H2/H6 of
23 residues, H4/H8 of 36 residues, and H3/H7 of 67 residues.
The smaller helices join together with the larger ones to form a
large, curved sheet of antiparallel helices. Each helix bundle
tilts approximately 20° from the axis of symmetry of the trimer.
The three protomers come together to form a transmembrane
β-barrel about 40 Å long and wide which extends toward the
periplasm by a large β-barrel 100 Å long and 70 Å wide. The
structure of OprM can be separated into three domains: the
transmembrane domain which forms a β-barrel, the
periplasmic domain which forms an α-barrel, and the
equatorial domain located at the level of the middle part of
the α-domain. The latter is a mixed structure consisting of two
α-helices (H1 and H5), loops, and 310 helices. The equatorial
domain forms a ring around the α-barrel.
Although the structures are very similar, there are some
differences between TolC and OprM. First, the N-terminal
extremity of OprM is anchored to the outer membrane via a
Figure 28. General organization of the typical OMF channel on the
example of OprM. (A) Topological diagram. Principal helices (H)
and β-sheets (β) are denoted. The chain is colored rainbow from the
N-terminus to the C-terminus. Pseudosymmetry within the protomer
provided by the structural repeats, arising from a gene duplication
event, is evident. (B) 3D structure based on the palmitoylated OprM
structure (PDB ID 4Y1K).643 See text for more details.
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palmityl moiety that originates from the equatorial do-
main.642,643,645 The palmitate anchor provides a second
attachment point of the protein to the outer membrane.
The equatorial domain also presents significant variations,
particularly in the C-terminal, probably reflecting interaction
with structurally diverse PAPs in the tripartite efflux pump. As
will be discussed in more detail below, proposed models of
assembly between TolC and AcrA show that this loop is
involved in the recruitment and interaction of the OMF porin
with its PAP.649,650 The importance of the equatorial domain
has been shown by loss-of-function mutants of TolC.651−653 It
was shown that TolC requires a leucine residue at position
412, located in an equatorial domain that protrudes from the
main body of TolC into the periplasm, to be functional.651
Similarly, residues located at the base of carboxy-terminal
elongation in the equatorial domain of AatA, homologous to E.
coli TolC in enteroaggregative Escherichia coli, are required for
the export of its substrate, Aap.654 Finally, the inability for
TolC to form a functional complex with CusAB and to confer
resistance to copper and silver ions in vivo was also suggested
to be caused by the seemingly different equatorial domains of
CusC and TolC.648 In VceC, part of the loop is not visible in
the crystallographic structure probably because of its great
flexibility.
The C-terminal tail also seems to be of importance for
OprM as it is involved in its interaction with MexAB.655 The
role of the C-terminal tail of OprM has also been studied for
the hybrid complementation between OprM and VceAB in
order to highlight its role in the specificity of recruitment in the
assembly. OprM can no longer function with VceAB when its
20 C-terminal residues are truncated,656 but when a modified
VceA with mutation in the hairpin domain is used, the function
with OprM-Δ20Cter is restored.657 As will be discussed below,
this region has long been thought to be involved in the
interaction with the partner PAP. Overall, the equatorial
domain takes on a unique shape for each porin, which is not
surprising since it is one of the least conserved regions.
Accordingly, major structural differences between OprM,
OprN, and OprJ also lie at the equatorial domain and at the
periplasmic end of the β-barrel.645 However, the H1/H5
Figure 29. (A) Highlight of the conserved amino acids among 5 OMFs. The protomeric structures of TolC (1EK9, blue), OprM (3D5K, purple),
VceC (1YC9, ochre), CmeC (4MT4, green), and CusC (3PIK, red) are shown in the upper part of the panel. The side chains of the preserved
residues are represented as spheres of different colors according to their intrinsic location in the protein: orange for the β-barrel part, green for the
equatorial part, and blue for the periplasmic part. The position of each conserved amino acid within the primary sequence is shown in the table in
the lower part of the panel. (B) Visualization of the β-barrel domains within the quaternary structures of 5 OMFs. Each porin retains the same
structural color as in panel A. Two views are shown: a side view first and a top view second.
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helices and the large L1 loop appear to share redundant
patterns. In TolC, it was shown that exchanging the H4−H5
loop of TolC with that of other OMFs decreases susceptibility
to novobiocin, suggesting that this loop affects the transport
activity of AcrAB−TolC; hence, part of loop L1 (N188−
K214) is essential for the function of the channel.658
Compared to its homologues, TolC is the only one to have
an additional β-strand in this domain. Unlike the α- and β-
domains, the equatorial domain does not appear to be a
duplication of the same structural pattern.
Despite the strong structural analogy of OprM (PDB code:
3D5K) with its counterparts (TolC, PDB code: 1EK9; VceC,
PDB code: 1YC9; CmeC, PDB code: 4MT4; CusC, PDB
code: 3PIK), the identity of their primary sequence is rather
low (19% for TolC and 23% for VceC). A multiple alignment
of OprM and OMPs from different species highlights the
residues conserved during evolution (Figure 29A). These
residues, which probably play a key role in the structure or
function of OMPs of the TolC family, have a preferential
distribution at the ends of the α-helices and at the level of the
connections between the α-domain and the β-domain.
Furthermore, the majority of the conserved residues are
located on the C-terminal motif which could be an
evolutionarily ancestral sequence.
Gram-negative bacteria encode multiple RND transporters
which pair with a number of PAPs and OMFs forming a variety
of efflux systems with different substrate profiles (Table 1).
TolC from E. coli can be associated with several export
machineries located in the inner membrane including the α-
hemolysin HlyBD-TolC secretion system61 and antibiotic
efflux pumps (e.g. AcrAB-TolC, MacAB-TolC, EmrAB-TolC).
CusC is an exception in the versatility of association among
efflux pumps as it is specific for the CusBA CusC metal efflux
pump.10 OprM from P. aeruginosa also shows some
promiscuity as it is the common OMF for MexAB,659
MexXY,660 and MexJK.661 In addition, it can replace OprJ
and form a complex with MexCD.662 However, OprN is only
able to interact with MexEF.82,663 Electrostatic distribution at
the periplasmic entrance regions may be important for
formation of functional tripartite efflux pumps. OprM is fully
functional in complex with MexAB, MexCD, and MexEF, and
OprJ is partially functional in complex with MexAB, whereas
OprN is not.659,662,664 Crystal structures of the OMFs allowed
the suggestion that the electrostatic distribution at the
periplasmic entrance regions may be important for formation
of functional tripartite efflux pumps containing MexAB.
Indeed, electrostatic distribution of OprM at the interprotomer
and intraprotomer grooves of the periplasmic entrance of the
α-barrel domain is more similar to that of OprJ than that of
OprN.645 The substrate profile also seems to be a determinant
of assembly as it was shown that MexY forms a complex with
OprA when it effluxes β-lactams, carbenicillin, or sulbenicillin
and with the OprM when aminoglycosides are transported.665
Apart from direct involvement in efflux, OMFs play
additional roles, notably as adhesion molecules and phage
receptors. In Burkholderia, the gene for the outer membrane
collagen-like protein 8 (Bucl8)666 colocalizes with the
downstream fusCDE genes encoding fusaric acid resistance
leading to the suggestion that ift forms a tetrapartite efflux
pump.667 The recent characterization of the Bucl8 is an
unexpected unique architecture, where the canonical TolC-like
N-terminal portion of the protein is followed by two C-
terminal regions, one of which is a collagen-like (CL) region
composed of an uncommon repeating (Gly-Ala-Ser)n sequence
followed by a noncollagen low-complexity C-terminal tail (Ct).
The CL-region has been shown to form a triple helix, whereas
functional assays screening for Bucl8 ligands identified binding
to fibrinogen.667 While little is known about this protein, it
significantly expands the structural gallery of OMF proteins
and suggests additional adhesion and host-invasion-associated
functions.
6.3. Gates within the OMFs
OMFs of the TolC family display a mean internal diameter of
20 Å (reaching 26 Å at the widest) along the channel. When
not engaged with the cognate transporter-PAP pair, both ends
of the channel are suggested to be occluded, to prevent
uncontrolled diffusion of solutes, despite the fact that some
crystal structures (see e.g. CusC, pdb 3PIK, Figure 29B) have
been found to have external loops open. We discuss the
molecular explanations for the channel gating and the locks
that exist along the channel path and how recruitment of
protein partners allows for a long-range, allosteric, active, and
controlled opening.
6.3.1. Gates within the OMFs: Outer Membrane
Loops. Similar to other OMF family members known to
date, the transmembrane domain of OprM is a β-barrel formed
by the association of 12 antiparallel strands.668 In transverse
view, the β-barrel of OprM appears to be rather triangular,
unlike that of TolC, VceC, or CusC, which are cylindrical
(Figure 29B). As pointed out by Wong et al.,669 the β-barrel of
OMPs is delimited by two rings of aromatic residues, on either
side of the membrane, which ensures the stabilization and the
vertical positioning of the channel within the phospholipid
bilayer. The aromatic residues involved in the stability of the β-
barrel are predominantly phenylalanines. They are mainly
located at the level of the lower crown which also corresponds
to the junction zone with the α-domain. Furthermore, the
hydroxyl of the tyrosine residues logically points to the polar
groups of the phospholipids. The nature and number of these
residues is very variable from one porin to another. Unlike
OprM and VceC, aromatic residue crowns are not well-defined
in TolC. In the case of VceC, the side chain of residues F340,
Y131, and Y143 is localized inside the porin and therefore does
not interact with the cell membrane. It is possible that these
residues reorient outward to stabilize the β-barrel when the
canal is opened.
The cavity of porins is generally capped by a large loop
which regulates the flow. In the case of TolC and its
counterparts, there is no such loop, and the interior of the
channel is therefore completely free. However, extracellular
loops, topping their upper end, were postulated for the closed
state observed in crystallographic structures. Short molecular
dynamics simulations initially suggested that large motion of
the extra cellular loops indeed plays a gate function over the β-
barrel like a lid.670 However, simulation performed in the
presence of NaCl ruled out this outer gate hypothesis and
concluded that TolC is locked at the periplasmic side only.671
Differences most probably arose because it was shown that at
physiological values of ions, cations of the solvent are
seemingly able to constitute ionic bonds in place of the
removed salt bridges, which inhibited the opening of the
aperture in simulations.672 Similar studies performed for OprM
showed that extracellular loops open and close freely in the
simulations, suggesting that in the conditions of the simulation
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(isolated protein, absence of peptidoglycan and LPS), there is
no gating mechanism on the extracellular side.673
Studying the influence of the composition of the outer
membrane on porin is a difficult experimental challenge, and
examples of reliable in vitro models of envelopes of Gram-
negative bacteria are scarce in the literature.674,675 Remarkably,
major advances in the field of molecular dynamics now allow
for more and more accurate models of very complex lipid
environments.676−678 In the latter study, a fully assembled OM
bilayer of P. aeruginosa was built in silico in order to understand
the molecular determinants contributing to the rigidity and
stiffness of LPS-containing bilayers, e.g the low permeability of
cell envelopes of Gram-negative bacteria. In addition, OprM
was inserted, and its conductivity was calculated in a model
OM by comparison to a pure 1-palmitoyl-oleoyl-sn-glycero-
phosphocholine (POPC) bilayer. The authors conclude that
the presence of LPS modulates the conductivity of the channel,
increasing its conductance (from 600 pS to 890 pS) and
increasing the selectivity toward anions in an LPS-embedded
OM bilayer by comparison to what is found in pure POPC
bilayers. Accordingly, LPS was found to interact with the
residues of the extracellular loop of the protein through the
interaction of a network of hydrogen bonds. Opening of the
outer gate was not affected by the presence of LPS per se but
had a more pronounced interaction with the loops which is in
good agreement with a direct effect on the function of the
porin, as already shown for other porins.679−681 A cryo-ET
structure of AcrAB-TolC in E. coli intact cells682 suggests a
critical role of the loop in keeping the outer cavity open:
according to this structure, upon interaction with LPS at the
vicinity, the outer diameter is kept 10 Å wide, which is enough
to expel substrates.
6.3.2. Gates within the OMFs: Knob-into-Holes and
Bistable Switching between Opening and Closing of
the α-Helical Bundle. Behind the structural similarities of the
α-barrel domain of OMFs of the TolC family is hidden
interhelical interaction geometries that differ according to the
porin, in particular at the level of the upper α-cylinder. They
have been described through geometrical principles derived
from the definition of coiled coils by Francis Crick.683
In TolC, the α-barrel is separated into two subdomains, on
either side of the equatorial domain. In its lower part, H3 and
H7 initiate supercoiling with H4 and H8, respectively, hence
forming two canonical coiled coils which, in turn, result in a
curvature of the α-helices of about 20° with respect to the axis
of the channel curl and constrict to close the lower end of the
porin. Formed with a periodicity of seven residues over two
helical turns and a supercoil in the opposite direction of the
helices, these structures are stabilized by the interlocking of
side chains, most often nonpolar (dubbed “knobs”), in small
concavities (dubbed “holes”) formed by four residues of the
opposite helix. The packing cutof f is the distance between the
“knobs” residue and those which form the “holes”, which is
classically 7 Å.684 The periodicity of the lattice line that
contains the hydrophobic residues determines the “helix
crossing angle”, e.g. the hand of the supercoiling685 (Figure
30).
The upper part corresponds to an organization called the α-
cylinder,686 that can be imagined to be like an assembly of
coiled-coils. An α-domain, corresponding to a large barrel
formed from hydro soluble α-helices encompassing half of the
Figure 30. “Knobs into holes” packing analysis of the helix−helix interfaces of TolC. (A) The structure of TolC (PDB ID: 1EK9) is visualized as a
ribbon, with residues forming canonical coiled-coils (yellow and orange spheres) and residues forming noncanonical coiled coils (red and blue
spheres). (B and C) A closer look into the knobs-into-holes packing patterns at the interfaces between α-helices, which are also depicted in “ladder”
representation. Helical IDs are listed at the top, and amino acid residues are specified by the one-letter code. Heavy lines and bold helix
identification numbers correspond to α-helices viewed from the exterior, while dotted lines and light identification correspond to α-helices viewed
from the interior. (B) The layout of the four interfaces between α-helices participating in the construction of the 12-helix tube forming the α-
cylinder. (C) The layout of the two interfaces between α-helices in the construction of the four-helix bundle forming the canonical coiled-coil
restricting the periplasmic extremity of the TolC channel.
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Figure 31. View of the periplasmic tip of representative OMFs: TolC (1EK9), OprM (3D5K), CusC (3PIK), and BesC. (A) TolC. (B) OprM. (C)
CusC. (D) BesC. Structures are shown as cartoons, and residues involved in the channel gating are shown as ball and sticks representation, colored
depending on the type of interactions between them. In the resting state of the channels, the trajectories of the H7/H8 helices are bent and they are
prevented from adopting a relaxed superhelical trajectory by anchoring interactions with the H3/H4 helices, known as “primary gates”. These are
suggested to be disrupted upon interaction with the helical-hairpins of their PAP-binding partners. Intraprotomer interactions within primary gates
are colored red; interprotomer interactions are shown in orange; van der Waals interactions forming the hydrophobic gates in, e.g., OprM and
CusC are colored blue. The aspartate ring forming the “secondary” gate is shown in gray. The predicted primary gates of BesC (homology model),
from the B. burgdorferi pump BesABC, which operates with the PAP BesA, that lacks the helical hairpin domain, are significantly less stable.
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periplasmic space, is the signature of TolC-like proteins. The
interacting helices do not coil or adopt the canonical “knobs-
into holes” configuration because they have to adjust along the
curved surface of the cylinder to maintain a perfectly uniform
diameter. Two distinct deformations are needed: the bending
of the helices in a curve and the untwisting along the axis so
that they arrange like a sheet with the α-cylinder formed by the
association of three curved leaflets. By contrast to helices found
in classical two-stranded coiled-coils, the axis of each helix is
now tilted and translated, and α-barrel helices untwist and
distort so as to make their knobs approach closely one end of
the complementary holes. In addition, each helix packs laterally
with two neighbors to form parallel or antiparallel sheets. As a
consequence, this arrangement must fulfill geometrical
constraints on two separate interfaces simultaneously, on
either side of the helix. The periodicity of amino-acid side
chains is crucial because of the mechanical requirements for
interfacial compression and expansion on either side.685
6.3.3. Gates within the OMFs: Primary and Secondary
Periplasmic Gates. The periplasmic end is a key region for
channel opening641,668,687 as the constriction at the periplasmic
end has to allow the passage of cargoes as large as α-hemolysin
(160 kDa). The coiled-coil-derived “hydrophobic core” does
not have a sufficient stabilizing effect for the tight maintenance
of the bundle, and additional specific salt bridges and/or
hydrogen-bonding links between adjacent α-helices are
necessary to stiffen the interactions between the internal and
external helices or between protomers. Reciprocally, the
positioning of an intertwined coiled-coil on top of the α-
cylinder leads to an intrinsically tensed edifice, so that opening
movement can spontaneously arise upon the mere breaking of
the periplasmic gate(s): removal of the hydrogen bonds and
the salt bridges between these residues causes a reorientation
of the internal helices (H4 and H8) and the external helices
(H3, H7) of the trimer linked to the relaxation of the torsional
stress and to a widening of the periplasmic pore. An additional
constriction, located higher in the channel, is constituted by an
anionic ring formed by the carboxylate groups of the side
chains of the Aspartate residues present in this region. This
ring forms a cation-selective filter. These two obstacles do not
allow the efflux of substrates and need to be removed before a
productive efflux event.
The residues involved in the formation of the salt bridges
and intra- and interprotomer hydrogen bonds at the
extremities of the periplasmic helices differ between OMFs
(Figure 31). In TolC, the key interaction providing the
obstruction of the OMF periplasmic end is the intraprotomer
bond Y362−R367 that tethers the inner coiled-coil H7/H8 to
the outer H3/H4 coiled-coils. There, two major locks were
described: the D153−Y362 intraprotomer hydrogen bond
between helices H4 and H7 and the D153−R367 interpro-
tomer salt bridge between helices H4 and H8. In addition,
T152 also provides coordination to R367.
Mutational inactivation of the charged interactions that
anchor the H7/H8 to the H3/H4 helices results in
spontaneous relaxation of the superhelical trajectories of the
former, leading to a “leakiness of the channel” that could be
detected by electrophysiology essay,687 and the resulting
relaxation was also trapped in a crystal structures of the
TolC channel.688 That led to the suggestion that these residues
are targeted during the formation of the tripartite complex not
the partner proteins, and they were dubbed “primary gates”.689
The exact mechanics of these interactions are discussed in the
following sections, but it is also notable that in the TolC D371
and D374,690 a double concentric ring is formed above the
primary gates, which also prevents the passage of any cargo
beyond cations, which is often referred to as “the secondary
gate”, as it has to be disrupted to allow passage of the cargo.
In order to validate the importance of these residues, site-
directed mutagenesis and electrophysiology experiments were
carried out. On TolC, by electrophysiology measurements
carried out on the wild-type form and on the D371A-D374A
mutant, it was shown that porin was a selective channel with
respect to cations and this via a ring of negative charges formed
by D371 and D374.687,690,691 Breakdown of three inter- or
intramolecular bonds (D153A−Y362 between H4 and H7
intraprotomer, R367S−D153A and R367S−T152 V between
H4 and H8 interprotomers) induces a 6-fold increase in
conductance (500 pS instead of 80 pS) within the channel
compared to the wild-type TolC protein, reflecting a greater
opening. Combining mutations R367S and Y362F even made
it possible to increase the conductance further. Inactivation of
the ionic bond network at the R367S and Y362F mutants
relaxes the protein accompanied by an increase in conductance
at 205−370 and 800−1000 pS, leading to an approximately 16
Å opening at the periplasmic end.687 A reverse experiment,
aiming at blocking the movement of the helices thanks to the
introduction of cysteines, confirmed, both by electrophysiology
and complementation in a strain of E. coli, the importance of
the opening of the helices for the efflux of antibiotics. Indeed, if
a disulfide bridge between the H4 and H7 interprotomer
helices (A159C−S350C) reduces the export of hemolysin by a
factor of 5, it is completely abolished when the H4 and H8
helices or Asp374C is cross-linked.692 However, these mutants
retain the ability to interact with their partners, which suggests
that the movement of the helices is essential for the efflux of
molecules. The importance of residues D374 as well as D371
was later confirmed by a biochemical and structural study of
the porin in the presence of hexaamminecobalt which has a 20
nM affinity for TolC and forms a plug at the entrance to the
periplasmic pore upon interacting with aspartate D374.693 The
TolC periplasmic end is tightly sealed, and several laboratories
have provided insights into how the association of the channel
with its inner membrane partners may cause its open-
ing,694−698 as will be discussed with more details below.
In OprM, the equivalent residues are not all conserved
(Figure 31B). Surprisingly, only one aspartate ring is present at
D416 (corresponding to D374 in TolC), contributing to the
closure by creating three interprotomer salt bridges with R419.
Other salt bridges were also described as important for the
opening mechanism: between D205−Y404 (equivalent to
D153−Y362 in TolC) and D209−-R403 (D153−R367 in
TolC). In addition, L412 adds additional “glue” at the smallest
constriction of the tunnel via van der Waals interactions. Note
that X-ray crystallography under xenon gas pressure located
xenon trapped in a sandwich between the three symmetry-
related corresponding leucines in OprN (L405) forming a tight
hydrophobic constriction of the channel. Xenon was further
coordinated by the three-symmetry related D409 (correspond-
ing to D416 in OprM), part of a salt bridge with R412 (R419
in OprM).644 Recent cryo-EM structures of the complete
MexAB−OprM pump270,306 have allowed for a detailed
reconstruction of the trajectories of the gating helices, which
are discussed in section 8.2 (Figure 42).
Electrophysiology recordings were similarly used for the
characterization of OprM669,699 and EefC from Enterococcus
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aerogenes.700 Similarly, D371 and D374 are conserved in TolC
of E. aerogenes (D365 and D368) but are replaced by a serine
(S401) and a threonine (T404) in EefC. Both TolC from E.
coli and E. aerogenes have similar ion selectivity. EefC was
found approximately 10-fold lower than that of E. aerogenes
TolC. Interestingly, single channel conductance studies
performed at acidic pH showed that conductance decreases
when pH decreases,691,700 probably because protonation of
D371 and D374 reduces the cation selectivity and the like
charge repulsions that help to expand the tunnel entrance. This
hypothesis was supported by systematic molecular dynamics
simulations of WT versus mutated TolC that showed that the
closed state is favored at low pH.701 Along similar lines, MD
simulations suggest that cations of the solvent may form ionic
bonds when salt bridges are removed, thereby inhibiting the
opening of the aperture.672 More specifically, TolC seems to be
locked in a sodium-dependent manner: the inner periplasmic
bottleneck region at D374 is kept closed unless all NaCl is
removed from the simulation.671
The resolution of the X-ray structure of VceC646 suggested
that opening occurs by changes at the interfaces between helix
H4 of one protomer and the helical pair H7−H8 of the
adjacent protomer concomitant to changes between helices H3
and H7−H8 of the same protomers. VceC is structurally closer
to OprM than to TolC, and comparison of the structures
revealed that hydrogen bonds and salt bridges are not
conserved between VceC and TolC (Figure 31C). Although
we do not have structures of the open VceC channel, it has
been supposed that it is stabilized in its closed conformation by
a different set of interactions than those present in TolC. The
two intraprotomer links D153−Y362 and Q136−E359 from
TolC are not conserved in VceC. The TolC D153 corresponds
to S233, and the serine side chain interacts with a glutamine
rather than the corresponding tyrosine.
TolC Q136 and D359 correspond in VceC to T216 and
T430, respectively. The side chains of these threonines are too
distant to form a hydrogen bond. None of the TolC
interprotomer salt bridges (D153−R367 and R367−T152)
are possible in VceC where the D153, R367, and T152 are
respectively replaced by S233, A438, and G232. In CusC, the
surface of the periplasmic end is relatively hydrophobic. The
channel is gated by van der Waals contacts between L403
residues from the three protomers. An adjacent ring of
negatively charged residues (D407) provides an additional
layer of closure.648 TolC is not able to functionally replace
CusC in the CusABC-mediated resistance to copper and
silver,357 probably because the α-helical subdomain of CusB is
very different from that of all other known PAPs.702 For the
sake of systematic comparison, we have computed a model of
BesC from Borrelia burgdorferi703 based on the structure of
VceC. It shows a gating merely located on H8, through
interprotomer salt bridges between K391 and S390 (Figure
31D). This rather simplistic lock is consistent with the fact that
its corresponding PAP has no actual hairpin and may in fact
not be involved in maintaining the OMF open.
Opening of the channel is necessary during the translocation
process, and it was long thought that the other two partners
were needed to open. Deletion of efflux pump genes gives rise
to various sensitivity profiles,56 and use of drug sensitive
mutants to monitor the effect of pump deletion, sequence
insertion, and site-directed mutagenesis and to select
suppressor mutants has long been a method of reference311
to depict what could be the residues involved in the opening of
the OMFs. In the following we describe how this strategy that
allowed understanding of the reversible assembly of the pump
acts as a switch for opening of the periplasmic gate. The role of
the PAP in the bridging and in the stabilization of a tripartite
pump has been well documented. For instance, Mokhonov et
al.704 showed that there is tight association between MexA and
OprM in the absence of MexB, whereas the expression systems
lacking MexA failed to copurify MexB or OprM. The same
conclusion was raised from in vitro experiments where MexAB
OprM was reconstituted in respective liposomes and subjected
to pull-down in vitro.705 But the PAP is certainly much more
than a simple connector and could play an active role in
channel opening by transmitting the work liberated at the level
of the RND transporter, in the inner membrane. The interplay
within the tripartite assembly is of definitive complexity. The
pump is described as a highly allosteric system in which
conformational changes associated with ligand binding to the
RND are communicated to the OMF305 and, reciprocally,
OMF induces activation of the RND via its PAP (see below),
indicating that a mutual interplay exists between the respective
partners of the pump.
For instance, it was shown that the PAP is mandatory for the
activity of the pump.311,706−708 Mutual functional interactions
have been thoroughly investigated using genetic screens for
AcrAB-TolC.689,695,709−712 Lower ion bridges can be destabi-
lized by direct interaction with transporters with large
periplasmic domains, such as the RND family.711 However,
the Asp-rings were believed to be too far up the channel to be
directly affected by the transporter and likely “unlocked” via
interaction with the tip of the PAP. Successful unlocking of
these bridges designated “primary” and “secondary gates”
respectively, is a requirement for productive transport.689 The
open structure of TolC presents extensive interaction
interfaces between the periplasmic and outer membrane
proteins, defined by the helices H3−H4 and helices H7−H8
from TolC. Site directed mutagenesis and docking simulation
of the coiled-coil domain of AcrA in these grooves were
performed and suggested that a functional salt bridge could
form in the groove and the equatorial domain, accounting for
effects of mutations in this exact region on activity,709 in line
with mutagenesis,652,711,713−715 cross-linking studies,650,716 and
mapping of the gain-of-function suppressor alteration of an
inactive TolC mutant710 or mutations in the α-helical region of
AcrA allowing cross reactivity within the nonfunctional
heterologous TolC-AcrA-MexB pump.717 It has been proposed
that PAP−OMF interaction can also be dependent on the
substrate.84,661 For the first time, substrate specificity was also
found within AcrAB-TolC after analyzing the effects of site-
directed mutations targeting the α-barrel of TolC on substrate
transport substrate specificity.718 Marshall and Bavro718
showed that those residues affecting the electrostatic properties
of the channel caused hypersusceptibility to all efflux-tested
substrates and affected cells’ ability to grow even in the absence
of antibiotics. Interestingly, mutations were shown to be
substrate specific.
Understanding the energy requirements for the assembly has
also been the subject of a wide range of converging studies. For
instance, the energization of the transition from the closed to
open state of MtrE from the efflux pump MtrCDE of N.
gonorrhoeae was evaluated by assessing the sensibility of the cell
to vancomycin. This antibiotic is a very large molecule that
does not penetrate the Gram-negative membrane unless the
OMF is sufficiently open to passively diffuse into the cell.689
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Cells expressing the wild-type MtrE or a mutant (E434 K)
which opens more easily than the wild-type remain resistant to
vancomycin, but if MtrC is now expressed, cells become more
sensitive. This means that MtrC is required by MtrE to
open.719,720 In addition, the full-length PAP is required to open
MtrE since a truncated version of the PAP, consisting of the α-
helical hairpin domain only, is not able to open the OMF.
When the RND, MtrD, is expressed with MtrCE, cells are
resistant to vancomycin whereas when expressed with
MtrCEE434K cells are susceptible to vancomycin.
The energy dependency of the pump assembly was
investigated, again using nonfunctional mutants of MtrD,
mutated in one or more residues involved in the proton-
transducing pathway (D405, D406, and K948). If these
mutants are expressed with MtrCE or MtrCEE434K, cells
remain insensitive to vancomycin. As discussed above, the
Figure 32. Periplasmic view of TolC in its resting, closed conformation (PDB ID 1EK9) and after full dilation of its aperture upon engagement
with the PAP protein as seen in the assembled tripartite complex PDB ID 5NG5. Structures are shown as cartoon view, and aspartate D374 is
shown as ball and sticks. Distances between hydroxyl groups of the carboxylic acid of D374 are measured.
Figure 33. Diversity of PAPs suggesting promiscuity of assembly. (A) In Salmonella, at least eight different tripartite assemblies are formed with the
participation of the OMF TolC. (B) In Anabaena sp. PCC 7120,553 the OMF HgdD partners with at least eight different PAP−transporter pairs.
Notably, while the tripartite assemblies in Anabaena are dominated by MacB and ABC transporters, the RND-based assemblies are predominantly
represented in Salmonella. The established roles of the ABC transporters in the lower panel are indicated.
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TolCYFRE variant had significantly lower affinity to AcrB,698
suggesting that opening of the channel could lead to
destabilization of interactions, disengagement of the complex,
and channel closing. Thus, the integrity of the assembled
tripartite pump seems to be transient, with a proton-
independent assembly and a dissociation that is probably
performed upon closing of the OMF, which is allosterically
coupled with the active transport of proton across the RND
transporter. This claim was later confirmed in vitro upon
reconstitution of the various partners of the MexAB OprM
pump into proteoliposomes.705 This is also in accordance with
what was shown for the hemolysin secretion system, in which
energy consumption is not necessary for the assembly of the
type 1 secretion system721 and in vivo cross-linking
copurification and ITC experiments showed that the AcrAB-
TolC does not require the proton motive force to
assemble.694,696 Ultimately, structural determinations allowed
for a detailed description of the periplasmic opening (Figure
32).688,689,693 Opening of the periplasmic end is believed to
occur in a comparable manner to a photographic diaphragm
where the “internal coiled-coils” undergo twisting to align with
the “external coiled-coils” H3/H4.690 Structural and molecular
dynamics studies641,642,689 later confirmed the photographic
diaphragm-style opening mechanism to untwist the helices at
the level of the coiled-coil domains.
7. PERIPLASMIC ADAPTOR PROTEINS
(PAPS)/MEMBRANE FUSION PROTEINS (MFPS)
The periplasmic adaptor proteins (PAPs), or as they were
previously referred to, “membrane fusion proteins” (MFPs),722
are a wide and diverse family of transporter-associated proteins
the primary function of which is to allow pairing of a limited
set of outer membrane factor (OMF) proteins to a wide range
of inner membrane transporters ensuring high-fidelity and
selectivity of assembly, thus contributing to the combinatorial
diversity of the tripartite efflux pumps and greater plasticity of
the response to xenobiotic stress.100,723 The unique feature of
PAP proteins that makes them central to the assembly of the
trans-envelope pump complex is their ability to interact
simultaneously with both the inner-membrane transporter
and the OMF using distinct protein−protein interfaces. In this
way PAPs allow for “promiscuity” of the OMF relative to the
inner membrane transporter, allowing the docking of a number
of different transporter types to a single OMF. In Salmonella at
least seven tripartite complexes are formed, including the five
RND complexes (AcrAB, AcrAD, AcrEF, MdsAB, and
MdtABC), MFS EmrAB, as well as the ABC transporter
bases MacAB that include the TolC as an OMF,724 which is
made possible by the range of PAPs (Figure 33A). Similarly, at
least eight separate PAPs appear to dock to the OMF HgdD in
Anabaena sp. PCC 7120553 (Figure 33B).
The existence of a wide range of PAPs that are able to
interact with a single OMF indicates that the primacy of the
determinants of substrate specificity resides with the specific
PAP−transporter pair, although the OMF may provide some
limited substrate differentiation.718 Despite their central
importance for the transport process, the role and function
of PAPs within the assembly remains least-well understood. In
the pages below we will try to summarize the recent advances
in our understanding of their function. Previous systematic
reviews from recent years have focused in more detail on the
diversity and phylogenetic grouping of PAPs725 and structural
organization and overall mechanisms of PAP−transporter
coupling,726,727 respectively.
7.1. Historical Note
PAPs participate in the formation of tripartite systems with a
number of different transporter classes including ABC
transporters (HlyD,728 MacA60,206), MFS transporters
(FarAB-MtrE79), and RND transporters; however, at the
time of writing there have not been any reports of tripartite
assemblies formed with the PACE, MATE, or SMR systems.
Tripartite efflux systems built around the ABC transporters
forming the RTX-toxin secretion systems, which later became
known as T1SSs, were the first tripartite systems to be
identified and provided the blueprint of the organization of the
other such systems, including the multidrug efflux pump
assemblies. The first PAP genes were cloned in association
with the hemolysin A (HlyA) secretion system from E. coli729
and the leukotoxin secretion systems from Pasteurella
haemolytica.535 The HlyBCD system built around the ABC
transporter HlyB was one of the first secretion systems to be
characterized, and its homology to P-glycoprotein allowed
some of the first models of efflux function in the context of
multidrug resistance to be proposed.730 The first indication of
the periplasmic localization and organization of the PAPs has
consequently also come from topological mapping of the
HlyD, part of the ABC-based T1SS HlyBCD responsible for
hemolysin export.728,731 It also provided the first insight into
the PAP function and linkage to TolC.732
Subsequent bioinformatic analysis of the available PAPs
suggested that they form a novel, clearly defined group, which
was ascribed “membrane fusion” capability, based on the
superficial resemblance of hairpin domain architecture to the
coiled-coil domains observed in bona f ide membrane fusion
proteins, e.g., paramyxoviral SV5.722 This inferred fusion
function has never been demonstrated in any PAP since;
however, the old-name association still persists, and they are
sometimes referred to in the literature as “membrane fusion
proteins” or MFPs.
7.2. Structural Organization of PAPs
Periplasmic adaptor proteins display significant structural
diversity; however, they are built around a common blueprint.
Topological analysis of the PAP-fold reveals a rather unique
nonlinear architecture, with each of the domains being
constructed with the participation of both N- and C-terminal
halves of the protein, due to the fact that the polypeptide chain
is effectively folded in the middle, similar to a “hairpin” or
“safety pin” arrangement.733,734 While both N- and C-termini
of the proteins are either associated with, or held close to, the
inner membrane, the elongated body of the molecule extends
away from it into the periplasmic space, eventually reaching the
OMF.725,726 This body is composed of three to four “core”
domains but is often augmented by additional N- and C-
terminal modules, which are specific to the different families of
PAPs and are dictated by the cognate transporters.
Rapid advances in the structural characterization of the PAP
proteins over the past decade have shed light on all of the main
group members, although the RND-associated proteins were
the first to be solved; for exampel, MexA (PDB ID
1T5E;733,734 PBD ID 2V4D716) and AcrA (PDB ID
2F1M735) remain the best-studied examples due to the
plethora of structures of assembled tripartite complexes with
their participation.270,287,305,306 The structures of the heavy-
metal efflux (HME) RND pump-associated PAPs have also
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been resolved both in isolation, e.g., the copper-efflux
associated CusB (PDB ID 3H94 3OOC, 3OPO, 3OW7)702
and ZneB from Cupriavidus metallidurans (PDB ID 3LLN),63
and in complex with cognate transporters, e.g. CusBA (PDB
ID 4DNR, 3T51, 3T53, 3T56, 3NE5, 4DNT, 4DOP).359,610
The structures of MacB-associated PAPs from E. coli
EcMacA (PDB ID 3FPP)736 and Aggregatibacter (Actino-
bacillus) actinomycetemcomitans AaMacA (PDB ID 4DK0)737
and the structure of the full MacAB-TolC pump have been
reconstructed from cryo-EM data (PDB ID 5NIL-5NIK).272
The structures of the PAPs associated with the MacB-type
Gram-positive efflux systems have also been resolved, including
the Bacillus YknX594 and the Spr0693 from Streptococcus
pneumoniae R6 (PDB ID 5XU0),571 both of which assemble
into a hexameric pattern very similar to MacA.
The first MFS transporter-associated PAP was EmrA from
Aquifex aeolicus (PDB ID 4TKO).738 The last group of PAPs
to reveal their structure was the PAPs associated with T1SS.
The structure of E. coli HlyD (PDB ID 5C21, 5C22)739 was
followed by the Serratia marcescens LipC PAP (PDB ID
5NEN).514
In addition, the structures of some aberrant PAPs have
become available, such as the PAP BesA from the Lyme disease
associated spirochete Borrelia burgdorferi (PDB ID 4KKS-
4KKU),703 which lacks the helical hairpin domain altogether.
In addition, some orphan PAP structures could also be found
in the database, as a result of structural genomics efforts, e.g.,
BACEGG_01895) from a putative efflux pump from
Bacteroides eggerthii DSM 20697 (PDB ID 4L8J); however,
its association with HAE-1 or HME pumps remains to be
established. Figure 34 presents the organization of a typical
PAP on the example of the MexA which functions with the
RND transporter MexB and the OMF OprM in P.
aeruginosa.704
In the paragraphs below, we will “walk” along the structure
of the typical PAP from the N-terminal to the C-terminal end,
describing briefly the central features and the domains involved
in building its unique architecture.
Many RND transporter associated PAPs in their mature
form, following processing by signal peptidase 2, are modified
by an N-terminal cysteine lipidation (e.g., triacylation or in the
case of AcrA, S-palmitoylation), which anchors the protein to
the inner membrane. The role of this anchorage is not fully
clear, as truncated delipidated AcrA carrying a His-tag at the C-
terminal is functional and has been used for biochemical
studies.740
The PAPs associated with ABC and MFS transporters, as
well as those involved in T1SSs, are typically anchored to the
inner membrane by an N-terminal transmembrane helix and
have sizable cytoplasmic domains;726 however, very little is
known of their structure at present. These regions, however,
are essential for correct substrate recognition and complex
assembly.206
7.3. Domain Organization of the PAPs Associated with
RND and MacB-Assemblies
The core domains, which are found in all RND-associated
PAPs, including MexA, present a beads-on-a-string arrange-
ment; starting with the closest to the membrane are the
membrane proximal domain (MPD), the β-barrel domain, the
lipoyl domain, and the α-hairpin (coiled-coil) domain. Some
modules are universal, while others are only shared within a
subset of the family, and this arrangement correlates with the
type of cognate transporter with which the PAP functions726
The closest domain to the membrane, as the name suggests,
is the membrane proximal domain, abbreviated from here on
as MPD. It is flexibly linked to the core of the protein and is
composed of both N-terminal and C-terminal elements. Its N-
terminal β-strand provides the direct link to the inner
membrane in the TM-containing PAPs, such as those
associated with the T1SS, MacB, and MFS-type transporters.
The rest of the domain is composed of the C-terminal part of
the protein and presents a β-roll domain topology716 loosely
related to the downstream β-barrel domain, from which it may
have originated via an early gene duplication event.
Notably MPDs are missing in the PAPs operating with
transporters that lack periplasmic domains, suggesting that
their function could be associated with supporting the
periplasmic assembly and substrate selection and presenta-
tion.726 This role has been clearly demonstrated for PAPs
associated with HME RND transporters, such as CusB,360,741
and hinted at by mutagenesis and transporter studies of
chimeric HAE-1 transporter assemblies.717,742 Furthermore,
MPDs are essential for the activation of ATPase function in the
MacB-class transporters,573,743 and they have been associated
with substrate binding as will be discussed further in the
Figure 34. Structural organization of a typical PAP based on the
structure of the MexA from Pseudomonas aeruginosa (PDB ID
6TA5).270 The topological organization of the principal PAP domains
is shown on the right. The polypeptide chain of the PAP has a form
with a hairpin-like fold with both N- and C-termini being close to the
membrane and both the N- and C-terminal parts of the protein
contributing to each domain. The N-terminal cys-residue that is
lipidated in the RND-associated PAPs is highlighted in yellow.
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context of their tripartite assembly. A possible break from the
rule is observed in the specialized MacB-like transporter
DevCA and related pumps in Anabaena, the PAPs of which
(e.g., DevB), appear not to possess MPDs.206
The MP-domain of RND-associated PAPs was shown to be
essential for the assembly and function of the AcrAB-TolC in
E. coli744 and more recently, in a range of Salmonella PAPs.742
In RND-based assemblies, PAPs play a significant role in
stimulation of the efflux activity and consumption of the
proton gradient as exemplified by the liposome-reconstituted
studies of AcrAB706 and MexA−MexB studies.707 While in
both cases the pump activity was increased in the presence of
the cognate PAP, the MexA dramatically increased the activity
of MexB only when the substrate was also present, suggesting
that substrate engagement plays a significant role in driving the
assembly.
The next domain up from the membrane is the self-
explanatorily named β-barrel domain, which presents a β-barrel
consisting of six antiparallel β-strands capped by a single α-
helix733,734 (Figure 34). The β-barrel domain presents
similarity to enzymatic ligand-binding domains such as the
flavin adenine nucleotide-binding domain of flavodoxin
reductase and ribokinase and also to domains with odorant-
binding properties. The roles of this domain appear to be
predominantly connected with self-association of the PAPs
into hexameric assemblies,737 as well as in forming contacts
with the periplasmic domains of respective transport-
ers.272,287,359
Among the MacA-family PAPs the residues equivalent to the
EcMacA E231, Y276, and T293 residing within the β-barrel
domain are strictly conserved. These three residues are
involved in the interactions between the β-barrel domains,
forming a closed six-membered ring in head-to-tail fashion.737
Notably equivalent residues are conserved in PAPs from Gram-
positive organisms, e.g., the B. amyloliquefaciens YknX and
Spr0693,571,594 and similar conservation of equivalent residues
in RND-associated PAPs is also observed, highlighting the
functional importance of this hexamerization.
At least in some subsets of PAPs, e.g., HME-associated
ZneB, the β-barrel domain also participates in ligand binding.46
We will discuss these functions further in the context of the
specific tripartite assemblies in the sections below.
The next domain up from the β-barrel domain is the lipoyl
domain, named due to the homology it exhibits to the
biotinyl/lipoyl-carrier domains found in dehydrogenase
enzymes.733,745 These domains consist of a β-sandwich of
two interlocking motifs, each consisting of three β-strands. The
role of these domains also appears to be in stabilizing the
oligomeric self-assembly of the PAPs, and mutations targeting
the domain have a destabilizing effect, often obliterating
function altogether.206 However, unlike the β-barrel domains,
the lipoyl domains do not appear to provide contacts with the
transporters, at least in the studied RND and MacB
assemblies.272,305,359 The lipoyl domains also provide sub-
strate-vetting and, at least in the case of MacB-based systems,
the lipoyl-domains of the MacA-family PAPs create a “gating
ring” restricting access to the α-helical tunnel formed by their
hexamerised hairpin domains, which is suggested to prevent
backflow of substrates272,737 (Figure 35, panel D).
The most-distant from the inner membrane and facing
toward the OMF is the α-hairpin domain, which in its
“canonical” form presents an antiparallel coiled-coil, formed of
two helical fragments, divided in the middle by a loop. The
distal end of this hairpin is suggested to be responsible for the
Figure 35. Hexamerization of PAPs and the formation of the helical−hairpin nanotube. RLS-motif of PAPs and its conservation across different
groups. (A) General view of the MacA hexamer from PDB ID 5NIK, highlighting principal domains. (B) Close view of the hairpin domains
presenting the RLS signature motif. (C) Top-down view of the lipoyl-ring of MacA as seen in PDB ID 3FPP.737 The N209 from the “gating ring” is
restricting the channel in the hexameric form. (D) Canonic RLS-motif as seen in RND- and MacB-associating PAPs. (E) Overlay of the tips of the
hairpin domains of MacA and AcrA showing close conservation of the RLS-motif. (F) Overlay of the tips of the hairpin domains of MacA and
T1SS-associated HlyD shows deviation from the canonic sequence.
Chemical Reviews pubs.acs.org/CR Review
https://doi.org/10.1021/acs.chemrev.1c00055
Chem. Rev. XXXX, XXX, XXX−XXX
BF
interaction with the reciprocal coiled-coils of the OMF;
however, the level of this interaction is either extensive, by
forming four-helical bundles in the so-called “deep-inter-
penetration” or “wrapping-up” model,649,716 or strictly
restricted to the tip of the hairpin and the loop that connects
the two helices in the so-called “cogwheel” or “tip-to-tip”
model.737,746,747 Nestled within the lipoyl domain, the α-
hairpin domain is an extension from the very loop that
contains the lysine that undergoes lipoylation (covalent
attachment of lipoamide, via an amide bond) in the
corresponding domain in the dehydrogenase subunits.
The α-helical hairpin domains of the “canonical” PAPs
associated with RND assemblies, such as AcrA and the MacB-
associated MacA, resemble inverted versions of the helical
hairpins forming the structural repeats within the OMF.716
Indeed, the Cα-backbone of the PAP α-helical hairpin domain
can be superimposed on both coiled-coils of TolC, when
inverted and viewed in an equivalent orientation. The coiled-
coils within this group of PAPs are formed upon a classical
heptad repeat (HxxHCxC) principle, where H is a hydro-
phobic and C is a charged residue,748,749 and they contain a
variable number of repeats. The heptad is also usually depicted
as abcdefg, with the core of the hairpin being formed by the
residues in the a and d-positions, which are conserved
throughout the PAP family and contain bulky hydrophobics,
while the exposed helical faces, directly opposite the core of
the hairpin are also conserved, with hydrophilic serine/
glutamate occupying the c-position, and alanine predominantly
found in the f-position733 (Figure 35 and connected figures in
section 8.2). The hairpin domains show considerable diversity
in organization, differing in length from four heptad repeats per
helix in MexA to 11 heptad repeats in EmrA;738 however, there
are some aberrant forms, such as the metal-efflux pump
associated CusB,702 which features a folded hairpin, with only
2 heptad repeats in its longest helices, as well as the spirochetal
BesA,703 which lacks an α-helical extension altogether.
Sequence alignment of the distal part of the hairpin domains
of the canonical PAPs reveals high conservation of the tip-
region of α1 and α2-helices, presenting a consensus sequence
RxxxLxxxxxxS/T, which became known as the RLS-
motif,737,750−753 which has been implicated in OMF binding,
which was subsequently confirmed by the cryo-EM structure of
the complete assembles. The leucine of the RLS-motif is the
most conserved residue within PAPs, mediating strong tip-to-
tip interactions between PAPs and OMFs. However, the last
position of the motif shows higher variability and can be
occupied by a serine or a threonine residue (Figure 35).
The role of the PAP hairpin-domain may not be limited to
the RLS-based pairing with the OMF, as witnessed by a
number of suppressor and compensatory gain-of-function
mutations which map to the stalk of the hair-
pin.709,711,717,754,755 The structures of the MacAB-like transport
complex from Gram-positive bacteria571 composed of the ABC
transporter Spr0694−0695 and the associated PAP Spr0693
(UniProt ID: Q8DQF9) revealed that despite the strikingly
similar architecture to that of the MacAB complexes seen in
the Gram-negative bacteria and notable preservation of the
hexameric tube-like assembly of PAPs creating a tight gasket-
like structure over the transporter, the tips α-helical hairpin is
mobile and disordered in the structure. Consistent with a lack
of OMF-association, the tips of the Gram-positive PAPs
examined to date show little conservation and no obvious RLS-
like motif.571,594,725 These findings highlight the functional
importance of PAP−hairpin domain oligomerization. How-
ever, they also pose a question regarding their role in these
organisms, and while the definitive answer to that is still not
known, an increasing amount of circumstantial evidence
suggests that they are involved in peptidoglycan binding;756
for example, both AcrA and YknX were found to bind to
peptidoglycan.594,751 Notably, E. coli, but not S. aureus
peptidoglycan was found to facilitate AcrA-TolC interac-
tion.751 Furthermore, the reconstruction of the assembled
AcrAB dimers from the in situ cryo-tomography of AcrAB-
TolC complexes is also compatible with the hairpin of the PAP
being in direct contact with the PG layer.307
Figure 36. Different types of PAPs associated with different efflux systems. Comparative structural gallery of PAPs of known 3D structure, colored
by domain. Membrane proximal domain (MPD) in red; β-barrel domain in green; lipoyl in blue; α-helical-hairpin in gold. From left to right: BesA
(PDB ID 4KKS); HME-associated CusB (PDB ID 3OW7); HAE-1 associated MexA (PDB ID 6TA6); MacB-associated MacA (PDB ID 5NIK);
MFS-associated AaEmrA (PDB ID 4TKO); and T1SS-associated HlyD (PDB ID 5C21). The missing loops and transmembrane fragments of
MacA/EmrA and HlyD have been modeled for illustrative purposes. Note that only RND- and MacB-associated PAPs appear to contain MPDs,
while the spirochaetal BesA lacks the α-helical−hairpin domain altogether.
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The α-helical hairpin of PAPs of the EmrA-family738 and
T1SS-associated PAPs such as HlyD739 features an “extension
subdomain”, representing a departure from the classical heptad
packing, which can be seen as an additional helical insertion
into the proximal part of the hairpin, which is highly similar to
the untwisted pairs of α-helices in the OMF α-barrel.726
The coiled coils of the α-hairpin domain show significant
flexibility and propensity for self-association, which has been
linked to their functional role.735,736,757,758 Apart from soluble
dimer and trimer formation that could be detected in the
periplasm, a particular subset of PAPs form hexameric tubular
structures, which match remarkably well the outer diameter of
the OMF channel.573,737,759 The stability of these oligomeric
assemblies differs between different PAP types and generally
correlates with the length of the hairpin domain, resulting in a
differential affinity to the OMF.697 These differences in hairpin
domain organization appear to be associated with the different
modes of engagement of the PAPs with their respective
transporters, and we will discuss in further detail the context of
specific assemblies, but here we will highlight some specifics of
the PAPs participating in T1SS and MFS transporter
assemblies.
7.4. PAPs Associated with MFS Transporters and T1SS
Unlike the “canonical” group of PAPs discussed above, which
function with transporters that feature large periplasmic
domains and only shuttle cargoes from the periplasm, the
PAPs from this group associate with transporters that transfer
cargoes directly from the cytoplasm and lack pronounced
periplasmic domains. Correspondingly, these PAPs present a
different architecture, as they face dual challengeson one
hand they have to provide extensive sealing of the relatively
small transporters to avoid leakage of substrate in the
periplasm, and on the other hand, they are required to reach
further out into the periplasm to bridge the OMF as they are
located much closer to the inner membrane.
Notably, PAPs f rom this group lack a MPD domain and
present a very long helical extension although they have slightly
dif ferent solutions to the common problem discussed above (Figure
36). The MFS-associated group is exemplif ied by the structure of
the EmrA f rom the hyperthermophile Aquifex aeolicus (AaEmrA
from here on).738 The lipoyl and β-barrel domains are rather
conserved and match those seen in the rest of the family, with
the exception of a notable loop (P321-V343) in the β-barrel
domain, which is both unique to and highly conserved across
the EmrA family, suggesting it may play an important
functional role. The periplasmic part of the protein binds the
transported drugs, and in addition, the E. coli homologue,
EcEmrA, is anchored in the membrane by an N-terminal helix,
which contains a leucine-zipper-like dimerization domain and
is involved in oligomerization and transporter association of
the PAP.760
The crystal structure of the AaEmrA revealed an antiparallel,
two-stranded, α-helical coiled-coil domain of 168 residues and
127 Å long with 11 heptad repeats per helix. Thus, the hairpin-
domain in AaEmrA is over twice the length of that in RND-
type PAPs, e.g., MexA and AcrA (47 and 58 Å, respectively),
although in its E. coli counterpart EcEmrA, that is estimated to
be around 80 Å in length738 (Figure 36). Notably, the coiled-
coil in EmrA appears nonideal due to disruption in packing
caused by positively charged residues in its hydrophobic core,
i.e., K84, K98, R130, R182, and K119 which occupy the
normally hydrophobic a and d heptad positions. In addition,
the heptad repeat pattern is disrupted by a four-residue
insertion in the N-terminal helix (residues 112−115) and a
three-residue insertion in the C-terminal helix (residues 210−
212), approximately 70 Å from the tip of the structure and
close to the center of the coiled-coil.738 These insertions
disrupt the knobs-into-holes packing, resulting in a weakened
interhelical interaction in this region of the coil. Heptad shifts,
known as “‘stutters’” and “‘stammers’”, are commonly found in
fibrous proteins with an extended coiled-coil structure,761 and
it has been long hypothesized that such regions serve as points
of flexibility for extremely long coiled-coils.762,763
7.5. T1SS Associated PAPs
Similar to the PAPs associated with the MFS assemblies, the
structure of the representative T1SS-associated PAP, namely E.
coli HlyD (referred to as EcHlyD henceforth) from the α-
hemolysin secretion system, presents an architecture lacking an
MPD and is characterized by an oversized α-helical hairpin
domain measuring ∼115 Å in length, thus being second only to
the MFS-associated EmrA, which is almost 130 Å long (PDB
ID 5C21-5C2).739
Similar to AaEmrA discussed above, the α-helical hairpin
domain of EcHlyD is divided roughly in the middle, into an N-
terminal and C-terminal part, by a loop at its distal tip (L2),
which is supposed to contact the OMF. Unlike the MFS-
associated PAPs, however, which have two continuous α-
helices forming each half of the α-hairpin domain, the HlyD
hairpin presents a complex, discontinuous architecture, which
deviates from the standard coiled-coils observed in the classical
RND-associated transporters and is composed of three helical
fragments (α1 to α3), linked by two connecting loops L1 and
L2.739
While the C-terminal part of the hairpin domain is formed
by a continuous α3-helix (residues 251−325), which runs the
entire length of the hairpin, the N-terminal part of the hairpin
domain is discontinuous and formed by two shorter helices, α1
and α2, connected by the long and flexible loop L2. While the
exact role of the long loop L1 is unclear, it provides a hingelike
arrangement for the α1- and α2-helices, allowing them to form
independent antiparallel-coiled coils with the α3, and such an
arrangement may purposefully allow for allosterically con-
trolled destabilization of the PAP α-barrel, providing greater
flexibility, and it may facilitate the disassembly of what
otherwise may be a too-rigid conduit. Thus, the breakage of
helices observed in the T1SS-associated HlyD likely serves the
same purpose as the nonheptad insertions in the EmrA,
allowing to alleviate structural stress, and furthermore, helical
breaks allow the helical trajectories to be corrected, providing
both more flexible lateral packing and easier disassembly of the
complex. Intriguingly, a similar solution to the cladding of the
alpha-barrel problem is presented by the OMF-proteins, the
inverted repeats of which follow the same discontinuous
hairpin arrangement.
Oligomerization of HlyD appears to be prerequisite for
TolC recruitment,492 and consistent with that forced
hexamerization of a HlyD fragment (covering 81−383) fused
to an Hfq-hexamer ring was able to recruit a TolC-MacA
chimeric protein, while the same HlyD fragment was unstable
on its own and was not capable of TolC-MacA binding.739
Indeed, formation of a helical bundle via lateral oligomeriza-
tion, similar to those observed for MacA and AcrA, has been
suggested based on the crystal structure of the hairpin and
lipoyl domain of HlyD,739 and modeling of hexamer creates a
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plausible PAP assembly, with an internal diameter of ∼40 Å.
Providing support to the plausibility of the model, packing of
the helices within the model brings into proximity two
critically important residues, mutation of which abolishes HlyD
function in vivo, as established from functional studies (R186
from α2-helix and D309 from α3-helix).752 Superposition of
the distal parts of the α-helical hairpins of HlyD and MacA
provides a good structural match (Figure 35E); however, the
RLS-motif is misaligned relative to the earlier sequence-
alignment-based predictions, which designated the R186,
L190, and T197 as the signature triplet.752
Furthermore, the RLS-motif as positioned at the L2-loop
appears to be significantly degenerated relative to the other
members of the PAP family which interact with TolC and
present a sequence which in the EcHlyD is formed of D238,
L243, and A250. The lack of RLS conservation suggests higher
promiscuity at the tip of the assembly than might be expected
by the limited interface that it presents. This unique
organization of the hairpin in T1SS-PAPs has also been
confirmed from the structure of the Serratia marcescens LipC
(PDB ID 5NEN), a PAP that forms a T1SS with the ATPase
LipB and the OMF LipD in the transport of the lipase cargo-
protein.514 The “RLS” sequence of the LipC is further
divergent from the canonical one, with S183 (in place of
R128 AcrA/D239 HlyD respectively); L187 (L132/L243
being the only fully conserved residue within the motif);
P194 (S139/A250); and E200 (D144/E256) in place.
7.6. PAPs Associated with the Heavy Metal Efflux (HME)
Family
PAPs associated with the heavy metal efflux (HME) family of
RND transporters often contain additional N- and C-terminal
domains, e.g., SilB from Cupriavidus metallidurans CH34,764
the C-terminal domain of which has been shown to provide
metal-chaperoning function. These domains have arisen from
gene-fusions with metal-binding proteins and could also be
found as stand-alone polypeptides (e.g., CusF of E. coli; PBD
ID 3E6Z), which display a unique metal-binding β-barrel
fold.765,766
CusB protein is part of the CusCBA periplasmic Cu+/Ag+
efflux system in Gram-negative bacteria,767 and it was the first
HME-associated PAP whose structure was solved (PDB ID:
3H9I)702 and presented several unexpected structural features;
notably, its hairpin domain was significantly shorter than the
ones of “canonical” HAE-1 associated PAPs and was folded
into an antiparallel, three-helix bundle. In addition, CusB was
found to directly bind to Cu+ ions via an intramolecular relay
of conserved methionine residues (e.g., M49, M64, M66, and
M311), undergoing a conformational transition, implicated in
the transport cycle of the pump.768−770
The structure of ZneB (PDB ID 3LNN), a PAP associating
with the second branch of HME transporters, responsible for
efflux of divalent cations, has also been solved; it presented an
architecture very similar to the canonical HAE-1 PAPs.46
Similar to CusB, it also has a specific metal-binding site, which
however is much more localized and located in the junction
between the β-barrel and the MP-domain. While the PAP
ZneB presents an architecture very similar to the PAPs
associated with the HAE-1 type RND transporters, it also acts
as a specific metal binding site, and the crystal structure
revealed Zn2+ ion coordinated by H220, H284, E328, and a
water molecule at the interface between the β-barrel and the
MPD domain.46
The demonstration of active substrate-binding and pre-
sentation function, as exemplified by the metal-pump
associated PAPs, showed that the PAP-proteins are more
than just passive adaptors and has shifted the attention to their
active role in organization of the tripartite assemblies, which
Figure 37. Modularity of the assembly of tripartite complexes. A schematic representation of the different tripartite assemblies based on their
transporter types reveals striking correlation with the domain composition of the PAP proteins associated with them. PAPs of the MFS- and T1SS
ABC transporter-based complexes lack MP domains, which is also correlated to the transport of their cargoes across the inner membrane (IM). On
the other hand, the MacB and RND transporter-based assemblies pick their cargoes from the periplasmic side of the membrane associated with
PAPs that have MPDs, hinting toward their role in presentation of the cargo to the transporters. Notably, the β-barrel domains of the PAPs are
universally present and allow adaptation to diverse transporter stoichiometries.
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we will discuss in the following paragraphs for each of the main
systems.
7.7. Fellowship of the RingsThe Role of PAP β-Barrel
Domains in Assembly and Processivity of Tripartite Efflux
Pumps
In the preceding sections we described a wide variety of
transporter families, PAPs and OMFs, which combine to create
a motley crew of tripartite assemblies. This leads to the logical
question, as to what the unifying feature of these assemblies is
and what brings them under the same umbrella. Linked to the
common use of the OMFs, the unifying feature of these
assemblies is the use of the PAP-family for bridging the
transporters. As noted previously,726 the domain utilization of
the PAPs is associated with specific transporter families (Figure
37), with the presence of MP domains being restricted to
transporters which have large periplasmic domains, i.e. the
MacB- and RND-families, which correspondingly take their
cargoes predominantly from the periplasm.
The examination of the remaining tripartite complexes
suggests that the PAP domains minimally required for forming
a functional assembly are the β-barrel and lipoyl domains, both
of which have been shown to form homooligomeric
assemblies. Structures of binary PAP−transporter com-
plexes610 and fully reconstituted pumps9,272,305 indicate that
while lipoyl domains never contact the transporter, the β-barrel
domains form a critical hexameric ring-seal around the
transporter in the periplasm, which is a defining structure of
the tripartite assemblies, shared across all transporter types.726
This gasket-like assembly allows seamless adaptation of the
different transporter stoichiometries and sizes to the trimeric
OMF and has some unique features, which we will discuss
below.
The PAP β-barrel domain shares the topology of the barrel
seen in ribokinase enzymes and lipid-binding proteins,733 and
our previous work linked the β-barrel domains of the PAPs to
the ribokinase-like domains seen in some flagellar basal-body
associated proteins.726 The bacterial flagellar motor consists of
a number of conserved components which include the inner-
membrane spanning MS-ring; a cytoplasmic C-ring and its
associated export apparatus; a periplasm-and-outer membrane
spanning rod structure; and associated with the latter, the
periplasmic (P-) and outer-membrane embedded L-rings; plus,
the optional H- and T-rings which are present in some
organisms such as Vibrio.771 The C-terminal domain of the
flagellar protein FlgT (FlgT-C; residues 256−356),772 which
associates with the outer membrane H- and T-rings in Vibrio, is
comprised of a six-stranded β-barrel, nearly identical to the N-
terminal domain of the β-subunit of F1-ATPase (e.g., bovine
mitochondrial F1-ATPase PDB ID 1BMF),773 the catalytic
subunit of the ATP-synthase complex.772
This topology is strikingly similar to that observed in the
PAP β-barrel domains (Figure 38), which only differ by the
lipoyl domain being spliced into the loop connecting the β1-
strand and β2-strand forming the core of the barrel.726
Consistent with that, despite lacking discernible sequence
homology, FlgT-C superposes on the Cα-backbone of the β-
barrel domain of EmrA (PDB ID 4TKO), with an RMDS of
∼3 Å.726 Our new expanded analysis, provided below, expands
this association of PAP β-barrel domains across a number of
the type III secretion system proteins as well, including the
cytoplasmic flagellar assembly export apparatus.
Away from the outer membrane, the cytoplasmic f lagellar
type III export apparatus used for the secretion of the flagellar
components consists of a transmembrane PMF-driven export
gate and a cytoplasmic ATPase complex composed of FliH,
FliI, and FliJ.774 There, the FliI is a Walker-type, homohexa-
meric rotary-ATPase, oligomerization of which is required for
ATP-hydrolysis;775 FliJ is the stalk unit, and the FliH is a
regulatory/stator subunit.776 This system is also evolutionarily
connected to the virulence associated “injectisome” appara-
tus,777,778 e.g. the one coded by the Salmonella pathogenicity
island 1 (SPI-1), where the corresponding components in the
so-called “sorting platform”, forming the base of the SPI-1
injectisome, are the ATPase InvC (aka SctN under the unified
nomenclature),779 its stalk subunit InvI (SctO), and the
regulatory/stator subunit OrgB (SctL).780
The FliI6FliJ complex was shown to be structurally similar to
the α3β3γ complex of F1F0-ATPase,
781,782 with the N-terminal
domains in the FliI-type ATPases being highly homologous to
the N-terminal domains of the F1/V1-ATPases (e.g., bovine
mitochondrial F1-ATPase (PDB ID 1BMF)773 or the E. coli
F1F0-ATPase (PDB ID 6OQR)),783 in agreement with earlier
Figure 38. Structural organization of the PAP β-barrel domains links them with β-barrel domains in flagellar basal body proteins. (A) Structure of
the isolated β-barrel domain of the MFS-associated PAP EmrA, based on PDB ID 4TKO. (B) Topological diagram. The lipoyl and α-hairpin
domains can be seen as inserted between the β1- and β2-strands of the β-barrel. (C) Structure of the C-terminal domain of the flagellar basal body
protein FlgT from Vibrio.
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bioinformatic predictions.784,785 This has been further
confirmed by the recent cryo-EM structure of the homohexa-
meric T3SS ATPase EscNin complex with its central stalk
subunit EscO,786 which revealed a rotary catalytic mechanism
analogous to that of the heterohexameric F1/V1-ATPases
despite its homohexameric nature and, furthermore, elucidated
the N-terminal domain of the EscN (residues 35−101) (PDB
ID 6NJO; 6NJP), which was missing in the earlier structures.
Comparison of these newly resolved N-terminal domains of
the InvC-class ATPases, with those belonging to the FliI-type,
shows that they are closely connected to each other
(overlaying with an RMSD of ∼1 Å over the Cα backbone)
and form a closed β-barrel with Greek-key topology.
Startlingly, these N-terminal β-barrel domains of the F1/V1-
(e.g., the β-subunit of F1-ATPase PDB ID 6OQR (residues 1−
76))783 and T3SS-associated ATPases (e.g., FliI residues 25−
97 (PBD ID 2DPY))781 are also closely connected to the β-
barrel domain of the PAPs, presenting an equivalent topology
to the one discussed above for the FlgT but lacking the
additional β-hairpin insert between β3 and β4 observed in the
latter (Figure 39; color scheme is the same as Figure 38).
Within the ATPase assemblies, the N-terminal β-barrel
domains form a head-to-tail hexameric ring assembly, which
could be formed by alternating α- and β-subunits, e.g., in the
case of F1-ATPases,773,783 or can be presented by a
homohexameric ring in the case of T3SS ATPases, e.g.
EscN.786 As seen in Figure 40, panel A, these rings share a
striking resemblance to the ones observed in RND, MacB,
PCAT, and MFS assemblies and are maintained by conserved
residues as discussed in the preceding PAP section.571,737
In the type III SS associated ATPases, the N-terminal
domain is essential for stable assembly of higher oligomers and
activation of the ATPases;776,787 it interacts with effector
proteins (e.g., the Salmonella negative regulator of the ATPase
OrgB)788 and has intrinsic phospholipid binding affinity.789
Similarly, in the N-terminal β-barrel domains of F1F0, ATPases
have been shown to play a role in stabilization of the
complex790 and providing contact of stator subunits b and
delta.783
Extending the functional analogy, mutations targeting the β-
barrel of PAPs impact complex formation and can be
detrimental to assembly of the complex presumably by
compromising the stability of the hexameric ring formation
in both RND- and MacB-based assemblies.571,594,711,737
Regulation of hexamerization and the modulation of the
stability of these hexameric rings in response to substrate
binding and OMF-engagement provide flexibility to the efflux
and secretion machineries employing PAPs.
Paradoxically, the currently accepted model of the peristaltic
cycle of the RND pumps318 has been inspired by the rotary
mechanism of the F1-ATPase773 and the structural connection
of the β-barrel rings of PAP and ATPase assemblies presented
Figure 39. (A) Structural connections of the β-barrel domains in the rotary ATPases and the T3SS-associated ATPases. (B) The β-barrel domains
of PAPs structurally homologous to those found in the rotary ATPases. Secondary structure elements are color coded identically to the topological
diagram in Figure 38. (C) Overlay of the C-alpha backbone between EmrA and F1-ATPase β-subunit highlights their close structural homology.
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here, which allows us to extend this analogy to actual
functional homology between the components of these
complexes.
8. ASSEMBLY AND FUNCTION OF THE RND-BASED
TRIPARTITE COMPLEXES
8.1. Cryo-EM Structures of Fully Assembled RND
Complexes
PAPs appear to play a crucial role in the assembly of the trans-
envelope complexes. Due to their unusual topology, early
studies have speculated that PAPs are able to bridge not just
the transporters and OMFs but also the opposing inner and
outer Gram-negative membranes directly,740 which has
partially led to their rather misguided assignment as
“membrane fusion proteins” or MFPs,722 a designation which
could still be found in some literature sources.
Until relatively recently our understanding of the structural
arrangement of the tripartite pumps came from speculative
models based on molecular docking, in vivo cross-linking, and
mutagenesis studies.269,649,650,693,713,716,759,791 While these
produced some convincing models, even such aspects as the
stoichiometry of the assembly remained debatable in the
absence of an experimental structure of a complete tripartite
complex. A quantum leap in our understanding of these
systems has been achieved by the maturing of the cryo-electron
microscopy (cryo-EM) technology. The first to be addressed
were cryo-EM structures of AcrAB-TolC, which were
generated by coexpressing AcrA-AcrB fusion proteins287,792
or after stabilization by in vivo disulfide bridges.305 Later,
reconstituted tripartite pumps could be prepared from purified
proteins without additional stabilization in the presence of
native lipids270,304,306 or even resolved by in situ by cryo-
electron tomography (cryo-ET)307
A crucial insight has been provided by the higher resolution
structures obtained by the group of Ben Luisi,305 in the
presence and absence of substrate and inhibitors revealing
different conformational states of the pump. The apo-state
(PDB ID 5V5S) revealed a closed tip of the TolC-channel
while the AcrB adopts a symmetric LLL conformation (resting
state). In the presence of puromycin (PDB ID 5O66), the
aperture of the TolC channel is dilated and while the AcrB is
seen adopting an asymmetric LTO conformation, while the
inhibitor in the presence of pyranopyridine inhibitor
MBX3132,341 the pump was found in a pseudosymmetrized
TTT state (PDB ID 5NG5).305 Importantly, the PAP, AcrA,
was found to form a hexamer wrapping around the RND
transporter through the trimerization of two conformationally
distinct protomers. These were found bound to two non-
equivalent interfaces on the surface of the transporter and are
Figure 40. Connection between β-barrel domains and rotary ATPases. (A) Upper panel. A view of the hexameric assemblies presented by the
rotary ATPases and PAP β-barrel domains. (B) Left, side view of a hetero-oliomeric F1F0-ATPase from E. coli; Center, type 3 secretion system
associated ATPase EscN from E. coli. Right, CusBA subcomplex from E. coli. The hexameric β-barrel rings are highlighted by the red parallelogram,
with individual subunits being red and magenta.
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referred to here as PAP1 (with binding fully restricted to one
RND-protomer and hence also referred to as intraprotomer-
PAP) and PAP2 (which binds between the respective RND-
protomers and is referred to as interprotomer-PAP) (see
section 8.3 and associated figures below for details). The
conformationally distinct RND-PAP interfaces between the
protomers are suggested to play a key role in the long-distance
allosteric coupling between AcrB and TolC. In the apo-state
(PDB ID 5V5S), a gap is present at the interfaces between
adjacent PAP dimer pairs, so that the PAP helical-hairpin,
lipoyl, and β-barrel domains do not pack tightly to seal the
channel from the periplasm.305 Based on these structures, it
was suggested that AcrAB−TolC initially forms a complex in
the closed state and that TolC opens upon rearrangement of
the AcrA-hexamer induced by a conformational change in
AcrB.305 In turn, the AcrA helical bundle would repack,
imposing a contraction of the pump along its long axis by
approximately 10 Å, and consequently seal gaps that would
otherwise cause the substrate to leak out.
Two structures of the nonstabilized wild-type multidrug
efflux pump, MexAB−OprM from P. aeruginosa, were also
resolved at near-atomic resolution.270,306 In these structures
OprM is found in two different orientations relative to MexB,
related by a 60° rotation along the long pump axis. In contrast
to the AcrAB-TolC structure described by Wang et al., both
structures are found with OprM open. In order to account for
the activation from a resting to an activated state, Tsutsumi et
al.306 proposed a model where the resting state corresponds to
the tripartite structure where MexB is under an LTO
conformation but with a closing of the gating loop in its T
protomer. Only in the presence of substrate is the gating loop
within MexB suggested to experience a slight conformational
change, allowing the substrate to access the distal-binding
pocket.306 The conclusion is slightly different in the structure
described by Glavier et al.270 for which it is described that
transition from the resting to activated state is mediated by the
binding of both MexA and OprM, allowing MexB to adopt an
activated LTO conformation, hence corroborating in vitro
functional results. In the sections below we will look at the
PAP-OMF and PAP-RND interfaces elucidated by these
structures in more detail.
8.2. PAP-OMF Interface
Due to their “adaptor” function, the PAP family plays a central
role in the assembly of the tripartite complexes, effectively
bridging the outer membrane (OMF) and inner membrane
(energized transporter components). In the absence of direct
structural data, a number of studies pointed out the primacy of
the α-helical hairpin domain in engagement of the OMF and
provided specificity of interaction between different pump
complexes. For instance, swapping of the hairpin domain of
MexA for that of MexE makes the MexA-E hybrid compatible
with the OprM-MexF pump. Conversely, the chimeric
construct is not able to function with OprN-MexF, and
MexA bearing the hairpin from MexE does not form a
functional complex with its cognate components OprM-
MexB.793 Similarly, swapping the AcrA α-hairpin domain for
that of MexA makes the chimeric OprM-AcrAB assembly
functional.713 Cross reactivity among heterologous pumps was
also tested, further highlighting the major role of PAPs in the
specificity of recognition of assembly. For instance, TolC does
not assemble with MexAB in E. coli652 but does interact with
and functionally complements both the AcrA-MexB794 and
VceAB.714 Conversely, while VceC is able to interact with
AcrAB in E. coli it does not provide functional complementa-
tion for the loss of TolC.714
Figure 41. Helix−turn−helix motifs in PAPs and OMF that are supposed to mediate their interaction. (A) Schematic view of the coiled coil
packing within the α-helical hairpin of the PAP showing its antiparallel interface. Conserved hydrophobic residues are interacting within the a and d
positions of the respective N- and C-helices (projection view looking down the hairpin helices outward from the lipoyl domain). (B) A view of the
α-helical hairpin tip of AcrA (based on PDB ID 2F1M),735 highlighting the interaction positions a and d; V126 (a) and A146 (d); and Y129 (a)
and Y143 (a) form heptad-pairs. (C) The RLS-motif is present at the tip of the HTH motif of the PAP hairpin. Presentation of the classic-RLS-
motif as observed in the (predominantly) RND- and MacB-associated assemblies, while MFS-associated PAPs show a deviation in the second half
of the motif, and the T1SS-associated PAPs only retain a positively charged residue in the front of the motif, suggesting a different association with
the OMF. Consistent with the lack of cognate OMFs, the PAPs in the Gram-positive organisms do not share any recognizable RLS. (D) R1 and R2
HTH-motifs at the tip of the static (H3/H4) and mobile (H7/H8) helices of the OMFs present a loosely conserved VG(L) motif, which is
suggested to interact with the connecting loop of the RLS in the PAPs. Alignments in this figure have been visualized with Espript3.795
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While the central role of the PAP hairpin domain in OMF
recognition and binding was never disputed, the nature of this
bridging interaction has been a matter of much debate, with
two competing models of assembly being proposed, which can
be straightforwardly distinguished by the extent of the
respective interaction interface between the OMF and the
PAP α-hairpins. The first one, known as the “deep-inter-
penetration” model of assembly, as the name suggests, predicts
an extensive binding interface between the PAP α-helical
domain with the OMF helical-hairpin repeats, with stable four-
helical bundles being formed on the inter- and intraprotomer
grooves of the OMF. This model was the first to emerge
historically and was primarily derived from biochemical data
based on in vivo functional studies and cross-linking, as well as
ab initio docking taking into account the propensity of coiled-
coils to form helical bundles.649,650,713,716,759,791
The second model, which has become known as “tip-to-tip”
or “cogwheel”,756 is predominantly based on the structural
information derived from crystallographic,737,750 cryo-
EM,270,287,305,306,747 and in situ cryo-ET data.307 The tip-to-
tip model initially came to existence from the observation of
the crystallographic arrangement of the PAP MacA from the
Actinobacillus actinomycetemcomitans (PDB ID 3FPP),737
which revealed a tight hexameric assembly, within which the
α-helical hairpins of the PAP have been organized into a
tubular structure, with a diameter strikingly similar to that of
the fully dilated OMF channel.687 Furthermore, similar tip-to-
tip assembly is formed by the OMF in isolation (PDB ID
2VDD),689 where two asymmetric TolC trimers were observed
to pack crystallographically in an interpenetrative fashion. This
similarity led to the suggestion that the two helical α-barrels of
the OMF and the hexameric PAPs could interact in a much
more limited way, resulting in the “cogwheel”, aka “adapter-
bridging” model,737,750 something that has been further
supported by cryo-microscopy of engineered MacA-TolC
chimeric proteins.746 Consistent with the critical role of the
RLS-motif (the canonical form of which is RxxxLxxxxxxS/T)
and taking the form of a helix-turn-helix (HTX) motif at the
tip of the α-helical hairpin domain, its targeting in different
PAPs, including AcrA, MacA, and HlyD, has a detrimental
effect on TolC-binding.750−753 The leucine of the PAP RLS-
motif in MFPs is the most conserved residue, while the last
position of the motif shows higher variability and can be
occupied by a serine or a threonine residue (Figure 41, panels
A−C).
Figure 42. Interaction between the tip-regions of OMFs and PAPs on the example of OprM and MexA. (A) Side view of the MexAB−OprM
complex as seen in the cryo-EM structure (PDB ID 6TA6270). The zone of PAP-OMF interpenetration is indicated by the rectangle. Helices of the
respective OMF protomers are shown in red, green, and blue; while the α-helical hairpins of PAP1 and PAP2 are colored orange and magenta,
respectively. (B and C) Zoom on the tip-to-tip interaction between OprM H3/H4 and H7/H8 helical tips (shown in blue and green, respectively)
and the docked α-hairpins of MexA (shown in orange (PAP1) and magenta (PAP2)). Principal interacting residues are shown (proposed RLS-
motifs are in bold). (D and E) Schematic view of the MexA channel and associated PAP protomers looking up the channel in closed and open
(MexA-MexB-engaged) form, respectively. The binding of PAP1 protomer to the interprotomer interface is suggested to result in destabilization
(orange dotted arrow in D) of the interprotomer gates (indicated by the cyan arrows), resulting in an outward swing of the mobile helices H7/H8
(black curved arrows), which are still attached to the H4 via intraprotomer interactions (gray arrow). The initial relaxation of the H7/H8 allows the
docking of PAP2, which in turn destabilizes the intraprotomer gates (see the pink dotted arrow in E), leading to full dilation of the OMF aperture.
While the exact gating residues differ between the specific PAP−OMF pairs, the general mechanism of PAP docking and relaxation of H3/H4
helices is suggested to be conserved. See the text for more details.
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Similar to the PAPs, the OMFs belonging to the TolC
subfamily present conserved HTH-motifs at the tips of their
H3/H4 and H7/H8 α-helical hairpins of the coiled-coil
domain, referred to as R1 and R2 motifs751,796 or VGL-
motifs.747 These motifs contain a Val-Gly-Leu/Thr consensus
sequence, which has been suggested to interact directly with
the RLS-motif of the PAPs (Figure 41, panel D).
Strong support to the tip-to-tip association as a main driver
of PAP-OMF interactions was provided by studies using
chimeric PAPs, e.g. a MacA-TolC chimera, with only the R1
and R2 regions of the TolC transplanted onto the tips of the α-
hairpin domain of MacA which was able to engage with
MacA,746 while a MacA-MexA chimeric protein, containing the
P. aeruginosa MexA α-helical domain (PDB ID 4DK1)751 was
able to bind a similarly engineered MacA carrying the tips of
the H3/H4 (Repeat 1 or R1) and H7/H8 (Repeat 2 or R2)
helices forming the periplasmic tip of the α-barrel of OprM,
showing that these are sufficient determinants for interaction.
One of the expected outcomes of such models is a level of
promiscuity and interoperability of the PAP-OMF pairs, and
indeed there is some experimental evidence in their support;
for example, the Vibrio vulnif icus TolC orthologues TolCV1
and TolCV2 appear able to interact with the E. coli PAP MacA,
forming functional complexes753 despite only having 51.3%
and 29.6% identity with the E. coli TolC. Song et al.797 have
also investigated the interaction between the putative tip-
regions of the PAP MdsA, belonging to the Salmonella-specific
tripartite transporter MdsABC, and its cognate OMF MdsC, as
well as TolC, in the formation of functional MdsAB-mediated
efflux pumps. Comparative sequence analysis revealed that
despite low overall sequence homology between MdsA and
MdsC with the endogenous Salmonella cognate PAPs (only
15% identity with MacA and 18.7% identify with AcrA) and
OMFs, respectively, there is clear conservation of key residues
in the putative tip regions of both the PAPs (MdsA has a
clearly conserved RLS-motif consisting of R135, L139, and
S146) and the OMFs, that suggests allowing interactions and
formation of hybrid tripartite systems. The predicted
promiscuity was indeed observed in complex formation,
suggesting that the productive complex formation is restricted
by a small number of conserved residues and interactions at
the respective tips of the hairpin domain of the PAP and the
H3/H4 (R1) and H7/H8 (R2) of OMF,797 further enhancing
the RLS-R1/R2 interaction hypothesis (Figure 42).
Based on these observations it has been postulated that the
RLS-motif is conserved across PAPs engaged in RND pumps,
MacB-family ABC transporters,746,750 as well as PAPs involved
in T1SS such as HlyD.752 However, the predicted RLS-motif in
the HlyD family of PAPs appeared to be significantly
degenerated, and later crystallographic studies revealed that
the predicted tip of the HlyD is misaligned,739 with the tip
sequence differing dramatically from the canonical RSL-
signature. Similarly, the structure of the LipC from the
lipase-secreting T1SS of S. marcescens514 does not present a
recognizable RLS-motif, suggesting that the T1SS systems may
employ a slightly different mode of OMF-unlocking and/or
stabilization and indicating that the role of the motif in OMF-
recognition is not as clear-cut as previously thought. In
addition, the hairpins of PAPs from Gram-positive organisms
have recently come to light, e.g., Spr0693 from Streptococcus
pneumoniae,571 and perhaps unsurprisingly they do not show
any significant conservation of the hairpin tip, while
maintaining the α-helical domain, raising further questions to
its actual function (Figure 41, panel C).
This predicted PAP−OMF interaction was indeed directly
observed in the cryo-EM structures derived from chimeric747
and covalently fused AcrAB-TolC assemblies,287,792 as well as
the later cysteine-cross-link stabilized AcrABZ-TolC struc-
tures.305 More recently conclusive evidence has been provided
by the complexes reconstituted without any additional
stabilization,270,304,306 and thus the tip-to-tip model has
become a dominant paradigm of PAP−OMF interaction.756
The cryo-EM structures reveal an OMF−PAP interface
consistent with tip-to-tip interactions between their α-helical
hairpins, with participation of the conserved motifs from the
respective proteins discussed above; for example, within the
AcrAB−TolC complex,305 the conserved VGL/T R1-motif of
TolC is located at the concave region of the TolC cogwheel in
close proximity to the conserved R128 and L132 of the AcrA
RLS-motif. There, the G365 from the TolC R1-motif is found
to form backbone to backbone interaction with AcrA-K140
and the side chain of AcrA-S139.287,747 Furthermore,
consistent with earlier in vivo site-specific cross-linking
experiments, N145 and T366 of TolC are found to contact
L132 from the RLS-motif of AcrA.736 Due to the quasi 6-fold
symmetry of the TolC interfaces, similar interactions are seen
between the R2-motif of the OMF and the second copy of the
PAP. Homologous contacts can be seen in the high-resolution
structures of MexAB-OprM270,306 as illustrated in Figure 42,
lending further support to the tip-to-tip model of interaction.
Molecular dynamics simulations in POPC model-lipid bilayers
confirmed that this fully assembled tip-to-tip pump is stable
over microseconds. In addition, a sequence covariation analysis
confirmed that interfacial contacts do involve residues
consistent with those identified from the simulations.798
Despite the overwhelming structural biology support for it,
there are certain issues with the “tip-to-tip” model, stemming
from the limited interaction interfaces and the limited use of
strong side-chain specific interactions between the predicted
PAP-OMF binding surfaces, which limits the ability of each
protein to differentiate their cognate binding partners.
Furthermore, some experimental data is difficult to reconcile
with such models, including functional complementation of
concatenated pumps with enforced 3:3:3 stoichiometries,799
SPR measurements,698 and a range of direct in vivo cross-
linking and mutagenesis studies.650,652,711,717,718,791 While
some of these may be dismissed as artifactual, the existence
of PAPs without discernible α-hairpin domains, such as
BesA,32 which are able to form functionally active, channel-
forming tripartite assemblies could not be readily explained by
a classical tip-to-tip model.
8.3. RND−PAP Interface: Structural Data Suggests
Asymmetry of the Assembled Tripartite Assembly and
Different Roles for the PAPs
While earlier models of tripartite assembly gave preference to
the 3:3:3 stoichiometry,649,716 a number of conflicting data
have been accumulated that shifted the consensus toward 3:6:3
assembly. These included the discovery of RND transporters
which partnered with two separate PAPs, e.g., TriABC-
OpmH,88 as well as the demonstrable functionality of the
tandem-fusion AcrA constructs.736 Furthermore, in vivo cross-
linking to both inter- and intraprotomer grooves of the OMF
MtrE supported the existence of a 3:6:3 stoichiometry of the
OMF-PAP-RND, leading to the suggestion that such an
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arrangement would inevitably result in a nonequivalent binding
of the PAPs per protomer.759 Subsequent structural studies
have provided conclusive evidence of this nonequivalent
binding from both HAE and HME pumps.270,287,305,306,359
Correspondingly, the nonequivalent binding sites on the
surface of the RND pump create two functionally non-
equivalent PAP-conformers, which are referred to as PAP1 and
PAP2,270,305,306 as seen inFigure 43. PAP1 is exclusively bound
within the limits of a single RND transporter protomer with
which it makes extensive interactions and is hence referred to
also as an “intraprotomer-PAP” relative to the RND subunit.
PAP2, on the other hand, contacts both the RND-subunit to
which PAP1 is bound and the following anticlockwise
protomer (looking from the top down along the axis of the
pump from outer cellular space), straddling the RND-
interprotomer gap, and hence in the text below is also referred
to as an “interprotomer-PAP.
The PAP1 β-barrel domain docks onto the DN- and DC-
subdomains of the RND-porter domain (Figure 5 and Figure 6
RND transporter section and Figure 43, showing the
arrangement seen in the MexAB−OprM complex), while its
MP domain interacts with the PC1 subdomain, as well as with
the linker region between PC2 and DC, and an extended loop
of the DN subdomain from the follow-up RND (Figure 43,
panels A−C). PAP2 on the other hand forms fewer contacts,
which are focused predominantly on the crown of the DN-
subdomain, which is contacted by the β-barrel domain of
PAP2, plus its MP-domain appears to be relatively loosely
associated with the surface of the RND protomer, correspond-
ing to the PN2-DN linker region (Figure 43A, B, and D).
Despite the big discrepancy of the PAP binding sites relative to
the transporter and their complex 3D arrangement, a closer
analysis of the interacting PAP residues revealed that the
contacts provided by both PAP1 and PAP2 are closely
overlapping and restricted to several discrete linear sequences,
which we have previously dubbed “binding boxes”.742 These
are restricted to the β-barrel (boxes 1−5) and MPD domains
(6−9) and are highly conserved within specific PAP families;
however, not all of them appear to have a pronounced
functional role. Disruption of a few key residues within boxes
1, 4, and 5, mapping to the exposed β-barrel loops, abrogates
transport, and hence, these have been suggested to play a role
in assembly of functional complexes and the differentiation of
cognate PAP−transporter pairs.742 Notably, while PAP1 and
PAP2 share the same β-barrel binding sites, there are
discrepancies in the MPD attachment, and the domain is
seen to be undergoing significant reorientation akin to “rolling”
between the two protomers, resulting in PAP1 and PAP2-
specific binding boxes, highlighting their differential modes of
engagement and, likely, function.742
Furthermore, comparisons of the structures of RND
transporters in isolation (also referred to as “mono”-structures
below) vs their structures within tripartite assemblies in the
presence of PAPs revealed by cryo-EM demonstrate significant
differences, suggesting allosteric changes are enhanced and
perhaps actively mediated by the PAPs,305 e.g., spatial
Figure 43. Two nonequivalent binding sites on the surface of the RND transporter accommodate two distinct conformers of the PAP, which serve
distinct functions during the cycling of the pump. (A) Side view of the MexAB-OprM assembly (PDB ID 6TA6)270 showing the binding of the
intraprotomer-PAP subunit (PAP1) (orange) and the interprotomer-PAP subunit (PAP2) (magenta). The different RND subdomains are colored,
and neighboring RND protomer is colored gray. (B) Cartoon representation of the same angle of view labeling the different subdomains of the
PAPs and RND. (C) Isolated views of the contact areas of the PAP1 and PAP2 relative to the RND; for clarity the lipoyl and hairpin domains
which do not contact the transporter have been removed.
Chemical Reviews pubs.acs.org/CR Review
https://doi.org/10.1021/acs.chemrev.1c00055
Chem. Rev. XXXX, XXX, XXX−XXX
BP
orientation of the DN-domain β-hairpin motifs forming its
crown, which have been implicated in the assembly of the
pump,712 was noted to be impacted, and it was suggested that
this conformational rearrangement facilitates the interactions
between the RND-protomer and the β-barrel domain of PAP2,
as well as the short “crown” α-helix of the DC-subdomain from
the next-RND protomer.305 Identical contacts are also seen in
the MexAB-interface of the assembled MexAB-OprM
pump,270,306 and similar interaction is revealed by the binary
CusBA complex,359 although the orientation of the β-barrel
and lipoyl domain differs from the HAE1 pumps and the PAPs
are rather loosely fitted to the crown of the transporter. The
PAP1 MP-domain locates to the entry of the proximal binding
pocket and thus has been suggested to play a role in substrate
presentation and/or sensing of the cargo-load state of the
transporter, which is also supported by the location PAP1
MPD observed in the CusBA complex, where such a role has
been clearly shown.359
A significant new insight into the allosteric effects of the
PAP-association came from the recent works on the MexAB-
OprM,270,306 which highlighted the special role of the short
helix (formally known as Nα2′),279 which is found on the loop
connecting the α2-helix and the β4-strand of the central β-
sheet of the PD module of the PN1 subdomain of the
transporter (Figure 6 and Figure 43, panel C). This short helix,
which has been dubbed “helix gate”,270 participates in
formation of the exit gate, which controls the exit of the
substrates into the PAP-OMF funnel and in the case of MexB
is formed by the Q124, Q124 belonging to the helix gate plus a
critical residue (Y758) from the DC domain of the RND.
Comparison of isolated RND transporters (aka “mono”-
structures) vs the assembled RND tripartite complexes
available shows that the interprotomer groove between T
and O protomers is wider than the one observed at the LL-,
LT-, or OL-interfaces. Intriguingly, this interface widens even
further in the PAP2-engaged fully assembled “trio” state.270 A
closer inspection of the mono structures of MexB revealed that
despite the seeming L-T-O cycle being present and the
corresponding transformation of the deep binding pocket to
outward-facing conformation, the drug exit gate remains
occluded, and thus the drug cannot leave the pocket. This
“closed” transition state was dubbed the C-state.270 The closed
(C) intermediate appears to be a state between the T and O
states. Only after C converts to O is substrate released. Of
note, the process from the apo-state (L) over drug bound state
(T) to the release of the drug in the O state is postulated to be
PMF-independent.
In the “trio”-structure, the PAP2 MPD appears to act as a
wedge, which is slotted into the T-O interprotomer crevice,
which is associated with a concerted movement of the PN2
subdomain of the T protomer and the PC2 domain of the
neighboring O-protomer sidewise (Figure 44). These domain
reorganizations have been suggested to translate to the
underlying PN1 domain and its “helix-gate” mentioned
above, allowing for the transition of the closed C-form to the
Figure 44. Comparison of interprotomer interfaces of RND transporters in isolation and upon PAP binding. (A) Side view of the superposition of
the T-protomers of AcrB (as seen in asymmetric LTO and symmetrized TTT structures) and MexB (LTO) as seen in tripartite complex as
observed in PBD ID 6TA6.270 RND-conformers are colored: L, blue; T, yellow; O, red; PAP2 confomer, green. (B) Top-down view of the trimeric
assemblies of MexB solo (PDB ID 6T7S),270 MexB “trio” from the tripartite MexAB-OprM structure (PBD ID 6TA6),270 and the AcrB (TTT-form
stabilized by the presence of the MBX3132 inhibitor) (PBD ID 5NG5).305
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open O-form of the transporter,270 emphasizing the specific
role of the PAP2 in the efflux-vetting process.
There is a general consensus that PAP and the RND
transporter initially form a binary complex, as corroborated by
in vivo evidence,696,800 as well as by biochemical inves-
tigations,694,698 and that subsequently this binary assembly
recruits the OMF to form a functional tripartite complex. It
was suggested for a long time that PAPs play an active role in
transducing conformational energy from substrate/proton
binding in the RND transporter to the OMF to help in
transitioning its channel from its closed to open state allowing
for the creation of a functional efflux conduit, via mediation of
the helical hairpins of the PAPs.288,318,649,689,801 Substitutions
in the R1 motif targeting the loop connecting H3 and H4 in
TolC result in antibiotic hypersensitivity despite the fact that
their physical interaction is maintained as judged by in vivo
chemical cross-linking. Vancomycin sensitivity assay revealed
that AcrA-mediated suppression of this antibiotic sensitivity
was achieved by dilating the aperture of the TolC channel in an
AcrB-dependent manner,711 allowing suggestion that the
allostery of the overall RND-cycle mechanism substrate
binding by AcrB is linked to proton transport, whereby
conformational movements occurring within AcrB would be
captured by the AcrA MP- and lipoyl domains (which at the
time were believed to be in contact with the RND transporter)
and transferred to TolC via the α-helical hairpin of the PAP.
While later structural studies did not support the direct
contact of the lipoyl domains of the PAP with the transporter
and the deep-interpenetration models of PAP−OMF inter-
action have fallen out of fashion, the idea of the conformational
transitions in the RND being conveyed by allosteric PAP
mediation was proven largely correct. The cryo-EM data of the
AcrAB-TolC complex obtained in the presence or in the
absence of puromycin by the group of Ben Luisi allowed us to
further elaborate on an allosteric, concerted, opening305
There, conformational changes in the periplasmic headpiece
of the RND transporter upon substrate binding are suggested
to instigate repacking of all four of the PAP-domains, which in
turn leads to reorganization of the coiled−coiled domain of the
PAPs, which is implied to be the key step in organization of the
RLS-motifs and opening of the OMF channel,305 which is
engaged in a tip-to-tip fashion. Upon opening of the OMF, the
3-fold symmetry in the apo-complex transitions to a quasi-6-
fold symmetry of the interface between PAP α-hairpin and
open-state OMF. This leads to rearrangement of the helical
bundle, creating a tightly sealed nanotube, which in turn leads
to rearrangements further down, resulting in repacking of the
lipoyl and β-barrel domains of the PAPs and sealing of any the
gaps to the periplasm,305 allowing for productive efflux even to
take place. A similar mechanism has been suggested for the
MexAB OprM pump in the presence of novobiocin.306
There is also a visible reorganization of the MPD domains
between the PAPs in apo- and asymmetric, substrate engaged
state, which is likely associated with their changing functional
role through the cycle;305 however, due to the interoperability
of the PAP1 and PAP2 in such pumps as AcrAB-TolC and
MexAB-OprM, narrowing the specific roles of PAP1 and PAP2
has proven difficult.
8.4. Heterooligomeric Complexes Allow Unambiguous
Assignment of PAP1 and PAP2 Highlighting Their Distinct
Roles during Assembly and Cycling of the Pump
In P. aeruginosa, the tripartite pump TriABC-OpmH, which is
associated with triclosan resistance,88 has a distinct organ-
ization, as its transporter component, unlike most of the RND
transporters discussed above, which function with a single
PAP, creates a heterooligomeric complex with the participation
of two different PAP subunits: TriA and TriB. The two PAPs
only share 36% identity and are not interchangeable,
suggesting specialization of function, which is consistent with
each of them occupying a specific binding interface in respect
to both the RND transporter TriC and the OMF protein
OpmH.802,803 Due to these unique characteristics, this system
has provided a valuable insight into the distinct roles played by
PAP1 and PAP2, allowing assignment of each of the PAPs to a
specific functional role. A recent cryo-EM structure of the
TriABC subcomplex (PDB ID 6VEJ)302 confirmed the
locations of the TriA and TriB relative to the transporter
and unambiguously assigned the PAP1 and PAP2 roles to
them, respectively. The subcomplex was resolved in its
unliganded “drug sweeping” state, which displays high mobility
of the PAPs, with the hairpin domains being in disarray.
However, the MP-domains could be resolved in their
respective positions, and as expected the PAP1 (TriA) was
found to have high-contact area and occupy the intraprotomer
interface between the PC2 and PC1 subdomains, just above
the substrate entry point to the proximal drug binding pocket,
while the MPD of PAP2 (TriB) was found bound closer to the
interprotomer interface between the RND-protomers. Notably,
however, while the PAP1 MPD is fully resolved, the electron
density for the PAP2 MPD is patchy, corresponding to low
occupancy. Furthermore, intriguingly, in this substrate-free
state of the pump, the MPD of PAP2 seems to be primarily
localized to the PN2 domain of the RND protomer and is very
loosely attached to it,302 in stark difference to the snug-fit
observed in the recent MexAB-OprM structures, where it is
also bridging the interprotomer gap.270,306
Mutation of the RLS-signature motif within the TriA/TriB
seems to have different effects. While the TriA-R130D mutant
fails to assemble a functional TriABC complex with the OMF,
the alteration of the corresponding R118D in TriB does not
significantly affect the assembly and activity of the complex.802
At the same time, mutation of the conserved MPD residue
G350C (TriA) and G339 (TriB) had the opposite effect, with
the first one being tolerated and the second being detrimental
to pump function,802 suggesting that it only plays a significant
role in the PAP2. Intriguingly, the mutation of the
corresponding residue, which maps to “binding box 9”, also
obliterates efflux in the Salmonella AcrA/AcrE PAPs.742
Antimicrobial susceptibility, site-directed mutagenesis in-
formed by homology modeling, alongside with in vivo disulfide
cross-linking and azithromycin-sensitivity assays allowed
further differentiation of the PAP1 and PAP2 roles relative
to the cognate OMF (OpmH).803 It was further confirmed that
while PAP1 (TriA) is required for OMF recruitment, the
activation of the transporter (which, as mentioned above is
linked to the MPD of PAP2) is coupled to the opening of the
OMF aperture.803 Data compiled from azithromycin sensitivity
studies, which indicate leakiness of the OMF-channel, as it
does not normally penetrate the channel and is not a substrate
of the pump, suggested that TriB is essential for keeping the
channel dilated, which is consistent with it associating with the
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mobile H7/H8 helices of the R2 motif.803 Such interpretation
is compatible with the position of the PAP2 observed in the
“zero-degree” structures of the OMF (PDB ID 5NG5,305
6IOK,306 6TA6270).
Further, in vivo proteolysis suggested that both TriA and
TriB are conformationally flexible, causing susceptibility of
their α-hairpin domains to digestion. However, while TriA
(PAP1) is stabilized by the presence of the OMF and the
transporter, the proteolysis of TriB (PAP2) is dependent on
the presence of transporter, further suggesting that it may be a
more dynamic and loosely associated member of the
complex.302 As the TriA and TriB are noninterchangeable,
these studies allow us for the first time to correlate the
rotationally symmetrical PAP−OMF interface with the under-
lying and already established PAP−RND interfaces, giving a
unified view of the tripartite assembly and the roles of
respective components which we will present in the following
sections.
8.5. Conformational Cycling of the Protomers within the
AcrB/MexB Trimer
Before we proceed with a unified model of the assembly, we
would like to recapitulate a few key elements of the
conformational cycling of the RND transporters. The majority
of the current understanding of the RND-transport to date has
been derived from the study of the inner-membrane trans-
porters in isolation. The conformational LTO cycling
hypothesis suggested an allosteric bisite activation270,321,335
and is not necessarily suggesting that the three protomer
conformations (LTO) are constantly present within the trimer
at all times during the cycling. This notion is supported by
cross-linking data,321 suggesting that the LLT, LTT, and TTT
trimeric conformations (next to LLL and LTO) are possible
trimeric conformations. Structural support for this conforma-
tional flexibility came recently by observations via single-
particle cryo-EM as this variety of different conformational
setups was adopted by trimeric AcrB in the AcrABZ-TolC
complex in complex with the inhibitor MBX-3132.305
Experimental support for bisite activation (allostery) came
from molecular dynamics studies and kinetic β-lactam
transport studies in whole cells, which were in dependence
of the substrate concentration non-Michaelis−Menten kinetics
with Hill-coefficients >1 measured.346,804−806 All these
conformational cycling models did not include a systematic
role for the PAPs thus far, despite them being clearly
implicated in the initial opening (and closing) of the OMF
channel.
In the original LTO cycle,288,292,318,335 the cycle starts with
the symmetric metastable LLL conformation and the efflux
substrate is anticipated to bind to the proximal binding pocket
of one of the L protomers (to the AP) (Figure 5). Upon
conformational change to T (thus forming an LLT trimer), the
substrate is suggested to be further transported to the DBP
(comprised by the PN2 and PC1 subdomains). In this drug-
bound conformation, TM2 transduces the binding energy
toward the TMD of the transporter allowing protons to enter
the TMD and to bind to the titratable residues (D407 and/or
D408 in the case of AcrB),328 which causes a change in the
electrostatics within the TMD. This results in a conformational
change, and the transduction of the energy of proton binding is
mediated via TM8 to the rigid PN1/PC2 subdomain unit292 of
the periplasmic domain. This results in the closing of the AP
and DBP and the opening of a substrate exit gate. However, in
order to anticipate a bisite activation in analogy to the
functional rotation cycle of the F1Fo-ATP-synthase,
320 the
neighboring protomer has to be in the T state as well. In the
presence of substrates or inhibitor,305 any L protomer (and T
protomer) can accept substrate and reach the conformational
transduction state that allows protons to enter from the
periplasm to the protonation sites.
Under the current models, the LLL to LTO transition
appears to only require substrate binding, which has been
corroborated by MD-studies,806 and indeed, the very existence
of the LTO conformation in crystals and EM-resolved
complexes reconstituted from purified components suggests
that the conformational transitions could be obtained in the
absence of PMF energy. However, the pre-existence of the
LTO in a resting apo-state has been subject to considerable
debate,338 and recent studies suggest that while LTC
transitions could indeed happen in the absence of PAPs, the
substrate binding alone may not be sufficient for the transit of
the transporter from an LTC to the LTO configuration in vivo.
Earlier FRET studies of CmeB transporter reconstituted into
liposomes have shown that it could cycle, albeit inefficiently, in
the absence of the PAP or OMF components.299 While
individual protomers have been detected undergoing L-T-O
transitions, there seems to be little evidence of cooperativity
and directionality of cycling. These findings raise the question
on whether the role of the PAPs may be associated with both
the facilitation of the conformational transitions between the
RND protomers and enforcing the directionality of the cycle.
In the section below we try to integrate the latest structural
advances in understanding of the RND assembly and the roles
of the PAPs within it into an integrated model of assembly of
the complex, which takes into account both the PAP−OMF
and PAP−RND interactions.
8.6. Toward the Unified Model of RND Pump
AssemblyAn Integrated Model of PAP Participation in
the Efflux Cycle and Resetting of the RND Assemblies
Corroborating the recent results on the MexAB-OprM270,306
and TriABC-OpmH systems,302 with the earlier allosteric
model derived from the AcrAB-TolC discussed above,305 we
would like to suggest a modest modification of this model,
incorporating a simple mechanism based on varying the
affinities of the interprotomer binding sites created by the
peristaltic cycling of the RND transporter toward the PAP2.
The key to pump stability and processivity during these
cycles and detachments is the continuous association of the
hexameric β-barrel gasket with the transporter, which allows
for bespoke regulation of the engagement of their MP-domains
with the different conformers of the transporter. In essence, we
propose that while the intraprotomer (PAP1-binding site)
remains high-affinity throughout the pump cycle, the affinity of
the PAP2 binding site changes due to the conformational
changes of the RND-protomers depending on drug-binding
and proton-occupancy, with the L/L, L/T, and L/O presenting
low-affinity sites, while the PAP2-binding site formed by the T-
protomer is strongest. This applies specifically to the MP-
domain, which could possibly detach fully between the
different transitions.
The flexibility and the strategic position of the PAP2
straddling the interprotomer interface of the RND make it an
ideal candidate for both sensing and communicating the state
of the preceding RND-conformer to the next. It seems
therefore possible that the PAP2 MPD acts as molecular
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“latch” or “ratchet” to prevent backsliding of the conformations
during cycling, thus stabilizing the metastable form C/O
conformer and allowing the exit of the transported cargo.
We also suggest a two-way communication between the
RND transporter and the PAPs. The first stage is an upward
signaling from the RND toward the OMF via PAP1, forming
the molecular basis for OMF recruitment, which in turn
enables the second, downward signaling stage, which
commences with the association of the PAP2 with the OMF,
resulting in the stabilization of its dilated aperture. This
translates into a rearrangement of the α-helical hairpins of the
PAP2 sealing the PAP-OMF drug-export conduit and is
communicated back to the RND via allosteric transitions
within the PAP2 allowing the MP-domain to slot into the T/C
interprotomer crevice, that ultimately leads to movement of
the “helix-gate” in PN1 (see Figure 43). This latter retrograde
communication would correspond to the “activation signal”
described as a switch from LTC to LTO in the cryo-EM
structure of MexAB OprM.270
A summary of the key points of the model is presented in
Figure 45, which provides three slices focusing on the PAP−
OMF interface (top), the transporter−PAP interface from a
side-view (middle), and a top-view rotary diagram (lower
panel), taking account of the substrate and proton occupancy.
Under this model, the two PAPs within the RND assembly
have clearly delineated and distinct functional roles. PAP1 is
primarily associated with the first phase of the efflux cycle and
is involved in presentation and feeding of the cargo to the
transporter’s proximal binding pocket and sensing the
successful transition of the drug onto the deep binding pocket,
which is associated with the L-to-T transition, while PAP2 is
predominantly associated with the second phase, namely
detection of the successful docking of the OMF and vetting the
release of the drug toward the OMF-funnel by facilitating/
stabilizing the T-to-C transition and actively enabling the C-to-
O switch, which leads to productive efflux of the drug. The first
function requires a close association of the transporter-PAP, as
the conformational change associated with the drug-binding
and L-to-T switch needs to be communicated “upward” toward
Figure 45. Conformational cycling of AcrB/MexB protomer and trimer in dependence of PAP engagement and disengagement. The tree panels
present different aspects of the interaction focusing on the PAP-OMF (top) and PAP-RND (middle and bottom). In the upper panel the
engagement state of the periplasmic adaptor protein conformer 2 (PAP2) is indicated based on the studies by Tsutsumi et al.306 and Glavier et
al.270 Moreover, as an extension of the previous models,288,318,335,807 the closed state structure (denoted “C”) found by Glavier et al.270 is
implemented, as well as the structural interpretation by Glavier et al.270 concerning the engaging role of PAP2 at the AcrB/MexB interprotomer
interface. In the middle panel, the conformational cycling of a single RND protomer is shown (L-protomer, blue; T, yellow; C, gray; O, red).
Whereas all PAPs (PAP1, PAP2) form a stable hexameric arrangement via their β-barrel and lipoyl domains, the membrane proximal domains
(MPDs) are anticipated to be in a disengaged or engaged state. The binding of the MPD-domain of the PAP2 is suggested to take place at the
interprotomer interface of the RND. The interprotomer crevice is closed between L and L (LL) as well as in LT and OL. Between TT this interface
crevice is widened, and in TO, the gap is large. In the lower panel the conformational state of the protomer shown in the upper panel is given in
relation to the states of the other protomers in the trimer (“wheel” representation). The role of the PAP2 MPD engagement is postulated to be
supportive for the direction of the cycling (L → T → O → L), preventing the backward sliding of the O-to-T state by acting as a molecular latch.
The complete conversion from L to O in the presence of substrate (S) including the protonation of the TMD and the release of the substrate from
the O protomer is suggested to be PMF-independent and might explain why the LTO conformations are observed in isolated protein samples upon
structural analysis. The return from the O state to the L state, however, is a PMF-dependent step in analogy with the ABC transporter cycle shown
in Figure 16. FD, funnel domain; PN1, PN2, PC1, and PC2 are the subdomains of the AcrB/MexB porter domain; TM2 and TM8 are the
transducing helices coupling energy transduction from the porter domain to the TMD and vice versa); TMD, transmembrane domain.
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the OMF, via reorganization of the β-barrel and lipoyl
domains, leading to the stitching-up of the helical-hairpin
assembly to form a tube and recruit the OMF, which in turn
enables the OMF opening and stabilization of the OMF-PAP
assembly by PAP2 by completing the interlocking of their
respective helical hairpins as suggested by Tsutsumi et al.306
Indeed, studies of binding of hairpins in isolation to the WT
OMF MtrE vs mutationally stabilized open state (MtrE E434
K) indicated approximately 100-fold increase in affinity of the
interaction.719 The significant realignment and tightening of
the helical bundle of the PAPs upon OMF binding is
associated with a subsequent compression of the lipoyl and
β-barrel domain gaskets by ∼10 Å completing the formation
and the sealing of the tubular conduit.287,305 The conforma-
tional trigger from this compression and realignment is
propagated through the PAP2 enabling its MPD to engage
with the DN/PN2 of the T-state RND protomer.
Via these protomer-specific interactions, PAP1 and PAP2
provide outward and inward communication from the RND
and from the OMF, respectively, utilizing their conformational
changes for coupling remote allosteric sites, which are
con s i s t en t w i t h th e mode l s s ugge s t ed p r e v i -
ously.270,305,306,698,757,758 Intriguingly, we have identified
significant differences between the different RND-conformers
in the engagement of the DC domain’s β-hairpins with the
PAP2 (box 6) in the MexAB-trio structures (PBD ID
6TA6),270 specifically involving the MexB R764 and the
main chain of the PAP D278. This interaction may provide an
additional level of allosteric communication, as the critically
important Y757, which forms part of the MexB drug-exit gate,
is located at the base of the same β-hairpin that provides the
PAP2-attachment point, and conformational changes as a
result of PAP2 binding may be communicated via it to the drug
exit gate. Furthermore, the box6-interaction mediated by the
PAP2 R277 and the RND transporter E244, which maps to the
short helix at the base of the DN-domain hairpin, may convey
conformational changes from one RND protomer to the other.
While the significance of these interactions needs to be
investigated further, they could help explain the C to O
transition trigger and forward communication between the
PAP2 and subsequent RND-protomer. It is therefore tempting
to suggest that the hexameric PAP β-barrel ring not only
provides increased processivity but also enables the one-way
PAP2 “latch system”, which in turn gives directionality to the
cycle. This system can elegantly explain the lack of
cooperativity or directionality observed in individual trans-
porters.299
In respect to the PAP−OMF interface our model allows for
the first time to tentatively assign a specific role to each PAP
conformer within the cycle. As described above in the closed,
resting state of the OMF the coiled-coil α-helical hairpins at its
tip are stabilized by a network of predominantly ionic
interactions, aka “primary gates”, that keep the inner coiled-
coil helices (H7/H8) in a tensed supercoiled state relative to
the relaxed superhelical trajectories of the outer coiled-coil
helices (H3/H4). The disruption of the “primary gates” has
been demonstrated to result in a spontaneous relaxation of the
super helical trajectories of the “mobile” inner (H7/H8)
helices relative to the “static” H3/H4 helices, resulting in
dilation of the OMF aperture following an “iris-like”
mechanism.687−689 This interaction is induced by the PAP−
OMF interaction and does not require energy input from the
transporter.720 Analysis of the positions of the PAP1 and PAP2
in the zero-degree structures of MexAB-OprM (PDB ID
6IOK,306 6TA6)270 and the corresponding AcrAB-TolC305
suggests that PAP2 is the main interacting conformer with the
OMF-R2 (H7/H8) motif, which is consistent with it being the
final recipient (and stabilizer) of its relaxed helical trajectory,
the release of which could plausibly be deduced to be triggered
by an initial docking of the PAP1. While in the case of MexA
and AcrA it is difficult to assign a specific role to each PAP due
to their ultimate interchangeability and the quasi-equivalence
of the 60° structures, the roles of PAP1 and PAP2 can be
established to be distinctly different.
On the example of the TriABC-OpmH system it has been
established that PAP1 (TriA) is detrimental to recruitment of
Figure 46. Proposed model for concerted tripartite assembly along sectional views of the OMF-PAP-RND interaction surface. RND protomers are
colored according to their adopted conformation (Loose in blue, Tight in yellow, Closed in gray and Open in red). Six PAPs protomers bind as
pairs to the RND trimer. The resting, closed OMF trimer interacts with the PAP hexamer (one pair of PAPs is omitted for clarity). Upon
interaction with the OMF periplasmic end, PAP1 destabilizes the lock anchoring the H7−H8 helices to the static H3−H4 helices, resulting in a
spontaneous relaxation of the superhelical trajectories of H7−H8 helixes as depicted by arrows. Engagement with the OMF is communicated down
to the RND via PAP2, allowing the positioning of the MP-domain at the T/C crevice (indicated by the pink arrow), which in turn results in a
rearrangement in the underlying PN1 domain leading to the opening the helix gate, denoted by the rotation of the flap symbol, thereby enabling the
Closed to Open transition of the protomer.
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the OMF and hence likely makes first contact with it, which is
supported by mutagenesis,802,803 while the MPD of the PAP2
(TriB) is responsible for the activation of the transporter,
which, in light of the latest findings of Glavier et al.,270 is likely
mediated via the conformational changes that propagate to the
“exit-gate”.
We therefore propose that the PAP1 plays the primary role
in sensing the drug-bound state T-state of the transporter and
the recruitment of the OMF. Due to the differing helical
trajectories of the R1 (H3/H4-associated) and R2 (H7/H8-
associated) motifs of the OMF, the primary interaction of
PAP1 (based on the TriA data) is suggested to be the R1-
motif, although in single-PAP assemblies such as MexAB and
AcrAB the interface is quasi-6-fold symmetrized, and 60°
rotation of the OMF may possibly produce functional
complexes as suggested by the existence of the alternative
structures (e.g., PDB ID 6IOL,306 6TA5270). In the case of a
binary AcrAB complex which is transitioning from an LLL
state, the drug binding and conversion on L to T would serve
as an allosteric signal from PAP1 toward the OMF enabling its
attachment.
The initial docking of the PAP1 to the H3/H4 helices of the
OMF, which serves as an upward communication signal,
triggers at least partial release of the H7/H8-helices, possibly
by attacking the interprotomer H8−H4 attachment gate, the
full relaxation of which is achieved by breakage of the
intraprotomer H7−H4 gate (containing a conserved Y-residue,
e.g., Y404 OprM or Y362 TolC) upon subsequent PAP2
docking (see Figure 42D, E and Figure 46). The relaxed
trajectory of H7/H8 is then stabilized by the PAP2 which ends
up being attached to the tip of H7−H8 (R2 HTH-motif) with
its own RLS-motif, as seen in the recently assigned 0-degree
OMF-structures (PDB ID 6IOK,306 6TA6270) (see Figure 42B
and Figure 46). Indeed, the analysis of the tip-to-tip
interactions and the possible starting and finishing trajectories
of the H7/H8 helices as seen in the 0-degree structures
suggests that these are the only arrangements which are
compatible with the cross-linking data presented by Ntreh et
al.,803 strongly indicating that TriB binds in a compatible
fashion to the one presented by PAP2.
8.7. RND−PAP Interface and Energetic Considerations
Bridging of the RND transporter and the OMF by the PAP
does not appear to require energy as the stable complex
assembly can be achieved in vitro. Bipartite interactions
analysis showed tight association between MexA and OprM
in the absence of MexB, whereas the expression systems
lacking MexA failed to copurify MexB or OprM.704
Furthermore, binary interactions between purified proteins
probed by surface plasmon resonance (SPR) also suggest a
sequential assembly of the RND complex in the absence of
energy input,697,698 with PAP-RND subcomplexes creating a
tight formation which appears to be independent of substrate
presence. Consistent with this, pump substrate novobiocin and
a broad-spectrum pump inhibitor Phe-Arg-β-naphthylamide
(PAβN; MC-207,110) were able to bind to the immobilized
AcrB but did not affect interactions between the components
of the complex.698 Crucially, the pump assembly, including the
recruitment of the OMF channel, and its opening were found
Figure 47. Qualitative energy diagram of the assembly and cycling of the RND-tripartite assemblies taking into account the role of the PAPs and
the newly discovered C-to-O transitions. The symmetrical LLL state is suggested to be a metastable high-energy state of the RND trimer and is
prone to spontaneous collapse upon substrate binding. The L to C transitions are suggested to be driven solely by the binding energy between the
components and can occur in isolated RND transporters, as witnessed, e.g., by the “mono” structures of MexB.270 The C-to-O transition does not
happen spontaneously, suggesting that the C-to-O is an upper energy transition and is offset by the binding of the PAP2 MPD (represented by the
lower part of the magenta protomer being colored in orange). PAP2 MPD cycling provides directionality of the cycle and prevents backsliding of
the C/O-to-T which in its absence is suggested to be in an unstable equilibrium. The energy from proton release allows for the upper-energy level
O-to-L conformational transition, which enables repeat of the cycle.
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to be energy independent in vivo719,720 as well. The energy
input from cytoplasmic proton release is likely required for
resetting the protomer to the initial L-state as evidenced from
both in vivo720 and in an isolated controlled system in vitro.705
Based on the above considerations we postulate that the
process from the apo-state (L), over drug-bound state (T), to
the release of the drug in the O-state is PMF-independent
(Figure 47).
Thus, the only energy involved is the binding of the
substrate, plus the binding energy of PAP-association,
alongside with and the binding of proton(s) to the transporter,
with its occurrence in dependence of their concentrations
present in the periplasm. On the other hand, the “reset” of the
O conformation into the L conformation is suggested to be
PMF-dependent. This might explain why the LTO con-
formations are observed in isolated protein samples upon
structural analysis. The reset of the structure from the O-state
to the L-state is suggested to take place upon the substrate
release from the drug-binding pocket and the associated release
of the proton from D407 and/or D408, which causes a large
conformational transition.352 Upon proton release, the O
conformation returns to the L conformation and the TO
interface changes into a TL interface which closes the gap
between the protomers, and rearrangement of the RND-
surface leads to the disengagement of the PAP2 MPD domain.
Our model suggests that the LLL state of the pump is
metastable and does not require additional input of energy to
undergo L to T transition other than that provided by the
substrate binding. Concomitantly, the allosteric transitions
associated with the L-to-T transition upon the substrate
binding are transmitted to PAP1, which initiates OMF-
recruitment (Figure 47).
The binding of the substrate opens the proton access
channel in the T-conformer, and the occupation of the proton
relay causes the T to C conversion (as demonstrated by a
recent MD study).808 This in turn recruits the PAP2 MP-
domain to the interprotomer groove, which by acting as a
“door stop” or “latch” stabilizes the C-state, preventing
backsliding to the T-conformation, and enables the C-to-O
transition. While the occupation of the proton relay facilitates
this C-to-O transition in vivo, it can be achieved in the absence
of PMF in the isolated transporters. Indeed, the energy barrier
of the T-to-C transition appears to be relatively small, as
additional binding energy provided by the interaction of the
MBX3132 inhibitor over native substrate appears to be
sufficient to overcome it and stabilize the pump in a quasi-
symmetric TTT-state, as seen in the PDB ID 5NG5.305 The C-
to-O step does not occur spontaneously, and in isolation it is
likely to represent a higher energy step, which is offset by the
binding energy provided from the allosteric association of the
MPD of PAP2 with the RND-protomer as suggested by
Glavier et al.809 In agreement with that a peak force of ∼8
kcal/(mol Å) was required for the indole to overcome the
closed gate barrier,808 while a smooth energy profile is seen
when the gate is open.810
In the next step of the cycle the substrate release from C- to
the O-state causes the exit gate to collapse, leading to the TM-
conformational transition that leads to release of the protons
on the cytoplasmic side, which also causes the consumption of
the proton gradient. It has to be noted that the MexB-solo
incorporated in liposomes270 in the presence of its substrate
Meropenem was not able to achieve any proton transport,
which is consistent with the requirement of PAP2 association
for proton release. The collapse of the exit gate, which initiates
the O-to-L transition, is also translated to the change of the
surface of the PN2 subdomain of the RND-protomer, which
lowers the binding affinity of PAP2 to it, leading to its release.
Thus, substrate release is sufficient to disengage the molecular
“latch” that is the MPD of PAP2, the release of which causes
the proton release on the cytoplasmic side, closing the
cytoplasmic access (Figure 45, Figure 46, and Figure 47).
The preference of the MP-domain of PAP2 to the substrate-
bound T-protomer provides a straightforward control of the
pump activity in response to the substrate concentration.
However, in the discussed scenario this on−off cycle of PAP2
MPDs is enabled by the β-barrel ring that keeps the tripartite
pump assembled through repeated cycles. However, a
complete disengagement of the PAPs might be required
under certain conditions. It has been previously suggested that
a drop in the drug concentrations in the periplasm may drive
the adoption of a symmetric LLL-state of the AcrB trimer,807
which under the current model (Figure 45) could shift the
equilibrium toward pump disassembly. While future research
will need to provide a definitive answer to the actual
mechanism of disassembly, the following findings may provide
circumstantial evidence. The PMF is linked to the pH levels in
the periplasm,811 and lower periplasmic pH at ∼6.0, which is
associated with high PMF, was found to favor pump assembly,
while elevated pH at 7.5, corresponding to the decreased PMF,
promotes pump disassembly in a PAP-dependent fash-
ion.698,757,758 Similarly, Ip et al.812 using site-directed spin-
labeling EPR demonstrated that AcrA undergoes not just
significant pH-induced conformational transitions but also
oligomerization. Thus, the PAPs may also play the role of a
PMF-sensor for the assembly.
Such interpretation is consistent with the observation of
two-liposome reconstituted MexAB-OprM complexes, where
substrate transport was associated with a rapid PMF-
consumption813 followed by a subsequent dissociation of the
MexAB and TolC complex.705 Furthermore, in E. coli, the
rapid spiking (∼1 Hz) of the PMF coincided with the efflux of
the potential AcrB substrate tetramethyl rhodamine methyl-
ester (TMRM)814 allowing the suggestion that the transient
AcrAB−TolC complex operates in a discontinuous fashion.807
In summary, while further functional validation is required
to fully confirm the roles of PAP1 and PAP2 at the level of
specific OMF-gate opening, this model provides a non-
controversial unification of both PAP−OMF and PAP−RND
interfaces, allowing us to rationalize the available data, and
furthermore provides a testable platform for future studies that
we believe will benefit the wider community in the field.
8.8. Tripartite Complexes of HME-RND Family
The active role of PAPs in the efflux pump assembly has also
been demonstrated in the HME-RND transporters, which are
closely homologous to the drug-efflux associated HAE-1 family
discussed above and are thus anticipated to form similar
tripartite assemblies.
One of two main branches within the HME-family
specializes in pumping out divalent ions, e.g. CzcABC,
CznABC, and NccCBA involved in Cd2+, Zn2+ and Ni2+ and
Cd2+, Co2+ and Ni2+ detoxification respectively45,67,815,816 and
with ZneCAB from Cupriavidus metallidurans CH34 being a
relatively well-studied system.46,358 In contrast to the HAE-1
RND pumps discussed above, the ZneA transporter does not
appear to undergo dramatic LTO conformational transitions,
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which can be expected as its ion-cargoes do not require such
major reorganizations in order to pass through. There is also a
strong indication that unlike other RND transporters discussed
here, it may actually be capable of moving the Zn2+ from the
cytoplasm directly to the extracellular space, in an electrogenic
fashion suggesting a proton to Zn2+ ratio of greater than 2:1.358
However, little is currently known of the higher order
complexes with its participation, although, as mentioned
earlier, its cognate PAP ZneB presents an architecture very
similar to the PAPs associated with the HAE-1 type RND
transporters. ZneB, however, has a well-defined specific metal-
binding site, and the crystal structure revealed Zn2+-ion
coordinated by H220, H284, E328, and a water molecule at
the interface between the β-barrel and MP-domain,46 yet again
highlighting the important substrate-binding role for the PAPs.
The active role of PAPs in the assembly of the tripartite
efflux complexes is probably most clearly demonstrated on the
example of the Cu+/Ag+ tripartite transporter CusCBA,359,702
where CusA is an RND-pump belonging to the HME-family,
CusB is a PAP, and CusC is an OMF.817 The system is
complemented by a periplasmic chaperone, CusF (which is
homologous to the C-terminal domain in SilB),764 whose role
is to transfer the metal ions from the transmembrane ATPase
CopA to CusB.818 This CusB−CusF interaction functions as a
switch for the entire Cus-efflux system and facilitates the
transfer of copper to the CusA component.360 Binding of
copper is coordinated by a relay of conserved methionine
residues, which stretch from the membrane-proximal domain
to the helical hairpin of CusB, and importantly, binding to
these sites causes CusB to undergo substrate-linked conforma-
tional changes.768 Electron paramagnetic resonance (EPR)
distance measurements revealed that CusB exists as a dimer in
solution, which undergoes major structural changes associated
with Cu+ binding,819 resulting in a compactification of the apo-
structure, to produce a “holo-CusB”. Furthermore, CusB has
been demonstrated not just to be the key mental sensing
element in the pump but to actively drive pump its assembly in
response to metal stress.820 CusB switches the pump on, once
excess metal ions are detected, but once the periplasmic ion-
concentration goes down, CusB transfers the bound ions back
to the periplasmic chaperone CusF, leading to deactivation of
the pump and maintaining copper homeostasis.820 Thus,
through its interplay CusF, CusB not only plays a central role
in substrate binding and pump activation but also functions as
a metal sensor controlling the whole system and is directly
responsible for complex assembly.
8.9. Could the Structure of the Metal Pump CusBA
Suggest a Conformation for a Pre-engagement Apo-State
for the Transporter−PAP Complex?
Crystal structures of the binary CusBA complex359 revealed a
hexameric assembly of the PAP forming the typical β-barrel
and lipoyl domain gaskets on the top of the transporter;
Figure 48. Comparison of the binary CusBA complex and MexAB-trio suggests a possible pathway of conformational reorganization of the PAPs
upon engagement with the OMF. (A) Crystal structure of the CusBA subcomplex as seen in the PDB ID next to the cryo-EM MexAB-OprM
structure (PDB ID 6TA6), showing significantly different orienations of the helical hairpins and the difference in packing lipoyl domains of their
PAPs. Also, while PAP1 conformer binds at the approximately equivalent interface of the RND surface, the PAP2 conformer, and particularly its
MPD domain, appears divergent. (B) Several snapshots from a molecular morphing movie illustrating a possible transition from the OMF-free state
to the OMF-engaged state, suggesting possible reorganization of alignment of the helical bundle between the two PAP forms (shown in yellow
arrows), as well as the proposed dislocation of the PAP2 MPD within HAE1-systems, which may reflect the engagement of PAP2 in the apo- and
OMF-engaged state of the complex.
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however, CusB forms a clearly delineated trimer of dimers,
with each pair being relatively loosely associated with each
other. Notably, PAP2 is fully engaged and resolved in the
structure, and the electron density is particularly good around
the N-terminal segment of PAP2 which appears to be in
contact with PAP1 (PDB ID 4DNT,610 3NE5359).
The positions of the different PAP protomers, and especially
their respective MPDs, are diverging from the one seen in the
cryo-EM structures of the HAE-1 assemblies. The orientation
of the MPD domain of PAP2 in the CusBA complex is notably
different from that in PAP2 seen in HAE-1 assemblies, where it
is firmly associated with the interprotomer crevasse and PN2/
DN domains of the RND protomer. The PAP2 features an
extended N-terminal tail (in PDB ID 4DNT it is resolved from
residue 79 to 96), making extensive contact with the surface of
the RND transporter, engaging with the PC1 and PN2 domain
of the protomer in an unfolded state. Notably this N-terminal
tail of PAP2 also contacts PAP1 directly, making specific
contact with the equivalent N-terminal tail of PAP1, which
however presents a strikingly different configuration, specifi-
cally in the contact range (residues 84−93), where if it forms
an α-helix, that contrasts the unfolded region of PAP1.
Importantly, the helical trajectories of the α-hairpins of
CusB are pointing away from the center of the pump axis,
without participating in helical-bundle tubular formation (PBD
ID 3T53).610 Along with a loose association of the lipoyl
domains, such a hairpin orientation of the PAP is inconsistent
with sealing of the OMF-channel.
While this may be explained away by functional differences
between transporter types, several points suggest that the
conformation trapped by the crystal structure of the CusBA
complex is one of a pre-engagement LLL, and indeed the
complex is trapped in a symmetrized conformation in all the
available structures, even those which are supposedly in an
extrusion state (e.g., PBD ID 3T53).610 This symmetrized, pre-
engagement state may explain the hairpin domain orientations,
as after all, effective sealing of the gasket between the OMF
and the short hairpins of the CusB is even more important as it
only expels Cu(I) ions, and any leakiness would be
nonpermissible.
A speculative morph of the PAP1/PAP2 transitions between
the ones observed in the CusBA complex and the MexAB trio
complex270 is provided in Figure 48, and the associated video
can be found as Supporting Information. The morph highlights
the realignment of the hairpin vectors upon engagement of the
incoming OMF (shown as yellow arrows), allowing effective
sealing of the efflux conduit. Second, the discrepancy of the
position of the MPD domains of the respective PAP2
protomers between the HME (left) and HAE1 (right) systems
is suggestive of possible structural changes during the
peristaltic cycling experienced by the HAE1 transporters,
which appears to be lacking in the HME family. It has to be
noted that there is no experimental suggestion of unfolding of
the hairpin of the HME-PAPs during such a cycle and that a
local variation of the height of the periplasmic space could not
be excluded.
8.10. Additional Level of Regulation of RND Pumps May
Be Provided by the Transmembrane Modulators of the
AcrZ-Family
A fourth transmembrane component is sometimes present
within the RND complexes, e.g., YajC283 or AcrZ.821 These
small proteins are entirely α-helical and bind the transporter
within the inner membrane, packing against the TM-helix
bundle (Figure 49) in a fashion similar to the γ-subunit of the
SecY-complex.283,287,305 These proteins appear to be non-
essential, playing a modulatory role, possibly changing the
efflux profile of the pump in response to environmental
stimuli.283,821 Recent cryo-EM structures of the AcrBZ-
complex in lipid environments and MD studies indicate that
the lipid environment affects the packing of the AcrZ on AcrB,
resulting, e.g., in preferential interaction of the cardiolipin with
AcrBZ. The removal of AcrZ in combination with cardiolipin
deficiency increases the bacterial sensitivity to chlorampheni-
col,822 suggesting that the combination of AcrZ and the lipid
environment works synergistically to allosterically modulate
AcrB activity. Furthermore, the interaction has also been seen
to differ between the different conformer states of the RND
transporter. The role of these small proteins remains unclear,
as they are nonessential and are lacking in most studied RND
systems, including the MexAB-OprM.
8.11. Functional Assays in Artificial Membrane
Environments Provide Additional Insights into the
Regulation of the RND Transporters and the Role of the
Lipid Environments
Understanding of the molecular basis of pump function and
especially the finer modulation and regulatory aspects of the
RND tripartite systems requires the use of membrane mimics
that enable their characterization in physiologically relevant
Figure 49. AcrBZ co-structure. The asymmetric AcrB trimer (gray
cartoon) with the three protomers in the L (loose), T (tight), and O
(open) conformations. The auxiliary transmembrane modulator AcrZ
(raspberry cartoon) is located at the surface periphery on each of the
AcrB protomers at the transmembrane domain. The X-ray structure
display (PDB: 5NC5) was solved in complex with DARPins (not
shown) and puromycin (PUY, orange spheres).
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environments. Methodologies for the structural study of
detergent-free membrane protein stabilization involve scaffold-
ing of membrane fragments around the proteins of interest
using engineered lipid-avid peptides (nanodiscs), fatty amines,
or styrene-grafted amphipathic polymers (amphipols or
SMALPs, respectively).823−825 All these chemical tools allow
for a more physiological environment around the protein.
Lipids have an effect on the activity of membrane proteins
because of the so-called “bulk” effect that reflects the physical
properties of the membrane: bilayer thickness, physical state,
curvature, and surface tension can significantly influence the
behavior of membrane proteins. For instance, as membrane
protein secondary transporters exploit the electrochemical
membrane potential to energize the transport of their
substrates, the composition of the membrane is obviously
crucial. In addition, there are also increasing clues for specific
phospholipid−protein interactions where bound lipids act as
chemical partners with a prominent role of the lipid
headgroup. Overall, the effect of the membrane composition
on the function of bacterial efflux pumps has never been
systematically explored, but emerging evidence that it plays a
significant role is described below. A major drawback is the use
of detergents, and it is questionable whether the structures
determined in such an environment are representative of what
is found in vivo. It has been suggested that in some cases, the
use of detergent can lead to artifactual structures and to their
misinterpretation.826 Youzhong Guo realized that the structure
of D407A AcrB obtained in detergent326 was significantly
different when obtained by cryo-EM after reconstitution into
polymer-wrapped lipid particles.330 Compared to the wild-type
protein, the AcrB D407A mutant in detergent shows a
significant shrinkage of the central cavity that was interpreted
as a mechanistic transport feature.326 The narrowing of the
central cavity turned out to be impossible in the presence of
lipids because of steric constraints. Following similar lines, it
was shown that the affinity of AcrB for rhodamine 6G (R6G),
determined by fluorescence polarization, is 100× higher in
SMALPs825 than in detergent.827 As further evidence for the
importance of lipids in maintaining a functional assembly, Qiu
reconstituted the AcrB transporter also in SMALPs and cryo-
EM experiments are conducted on these AcrB nanoparticles
surrounded by lipids from the in vivo E. coli membrane. The
resulting structures (R = 3.2 Å) show a trimer of the AcrB
transporter with additional densities in the transmembrane
part of the protein. A lipid patch within the central cavity of the
AcrB trimer and isolated lipids around the transmembrane
domains that may belong to the lipid belt were described.330
This is the first time that such a patch structure is described. It
is proposed that this lipid patch is directly involved in the
transport mechanism of AcrB by allowing the harmonization of
the trans-conformational LTO changes occurring within the
three protomers of AcrB. The membrane patch consists of 24
lipids modeled as phosphatidylethanolamine (PE),330 the
major lipid in the E. coli membrane.828 Molecular dynamics
has been performed on a membrane representative of the one
mentioned above with AcrB inserted in this membrane. At the
beginning of the simulation, the transporter only interacts with
PE molecules; the CL and PG molecules are far away from the
protein. During the simulation, the latter 2 lipids come closer
to the protein suggesting a role of PG and CL in the
stabilization of the AcrB trimer.822 Thus, the membrane patch
would consist of a more complex mixture than just PEs, with
the addition of the lipids PG and CL. The role of PE was also
revealed thanks to X-ray structures of the AcrB complex in
complex with fusidic acid. Both fusidic acid and DDM were
identified at a TM1/TM2 groove of AcrB that was postulated
to be an access path for carboxylated substrates. The possible
presence of physiological phospholipids at this site was
confirmed by performing ensemble docking calculations
using structures of AcrB as well as molecular dynamic
simulations of the protein embedded in a model POPE
bilayer.334
Mass spectrometry has developed significantly over the past
decade and allows the identification of specific interactions
between a membrane protein and a phospholipid which are
now maintained in the use of this method.829,830 This
technique could be envisaged to study AcrB in SMALPs and
its lipid composition in a very precise way. The latest advances
even make it possible to study the vesicles of the inner and
outer membranes of E. coli and determine their protein
components and associated lipids.831 More generally it is
believed that it is important to consider the endogenous
membranous environment as a pool of potential regulators,
local effectors at the membrane, or allosteric ligands. Of
foremost importance, AcrZ is a transmembrane protein that
was shown to potentiate the activity of AcrAB-TolC against
some antibiotics, but the molecular explanation for this effect is
lacking.
In vitro proteoliposome assays have been shown to be
excellent and tunable tools for the characterization of
transporters at the molecular level. They offer the possibility
of studying purified proteins isolated from the complexity of in
vivo systems, without pleiotropic and off-target effects, which
complicate measurements and interpretations from experi-
ments performed in whole cells. In addition, they allow for a
compartmentalization of the protein and hence make it
possible to tackle the difficult challenge of determining their
catalytic parameters. The path toward the successful
reconstitution of a tripartite pump is interspersed with many
pitfalls, and several laboratories have contributed to reach a
sensible framework to reach this goal. The milestones, major
results along this path, and possible improvements are
reviewed in refs 832 and 833. For a long time, protocols
were based on the reconstitution of the RND pump in the
presence or absence of its periplasmic adaptor. As major inputs
in the understanding of efflux pumps, reconstitution assays
demonstrated that the PAP is mandatory for active trans-
port311,706 probably because its presence is required to make
the substrate/proton antiport perfectly coupled.707 In vitro
studies also allowed a better understanding of the path
experienced by the substrate through the transporter311,354 or
the possible cross reactivity between unrelated pumps.794
Ultimately, such methodologies should eventually allow
measurement of orders of magnitude of substrate affinities
and rates of transport. In their system, Helen Zgurskaya and
Hiroshi Nikaido relied on the use of fluorescent phospholipids
which are trapped by protein-free acceptor vesicles upon
transport. When known substrates of AcrB were added to the
test buffer, the efflux of fluorescent phospholipid was inhibited.
Measurements of competition of the binding at the equilibrium
of the fluorescent lipid by various potential substrates
(antibiotics, bile salts, etc.) resulted in IC50 values in the
order of ten micromolar.706 Reconstitution of another RND,
CzcA from the efflux pump CzcB(2)A, responsible for heavy
metal resistance in Ralstonia spp.,815 yielded for the first time a
rate constant of 385 s−1 and a sigmoidal kinetics with a Hill
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coefficient of 2. However, caution should be taken regarding
the physiological relevance of these data because the reported
Michaelis−Menten constant (of 6.6 mM) seems to be
abnormally high. The overall order of magnitude for the
velocity of transport is a matter of heated debate: Aires and
Nikaido concluded that ∼0.3 protons are consumed per trimer
of AcrD and per second,311 and by contrast, in another study,
EtBr transport by MexB gave rise to an impressive turnover
rate of 500 s−1 based on a number of pumps previously
estimated by immunoblotting methods. In 2015, it was
possible for the first time to measure in vitro the transport
by the MexAB-OprM efflux pump of P. aeruginosa entirely
reconstituted in proteoliposomes.813 In this setup, a functional
reconstitution of the MexAB−OprM system made it possible
to trace the respective transport of a fluorescent substrate and
protons via a pH-sensitive fluorescent reporter. This system
promises insight into the largely unanswered question of H+/
drug stoichiometry, substrate specificity, and measurement of
the catalytic constants of the various pumps.
9. TRIPARTITE ASSEMBLY OF MACAB-TOLC
The lack of clear substrate membrane access channels, the very
narrow TM-helical bundle, and the reported involvement in
the transport of Sec-dependent peptide cargoes154,548,550
strongly imply that MacB operates differently from the
canonical type IV ABC transporters and floppases. The latter
operate on a two-step alternate access model, providing
transmembrane shuttling either from the inner-leaflet of the
cytoplasmic membrane or directly from the cyto-
plasm,390,465,524 while the cargo of the MacB/FtsX transporters
is acquired from the periplasm only. In that respect there is a
functional overlap of the family with that of the tripartite RND
transporters, which are suggested to work as a universal
“second stage” supplementing the single-component trans-
porters that remove the xenobiotics from the cytoplasm.834
A reconstruction of the complete E. coli MacAB-TolC pump
produced from docking of MacB into a hybrid cryo-EM map
with varying local resolution (from 3 to 8 Å), derived from the
analysis of the fusion-stabilized EcMacB-MacA MPD-domains
and of a higher resolution disulfide-stabilized MacA-TolC
subcomplex, has been reported by Fitzpatrick et al.272 The
assembled structure revealed MacB:MacA:TolC protomers in a
2:6:3 stoichiometry consistent with the earlier biochemical and
biophysical essays.573 The complex presents dimensions
comparable to the ones observed in the RND-based assemblies
measuring some 320 Å along its long axis (membrane to
membrane) to span the whole periplasm.272
The PAPs associating with the MacB-FtsX like transporters,
such as MacA, similar to the PAPs of RND systems, have a
strong propensity to form hexamers in isolation,759 that are
stable under native-MS conditions573 and can be readily
crystallized.571,737,746 Functional studies have shown that
MacA has a role in regulating the function of MacB, increasing
its affinity for both erythromycin and ATP.573 While the
MacA−MacB complex is formed with a nanomolar affinity
even in the absence of ATP, the affinity of interaction further
increases in its presence,835 with the PAP acting as a switch for
allowing ATP-hydrolysis by MacB.836
Studies by Tikhonova et al.743 demonstrated the functional
dependency of MacB on MacA, showing that after
reconstitution into proteoliposomes, the ATPase activity of
MacB was strictly dependent on MacA. The catalytic efficiency
of MacAB ATPase was more than 45-fold higher than the
activity of MacB alone. Both the N- and C-terminal regions of
MacA were essential for this activity. MacA stimulated MacB
ATPase only in phospholipid bilayers and did not need the
Figure 50. MacAB-association highlighting the differential binding of PAP protomers based on PDB ID 5NIK.272 Different PAP protomers can be
named PAP1-PAP3 based on their interaction with the MacB transporter in an analogy to the RND transporter complexes. PAP1 can be seen as an
intraprotomer relative to the transporter, while PAP2 interacts exclusively with the SABRE subdomain of the same transporter protomer. PAP3
appears to occupy an interprotomer position extending over the cleft between the neighboring transporter protomers. (A) Top view looking down
at the interprotomer interface of MacB. (B) Side view showing the position of the β-barrel gasket of the PAP hexamer. (C) Different PAP
conformers make inequivalent contacts with the crown of the transporter, and PAP3 in particular, which is interprotomer-bound, is loosely
associated with the complex.
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presence of macrolides suggesting that MacA forms a
functional subunit with the MacB transporter.743
Notably, the lipoyl domains of the PAPs in these assemblies
form tight hexameric gaskets, similar to the ones formed by the
PAPs in isolation737 with an extended flexible loop donated
from each protomer creating a “gating ring”,272,571 which is
suggested to prevent backflow, favoring unidirectional
substrate efflux in an outward direction (Figure 35C). In the
hexameric structure of E. coli MacA, the lipoyl domain loops
(G56-L72; T199-I214) protrude into the cavity delineated by
the assembled hexamer, providing a constriction of the lumen,
which is narrowest at residue N209, which in the stand-alone
structure (PDB ID 3FPP)737 is effectively sealed (Figure 35C
in section 7.3).
Similarly, in the PAP Spr0693 (PDB ID 5XU0), which pairs
with the Gram-positive MacB-homologue Spr0694-0695, the
hexameric α-helical barrel has an inner diameter of ∼31 Å. A
gating ring is formed by the flexible loops from the lipoyl
domains (N211−V224), with six G220 residues at the
innermost site restricting the internal diameter to around ∼7
Å.571
The β-barrel and MP-domains of MacA mediate the
interaction with the periplasmic domain of MacB, in agreement
with the reported functional data60,573,836 and the observation
that the MP domain is required for MacA and MacB to
associate in solution (with nanomolar dissociation con-
stant).836
In the reconstructed tripartite assembly,272 three MacA
MPDs are found to bind to a single MacB protomer, with one
MPD contacting the PD-sub domain and two contacting the
SABRE subdomain. Located above the PCD-crown of the
transporter, the β-barrel domains of MacA form what we refer
to as a head-to-tail hexameric “gasket”-ring, which docks to the
periplasmic domain of MacB (Figure 50 and Figure 40
ATPase rings). Stabilization of this β-barrel gasket-ring is
mostly due to the interprotomer interactions of three residues
(which in the EcMacA correspond to T293, Y275, and E231),
that are strictly conserved across the MacA-family indicating a
common mechanism.737
The β-barrel domains of the three MacA protomers make
nonequivalent contacts with the PCDs of the transporter,
which could, in an analogy to the PAP1 and PAP2 discussed in
the context of RND transporters, be named PAP1−PAP3,
respectively (Figure 50). Of these, PAP1, similar to the PAP1
in the RND assembly, makes intraprotomer interactions only
relative to the transporter (e.g., using the chain identifiers from
the PDB ID 5NIK).272 PAP1 could be assigned to chain D,
and both its MP-domain and β-barrel domain interact with the
PD-base of the PCD domain of the MacB (chain J), while
PAP2 (chain F) interacts exclusively with the SABRE domain
of the same transporter protomer (chain J), and the last, PAP3
(chain G), appears to occupy an interprotomer position
extending over the cleft between the neighboring transporter
protomers. However, in contrast to the tight association of the
RND−PAP2 with the interprotomer space in the RND
Figure 51. Comparison of the assembly of MacAB with the MlaEF-complex reveals a common organization. Both transporter complexes are
stabilized by a hexameric β-barrel gasket (colored green and red), formed of their respective periplasmic partner proteins, which, although
structurally nonhomologous, provide an identical solution to binding to a dimeric transpoter interface. Left, a homology model of the MacAB
subcomplex based on the PDB ID 5NIK, taking into account the transmembrane portions of the MacA which were unresolved in the cryo-EM
structure, indicates that these are of sufficient length to reach the connecting helix (CoH) of MacB and could provide additional allosteric coupling
across the membrane, as established for the MlaEF-D complex (on the right, experimental structure (PDB 6XBD)).
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transporters, the “inter-protomer” PAP3 in MacB appears to
make very few direct contacts with the underlying MacB using
its β-barrel domain, and its association is mainly maintained via
lateral contacts with the other PAP mediated via the β-barrel
domain loops. Similarly, while the PAP3 MPD does contact
the SABRE subdomain of the PCD; this contact, at least in the
conformation observed in the cryo-EM structure, is restricted
to a single loop. Such limited contact of this PAP3-protomer
with the transporter makes this site particularly susceptible to
allosteric modulation and may provide a natural switch for
assembly/disassembly of the complex.272 Furthermore, the
asymmetric interactions of the MPDs as well as the β-barrel
domains of MacA with the underlying transporter result in
distortion of the hexameric β-barrel ring relative to the shape
formed by the MacA MPDs in isolation, allowing it to
accommodate the 2-fold symmetry of the MacB PCDs.272
In an organization which mirrors that observed in PAPs
participating in the RND transporter assemblies, the lipoyl
domains of MacA form an additional hexameric ring that stacks
above the β-barrel gasket but does not contact MacB. The self-
association of the “lipoyl-gasket” clearly plays a role in
stabilization of the whole PAP hexamer, as can be seen in
the example of DevB−DevAC interaction.206 From the lipoyl
domain-gasket up, the hairpin arrangement of the PAPs from
the MacA-family and that of the AcrA-family follow similar
trajectories and present a unified interface to the OMF, which
is further supported by the aforementioned chimeric-protein
studies, swapping the hairpins between MexA and MacA (PDB
ID 4DK1).751 Consistent with this the MacA-family also shares
the conserved RLS-motif at the tip of their α-hairpin.
Thus, the arrangement of PAPs around the MacB-dimer
differs substantially from the organization of the RND
transporter complexes, showing a much-lighter engagement
with the transporter, and the PAP−MacB interactions are
restricted to within the same transporter protomer, with any
interprotomer contacts being mediated by PAP−PAP inter-
actions instead. This loose association, along with an exposed
proposed substrate location site and the apparent lack of
enclosure provided by the two stalk helices, poses some
questions regarding sealing of the assembled complex and
cross-membrane communication with the NBDs, which are
suggested to provide remote allostery to the complex.
An unexpected analogy to the PAP-MacB communication
may be found in the function of the maintenance of the
phospholipid asymmetry (Mla) MlaFEDB complex, the
structure of which has recently become available (PDB ID
7CGN; 7CH0; 7CGE; 6XBD).437−439 In the sections above
we mentioned the close topological connection of the MacB
(and other type VII ABC transporters) with the new MlaE-
family, which is suggestive of common operational mecha-
nisms. It is thus even more notable that the same stoichiometry
of 2:6 as in the MacB−Mac complex is also observed in the
complex between the transporter MlaEF and the periplasmic
protein MlaD, which belongs to the mammalian cell-entry
(MCE) family, which while phylogenetically not connected to
the PAPs,837 forms analogous hexameric assemblies with
participation of their respective β-barrel domains (Figure 51).
Similar to MacA−MacA interaction, three MlaD protomers
associate with a single MlaE protomer.
Within this complex, a striking arrangement of TM-helices
emanating from MlaD can be seen in the MlaED complex,
where it is tempting to suggest the N-terminal helices of MlaD
are facilitating the substrate transfer and activity of the
transporter.
The TM-helices of different MlaD protomers make distinct
contacts with the TMD and connecting helix (CoH) of the
transporter MlaE (also referred to as elbow or interfacial helix-
1 (IF1),439 with the TMs of D1- and D2-protomers of MlaD
forming close hydrophobic contacts with the elbow CoH of
MlaE, while D3-protomer packs closely against the TM1 and
TM3 of MlaE. Mutagenesis of the respective contact residues
in MlaE rendered the bacteria sensitive to the treatment of
SDS/EDTA,437 and correspondingly, mutations in the MlaD-
TM domain also rendered the transporter nonfunctional.439
Furthermore, truncations of the coupling helix (IF1) of MlaE
also abolish transporter function, highlighting the importance
of this structural element. The existence of the CoH is a
notable feature of MacB, and similar to MlaE, it only has a
single coupling helix, with its NBDs being connected to only
one porter domain subunit, which suggests a similar
mechanism of action. Intriguingly, in the absence of nucleotide
MlaE adopts an outward facing conformation.
While the TM-domains of MacA are not resolved in the
cryo-EM structure of the complex,272 modeling the full-length
MacA (see Figure 51) suggests that, similar to the MlaEF−
MlaD interaction, these TM-helices could reach and plausibly
contact the CoH and/or intramembrane helices of MacB, thus
providing direct coupling of the conformational transitions in
the periplasm to the transporter and its NBDs. Consistent with
such a model and interpretation, while MacB is able to interact
with a MacA, which lacks the TM-helix,573 this TM-helix is
required for activation of the ATPase activity in vitro, and its
deletion obliterates the MacAB-mediated macrolide resistance
in vivo.743 This also holds true for the MacAB homologues
from the Gram-positive organisms, as the ATPase activity of
the Streptococcal Spr0694−0695 MacB-like transporter was
activated by full-length, but not by the N-terminally truncated
version, of the cognate PAP Spr0693 when reconstituted in
proteoliposome,571 suggesting that the intramembrane com-
munication between the PAP and the transporter is essential
for the general function of the MacB-like assemblies and not
restricted to tripartite complexes with their participation.
Furthermore, evidence from the related DevBAC system in
Anabaena shows that N-terminal cytoplasmic domains in the
PAPs of MacB-group play an important role in activation of
the ATPase activity.206 There, a variant of the PAP DevB,
lacking 22 N-terminal residues completely abolished the
recognition of the glycolipid substrate by the DevAC ATPase
despite not having an impaired binding to the transporter.
Similarly, the DevB homologue, All0809, is not able to
promote a substrate-dependent reaction of the ATPase activity
of DevAC, although it binds to DevAC,555 suggesting a further
layer of the underappreciated PAP role in the process may be
present. Importantly, besides the wild-type reference DevB,
none of the PAP variants harboring hairpin deletions tested
(with small exception) could mediate the substrate-dependent
ATPase activity,206 suggesting that formation of the hexameric
PAP-assembly is critical for the activation of the pump, which
is in agreement with an earlier-reported PAP hairpin-targeting
mutation causing similar defects.559
The above observations suggest that full understanding of
the functional cycle of the MacB-based pumps could not be
achieved by looking at the transporter in isolation, as similar to
the MlaE2F2D6 which presents a complex 10 + 6 TM-assembly,
the MacB2−MacA6 complex should be interpreted as an
Chemical Reviews pubs.acs.org/CR Review
https://doi.org/10.1021/acs.chemrev.1c00055
Chem. Rev. XXXX, XXX, XXX−XXX
CC
integrated 8 + 6 TM-system, with the MacA-protomers
forming an active part in the presentation of the cargo as
well as communication of allosteric changes across the
membrane while also providing an additional level of
cooperativity.
While such communication would be analogous to the
vertical communication from the PAPs to the TMD of the
RND transporters discussed in the preceding section, its trans-
membrane nature involving the MacB-CoH, and PAP-TM-
helices is suggested to enable the periplasm-to-inner-
membrane signaling leading to the activation of the NBD-
ATPase activity on the opposite side of the membrane. This is
in stark contrast to the RND transporter assemblies, where
major allosteric communications, as well as energy coupling
access (in the form of opening of the proton-accessible channel
upon substrate-driven L-to-T transition) are restricted to the
periplasmic side of the membrane. This is providing a further
suggestion that the unique organization of the MacB
transporters and their piston-like TM-assembly suggest that
their ATPase cycle may differ significantly from that of the
classical “clam”-like type IV ABC transporters and the classical
alternating access model.
9.1. Functional Cycle of the Tripartite MacB-Pumps
The significant conformational changes of the PD/SABRE
domains observed in the different apo- and nucleotide-bound
structures, as well as the close proximity of the NBDs in some
of the nucleotide occupied structures,24,272,431 hint at a
possible efflux model, which has been dubbed the “molecular
bellows model” in analogy to the blowing of the compressed
air in the macroscopic analogue. These parallels are enhanced
by the existence of the one-way-valve operation of the gating
ring of MacA,272 with asymmetric energy need for the drug
passage in an outward and inward direction on the example of
erythromycin MD. Such an arrangement is supposed to
prevent backflow from the OMF and suggests that the gating
ring is always engaged. Under the emerging model discussed
here, the engagement of PAPs with the OMF could be
communicated downward to the lipoyl ring, which experiences
a twisting motion settling down, and this causes the gating ring
to dilate, allowing simultaneous cargo export. While the
“bellows model” agrees that the stitching of the “stalk helices”
(leading to the formation of the TM1-TM2 bundle) and the
associated compression of the supposed substrate binding site
is associated with the efflux of the cargo, the exact nature of the
power-stroke has been less clear.
Taking into account the ABC transporter cycles discussed in
section 5.6.7, we believe that a very modest modification of the
initially proposed “bellows” model can unify the operation of
the MacB and type IV ABC systems. In parallel to the
differential binding of PAP1 and PAP2 to the different RND-
conformers, the differential affinity of MacA to the substrate-
occupied and empty states of the MacB PCDs could be a
driving force for tripartite complex assembly. Such a model
may also explain how separation of the two PCD domains of
the transporter upon the ATP-hydrolysis may, due to the loose
binding of the PAP3, result in a dissociation of the tripartite
assembly. Given the existence of the stable crystal and cryo-EM
complexes of MacA-TolC, it is tempting to suggest that in
contrast to RND complexes, where the PAP-RND forms a
more-stable complex, in the MacB-based pumps the PAP-
OMF subcomplex may be more stable. In such case a “top-
down” assembly of the PAP-OMF onto the MacB may be
possible, with this being contingent with the MacB being
already substrate-occupied.
Under our modified bellows model, illustrated in Figure 52,
the substrate binding is the primary driving force of tripartite
assembly, and similar to the situation discussed in the RND-
PAP association, the MPDs of the MacA-type PAPs are
suggested to have a strong preference to the substrate-bound
conformer of the PCDs, with such binding likely being
associated with the recruitment of the OMF.
Figure 52. Modified molecular bellows mechanism for the MacAB-TolC pump. MacA (green-cyan) and MacB (blue) undergo allosteric
conformational transitions (symbolized by orange arrows) upon binding of substrate and ATP. Similar to type IV ABC transporters, substrate
binding is suggested to bring a conformational transition that enables the nucleotide bidning domains (NBDs) to engage with ATP. Substrate is
expelled through TolC (orange) upon ATP binding. ATP-hydrolysis (symbolized by the small orange lightning bolts) resets the pump, in order for
another cycle of efflux to proceed. Interactions within the membrane between the TM-domains of the MacA and MacB are suggested to provide an
additional level of transmembrane communication. See text for further details.
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Indeed, based on the structural homologies discussed above
(see the PD-domain connection section), it is plausible that
the PCDs may undergo significant conformational changes
upon substrate binding, e.g., similar to the PD-transitions seen
in the Super F to I -form of the SecDF transporter.366 This
initial substrate-binding is suggested to bring the PCDs closer
together, creating a conformation analogous to the substrate-
bound occluded conformation seen in the type IV transporters,
e.g., during the TmrA cycle.524 This allosteric transition is
communicated via the stalk helices downward across the
membrane, enabling the binding of ATP by the NBDs.
In turn, the dimerization and allosteric changes in the NBDs,
caused by ATP-binding, result in further tightening of the
transmembrane helical bundle, which is communicated back to
the PCDs and likely provides the power stroke that leads to the
ejection of the substrate into the PAP-OMF cavity above the
crown of the transporter, by stabilizing the outer-facing
conformation of the PCDs in agreement with the previously
proposed models.431 Under this scenario, the substrate
engagement is the main driver of PCD rearrangement, leading
to the initial stitching of the TM1 and TM2, facilitating the
ATP-engagement by the NBDs, with the power-stroke being
associated with the ATP-binding, rather than ATP-hydrolysis.
The departure of the substrate causes the closure of the
outer-facing conformation and produces a stable, ATP-bound,
occluded conformation of the transporter, that requires ATP-
hydrolysis to drive the NBDs apart. We further suggest that the
rearrangement of the PCDs and the TMD of the transporter is
sensed by the MPDs and TM-domains of the PAPs, providing
additional allosteric signaling. Our modeling suggests that
upon ATP-binding by the NBDs, the rearrangement of the
transporter TMD allows the MacA-TMs to pack better against
the helical core of the TMD, which is likely associated with
their ability to convey an ATPase-stimulatory signal (possibly
via their interaction with the connecting helix (CoH)), which
would explain the functional data.573,743,835
Under such a scenario, there could be a possibility of a single
ATP-hydrolysis independent cycle of the transporter. Indeed,
exactly such an event has been reported in the closely related
LolCDE system, the ABC-components of which are virtually
identical to MacB.838 Uniquely, LolCDE can be purified in a
liganded form, which is an intermediate of the lipoprotein
release reaction, and it has been demonstrated that the
lipoprotein transfer from liganded LolCDE to the periplasmic
chaperone LolA in a detergent solution does not require ATP-
hydrolysis and a single transfer event can be stimulated by
vanadate. The close homology of the two systems suggests that
a similar operation may be in place with MacB-based
transporters which will support the ATP-binding power-stroke
hypothesis.
However, an alternative mode of operation could not be
fully ruled out, as recent analysis of MacAB-TolC incorporated
into liposomes containing quantum-dots suggested close
synchronization of the substrate efflux with ATP-hydrolysis.
Furthermore, using the same system did not detect any transfer
in the vanadate-treated sample.839 While a power-stroke
associated with ATP-hydrolysis may be an explanation for
such behavior, a closer analysis of the MacAB-assembly
provides one intriguing alternative. As mentioned previously,
the crown formed of the β-barrel gasket and the lipoyl domain
gasket is much-more loosely associated with the transporter
than in the case of RND-based assemblies, and it presents a
domelike structure, which along with the gating-loops of the
lipoyl domain (Figure 50 and Figure 52) creates a “waiting
room” type of cavity, where the substrate would plausibly be
transferred after the PCD-contraction. The ATP-binding
causing the “occluded” substrate-free state of the PCD is
suggested to cause contraction of the cavity, squeezing the
substrate through the “one-way valve” formed by the gating
loops of the lipoyl domain,272 and may serve as the trigger
initiating the NBD-activation and resetting of the complex.
However, taking into account the additional allosteric
communication between the PAP TM-domains and the
NBDs, their engagement with the ATP-bound NBDs may
cause additional twist in the lipoyl domain, which may facilitate
the passage of the cargo through the gate. Upon ATP-
hydrolysis, the gating loops equilibrate back into the closed
state, preventing substrate back-sliding.
Thus, to answer all these questions conclusively, a bona f ide
substrate-bound structure of MacB in complex with the PAP is
required, along with functional analysis, and given the rapid
progress achieved in the past few years, we are hopeful that this
riddle will be resolved soon.
10. TRIPARTITE ASSEMBLY OF THE MFS-BASED
SYSTEMS
Tripartite assemblies based on the MFS transporters remain
the least-well studied and correspondingly least-well under-
stood, with even complex stoichiometry being a matter of
debate. Similar to other PAPs, E. coli EmrA in isolation was
found to form dimers, and as the dimerization was more
pronounced in the full-length, membrane bound protein, it was
suggested to take place via a leucine zipper domain located
within the N-terminal part of the protein, covering part of the
TM-helix domain.760 Removal of the N-terminal portion of the
protein impacted dimerization even when a major part of TM-
helix and membrane anchoring was preserved, suggesting the
cytoplasmic N-terminal tail is essential. Later surface plasmon
resonance (SPR) measurements697 have suggested a trimer
formation in agreement with the sequential trimerization (ST)-
model, with participation of preassembled dimers with a Kd of
1.87 μM. The EmrA trimers were also found to be the
prevalent cross-linked species.
Although an experimental structure of EmrB is not available
at present, reasonably reliable topological estimates could be
obtained from the analysis of the structures of the related MFS
pumps such as YajR,382 EmrD (PDB ID 2GFP),380 and
PepTSo (PDB ID 4UVM).271 The C-terminal part of EmrB
likely presents a helical arrangement equivalent of the TM14 of
the PepTSo,271 and earlier studies suggested that this TM
region of the MFS transporter may be involved in a leucin-
zipper like interaction with the TM-domain of the PAP EmrA,
forming a TM-helical bundle.760 A similar suggestion was
extended to the N-terminal portion of the transporter, covering
a major part of TM1, with the implication of a 2:1 PAP to
transporter subunit interaction,760 and although current
structural data on the organization of TM-helices in the
known MFS transporters does not lend itself to a
straightforward model of such an assembly, as it requires
another PAP-binding site per MFS-protomer, such overall
arrangement is appealing as (assuming a dimeric transporter
MFS) it gives rise to six PAPs and a 34 TM-helical model (six
from PAPs and 28 from the transporter-dimer), which is
roughly equivalent to the 36 TM-section observed in the
RND-assemblies. Despite their low resolution, the latest EM
data on the complete reconstituted EmrAB-TolC9 is
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compatible with such an arrangement, and earlier EM data
based on isolated EmrAB has suggested that it forms a “dimer
of dimers” in a back-to-back formation;840 however, at present
a model with a monomeric transporter with six PAPs giving a
20 TM-helix assembly could not be excluded entirely.738 A
possible hint for such an assembly, where one EmrA is being
permanently associated with the EmrB and an additional pair is
being recruited, is suggested from the SPR studies which
resulted in the ST-model of trimerization mentioned above.697
There is limited data available on the potential substrate role
in the assembly; however, PAPs from MFS-associated systems
are capable of binding drug specifically, providing substrate
differentiation as demonstrated for EmrA and HmrA (46.2%
identity), and binding to native pump substrates, e.g., CCCP,
DNP, and nalidixic acid, provokes conformational changes
within the EmrA, which however does not respond to
erythromycin, which causes a similar effect in the erythromycin
efflux-competent HmrA.760 Cargo-specific effects have also
been demonstrated for the VceA, a PAP component in the
equivalent MFS-based assembly VceABC in Vibrio.122 This
binding occurs in the periplasmic domain and appears to be
dependent on the presence of the TM-domains, as no binding
was detected to the soluble, TM-truncated versions of the
EeEmrA and AeEmrA tested,738 providing strong indication
that functional TM-domains are needed for such a function.
Thus, the existence of extended TM-domains in this class of
PAP and their implied engagement in transporter association
provide a plausible model for allosteric control and activation.
While future work is needed to elucidate the exact nature of
the PAP-MFS interaction, it is clear that the mode of operation
of these assemblies is markedly different from the RND- and
MacB-based systems, due to the lack of extended periplasmic
domains. Consistent with this, the PAPs engaged with the MFS
transporters also lack MDP domains, and their TM regions are
essential for dimerization and engagement with the trans-
porter.760 The rigidity of the extended α-helical hairpin
domains also likely provides less allosteric control of the
cycle, with the stability of these assemblies being higher than
the corresponding RND systems,697 and they might be
engaged in a constitutive low-level efflux, rather than being
engaged temporarily for high-intensity stress-related responses,
which is also consistent with their much lower copy numbers
in the cell.696
11. ASSEMBLY OF TYPE 1 SECRETION SYSTEMS
The cargoes for the type 1 secretion systems (T1SSs) are
secreted in a Sec-independent fashion6,841 and correspondingly
lack the N-terminal signal-sequence typical of periplasmic
bound cargoes of the Sec-system.842 There are two broad
ranges of cargoes secreted by the T1SSs.843,844 The first
includes relatively small molecules with a molecular weight in
the sub-10 kDa range that are secreted in a single step, such as
bacteriocins (in the context of Gram-negative bacteria,
Figure 53. Principal modes of T1SS depending on the cargo. (A) Typical RTX-toxin secretion system based on the HlyABD-TolC. The complex is
assembled upon substrate binding and remains stable through a number of iterative ABC-cycles by the HlyB transporter. There is no periplasmic
intermediate of transport and no processing of the cargo (HlyA), with the CLD-domains of HlyB (in yellow) playing a cargo-recruitment and
chaperoning role. (B) An example of the transport by the bacterial transglutaminase-like cysteine proteinase (BTLCP)-associated transporter family
on the example of the LapBCDEG system. Notably, the complex disassembles upon association of the cargo (LapA) with the OMF, where it may
be anchored for extended periods by its N-terminal “plug” domain, creating a periplasmic intermediate. While the CLD of the LapB does not
proteolytically process the cargo, this is achieved by a periplasmic protease LapG, which is controlled by a cyclic di-GMP receptor LapD in
response to environmental stimuli providing control of the cell adhesion. (C) The microcin-based secretion system is exemplified by the CvaABC.
The PCAT transporters associated with this type of secretion have catalytically active C39 domains. (D) The HasDEF system of Serratia marcescens
involved in the secretion of the hemophore HasA presents a departure from the common pattern presented in panels A−C, where the cargoes are
fed C-terminus first and instead HasA is threaded N-terminus first. Furthermore, the system lacks both C39 and CLD domains and relies on the
chaperoning function of the SecB. Additional details are provided in the main text. Figure modified based on Smith et al.6 and Masi and
Wandersman.512
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microcins), e.g., colicin V (aka microcin V; CvaC).845
Microcin secretion is facilitated by an N-terminal signal,
which is recognized by the C39-domain of the cognate PCAT-
type ATPase forming the core of the transporter complex and
is then proteolytically processed concomitantly with the
secretion of the cargo. This has been discussed in the
preceding sections on the example of PCAT1,505 so to avoid
repetition we will not discuss this group further in great detail.
A schematic of their transport is presented in Figure 53, panel
C.
The second diverse group of cargoes are generally larger
proteins, some of which are among the largest coded within
the bacterial proteome and include a number of toxins,
adhesins, lipases, and proteases.449,846,847 Rather uniquely, the
targeting signal for the cargo secretion in this second group is
located within the 50−60 residues of the C-terminal.848−850 As
the nature of this signal is quite diverse and reveals no clear
sequence consensus, it has been suggested that secondary
structure is at least partially involved.851 It appears to present a
set of two short α-helical fragments bridged by a linker peptide,
with a downstream low-complexity region.852,853 The secretion
of some of the cargoes within this group relies solely on this C-
terminal signal, e.g., the well-studied heme acquisition protein
HasA.529,854 A major group of the cargoes secreted by the
T1SS present additional Ca2+ binding motifs known as RTX-
motifs or GG-repeatsGGXGXDXUX (where X is any amino
acid and U is a hydrophobic amino acid)precede the C-
terminal secretion signal in some of the passenger proteins,
including HlyA and LipA.449,497 These play an important role
in folding of the cargo, and X-ray structures reveal that they
form a β-roll motif (e.g., PDB ID 1KAP500,501). Within the
RTX-group, there is significant diversity of cargoes, which can
be ranked in the order of organizational complexity. The
hemolysin/cytolysin family of pore-forming toxins includes
hemolysin A (HlyA), in which the region N-terminal of the
glycine-repeats code just one functional domainthe pore
forming toxin itself214 and the CyaA from Bordetella
pertussis,855 which apart from the toxin domain, possesses an
adenylate cyclase module which affects the cAMP levels upon
entering the target host cell. More complex architectures are
present in the so-called MARTX (multifunctional autoprocess-
ing repeats in toxins), which contain protease domains and
target eukaryotic cells, where they undergo autoprocessing
upon binding to inositol hexakisphosphate (InsP6).847,855,856
Another large group is the large repetitive RTX adhesins
(e.g., FrhA of Vibrio cholerae, RtxA of Legionella pneumophila,
and SiiE of Salmonella enterica), which function in biofilm
development and cellular adherence and attain very large sizes,
sometimes in excess of 1.5 MDa, e.g., in the case of the MpIBP
of Marinomonas primoryensis.449,856,857 These are critical
molecules for biofilm formation, and they feature a number
of repetitive domains, in addition to the RTX repeats; for
example, the MpIBP possesses some 120 bacterial immuno-
globulin-like domains (BIg) and a unique ice-binding domain,
which is associated with the lifestyle of this bacterium.857
The majority of the T1SS appear to translocate their cargoes
from the cytoplasm to the extracellular space in a single
translocation event,858 without disassembly of the complex or
any periplasmic intermediates. While the details of the
secretion are still not fully confirmed and vary between
different assemblies, in a first approximation the process
features the following key elements (Figure 53, panel A). The
typical RTX cargo (e.g., α-hemolysin) is fully synthesized prior
to secretion and is threaded in an unfolded state, C-terminus
first. The C-terminal part of the protein carrying the RTX
motifs emerges on the cell surface and binds to Ca2+ ions to
facilitate the folding of the jellyroll RTX domains, which
contributes to the secretion process.214
As a first step, the RTX-cargo is recruited by the ATPase,
and the secretion motif is recognized by the catalytically
inactive C39-like (CLD) domain of the PCAT transporter,506
which feeds the C-terminus of the cargo into the substrate-
binding cavity of the transporter, keeping it unfolded. This
association leads to the assembly of the complete translocase
and causes a conformational switch in the transporter, allowing
for the outer-facing conformation to be attained, which brings
the NDBs together, allowing them to bind the ATP721 (Figure
53, panel A). ATP-hydrolysis in turn resets the system back for
another cycle, continuously threading the cargo, and these
cycles continue until the N-terminal end is reached. Following
the release of the cargo outside of the cell, the complex
disassembles. This is in contrast to the secretion of the
microcins (Figure 53, panel C), where the PCAT has an active
C39 domain and the secretion signal is N-terminally located on
the cargo, which also gets proteolytically processed.
Importantly, and in common with the RTX-toxins depicted
in panel A, the transfer of the cargo takes a single step.
Recently, a group of RTX-containing proteins related to the
RTX-adhesion proteins has been identified and separated into
its own class, named, due to linkage to the bacterial
transglutaminase-like cysteine proteinase (BTLCP),859
BTLCP-adhesins.6,860 The prototype of this BTLCP-adhesin
group, LapA of Pseudomonas f luorescens Pf0-1, also possesses a
number of BIg motifs but also a novel, specialized N-terminal
“retention module” to anchor itself at the cell surface as a
secretion-intermediate threaded through a dedicated OMF
LapE (Figure 53, panel B). In addition, they often feature von
Willebrand factor A domains (vWFA), which are peptide-
binding folds, also found in Pseudomonas putida LapA and
LapF.860,861 The first stage of the transport involves the
association of the cargo with the CLDs of the LapB ABC
transporter, thus resembling the HlyBCD system. However, a
startling discovery has been made, showing that these adhesins
break the dogma of “one-stop-transport” which has been
associated with T1SS, and instead their translocons are able to
dissociate before the adhesin has left the OMF barrel, releasing
the PAP transporter pair860 (Figure 53, panel B).
Indeed, the very nature of the “retention module” or “plug
domain” is to embed the adhesin within the OMF-channel,
where it may stay permanently, unless processed by a
periplasmic protease, LapG. The stalled LapA functions as a
biofilm-promoting factor, which is dependent on the cyclic-di-
GMP levels, as the LapG protease is sequestered in the
presence of cyclic-di-GMP by a membrane-anchored cyclic-di-
GMP receptor LapD but can be released once the levels of
linear di-GMP (pGpG) increase862 (Figure 53, panel B). Thus,
while the actual transporters associated with the T1SS of
BTLCP-linked adhesins do not possess active proteolytic sites,
their cargoes are proteolytically processed in response to
environmental stimuli.
Intriguingly, all the PCAT transporters associated with three
groups of T1SS presented so far have N-terminal domains,
which are implicated in substrate binding. However, while the
CvaB transporter has a C39-domain with an active catalytic
site, both the transporters associated with the transport for
pore-forming cytolysins (HlyB-type PCATs) and LapB-type
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transporters associated with the secretion of the BTLCP-linked
adhesins have catalytically inactive CLDs. These however differ
dramatically in their consensus sequences, suggesting a
different mode of operation and cargo specificity.6
A surprisingly similar arrangement was also discovered in the
secretion of the giant adhesin MpIBP,857 where two dedicated
modules were found to anchor the adhesin to the inside of the
OMF-channel, as a stable periplasmic intermediate, suggesting
that this is a more widespread mechanism than previously
thought.
This is achieved, as in contrast to the RTX modules, which
require a Ca2+ concentration of above 3 mM (typically
associated with the extracellular medium) to fold, the N-
terminal “retention modules” of LapA, and the corresponding
N-terminal “plug” domains, and β-barrel spanning domains
seen in the MpIBP are structured in the absence of Ca2+ and
capable of folding during the secretion process, allowing them
to engage and anchor themselves with the OMF partner
proteins.6,497
While markedly divergent, the different T1SSs discussed
above present a uniting feature, which is that all of their
cargoes are transporter C-terminal first. The implication of this
characteristic is that the cargo polypeptide needs to be
synthesized in its entirety prior to secretion and may be
expected to become at least partially folded. Unless active steps
are taken to the contrary by chaperoning systems, and as
discussed in the earlier section on the PCAT transporters, this
is provided by both the transporter cavities themselves and
their associated CLD-domains and in some cases auxiliary
chaperones.214
In addition to the cargo interaction with the PCAT
transporter itself, which is at the heart of the T1SS and was
covered in the preceding sections, the second major-driving
force behind the assembly of a functional T1SS is the PAPs.
Their role appears to be rather multifaceted and involves direct
binding of the cargo, stimulation of the assembly process, and
recruitment of the OMF, as well as possibly participation in the
folding of cargoes. Distinct regions of the PAPs seem to play a
different role in the process. Many of the studies into the role
of the PAPs in T1SSs derive from the hemolysin A (HlyA)
secretion system in E. coli, which involves the PCAT-type
ATPase HlyB and its cognate PAP HlyD and the OMF
TolC.61
As mentioned in the previous sections, the transport of HlyA
does not involve proteolytic processing,849 and correspond-
ingly, the C39-domain of the HlyB is catalytically inactive and
is referred to as a CLD.506 The regions covering the N-
terminal section of the α-helical hairpin domain (residues 127
to 170) and the C-terminal 33 residues of HlyD, respectively,
were shown to be required for in vivo secretion.863 HlyD was
also shown to interact directly with the toxin substrate by
direct cross-linking, and in addition, masking its C-terminal
fragment by in-frame fusion to a c-Myc epitope blocked cargo
translocation,721,863 suggesting an active role of the PAP in
substrate recognition and its presentation to the transporter.
Furthermore, the N-terminal 59 residues of HlyD form a
small cytoplasmic domain,731,864 truncation of which abolished
the secretion of HlyA.865 A more detailed analysis of the
region, including a dissection of the residues (1−25) forming a
predicted amphiphilic helix and a downstream charged region
(residues 26−38), demonstrated that these regions are
necessary for direct interaction of the PAP with its cargo
(HlyA) and subsequent recruitment of the OMF into the
functional translocator but not required for either the
oligomerization of HlyD or the formation of the PAP/ABC
transporter complex.866 This data also suggests that HlyA
binding to the cytosolic domain of HlyD promotes an outward
trans-membrane conformational change, propagated to the
periplasmic domain of HlyD, leading to the recruitment of the
OMF.
The periplasmic portion of the PAP has also been implicated
in cargo-related function, and analysis of random point
mutations in PAPs, in particular HlyD755 and related PAP
CvaA, involved in colicin V secretion754 demonstrated that
they result in misfolding of the substrates, even when their
secretion rate was not affected. These mutations map to the
lipoyl domain and the α-helical hairpin of HlyD, and their
impact of cargo-folding suggests that the α-barrel of the
hexamerised PAP may provide a chaperoning function.755
Similarly, TolC barrel mutations have been reported to result
in incorrect folding of substrate HlyA affecting its hemolytic
activity,867 which could be restored by refolding in vitro.
Furthermore, by analyzing a variety of passenger proteins
spliced in front of the HlyA C-terminal signal sequence and
introducing folding mutations into the cargo, Bakkes et al.530
were able to demonstrate that the efficiency of secretion of
HlyA by the E. coli HlyBD-TolC is dictated by the folding rate
of the substrate.
Importantly, the formation of the inner-membrane HlyBD
translocase complex is not just initiated by the substrate but is
also ATP-independent, as demonstrated by the use of a HlyB
mutant competent in ATP-binding but not in ATP-
hydrolysis.721 This mutant was capable of ATPase-PAP
assembly, substrate recruitment, and bridging of the OMF;
however, HlyA stalled in the channel. A similar result was
obtained when the PAP HlyD C-terminus was masked. This
leads to the conclusion that HlyA export likely occurs via the
assembly of a contiguous double-membrane channel which is
formed without the requirement for ATP-hydrolysis by the
PCAT transporter, by substrate-induced, transient, and
reversible bridging of the HlyBD-translocase to the OMF.721
In the aforementioned protease secretion system PrtDEF
(see PCAT ABC transporter section 5.6) from Dickeya
dadantii ( formerly Erwinia chrysanthemi),531 responsible for
the secretion of a number of proteases, including PrtA, PrtB,
PrtC, and PrtG,532 the ABC transporter PrtD displays a basal
ATPase activity that is specifically inhibited (half-inhibition at
0.1 μM) upon encountering a cognate C-terminal secretion
signal of its substrates (PrtB and PrtG metalloproteases) but
not by the C-terminal sequences from nonrelated cargoes.868 It
is thought that this inhibition may take the form of a
stericprevention of NBD closure in a manner similar to the
inhibition of eukaryotic TAP1/2 by the viral peptide ICP47,869
which forms a long-helical hairpin plugging the translocation
pathway of TAP from the cytoplasmic side stalling the
system.515 This inhibited conformation of PrtD binds the
PAP PrtE, with the complex of PrtD and PrtE recruiting the
OMF PrtF.492 Thus, this system presents a clear ordered
sequence of assembly, where the substrate first recognizes the
PCAT-ABC transporter, which then binds the PAP assembly,
which in turn recruits the OMF component.492 Notably, while
substrate binding was shown to be required for assembly of the
three components, there was no evidence for ATP being a
driver of the assembly.
A related T1SS in Serratia marcescens, formed around the
PCAT type transporter HasD, and the PAP HasE are involved
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in the secretion of the heme acquisition protein HasA153,870
(Figure 53D). In E. coli, the reconstituted HasA secretion
system was dependent on the presence of an OMF channel,
which could be either TolC871 or the recombinant PrtF, the
OMF from the Dickeya dadantii T1SS PrtDEF. The analysis of
the secretion of the Serratia marcescens HasA protein by the
HasD indicated a strong coupling between synthesis and
secretion in the type 1 secretion pathway529 due to slow
threading of the substrate, suggesting active maintenance of the
cargo folding is involved, and indeed folded HasA has been
found to inhibit its own secretion. Primary interactions
between HasD and newly synthesized HasA have been
suggested to be driven by linear sites which are sequentially
exposed on the unfolded cargoes.512 ATP-binding promotes
dimerization of the NBDs, facilitating and stabilizing the
outward facing transporter conformation, and the substrate is
then fed into the recruited OMF N-terminus first, while
presumably the C-terminus stays associated with the trans-
porter until the threading is complete. These data support a
model of type 1 secretion involving a multistep interaction
between the substrate and the PCAT transporter that stabilizes
the assembled secretion system until the C-terminus of the
cargo is presented, and such interaction is suggested to
underwrite the multistep processivity required for translocation
of large, unfolded cargoes. Crucially, the C-terminal signal of
the cargo hemophore HasA was shown to trigger ATP-
hydrolysis, driven by the PCAT ABC transporter HasD,
leading to disassembly of the complex and separation of OMF
(HasF) to its pre-engagement state.512 In agreement with this,
it was reported that the C-terminal peptide of HasA may also
possess an intermolecular activity that is capable of triggering
complex dissociation in vivo when it is provided as a distinct
peptide.872 This appears to be a departure from the general
model of type 1 secretion discussed above (Figure 53A−C),
where the C-terminal part is driving the secretion with a
contribution from folding of the RTX-motifs. Furthermore,
HasA is not proteolytically processed and its cognate ATPase
HasB does not possess a CLD-domain. While at 19 kDa HasA
presents a relatively small cargo, it still is necessary for it to be
transported in an unfolded state, which is facilitated by SecB
on the cytoplasmic side.873 Thus, HasA secretion appears to
present a distinct mode of T1SS as presented in Figure 53D.
Despite their considerable variety, an emerging common
pattern across all the T1SS assemblies discussed above is that
the ATP-hydrolysis does not appear to be required for the
formation an ABC transporter−PAP−OMF complex, which
instead is substrate and PAP-driven,512,721,866 while the C-
terminal signal of HasA triggers HasD-driven ATP-hydrolysis,
leading to disassembly of the T1SS complex.512 Such energy
dependency also provides further parallels between the
assembly and disassembly of the PCAT-based T1SS tripartite
complexes and the tripartite complexes arranged around RND
transporters discussed above,705,720,813 with the interprotomer
association being driven by protein−protein interaction and
substrate-binding/cargo folding without the requirement of
energy input, while the energy-dependent step is likely
required for resetting and disassembly of the complex. As
discussed in the previous section, similar energy-dependency
for complex dissociation has also been described for a MacB-
related LolCDE complex, where membrane-extracted lip-
oproteins are passed over to the periplasmic chaperone
LolA,838,874 in a process that requires ATP-binding and
hydrolysis but not the conformational change associated with
the release of the ADP and Pi (as it could be trapped by
vanadate), suggesting that a full cycle of ATP-hydrolysis is
similarly required for complex disassembly.
Despite the recent advances in the understanding of the
functional organization of the T1SS, the structural data on
these systems lags compared to other tripartite assemblies.
However, the recent availability of all principal components of
the T1SS machinery allow for some tentative reconstructions
of the complete assembly.
Previous attempts stopped short of modeling the complete
assembly, and to gain some insights into its possible
organization, here we have extended the modeling of the
HlyAB-TolC system to include both the full HlyD transporter
(based on the homology with PrtD and PCAT1 struc-
tures)505,515 and the β-barrel and the transmembrane domains
of HlyD, which have not been resolved in the crystal
structure739 (Figure 54). The overall assembly is compatible
with the available functional data752,755 and suggests a unique
helical trajectory of the HlyD, which mimics the helical paths
of the TolC, and arrangement that is facilitated by the helical
breaks in the hairpin domain of HlyD. The modeling of the
extended TM-helices of HlyD suggests, similar to the MacAB-
model presented earlier, that they may be able to participate in
direct intermembrane interactions with the TMD of the HlyB,
possibly providing additional allosteric control and modulation
Figure 54. Qualitative model of the complete tripartite T1SS
assembly based on the HlyBC-TolC. The assembly is notable for
the extended tubular architecture, which presents a unique break in
the supercoiling pattern, associated with the architecture of the T1SS
PAPs. The hexameric β-barrel ring of HlyD binds closely to the
membrane due to absence of the MP-domains, and the PAP-
associated transmembrane helices could provide interactions within
the membrane. The approximate membrane boundaries are shown
with the blue rectangle. See the text for more details.
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of the ATPase activity which could explain the previously
accumulated functional data. While the near future will no
doubt provide experimental proof of such models, they provide
the best current approximation of the function of the T1SS.
12. TARGETING TRIPARTITE ASSEMBLIESPUMP
INHIBITORS AND DISRUPTORS
The growing threat of antibiotic resistance has significantly
reduced the efficacy of existing antibiotics. Therefore, there is
an urgent need to develop new therapeutic approaches to treat
infections caused by MDR bacteria.875 The manifold roles of
tripartite efflux systems in Gram-negative bacteria make them
attractive drug targets; therefore, efflux inhibition is seen as a
prospective strategy to overcome efflux-mediated resistance.
Compounds that inhibit the function of efflux pumps directly
or indirectly are known as efflux inhibitors (EIs). Although the
term efflux pump inhibitor is also used in the literature, EIs is
deemed more accurate since not all compounds interact
directly with efflux systems to inhibit efflux. The primary
rationale for using EIs is to restore the susceptibility of
multidrug resistant (MDR) bacteria to antibiotics by
preventing their extrusion, thereby increasing intracellular
concentrations of antibiotics.876 EIs could also be used to
revive the effectiveness of older antibiotics that have fallen out
of use due to their loss of efficacy against MDR bacteria.
Furthermore, due to the reported roles of tripartite efflux
systems in biofilm formation and virulence, EIs could also be
employed as antibiofilm and antivirulence agents.185,877 For a
compound to be classified as an EI, it must fulfill two
important criteria. First, an EI should not exhibit antibacterial
activity, but when used in tandem with an antibiotic, it should
potentiate the activity of that particular antibiotic. Second, an
EI should not possess activity against a strain that lacks the
efflux pump that it is supposed to inhibit. Lastly, an EI should
not be a substrate of efflux pumps.878 Importantly, EIs should
be able to pass across the outer membrane into the periplasm
to exert their activity. The chemical diversity of idenitifed EIs
has been recently reviewed in detail elsewhere.879,880 Studies
have found that EIs can exhibit different mechanisms of action
(Figure 55), and here we review the literature on this basis.
12.1. Targeting the Inner Membrane Transporter
The inner membrane component of tripartite systems plays an
important role in energy transduction, substrate recognition,
and uptake. Therefore, the majority of EIs described in the
literature are posited to target the inner membrane transporter,
such as AcrB. One of the first EIs to be characterized was
phenylalanine-arginine β-naphthylamide (PAβN, 1; Figure
56), a synthetic peptidomimetic inhibitor of the RND family
tripartite efflux systems MexAB-OprM, MexCD-OprJ, and
MexEF-OprN of P. aeruginosa.881 Since then, PAβN has been
shown to be a broad-spectrum inhibitor of several different
tripartite RND efflux systems in Gram-negative bacteria,
including AcrAB-TolC from S. Typhimurium, and CmeABC
from C. jejuni and C. coli.50,882 PAβN has been suggested to act
as a competitive inhibitor of RND efflux systems by binding to
the distal binding pocket, specifically the hydrophobic trap, to
prevent the binding of substrates.343 Surface plasmon
resonance (SPR) studies have shown that PAβN binds to
both AcrA and AcrB with a micromolar affinity.883 Lamers et
al.884 also reported that PAβN can permeabilize the outer
membrane of Gram-negative bacteria, indicating an additional
mechanism of action for PAβN. A recent study reported that
PAβN exerts its EI activity in AcrB by restraining drug-binding
pocket dynamics rather than acting as a competitive inhibitor.
Computational and experimental data suggested that cipro-
floxacin and PAβN bind to AcrB simultaneously at different
subsites within the distal binding pocket and that PAβN
inhibits efflux by perturbing the substrate translocation
pathway.885 PAβN was tested in vivo to be cytotoxic.886
However, it is still one of the most commonly used inhibitors
in assays to restore the activity of various antibiotics. One of
the other early broad-spectrum EIs to be identified was the
synthetic compound 1-(1-naphthylmethyl)-piperazine (NMP,
2; Figure 55), which was shown to potentiate the activity of
several antibiotics, including chloramphenicol, levofloxacin,
and linezolid, in E. coli strains that were overexpressing acrAB
or acrEF.887 In addition, NMP has been shown to potentiate
the activity of antibiotics in several other Gram-negative
bacteria, such as A. baumannii, K. pneumoniae, C. f reundii, and
K. aerogenes.888−890 SPR studies have shown that NMP binds
to AcrB with a higher affinity than PAβN, even though they act
as EIs at the same concentration,891 which could be explained
by the additional membrane-permeabilizing effects of PAβN.
To date, the exact mechanism of action of NMP has not been
elucidated. However, molecular dynamics simulations suggest
that NMP binds to the outer face of the distal binding pocket
to straddle the G-loop of AcrB, thereby reducing its flexibility
and impairing the proper binding of substrates.343,349 Further
development of this compound was discontinued due to its
low potency and structural similarity with serotonin
Figure 55. Schematic diagram of the different mechanisms of action
of efflux inhibitors. Inhibition of gene expression prevents tran-
scription of efflux genes, thereby reducing efflux pump expression.
Compounds that inhibit the functional assembly work by interfering
with the interaction surfaces between the components of the tripartite
efflux systems. Energy decoupling agents facilitate flow of protons,
thereby dissipating the electrochemical gradient, so that it cannot be
exploited as an energy source by efflux pumps. Inhibitors of substrate
efflux can work as a competitive inhibitor by actively competing with
the binding site to prevent substrate binding or by blocking
conformational change to prohibit enzymatic catalysis. Inhibitors of
periplasmic adaptor proteins (PAP) are thought to work by
preventing binding to the inner membrane transporter and by
preventing self-association of the PAP protomers. Outer membrane
factor (OMF) inhibitors block the periplasmic entrance site to
prevent translocation of substrates across the outer membrane. PAP,
periplasmic adaptor protein; OMF, outer membrane factor.
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agonists.892 Another strategy to inhibit inner membrane
transporters is by depleting the energy source required for
efflux. Carbonyl cyanide m-chlorophenylhydrazone (CCCP, 3;
Figure 56) is a protonophore that dissipates the proton motive
force, thus inhibiting all secondary active transporters. Due to
its toxicity, CCCP has no therapeutic potential; however, it is a
useful experimental tool as it is widely used in efflux assays.893
Certain clinically approved drugs have also been reported to
display EI activity. The psychotropic drug chlorpromazine (4;
Figure 56) has been reported to inhibit efflux in Gram-negative
bacteria.894 In S. Typhimurium and several other serovars,
chlorpromazine was shown to significantly potentiate the
activities of various antibiotics. In the same study, chlorpro-
mazine was reported to repress acrB expression, suggesting that
it may inhibit efflux by reducing efflux gene expression.895
Chlorpromazine can also affect cellular morphology and
replication, membrane permeability, and energy generation,
suggesting additional mechanisms of action.894 A recent study
has shed some light into the mechanism of how chlorproma-
zine acts as an EI. Grimsey et al.896 reported chlorpromazine
and amitriptyline to be substrates and inhibitors of the AcrB
pump. Exposure to subinhibitory concentrations of chlorpro-
mazine in E. coli and S. Typhimurium was found to select for
ramR- and marR mutants, which encode for the regulators of
the AcrAB-TolC system. Additionally, it was reported that
when S. Typhimurium cells with a nonfunctional AcrB pump
Figure 56. Structural formulas of representative efflux inhibitors that have been discussed in this review.
Chemical Reviews pubs.acs.org/CR Review
https://doi.org/10.1021/acs.chemrev.1c00055
Chem. Rev. XXXX, XXX, XXX−XXX
CK
(D408A mutation) were exposed to subinhibitory chlorpro-
mazine and amitriptyline concentrations, the D408A acrB
mutants were found to revert to a wild-type acrB allele,
suggesting that both compounds act as substrates of AcrB.
Lastly, molecular docking and dynamics simulations and free
energy calculations were shown to demonstrate that both
chlorpromazine and amitriptyline bind to the hydrophobic trap
within the distal binding pocket of AcrB.
Through high-throughput drug screening and rational drug
design, new and more potent EIs have been identified. A
pyridopyrimidine (D13-9001, 5; Figure 56) derivative acts as
an inhibitor against the MexAB-OprM pump in P.
aeruginosa347 and AcrAB-TolC of E. coli and was co-crystallized
with AcrB (E. coli) and MexB (P. aeruginosa).291 This
compound was shown to bind to the deep binding pocket
area, which was designated the hydrophobic trap due to the
enrichment of phenylalanine residues in this region.
Furthermore, isothermal titration calorimetry was used to
show that D13-9001 binds to AcrB and MexB with binding
affinities of 1.15 μM and 3.5 μM, respectively.291 MBX2319
(6; Figure 56) is another pyranopyridine inhibitor of the
AcrAB-TolC system which was identified through high-
throughput screening of 183,400 compounds. It was shown
to potentiate the activity of multiple antibiotics against E.
coli.348 MBX2319 binds tightly to AcrB;349 however, it does
not display any detectable binding affinity to AcrA as verified
by SPR.883 Later, molecular docking studies led to the
development of more potent derivatives of MBX2319, such
as MBX3135 (7; Figure 56). Pyranopyridine derivatives
(MBX2319, MBX2931, MBX-3132, and MBX-3135) were
found to be highly potent in the inhibition of efflux pumps in
E. coli, E. aerogenes, K. pneumoniae, and S. enterica.348,349,897
Crystal structures of the MBX inhibitors (MBX2319,
MBX2931, MBX-3132, and MBX-3135) were obtained with
the soluble periplasmic domain of AcrB (AcrBper) and were
found to bind in the proximity of the same region in the
hydrophobic trap.341 The inhibitory effect was suggested to be
due to the competitive and overlapping binding of the
inhibitors to the deep binding pocket of the T protomer,
and due to the tight interaction, it possibly halts the
conformational LTO cycling. Interestingly, single-particle
cryo-EM structures revealed an LTO trimeric setup in the
presence of substrate (puromycin), whereas in the presence of
MBX-3135, mostly particles in the TTT conformation were
found.287,305 A recent study reported the identification of 43
novel EIs of Gram-negative bacteria from a high-throughput
drug screening of the Prestwick drug library and the
proprietary compound library from Roche. It was found that
the majority of identified EIs had a specific EI−antibiotic
combination and/or species-specific synergy with antibiotics.
Of the EIs identified, auranofin (8, Figure 56), an
antirheumatic agent, increased ethidium bromide accumulation
and potentiated antibiotic activity in checkerboard assays.898
While most drug screening efforts have focused on looking at
inhibitors of RND inner membrane transporters, a recent study
identified an inhibitor of the ABC type efflux pump MacAB in
S. Typhimurium. Compound 9 (Figure 56) was identified from
screening a drug library for compounds that inhibited the
growth of a macAB-overexpressing strain in the presence of
erythromycin. It was reported to increase the susceptibility of
this strain to several different macrolides, although its
mechanism of action remains to be explored.899
The EIs discussed so far, and indeed the majority of the EIs
designed and tested so far, target the transporter component of
the system, notably the RND transporters, within which the
majority of the substrate specificity is thought to reside.
However, there is growing evidence for the involvement of
PAP and OMF partners in contributing to the selectivity,
making them possible targets for competitive inhibition. A
recent study by Marshall and Bavro718 found several antibiotic-
specific phenotypes associated with novel point mutations in
TolC from E. coli. For example, Q129L and Q352E mutations
in TolC were shown to increase susceptibility to only
tetracycline and acriflavine, respectively. Another recent
study found that the MexXY RND pump of P. aeruginosa
exports anionic β-lactams, such as carbenicillin and sulbeni-
cillin, when it forms a tripartite complex with OprA but not
with OprM. Interestingly, both MexXY-OprA and MexXY-
OprM tripartite complexes can extrude aminoglycosides,
whereas OprA confers an expanded substrate profile.665 This
suggests a new role for OMF components of tripartite efflux
systems in the vetting of substrates. In other studies, the PAPs
ZneB and CusB of the tripartite ZneCAB and CusABC RND
efflux systems, respectively, have been reported to contribute
to the metal ion specificity of the two systems.46,360 Thus,
these components may also present themselves as possible
chemotherapeutic targets.
12.2. Targeting the Periplasm Adaptor Protein
Although the bulk of EIs described in the literature are
reported to target inner membrane transporters, the PAP
component of tripartite systems has also been shown to be a
viable target for efflux inhibition. Abdali et al.883 carried out the
parallel experimental and structure-based screening of two
drug libraries to identify inhibitors of AcrA, the PAP
component of AcrAB-TolC. Several EIs were identified and
shown to bind to AcrA, change its structure in vivo, and
potentiate the activities of several antibiotics in E. coli and
other Gram-negative bacteria. Additionally, the identified EIs,
including NSC 60339 (10; Figure 56), were found to require
AcrA binding to inhibit efflux activity. Further optimization
efforts of compound 9 lead to more potent derivatives, such as
SLUPP-225 (11; Figure 56), which was shown to penetrate
the outer membrane of E. coli cells and exhibit more potent
efflux inhibition activity.900 Later, Darzynkiewicz et al.901
investigated the potential binding sites of compound 9 and
found that it likely binds to a site situated between the lipoyl
and β-barrel domains of AcrA. The β-barrel domain of AcrA
has been previously shown to be involved in RND binding, and
the lipoyl domain is involved in self-association; therefore,
AcrA inhibitors may function to prevent the functional
assembly of AcrAB-TolC.902 In a recent study, Green et
al.903 searched the ZINC15 database for compounds with
physicochemical properties matching those of existing EIs and
Gram-negative antibiotics. Subsequently, compounds with
matching criteria were computationally docked onto AcrA of
E. coli at the previously reported binding site of compound 9,
as well as several other sites that when disrupted have been
reported to disrupt efflux. The top 34 hits from all docking
poses were then analyzed using a combination of in vitro
binding assays to measure binding affinity to AcrA and AcrB
and in vivo antibiotic potentiation assays. They identified six
compounds (12a−f, Figure 56) with a shared scaffold that
bound to AcrA within the millimolar range as verified by SPR.
Given that the compounds had weak binding affinities, it is
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possible that they bind to AcrA weakly at multiple sites.
Promisingly, the six compounds also potentiated the activities
of erythromycin and novobiocin in hyperporinated E. coli cells,
as well as in wild-type A. baumannii and K. pneumoniae.
However, PAPs are promiscuous, which must be taken into
account when targeting PAPs to inhibit efflux. McNeil et al.902
demonstrated that in S. enterica inactivation of AcrA results in
AcrE compensating for its loss, indicating interchangeability
between the two PAPs. Therefore, a successful PAP inhibitor
would need to target both AcrA and AcrE in S. enterica to
inhibit efflux.
12.3. Targeting the Outer Membrane Factor
The OMF component of tripartite efflux systems plays an
important role in expelling substrates across the outer
membrane to the external environment. As a paradigm
OMF, TolC is rather promiscuous and functions with several
different tripartite efflux systems, including T1SS, RND, ABC,
and MFS efflux systems. Despite being an attractive drug
target, TolC inhibition is relatively under-researched. Higgins
et al.693 reported the crystal structure of TolC in complex with
hexaamminecobalt (HC), a trivalent cation, and showed that it
blocked the periplasmic entrance of TolC by forming salt
bridges with D374 of each TolC monomer. Later, Gilardi et
al.904 investigated the biophysical interaction of HC with TolC
and found that it binds to TolC with a high affinity and fast
association and dissociation rates. Furthermore, HC was found
to not exhibit any intrinsic antimicrobial activity nor potentiate
antibiotic activity in E. coli. Thus, further research is required
to identify more potent TolC inhibitors capable of inhibiting
efflux and potentiating antibiotic activity. However, TolC
inhibition may not be a good target for efflux inhibition in
practice. Krishnamoorthy et al.653 found that the activity and
assembly of the AcrAB-TolC complex in E. coli can tolerate
substantial fluctuations in the amount of TolC available.
Furthermore, they reported that only a small fraction of
intracellular TolC is necessary for the efflux requirements of E.
coli cells, indicating that significant depletion of TolC is well
tolerated in bacterial cells.
12.4. Other Strategies to Inhibit Efflux
Although chemical inhibition of efflux is predominantly
reported in the literature, there have been recent developments
in inhibiting efflux through different strategies. One example is
using antisense oligomers to reduce or inhibit efflux pump
protein translation in a sequence specific manner. Peptide-
conjugated phosphorodiamidate morpholino oligomers
(PPMOs) are an example of synthetic nucleotide oligomers
that inhibit antisense mRNA translation. Ayhan et al.905
developed and identified an acrA-PPMO capable of increasing
the efficacy of several antibiotics, such as cefotaxime,
chloramphenicol, clindamycin, and fusidic acid, by up to 40-
fold and preventing AcrA protein translation in a dose-
dependent manner in E. coli. Additionally, the acrA-PPMO was
shown to be effective in K. pneumoniae and S. enterica by
significantly increasing the activity of piperacillin-tazobactam.
More recently, an optimized acrA-PMMO was shown to
potentiate the activity of azithromycin and levofloxacin in
several clinical Enterobacteriaceae strains. Crucially, the acrA-
PPMO was demonstrated to increase the efficacy of
azithromycin in vivo in a K. pneumoniae septicemia murine
model. Inhibition of MexAB-OprM, the homologous RND
system in P. aeruginosa, was also reported to enhance the
efficacy of several antibiotics. PPMOs targeting mexA and
mexB were found to enhance the activities of azithromycin,
cefotaxime, and piperacillin-tazobactam by at least 4-fold in the
majority of tested clinical P. aeruginosa isolates.906 In a
different study, antisense oligonucleotides were developed to
inhibit the translation of the cmeA gene, which encodes for the
periplasmic adaptor protein CmeA of CmeABC in C. jejuni.
The cmeA antisense oligonucleotide was reported to sensitize
C. jejuni cells to ciprofloxacin and erythromycin at very low
concentrations.907
Another strategy for inhibiting efflux is through CRISPR
(clustered regularly interspaced short palindromic repeats)-Cas
(CRIPSR-associated protein)-mediated genome editing.
Owing to the versatility of CRISPR-Cas, it has also been
demonstrated to sensitize bacteria to antibiotics by targeting
antibiotic resistance genes, such as β-lactamases.908 A recent
study demonstrated that CRIPSR-Cas can also be used to
delete efflux genes. As a proof of principle, Xu et al.909 used
native CRISPR-Cas in P. aeruginosa to delete the mexB efflux
gene, thereby sensitizing cells to several antipseudomonal
antibiotics. Although in its infancy, the CRIPSR-Cas system
has the potential to specifically target the sequence of bacterial
efflux pump genes, thereby avoiding the problem of toxicity
associated with off-target effects of classical EIs. Peptide-based
approaches have also been explored as a means to inhibit
tripartite efflux systems. By exploiting the transmembrane AcrB
TM1−TM8 protein−protein interface, Jesin et al.910 designed
synthetic peptides to mimic TM1 or TM8 of AcrB to interfere
with AcrB trimerization. Using Nile Red efflux assays and
antibiotic susceptibility testing, TM1 and TM8 peptides were
shown to significantly reduce efflux activity and potentiate the
activity of antimicrobials. Targeting protein−protein inter-
actions between components of tripartite efflux systems to
prevent complete assembly could be another strategy to inhibit
efflux.
13. CONCLUSION
The Gram-negative double membrane is a formidable barrier
across which many molecules must be transported. As shown
above, bacteria have addressed this challenge by evolving a
diverse array of tripartite efflux pumps and type 1 secretion
systems, many of which play important roles in the export of
xenobiotics and toxic compounds, including antibiotics and a
number of other cargoes, including very large virulence factors
and adhesion molecules.
We have shown that despite the apparent diversity in
structure, function, and role between the complexes there are
commonalities between seemingly disparate systems. In
particular, our comparative analysis has highlighted the roles
of the periplasmic adaptor proteins, indicating that far from
being passive connectors they in fact are active architects of the
assembly and couple allosteric transitions between the inner
membrane transporters and outer membrane factors.
In the case of the tripartite systems which utilize proton
motive force, the association of the PAPs with the respective
RND- and MFS-based transporters allows these assemblies to
combine two different electrochemical gradients across two
separate semipermeable membranes in a unique way. This is in
stark contrast to classical transporters that perform transport of
substrate and counter-transport of ions in opposite directions
by coupling their respective electrochemical gradients created
across a single membrane.
Unifying the wealth of functional data with the recent
advances in the structural biology of tripartite assemblies
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allows us to propose an integrated model of their assembly and
functional cycling. The importance of many of these tripartite
systems in resistance to antibiotics and also in virulence makes
them attractive targets for the development of inhibitors. While
much progress has been made in this field, we believe that a
better understanding of the structure−function relationship of
individual efflux systems alongside an integrated view across
families of these systems will accelerate progress toward finding
clinically useful inhibitors.
14. REMAINING CHALLENGES AND FUTURE
DIRECTIONS
Despite recent progress, there are still some persistent
questions that remain unanswered within the field. As our
understanding of the basic structure of the isolated
components of tripartite pumps has grown, the research
focus direction has been shifting toward the complete
assemblies, including specifically the control of their assembly
and disassembly, which could be targeted for therapeutic
purposes.
One clear tendency is moving away from in vitro studies
toward understanding the more dynamic aspects of their
function and regulation, especially in the context of the cell.
This includes on one hand the structural aspect, e.g., where the
potential of future use of cryo-electron tomography has been
recently demonstrated and the resolution of the reported in
situ protein assemblies is rapidly increasing. On the other hand,
it also applies to the functional characterization of these
assemblies, where significant headway has been made by
creation of functional reconstitution assays in native membrane
environments. In combination with the rapidly developing field
of transportomics, these developments promise to accelerate
the characterization of substrate specificity, as well as the
screening of potential efflux inhibitors (EIs) targeting these
assemblies.
These technologies also promise to address the remaining
questions in the energetics of the pump assembly and cycling;
as e.g. the H+/drug stoichiometries of RND assemblies remain
to be established and are difficult to address in vivo, they thus
would benefit from the controlled environments and sensitivity
afforded by such studies. Similarly, the exact nature of the
power-stroke and efficiency of the cycle for ABC transporters,
which remain a much-discussed subject, could hopefully be
addressed by a combination of structural studies of trapped
intermediates and functional analysis.
Modularity of the assemblies, in the form of pumps
presenting e.g. heterooligomeric IMPs or PAP components,
could potentially provide a way to impose regulation on the
efflux systems. This is most likely kinetic regulation. While
cooperative kinetics have been shown for AcrAB-TolC, its
implication for the cell physiology is obscure. One possible
explanation for that could be the high energy consumption of a
permanently active pump, resulting in wasteful drainage of the
proton gradient. In the case of lower concentrations of the
drug, a more moderate pace would save energy, whereas at
high drug concentrations the pump is fully activated. However,
clear experimental proof of the above model is still awaiting.
While the increased understanding of interprotomer
interactions within the RND complexes has allowed the
development of the integrated model above, the exact roles of
PAP1 and PAP2 protomers remain to be fully validated
experimentally. The existence of systems such as TriABC,
which utilize separate PAPs, also poses the question of their
biological function and the benefits that these provide for the
bacterium. While our current models of the tripartite complex
suggests that the transporters and OMFs do not interact
directly and that such interaction is solely moderated by the
PAPs, it is difficult to reconcile these models with the existence
of PAPs such as BesA which lack their hairpin altogether,
suggesting alternative modes of interaction and assembly are
possible, if even in just a subset of tripartite assemblies.
Also, while understandably the RND transporters have
attracted the lion’s share of research interest over the past
decade, the understanding of the mechanisms of the other
tripartite assemblies is still lagging behind, and notably the
questions of the transmembrane allostery in the T1SSs and
MacB-based systems needs to be elucidated. As shown above,
full understanding of the transport cycles of these assemblies
could be achieved by studying the transporters in isolation due
to the close involvement of the PAP in their function, which
has been largely ignored to date.
Given the broad substrate specificity of the multidrug efflux
pumps, it is unclear why they are presented in so many
versions in the bacterial genomes. The overlapping specificities
and joint action of the pumps, especially in the context of
multiple antibiotic stress, need to be clarified. The under-
standing the synergistic effects of the activity of the members
of the different (super)families is also a rapidly developing field
and will likely benefit from the wider deployment of the
technologies listed above.
Antimicrobial resistance is a current global health
emergency, and tripartite efflux pumps are an important
mediator of this resistance. Efflux pumps underpin many
mechanisms of resistance; for example, they not only directly
lower the intracellular concentration of antibiotic drugs but
also reduce the frequency at which mutations conferring
resistance via other mechanisms are selected. One significant
future challenge will be in developing new drugs that are not
subject to resistance via efflux. There has been significant
progress in understanding which drugs can be transported by
respective efflux systems and the specific residues involved in
their transport. In the future, a complete understanding of
substrate export will be needed to enable development of drugs
that cannot be transported by major efflux pumps and for
which selection of simple mutations does not permit
development of resistance.
The concept of inhibitors to potentiate the use of existing
and novel antibiotics holds a lot of promise, and there is also
evidence they may be useful as antivirulence or antibiofilm
compounds. However, no EIs have yet successfully reached the
clinic largely due to issues with either potency or toxicity.
Development of effective and safe EIs is an enormous future
challenge, but better understanding of the structure, assembly,
and mechanism of these systems will aid rational drug design
approaches and rationalize the mechanism of compounds
detected through high-throughput screening approaches. As
much of the current effort has been targeting transporters, the
promise of inhibitors targeting either OMFs or PAPs or
interfering with assembly of the functional pump has yet to be
fulfilled.
Efflux pumps and secretion systems are increasingly
important for biotechnological and industrial applications.
Efflux pumps are critical for increased export of synthesized
products to aid isolation and in other cases for providing
resistance to toxic products which can then increase yield. In
contrast to the medically related future challenges, in this
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sphere, work to optimize transport of specific products is
needed to improve the efficiency of industrial and biotechno-
logical applications, and this will rely on a future better
understanding of substrate export. Better understanding of the
molecular determinants of the interprotomer recognition and
the promiscuity of the assembly may allow the creation of
“designer pumps” with a priori desired specificities.
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